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Abstract 
 
Crohn’s disease (CD) is a chronic, relapsing inflammatory condition affecting the 
gastrointestinal tract of humans, of which there is currently no cure. The precise 
etiology of CD is unknown, although it has become widely accepted that it is a 
multifactorial disease which occurs as a result of an abnormal immune response to 
commensal enteric bacteria in a genetically susceptible host. Recent studies have 
shown that a new group of Escherichia coli, called Adherent Invasive Escherichia coli 
(AIEC) are present in the guts of CD patients at a higher frequency than in healthy 
subjects, suggesting that they may play a role in the initiation and/or maintenance 
of the inflammation associated with CD. Two phenotypes define an AIEC and 
differentiate them from other groups of E. coli. Firstly, AIEC can adhere to and 
invade epithelial cells; and secondly, they can replicate in macrophages. In this 
study, we use a strain of AIEC which has been isolated from the colonic mucosa of a 
CD patient, called HM605, to examine the relationship between AIEC and the 
macrophage. We show, using a systematic mutational approach, that while the 
Tricarboxylic acid (TCA) cycle, the glyoxylate pathway, the Entner-Doudoroff (ED) 
pathway, the Pentose Phosphate (PP) pathway and gluconeogenesis are 
dispensable for the intramacrophagic growth of HM605, glycolysis is an absolute 
requirement for the ability of this organism to replicate intracellularly. We also 
show that HM605 activates the inflammasome, a major driver of inflammation in 
mammals. Specifically, we show that macrophages infected with HM605 produce 
significantly higher levels of the pro-inflammatory cytokine IL-1β than macrophages 
infected with a non-AIEC strain, and we show by immunoblotting that this is due to 
cleavage of caspase-1. We also show that macrophages infected with HM605 
exhibit significantly higher levels of pyroptosis, a form of inflammatory cell death, 
than macrophages infected with a non-AIEC strain. Therefore, AIEC strains are more 
pro-inflammatory than non-AIEC strains and this may have important consequences 
in terms of CD pathology. Moreover, we show that while inflammasome activation 
by HM605 is independent of intracellular bacterial replication, it is dependent on an 
active bacterial metabolism. Through the establishment of a genetic screen aimed 
at identifying mutants which activate the inflammasome to lower levels than the 
xxiii 
 
wild-type, we confirm our observation that bacterial metabolism is essential for 
successful inflammasome activation by HM605 and we also uncover new 
systems/structures that may be important for inflammasome activation, such as the 
BasS/BasR two-component system, a type VI secretion system and a K1 capsule. 
Finally, in this study, we also identify a putative small RNA in AIEC strain LF82, which 
may be involved in modulating the motility of this strain. Overall this works shows 
that, in the absence of specialised virulence factors, the ability of AIEC to 
metabolise within the host cell may be a key determinant of its pathogenesis.
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Chapter 1: Introduction 
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1.1 Inflammatory bowel disease (IBD) 
Inflammatory bowel diseases (IBD’s) are chronic relapsing inflammatory conditions 
affecting the gastrointestinal tract of humans. The 2 major clinical forms of IBD are 
Crohn’s disease (CD) and Ulcerative colitis (UC). Whereas CD can affect any part of 
the gastrointestinal tract from the mouth to the anus (although the ileum and colon 
are most commonly affected), UC is typically restricted to the colonic mucosa 
(Kaser et al., 2010). IBD is most prevalent in North America and Europe. In the 
United States, an estimated 1 million people suffer from IBD, and about 30,000 new 
cases are reported each year (Hanauer, 2006). An estimated 2.2 million people 
suffer from CD in Europe (Loftus, 2004). IBD can occur at any age, although there is 
a typical bimodal age of onset, with the first peak between 15 and 30 years of age 
and a second peak between 50 and 60 years. Early onset of IBD, during childhood 
and adolescence, occurs in about 25% of cases (Hanauer, 2006; Van Limbergen et 
al., 2009). While the prevalence of UC is more common among males, CD is slightly 
more common among females, with the male:female ratio being 1.8:1 to 1:1 
(Hanauer, 2006). IBD’s are generally not associated with increased mortality, 
however they do cause significant morbidity. Although IBD sufferers are able to live 
normal, productive lives, IBD does impose a significant burden on the patient in 
terms of healthcare costs and time off work (Shanahan, 2002). Due to their rising 
prevalence, IBD’s also place a significant burden on healthcare resources 
(Shanahan, 2002). Statistics show that each year in the US, IBD accounts for 
700,000 physician visits, 100,000 hospitalisations and disability in 119,000 patients 
(Hanauer, 2006). 
CD and UC can be distinguished by pathologic features. Inflammation associated 
with CD is transmural, meaning that all layers of the bowel wall can be affected and 
it also occurs in a discontinuous fashion, characterised by skip lesions. In contrast, 
the inflammation associated with UC is typically confined to the superficial mucosal 
and submucosal layers of the intestinal wall and occurs in a continuous fashion 
(Bouma & Strober, 2003; Cho, 2008). Another hallmark feature of CD is the 
formation of large aggregates of immune cells such as macrophages, referred to as 
granulomas (Bouma & Strober, 2003; Cho, 2008). Symptoms typical of IBD include 
3 
 
diarrhoea, abdominal pain, rectal bleeding and malnutrition (Cho, 2008). CD can 
also cause many extraintestinal symptoms such as reddening and inflammation of 
the eye, joint pain, skin lesions and mouth sores (Naser et al., 2012). 
There is currently no cure for IBD. There are however, many treatment options 
which aim to relieve symptoms and create periods of remission. Medications which 
suppress the immune system have traditionally been used to treat CD. Salicylates 
such as 5-aminosalicylic acid (5-ASA) have proven successful in the treatment of UC, 
however they are not as successful in the induction and maintenance of remission 
in CD, as they only act topically and do not penetrate deep into the tissue (Randall 
et al., 2012). Corticosteroids such as prednisone, prednisolone and 6-
methylprednisolone have proven to be effective in inducing CD remission, however 
they are not a viable long-term solution due to adverse side-effects (Randall et al., 
2012). Immunomodulators such as azathioprine (AZT) and 6-mercaptopurine (6-
MP) are often used to maintain remission in CD patients but are not used as 
induction agents due to their slow onset of action (Randall et al., 2012). A 
significant advancement in CD therapeutics has been the development of biologic 
agents, which are now often first-line therapy. The most commonly used is 
infliximab, which is an anti-tumor necrosis factor-α (TNF-α) monoclonal antibody. 
Infliximab has a rapid response, has few associated side-effects and has achieved 
positive results in 60% of CD patients (Randall et al., 2012). However, despite these 
treatment options, >50% of CD patients still require surgery (Naser et al., 2012). 
Although the precise etiology is unknown, it has become widely accepted that CD is 
a multi-factorial disease and occurs as a result of an abnormal immune response to 
commensal enteric bacteria in a genetically susceptible host (Kaser et al., 2010; 
Xavier & Podolsky, 2007). 
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1.2 Gene polymorphisms associated with CD 
Epidemiological evidence points to a strong genetic contribution to CD. Twin 
studies show that there is a higher concordance rate in monozygotic twins (50%) 
than in dizygotic twins (10%) for CD (Tysk et al., 1988). Genetic studies, in particular 
genome-wide association studies (GWAS) have enhanced our understanding of the 
genetic basis of CD through the identification of a number of alleles which may 
predispose to the condition. The GWAS performed to date have identified more 
than 30 IBD-conferring loci, only 6 of which have been studied in any detail (Table 
1.1). The most consistently and strongly associated variants are in the genes 
NOD2/CARD15, ATG16L1 and IRGM, and are discussed in detail below. 
 
1.2.1 NOD2/CARD15 
NOD2 (Nucleotide-binding oligomerisation domain 2) is encoded by the CARD15 
(Caspase activation recruitment domain) gene. It is a member of the NLR (NOD, 
leucine rich repeat containing protein) family of proteins which function in the 
recognition of intracellular microbe-associated molecular patterns (MAMP’s) 
(Inohara et al., 2005). NOD2/CARD15 recognises muramyl dipeptide (MDP), a 
component of the peptidoglycan present in the cell wall of Gram positive and Gram 
negative bacteria (Inohara et al., 2005). NOD2 has a tripartite structure, consisting 
of two N-terminal CARD domains, a central nucleotide binding domain (NBD) and a 
C-terminal leucine rich repeat (LRR) domain. It is this C-terminal domain which is 
involved in the recognition of MDP. The NBD oligomerises upon ligand stimulation 
which is necessary for conformational changes to occur in the CARD region, thus 
facilitating interactions between NOD2 and downstream signalling molecules 
(Inohara et al., 2005).  
NOD2 function has an influential role on the pathogenesis of CD. The first CD 
susceptibility locus (IBD1) was identified by Hugot et al., in 1996 and further fine 
mapping of this region identified NOD2 as a CD susceptibility gene (Hugot et al., 
1996; Hugot et al., 2001). Three main polymorphisms in the NOD2 gene have been 
identified as risk factors for CD: a frameshift mutation at position 1007 (1007fs), 
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which results in only a partial translation of the LRR domain and therefore a 
truncated NOD2 protein; a glycine to arginine substitution at amino acid residue 
908 (G908R); and an arginine to tryptophan substitution at amino acid residue 702 
(R702W) (Hugot et al., 2001; Lesage et al., 2002; Ogura et al., 2001) (Figure 1.1). 
NOD2 polymorphisms have the strongest association with CD susceptibility in North 
America and Europe (Hugot et al., 2001; Ogura et al., 2001), but notably these 
NOD2 variants have not been detected in Asia (Ahuja & Tandon, 2010). Individuals 
who are homozygous or compound heterozygous carriers of the NOD2 variants 
have an approximate 17-fold increased risk of developing CD and heterozygous 
carriers have an approximate 2-fold increased risk (Cho, 2008). However, these 
variants are neither sufficient, nor necessary for the development of CD. NOD2 
polymorphisms occur in 0.5 – 2% of the general population and moreover, 60 – 70% 
of CD patients do not carry these polymorphisms, suggesting that additional and 
synergistic factors are involved in the perpetuation of the disease (Hruz & Eckmann, 
2010). The role of NOD2 variants in the pathogenesis of CD is discussed below, in 
the context of the normal function of NOD2. 
NOD2 is constitutively expressed in macrophages, neutrophils, dendritic cells and 
paneth cells (Hruz & Eckmann, 2010), where it has a number of anti-microbial 
functions. NOD2 plays a role in the induction of proinflammatory cytokines and/or 
chemokines, through a RICK (Rip-like interacting caspase-like apoptosis-regulatory 
protein kinase) dependent pathway (Strober & Watanabe, 2011). MDP-activated 
NOD2 binds to the downstream adaptor molecule RICK (RIP2), through CARD-CARD 
interactions. RICK is subsequently polyubiquitinated and recruits the TAK1 
(Transforming growth factor-β-activated kinase 1) complex, which is essential for 
nuclear factor kappa B (NFKB) activation and mitogen-activated protein kinase 
(MAPK) activation, resulting in the induction of pro-inflammatory cytokine genes, 
such as interleukin-6 (IL-6), TNF-α and interleukin-1β (IL-1β) (Strober & Watanabe, 
2011). There have been both gain-of-function and loss-of-function observations 
with NOD2 variants in relation to NFKB activation. Bone marrow-derived 
macrophages (BMDM’s) from mice harbouring CD-associated NOD2 variants 
exhibited increased activation of NFKB and IL-1β secretion in response to MDP 
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(Maeda et al., 2005). Additionally, when treated with dextran sodium sulfate (DSS), 
these mice exhibited increased IL-1β levels and colonic inflammation in comparison 
to wild-type mice (Maeda et al., 2005). In support of this, increased levels of NFKB 
activation have been detected in CD patients carrying NOD2 variants (Kosovac et 
al., 2010). However, NOD2 variants have also been reported to result in decreased 
NFKB activation and decreased cytokine production (Bonen et al., 2003; Netea et 
al., 2005). It has also been suggested that functional NOD2 suppresses mucosal 
inflammatory responses elicited by Toll-like receptor 2 (TLR2). In support of this 
NOD2 deficient mice gave rise to increased levels of cytokines when treated with 
the TLR2 agonist peptidoglycan in comparison to wild-type mice (Watanabe et al., 
2006). It has also been proposed that NOD2 variants lead to the suppression of the 
anti-inflammatory cytokine interleukin-10 (IL-10), leading to an increased 
susceptibility to inflammation (Noguchi et al., 2009). 
NOD2 has important functions in relation to autophagy. Specifically, it has been 
shown that NOD2 binds to ATG16L1 (autophagy-related 16-like 1), a key protein in 
the autophagy pathway and co-localisation of these proteins can be observed at the 
plasma membrane (Travassos et al., 2010). Therefore, it appears that NOD2 
functions to recruit ATG16L1 to the cell membrane, thereby facilitating the 
formation of an autophagosome around the invading bacteria. Moreover, the 
association of NOD2 with ATG16L1 at the cell membrane was not observed in 
BMDM’s from mice harbouring the NOD2 frameshift mutation, when infected with 
Shigella, resulting in the defective clearance of the intracellular organism (Travassos 
et al., 2010). Another study has shown that stimulation of NOD2 in dendritic cells 
(DC’s) with MDP results in the induction of autophagy, as well as induction of major 
histocompatibility complex II (MHCII) antigen-specific CD4+ T cell responses 
(Cooney et al., 2010). These effects were not observed in DC’s expressing NOD2 
variants. Moreover, in these NOD2-variant DC’s, there was a reduced localisation of 
bacteria within autophagosomes (Cooney et al., 2010). In combination, these 
studies show that NOD2 plays a role in both autophagy induction and antigen 
presentation which ultimately facilitate the clearance of intracellular bacteria.  
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NOD2 also functions in maintaining mucosal homeostasis. Paneth cells are 
specialised epithelial cells located in the crypts of Lieberkuhn, which express high 
levels of NOD2 in comparison to epithelial cells (Ogura et al., 2003). These cells 
function in the secretion of antimicrobial peptides such as α-defensins into the 
intestinal lumen, in response to MDP (Ayabe et al., 2000). Therefore, the 
production of α-defensins is markedly impaired in CD patients carrying NOD2 
variants (Wehkamp et al., 2004; Wehkamp et al., 2005). Additionally, NOD2 
deficient mice have a reduced expression of α-defensins (Kobayashi et al., 2005). 
Moreover, these mice carried an increased load of resident commensal microbes 
and were unable to control intestinal colonisation by the pathogen Helicobacter 
hepaticus, in comparison to wild-type mice (Petnicki-Ocwieja et al., 2009). 
Importantly, this study also showed that the expression of NOD2 is regulated by the 
presence of the intestinal microbiota. Commensal bacteria positively regulate 
NOD2 which in turn, helps to keep the microbiota in a homeostatic state (Petnicki-
Ocwieja et al., 2009). Therefore, an important function of NOD2 is to maintain 
homeostasis between the microbiota and the innate immune system. The link 
between NOD2 and α-defensin production was further supported in a study which 
showed that H. hepaticus infection of NOD2 deficient mice, but not wild-type mice, 
resulted in a granulomatous inflammation in the terminal ileum and this response 
did not occur in NOD2 deficient mice which carried a transgene expressing α-
defensin 5 (Biswas et al., 2010).  
 
1.2.2 ATG16L1 
Several genome wide association studies (GWAS) have identified a single amino 
acid polymorphism, T300A, within the ATG16L1 (autophagy-related 16-like 1) gene 
as a susceptibility factor to developing CD (Hampe et al., 2007; Rioux et al., 2007) 
(Figure 1.1). ATG16L1 plays a key role in the autophagic pathway, a biological 
process which maintains cellular homeostasis by encapsulating and degrading 
intracellular bacteria and damaged organelles within a membrane-bound organelle 
termed the autophagosome (Levine et al., 2011). ATG16L1 encodes a core 
autophagic machinery protein which is required for autophagosomal membrane 
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elongation (Levine et al., 2011) and is expressed in intestinal epithelial cells, antigen 
presenting cells and macrophages (Rioux et al., 2007). The T300A mutation is found 
within the C-terminal tryptophan-aspartic acid dipeptide (WD) domain of ATG16L1, 
which is involved in protein-protein interactions, but notably is absent from the 
yeast ATG16 homologue. The mechanisms by which the T300A mutation affects the 
functioning of ATG16L1 is unknown but it has been hypothesised that it may affect 
the regulation of certain subtypes of autophagy, such as autophagy in response to 
invading pathogens (Levine et al., 2011; Stappenbeck et al., 2011). In support of this 
it has been shown that basal levels of autophagy are unaffected in epithelial cells 
expressing the CD-associated ATG16L1 variant (Kuballa et al., 2008). However, in 
these cells, anti-bacterial autophagy was markedly impaired, with an observed 
impairment in the localisation of intracellular Salmonella within autophagosomes, 
in comparison to wild-type cells (Kuballa et al., 2008). Similarly, small interfering 
RNA (siRNA)-mediated knockdown of ATG16L1 in macrophages and epithelial cells 
favoured the intracellular persistence of Adherent Invasive Escherichia coli (AIEC) 
(Lapaquette et al., 2009; Lapaquette et al., 2012). AIEC are a new group of E. coli 
which have been implicated in the etiology of CD, and are discussed further in 
Section 1.4.2. Moreover, defects in autophagy have been linked to an excessive 
pro-inflammatory response mediated by bacterial infection or by TLR/NOD 
stimulation. Elevated levels of the mature form of the pro-inflammatory cytokine IL-
1β were observed in ATG16L1-deficient macrophages stimulated with LPS and 
inflammasome activators, in comparison to wild-type macrophages (Saitoh et al., 
2008). Moreover, ATG16L1 deficient mice were more susceptible to DSS-induced 
colitis than wild-type mice, the effect of which was alleviated by administration of 
anti-IL-1β antibodies (Saitoh et al., 2008). As previously mentioned, an ATG16L1 
deficiency favoured the persistence of intracellular AIEC (Lapaquette et al., 2009; 
Lapaquette et al., 2012), and this was also accompanied by an increase in the 
production of the inflammatory cytokines TNF-α and IL-6 from infected 
macrophages (Lapaquette et al., 2012). ATG16L1 is also crucial for normal paneth 
cell functioning. A key study noted abnormalities in the granule exocytosis pathway 
in ATG16L1 knockout mice in comparison to wild-type mice (Cadwell et al., 2008), 
suggesting that ATG16L1 controls the secretion of antimicrobial peptide-containing 
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granules into the intestinal lumen. Moreover, CD patients carrying the ATG16L1 
variant displayed similar paneth cell granule abnormalities as the above-mentioned 
mice (Cadwell et al., 2008). 
 
1.2.3 IRGM 
Polymorphisms in another autophagy-related gene, IRGM (immunity-related 
guanosine triphosphatase) have been associated with CD susceptibility in GWAS 
(Parkes et al., 2007; Wellcome, 2007). No polymorphisms within the coding region 
of IRGM have been identified, however the CD-associated variant has been shown 
to be as a result of a deletion of a 20 kb non-coding region upstream of the IRGM 
promoter, which normally functions to enhance IRGM gene transcription (McCarroll 
et al., 2008) (Figure 1.1). The mouse homologue of IRGM, LRG-47, has been 
assigned a role in the autophagic elimination of intracellular pathogens, and IRGM-
deficient mice were shown to be compromised in their ability to control the 
intracellular pathogens Listeria monocytogenes and Toxiplasma gondii (Collazo et 
al., 2001). Later, human IRGM was identified as a gene which plays a role in the 
control of intracellular Mycobacteria, through the induction of autophagy (Singh et 
al., 2006). It has also been demonstrated that reduced expression of IRGM in HeLa 
cells compromised the efficiency of anti-bacterial autophagy to Salmonella 
(McCarroll et al., 2008). Similarly, an overexpression of IRGM enhanced autophagy 
of Salmonella, indicating that the level of expression of IRGM positively correlates 
with the efficiency of anti-bacterial autophagy (McCarroll et al., 2008). Moreover, 
siRNA-mediated knockdown of IRGM in HeLa cells or THP-1 cells resulted in 
increased numbers of intracellular AIEC bacteria in comparison to control cells 
(Lapaquette et al., 2009; Lapaquette et al., 2012). In IRGM-knockdown HeLa cells, 
the authors noted an increased number of intracellular AIEC located within non-
acidic vacuoles, suggesting that IRGM may have a role in phagosome maturation, in 
addition to a role in autophagy (Lapaquette et al., 2009). Indeed, a role for IRGM in 
phagosome maturation has been previously described (Singh et al., 2006). 
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Figure 1.1 Gene polymorphisms associated with CD. Schematic representations of the 
NOD2/CARD15, ATG16L1 and IRGM proteins, illustrating the positions of the associated 
polymorphisms. CARD, Caspase activation and recruitment domain; NBD, nucleotide 
binding domain; LRR, leucine rich repeat; WD, tryptophan-aspartic acid dipeptide domain. 
Numbers indicate residue positions. The structure of each gene was obtained from Ogura 
et al., (2001); Saitoh et al., (2008); McCarroll et al., (2008). NOD2/CARD15 and ATG16L1 are 
drawn approximately to scale. IRGM is not drawn to scale. 
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Table 1.1 Major gene polymorphisms associated with CD susceptibility (Adapted from Naser et al., 2012) 
Gene Gene name Chromosome Function Polymorphism Reference 
NOD2/ 
CARD15 
Nucleotide binding 
oligomerisation domain 
2/Caspase activation and 
recruitment domain 15 
16q12 Intracellular sensor for bacterial 
peptidoglycan 
1007fs; G908R; 
R702W 
(Hugot et al., 2001; 
Lesage et al., 2002; 
Ogura et al., 2001) 
ATG16L1 Autophagy related 16-like 1 2q37.1 Encodes a protein involved in 
the autophagic pathway 
T300A (Hampe et al., 2007; 
Rioux et al., 2007) 
IRGM Immunity-related guanosine 
triphosphatase 
5q33.1 Protein involved in the 
autophagic pathway 
deletion of a 20kb 
non-coding region 
upstream of the 
IRGM promoter 
(Parkes et al., 2007; 
Wellcome, 2007) 
IL23R Interleukin 23 receptor 1p31 This protein interacts with IL-23 
and induces proinflammatory 
activities by the production of 
IL-17 via activation of Th17 
lymphocytes 
rs1004819 
(susceptibility); 
rs11209026 
(protective) 
(Libioulle et al., 2007; 
Schmechel et al., 
2008) 
TNFSF15 Tumor necrosis factor 
(ligand) superfamily, member 
15 
9q32 The protein encoded by this 
gene is a TH1 polarising cytokine 
involved in systemic 
inflammation 
7 SNPs identified 
within a 280kb region 
on chromosome 9q32 
(Libioulle et al., 2007; 
Michelsen et al., 
2009; Yamazaki et al., 
2005) 
IBD5 Inflammatory bowel disease 
5 locus 
5q31 Organic cation transporter 
genes 
SLC22A4 (OCTN1); 
SLC22A5 (OCTN2) 
(Peltekova et al., 
2004) 
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1.3 The gut microbiota and CD 
The identification of genetic risk factors that increase the susceptibility to CD has 
heightened our understanding of the pathogenesis of the disease. However, there 
has been a rapid increase in the frequency of CD over the past decade and this 
cannot be accounted for by changes in the gene pool, which has remained relatively 
constant (Bernstein & Shanahan, 2008). There are a number of lines of evidence to 
suggest that the microbiota may be an environmental risk factor for CD. As 
previously mentioned, many of the risk factors identified as predisposing to CD 
involve genes which code for proteins which either function in the sensing of the 
microbial environment (NOD2/CARD15) (Section 1.2.1) or that regulate the host 
response to this environment (ATG16L1 and IRGM) (Section 1.2.2 and 1.2.3). Early 
evidence for a role for the microbiota stems from the observation that diversion of 
the fecal stream is associated with an improvement in the clinical symptoms of CD 
and re-introduction of the luminal contents resulted in a reactivation of 
inflammation (D'Haens et al., 1998; Rutgeerts et al., 1991). Patients with CD have 
higher antibody titres against indigenous microbes, including E. coli outer-
membrane protein C (OmpC) antibodies, than healthy controls (Macpherson et al., 
1996; Mow et al., 2004). CD-associated inflammatory lesions occur primarily in the 
distal ileum and colon, areas which contain the highest population of bacteria 
(Sartor, 2008). Most convincingly, it has been demonstrated that germ-free mice 
with the appropriate genetic deficiencies only develop colitis when the microbiota 
has been re-introduced, thereby establishing an important role for gene-microbiota 
interactions in the development of CD (Sellon et al., 1998; Veltkamp et al., 2001). 
 
1.3.1 Changes in the gut microbiota associated with CD 
1.3.1.1 Reduced bacterial diversity 
The intestinal microbiota is colonised by 500 – 1,000 bacterial species and 
approximately 80% of these species cannot be cultured in the laboratory by 
traditional methods, thereby hindering studies on the composition of the 
microbiota (Eckburg et al., 2005). However, the recent application of culture 
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independent tools has provided a means to assess the diversity of the gut 
microbiota. In order to identify changes in the gut microbiota associated with CD, 
researchers have compared the composition of the mucosally-associated 
microbiota between healthy subjects and CD patients. Although still in the early 
stages, there have been some interesting observations. What has become evident, 
and is consistent among studies, is that CD patients exhibit a microbial imbalance or 
dysbiosis. The Firmicutes is the major phylum present in the normal gut microbiota, 
and studies have shown dramatic reductions in the relative abundance of this 
phylum in IBD patients, with a concomitant increase in the Proteobacteria (Frank et 
al., 2007; Gophna et al., 2006; Ott et al., 2004; Walker et al., 2011). Specifically, a 
reduced number of bacteria within the Clostridium leptum subgroup of the 
Firmicutes has been noted in CD patients, in particular Faecalibacterium prausnitzii 
(Frank et al., 2007; Sokol et al., 2008). This bacterium has anti-inflammatory effects 
in vitro, demonstrated by its ability to induce the highest levels of the anti-
inflammatory cytokine IL-10 and the lowest levels of pro-inflammatory cytokines 
from peripheral blood mononuclear cells (PBMC’s) in comparison to other strains 
tested (Sokol et al., 2008). Additionally, the F. prausnitzii supernatant was capable 
of blocking NFKB activation and reducing interleukin-8 (IL-8) secretion from cultured 
epithelial cells (Sokol et al., 2008). The anti-inflammatory effects of F. prausnitzii or 
its supernatant were also confirmed in an in vivo model of colitis (Sokol et al., 
2008). Therefore, the reduced numbers of this anti-inflammatory bacterium within 
the CD-microbiota may be a contributory factor to intestinal inflammation. In these 
studies, the absolute numbers of the Proteobacteria, including E. coli, were not 
changed, but their relative abundance was increased due to the observed 
decreases in the Firmicutes (Frank et al., 2007; Gophna et al., 2006; Walker et al., 
2011). Decreased numbers of Bacteroides, a member of the phylum Bacteroidetes, 
has also been reported in CD patients (Baumgart et al., 2007; Frank et al., 2007), 
however this was not reproducible in other studies (Kleessen et al., 2002; 
Swidsinski et al., 2005). Mucolytic species such as Ruminococcus torques and 
Ruminococcus gnavus have also been reported to be more prevalent in CD patients 
(Joossens et al., 2011; Png et al., 2010). 
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1.3.1.2 Increased mucosal-associated Escherichia coli  
In addition to the reduction in observed microbial diversity, a number of studies 
have reported increased numbers of mucosal-associated E. coli strains in CD 
patients. A key study carried out by Darfeuille-Michaud et al., (1998) assessed the 
prominence and virulence of E. coli strains associated with the ileal mucosa of CD 
patients. In this study, E. coli strains were isolated in increased numbers from 
mucosal biopsies from CD patients in comparison to healthy controls. The 
percentage of E. coli isolated from CD biopsies exceeded 50% of the total bacteria 
isolated; in comparison to only 15% from healthy control biopsies (Darfeuille-
Michaud et al., 1998). Similarly, increased numbers of E. coli have been isolated 
from colonic mucosal biopsies of CD patients (43%) than from control patients 
(17%) (Martin et al., 2004). This study also isolated increased numbers of 
intramucosal E. coli from colonic CD biopsies (29%) in comparison to control 
samples (9%) (Martin et al., 2004). At least 4 other studies undertaken by 
independent research groups have reported that mucosa-associated E. coli are 
increased in CD patients (Baumgart et al., 2007; Kotlowski et al., 2007; Mylonaki et 
al., 2005; Swidsinski et al., 2002).  
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1.3.2 Are these changes in the microbiota a cause or a consequence of CD? 
The above-mentioned studies have been highly informative in defining the 
differential composition of the gut microbiota in CD patients. However, it has 
generally only been possible to study the microbiotas of CD patients after they have 
been diagnosed, which is usually after the appearance of disease symptoms. 
Therefore, whether these changes in the gut microbiota of CD patients are a cause 
of inflammation, or are a consequence of disease is unclear.  
It is possible that the dysbiosis is a direct consequence of the underlying 
immunodeficiency in CD patients. It has been shown that loss of T-bet (a 
transcription factor which regulates the differentiation and function of immune 
cells of the innate and adaptive immune system) in mice results in the development 
of a colitogenic microbiota (Garrett et al., 2007). Both the T-bet deficiency and the 
resulting colitogenic microbiota are required for disease initiation, but when 
established, this microbiota was capable of inducing colitis in wild-type mice 
(Garrett et al., 2007). Two independent studies have recently shown that mice 
deficient for NOD2 have altered microbiota compositions and increased bacterial 
loads in their faeces and terminal ileums (Mondot et al., 2011; Rehman et al., 
2011). Moreover, this altered microbial composition was observed in weaning mice, 
indicating that NOD2 has a significant influence on the early development and 
composition of the microbiota (Rehman et al., 2011). 
On the other hand, inflammation-induced changes in the microbiota have also been 
reported. Using chemically (DSS) induced and genetic (IL-10-/-) mouse models of 
inflammatory colitis, it has been shown that inflammation can alter the colonic 
microbiota (Lupp et al., 2007). Specifically, in these mouse models, the 
inflammation resulted in an overgrowth of resident bacteria, in particular of the 
Enterobacteriaceae family, suggesting that inflammation could promote the growth 
of aerotolerant bacteria (Lupp et al., 2007). Moreover, this group showed that the 
inflammation also facilitated the expansion of introduced bacterial strains (E. coli 
and C. rodentium). It has been shown that induced colitis in a murine model is 
associated with a dysbiosis of the microbiota (a general shift from an abundance of 
Firmicutes to an abundance of Proteobacteria), inflammation and mucosal invasion 
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of AIEC (Craven et al., 2012). This outcome was enhanced in a NOD2 deficient 
background and ameliorated by administration of anti-TNF-α antibodies (Craven et 
al., 2012). Notably, in this study the highest AIEC counts were observed in mice with 
the highest levels of inflammation and dysbiosis, suggesting that the inflammation 
is favouring this outcome (Craven et al., 2012). 
Many elements of a modern life-style, such as dietary changes and the use of 
antibiotics, are associated with both changes in the microbiota and the progression 
of CD. An early study from Japan showed that the increased incidence of CD in this 
country was correlated with increased dietary intake of total fat, animal fat, 
polyunsaturated fatty acids, animal protein and milk protein (Shoda et al., 1996). 
The increased incidence of CD was not correlated with dietary intake of fish protein 
and the intake of vegetable protein was associated with a decreased risk for CD 
(Shoda et al., 1996). Moreover, consumption of a high-fat diet has been shown to 
alter the commensal microbiota in a murine study. Switching mice to a high-fat diet 
induced changes in the gut microbiota of these mice, including increases in the 
Firmicutes and Proteobacteria and decreases in the Bacteroidetes (Hildebrandt et 
al., 2009). A recent study has shown that mice fed a Western diet (rich in fat and 
simple sugars) have altered intestinal microbiotas, with observed lower total 
bacterial numbers, a greater Bacteroides-Prevotella spp abundance and increased 
numbers of Ruminococcus torques and increased numbers of E. coli (Martinez-
Medina et al., 2013). This dysbiosis was associated with low grade inflammation, 
which in turn, facilitated the colonisation and persistence of AIEC. This AIEC 
colonisation was associated with an increased pro-inflammatory response 
(Martinez-Medina et al., 2013).  
It has been well established that antibiotic use can cause major alterations in the 
composition of the intestinal microbiota. A study aimed at analysing the long-term 
effects of a 7 day clindamycin treatment on the gut microbiota, noted a sharp 
decline in Bacteroides isolates, with an increase in antibiotic-resistant isolates, 
which did not return to its original composition over a 2 year sampling period 
(Jernberg et al., 2007). The use of antibiotics, in particular during the early years of 
life, has been linked to the development of CD. One study evaluated the association 
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between the use of antibiotics and CD in Danish children, and showed a strong 
association between the two (Hviid et al., 2011). Similarly, another recent study 
based on children in Finland, showed that the use of antibiotics, in particular 
cephalosporins, in childhood increased the risk of developing CD, but not UC (Virta 
et al., 2012).  
In summary, it appears likely that the changes in the microbiota observed in CD 
patients may be a combination of environmentally induced dysbioses which may be 
amplified by the presence of underlying genetic abnormalities. Inflammation may 
intensify these perturbations and allow the proliferation of certain species, or 
pathobionts, which may then exacerbate the inflammatory state. 
 
1.4 Association of specific microbes with CD 
1.4.1 Mycobacterium avium subspecies paratuberculosis (MAP) 
Mycobacterium avium subspecies paratuberculosis (MAP) has traditionally been 
implicated in the pathogenesis of CD, however after extensive research a 
correlation between MAP and CD has neither been confirmed nor completely 
dismissed. MAP causes a spontaneous granulomatous enterocolitis in cattle, called 
Johne’s disease, which has clininal manifestations similar to that observed in CD 
patients, thereby making MAP a plausible etiologic agent in CD (Chiodini, 1989). 
MAP was first cultured from CD tissue in 1984 (Chiodini et al., 1984). The IS900 
insertion element, which is specific to MAP, has been detected in higher numbers in 
patients with CD than in healthy controls (Autschbach et al., 2005). MAP has also 
been cultured from blood samples from CD patients (Naser et al., 2004) and has 
also been detected in CD tissue at an increased frequency by PCR and fluorescent in 
situ hybridisation (FISH) analysis (Hulten et al., 2001; Sanderson et al., 1992). 
However, across all PCR-based and culture-based studies, the range of MAP 
positivity has been between 0% - 100% (Eckburg et al., 2005; Sartor, 2005). 
Moreover, a 2 year prospective trial of triple anti-mycobacterial antibiotic therapy, 
consisting of clarithromycin, rifabutin and athambutol, failed to show a sustained 
clinical improvement in CD patients (Selby et al., 2007). As previously discussed, 
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NOD2 polymorphisms are associated with an increased susceptibility to CD, 
however 2 recent studies have shown no correlation between NOD2 variants and 
the presence of MAP (Bernstein et al., 2007; Sechi et al., 2005). The above evidence 
would suggest that it is unlikely that MAP is the causative agent of CD. However, it 
has been shown that functional autophagy limits the intracellular growth of 
Mycobacterium tuberculosis (Gutierrez et al., 2004). Therefore, it may be possible 
that a MAP infection in a subpopulation of CD patients with underlying defects in 
autophagy, could lead to clinical symptoms of CD, although this has not been 
experimentally tested. 
 
1.4.2 Adherent Invasive Escherichia coli (AIEC) 
Over the past decade, a large body of evidence has accumulated to suggest that E. 
coli may play a role in the pathogenesis of CD. As previously discussed, E. coli have 
consistently been isolated in increased numbers from the mucosa of CD patients in 
comparison to healthy controls, by numerous independent research groups. Several 
other lines of evidence support the role for E. coli in CD. An immunohistochemical 
study detected the presence of E. coli in CD tissue, particularly within macrophages 
in the lamina propria, in the germinal centres of mesenteric lymph nodes, in giant 
cells and in granulomas (Liu et al., 1995). A study using laser capture 
microdissection (LCM) and PCR detected the presence of E. coli DNA in granulomas 
in 12/15 CD patients in comparison with only 1/10 non-CD granuloma control 
patients (Ryan et al., 2004). Numerous studies have detected an increased 
prevalence of antibodies against E. coli OmpC in CD patients in comparison to 
healthy controls (Landers et al., 2002; Mei et al., 2006). 
These CD-associated E. coli isolates have been shown to adhere to various epithelial 
cell-lines in vitro (Darfeuille-Michaud et al., 1998; Martin et al., 2004). Although 
there is no direct evidence to suggest that these E. coli isolates can invade epithelial 
cells in vivo, they have been shown to invade epithelial cell lines in vitro whereas 
laboratory strains of E. coli are non-invasive in these in vitro models (Boudeau et al., 
1999; Martin et al., 2004). Additionally, in vitro studies have shown that these CD-
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associated E. coli isolates are capable of surviving and replicating within 
macrophage cell lines, whereas laboratory strains of E. coli are effectively 
eradicated (Glasser et al., 2001; Subramanian et al., 2008). PCR analysis and 
hybridisation studies showed that these CD-associated strains lack classical 
virulence factors such as the secreted Ipa proteins of EIEC, intimin of EPEC, 
enterotoxin and shiga-like toxins of ETEC and the outer membrane proteins Tia and 
Tib which are believed to be involved in the pathogenesis of ETEC (Boudeau et al., 
1999; Darfeuille-Michaud et al., 1998).  
The above findings have led to the identification of a new group of E. coli, termed 
Adherent Invasive Escherichia coli (AIEC) (Darfeuille-Michaud, 2002). As mentioned, 
AIEC have 2 major characteristics that differentiate them from other groups of E. 
coli. Firstly, they have the ability to adhere to and invade intestinal epithelial cells; 
and secondly, they can survive and replicate within macrophages. AIEC have been 
shown to be highly associated with CD, where they have been isolated from biopsy 
samples from 36% of CD patients in comparison to only 6% of control patients 
(Darfeuille-Michaud et al., 2004). Moreover, AIEC strains have been isolated in 
higher numbers from boxer dogs and French bulldogs with granulomatous colitis 
(which has features similar to CD in humans) in comparison to healthy controls 
(Manchester et al., 2013; Simpson et al., 2006) and AIEC have also been shown to 
induce the formation of granulomas (a characteristic hallmark of CD) in vitro 
(Meconi et al., 2007). However, it is important to highlight the fact that AIEC are 
also present in the guts of healthy individuals (albeit at much lower numbers), 
indicating that they are not exclusively associated with CD. This suggests that AIEC 
could be opportunistic pathogens or pathobionts i.e. commensals that can take 
advantage of the CD-intestine, causing disease. 
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1.5 E. coli – from commensals to pathogens 
E. coli are Gram negative, non-sporulating, facultative anaerobic, rod-shaped 
microorganisms. Although they are a natural inhabitant of the intestine and faeces 
of warm-blooded animals and reptiles, they can also reside outside of the intestine, 
where they are commonly found in water and sediment (Tenaillon et al., 2010). E. 
coli are the predominant aerobic organism in the gut microbiota of humans, where 
they typically reside in the mucus layer of the colon (Tenaillon et al., 2010).  E. coli is 
one of the first bacterial species to colonise the human intestine, which typically 
occurs within a few hours after birth (Kaper et al., 2004). Normally, these 
commensal E. coli co-exist in good harmony with their human host. E. coli benefits 
the host by preventing colonisation by pathogens, and in return, the host provides 
E. coli with a supply of nutrients, which allow it to thrive in the intestine (Tenaillon 
et al., 2010). However, some strains of E. coli have evolved pathogenic mechanisms 
which enable them to cause disease in the healthy human host. This could be as a 
result of the acquisition of virulence genes encoded on plasmids, transposons, 
bacteriophages and pathogenicity islands (PAI’s) by horizontal gene transfer, or 
could be as a result of point mutations, insertions or deletions in existing genes, 
which enhance pathogenicity. 
Pathogenic E. coli can be classified as either diarrhoeagenic E. coli, which cause 
diarrhoeal disease in the intestine; or extraintestinal pathogenic E. coli (ExPEC), 
which cause non-diarrhoeal disease outside of the intestine. ExPEC are frequently 
associated with urinary tract infections (UTI’s) or neonatal meningitis. There are 6 
well-described subgroups within the diarrhoeagenic group – enteropathogenic E. 
coli (EPEC), enterotoxigenic E. coli (ETEC), enterohaemorrhagic E. coli (EHEC), 
enteroinvasive E. coli (EIEC), enteroaggregative E. coli (EAEC) and diffusely adherent 
E. coli (DAEC). ExPEC can be subdivided into 2 groups – uropathogenic E. coli (UPEC) 
and neonatal meningitis E. coli (NMEC). The major virulence mechanisms associated 
with each of these pathogroups are briefly discussed below. 
21 
 
1.5.1 Diarrhoeagenic E. coli 
1.5.1.1 Enteropathogenic E. coli (EPEC) 
EPEC was the first pathovar of E. coli to be recognised as causing diarrhoeagenic 
outbreaks in the developed world (Bray, 1945). Although the incidence of EPEC 
infections in the developed world is declining, for unknown reasons (Nataro & 
Kaper, 1998), numerous case-studies show that this pathovar still remains an 
important cause of infant diarrhoea in the developing world (Albert et al., 1995; 
Behiry et al., 2011; Dutta et al., 2013). EPEC colonisation results in the formation of 
attaching and effacing (A/E) lesions on the surface of epithelial cells. The bacteria 
bind intimately to the cell surface resulting in the loss of microvilli and the 
accumulation of polymerised actin directly underneath the attached bacteria. This 
process results in the formation of raised pedestal-like structures on the epithelial 
cell surface (Kaper et al., 2004). The initial attachment of EPEC to epithelial cells is 
mediated by bundle-forming pili (BFP), which are encoded on the EPEC adherence 
factor plasmid (EAF) (Tobe et al., 1999). BFP interact with other EPEC cells to 
mediate microcolony formation and they also interact with host cell surface 
receptors to mediate localised adherence (Giron et al., 1991; Hyland et al., 2008). 
The ability to form A/E lesions is encoded on a pathogenicity island called the locus 
of enterocyte effacement (LEE) which encodes genes for a type III secretion system 
(T3SS), regulators, chaperones and effector proteins (Elliott et al., 1998; McDaniel 
et al., 1995). The intimate attachment of EPEC to epithelial cells is mediated by the 
outer membrane protein intimin, which is found on the LEE (Jerse et al., 1990). The 
transmembrane intimin receptor (Tir), also encoded on the LEE, is secreted by the 
T3SS into the host cell membrane, thereby functioning as a receptor for intimin 
(Kenny et al., 1997). In this way, EPEC promote their own adhesion to host cells. Tir 
is also an important mediator of protein signalling within epithelial cells. The 
cytoplasmic portion of Tir mediates extensive localised actin polymerisation by 
directly binding to the adaptor protein Nck (Non-catalytic region of tyrosine kinase), 
which then recruits the Wiscott-Aldrich syndrome protein (WASP) and the actin-
related protein 2/3 (Arp2/3) complex, which ultimately results in actin 
polymerisation and pedestal formation (Kalman et al., 1999a). The binding of EPEC 
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to host cells via the Intimin-Tir interaction is then followed by the translocation of 
several T3SS effector proteins into the cell which mediate an array of downstream 
effects such as actin remodelling, disruption of gut integrity resulting in increased 
intestinal permeability, induction of active ion secretion, induction of an NFKB 
mediated inflammatory response and inhibition of phagocytosis (Clements et al., 
2012) (Figure 1.2 A). 
 
1.5.1.2 Enterotoxigenic E. coli (ETEC) 
ETEC is the most common cause of diarrhoeal disease in young children in the 
developing world (Qadri et al., 2000; Rao et al., 2003; Steinsland et al., 2002) and is 
also the most common cause of travellers diarrhoea (Jiang et al., 2002; Schultsz et 
al., 2000; Shah et al., 2009). ETEC expresses many proteinaceous surface 
appendages called colonisation factor antigens (CFAs) which facilitate colonisation 
of the intestinal epithelium. These appendages are morphologically diverse and 
more than 20 have been identified to date. However, approximately 75% of ETEC 
strains express either CFA/I, CFA/II or CFA/IV. CFA/I is composed of a single rigid, 
rod-shaped fimbria; CFA/II is composed of a flexible fibrillar structure in association 
with a rigid, rod-shaped fimbria; and CFA/IV is composed of a non-fimbrial structure 
in association with either a rigid rod or a flexible fibrillar structure (Kaper et al., 
2004; Nataro & Kaper, 1998). The outer membrane protein Tia and the glycosylated 
autotransporter TibA also mediate attachment of the prototype ETEC strain H10407 
to epithelial cells (Elsinghorst & Kopecko, 1992). An adhesin present on the tip of 
ETEC flagella, called EtpA has been shown to mediate attachment to mammalian 
host cells (Roy et al., 2009), while a SPATE (Serine Protease Autotransporters of 
Enterobacteriaceae) protein called EatA has been shown to degrade EtpA, thereby 
modulating bacterial adhesion and facilitating delivery of toxins (Roy et al., 2011). 
EatA has also been demonstrated to play a direct role in ETEC pathogenesis by 
facilitating fluid secretion into the intestinal lumen (Patel et al., 2004). A model has 
been proposed whereby EtpA initially anchors the bacterium to the host cell, 
thereby allowing shorter CFA’s to interact with the epithelial surface. EtpA is then 
degraded by EatA, allowing intimate attachment by Tia and TibA (Clements et al., 
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2012). ETEC expresses 2 classes of toxins: the heat-labile (LT) enterotoxins and the 
heat-stable (ST) enterotoxins. The ETEC ST toxin, STa, mimics the intestinal 
hormone guanylin by binding to and activating the membrane receptor guanylate 
cyclase C (GC-C), which in turn, increases the intracellular concentration of cyclic 
guanosine monophosphate (cGMP). This results in activation of the cGMP-
dependent protein kinase 2 and phosphorylation of the cyctic fibrosis 
transmembrane regulator (CFTR) causing increased salt and water secretion and 
impaired Na+ absorption, thus resulting in diarrhoea (Chao et al., 1994; Schulz et al., 
1990; Vaandrager, 2002). Enterotoxin LT-1 is an AB5 toxin expressed by human ETEC 
strains and is similar to the cholera enterotoxin (CT) (Spangler, 1992). LT-1 is 
secreted across the bacterial outer membrane by a type II secretion system (T2SS), 
where it then binds to LPS on the extracellular surface of the bacterium via the B-
subunit (Horstman et al., 2004; Tauschek et al., 2002). The toxin is then secreted in 
outer membrane vesicles (OMV’s) which can bind to the ganglioside receptor GM1 
on the host cell surface via the B-subunit, resulting in endocytosis of the OMV’s 
(Kesty et al., 2004). LT is then transported to the cytosol where the A1 subunit ADP-
ribosylates the stimulatory guanine-nucleotide-binding (G) protein α-subunit, which 
leads to permanent activation of the adenylate cyclase complex and increased 
intracellular levels of cyclic adenosine monophosphate (cAMP) (Spangler, 1992). As 
above, this results in activation of CFTR and increased chloride and water secretion 
from the cell (Spangler, 1992)  (Figure 1.2 B).  
 
1.5.1.3 Enterohaemorrhagic E. coli (EHEC) 
In addition to being associated with diarrhoea, EHEC also causes the more serious 
diseases haemorrhagic colitis, characterised by bloody diarrhoea, and haemolytic 
uremic syndrome (HUS), characterised by haemolytic anaemia, thrombocytopenia 
and potential renal failure (Gould et al., 2009; Karmali et al., 1983). EHEC have a 
zoonotic origin and cattle represent the major reservoir for human infections. A 
number of outbreaks involving the 0157:H7 serotype have been associated with the 
consumption of undercooked hamburgers, fermented sausage, radish sprouts, 
petting zoos and farm visitations (Anonymous, 2005; Bell et al., 1994; Michino et 
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al., 1999; Sartz et al., 2008). A defining characteristic of EHEC is the presence of the 
phage-encoded verocytotoxin Stx, which causes the above mentioned diseases. Stx 
is an AB5 toxin, where the B-subunits mediate binding to the membrane receptor 
glycolipid globotriaosylceramide (Gb3) and facilitate internalisation of the toxin by 
inducing membrane invaginations (Romer et al., 2007). Stx leaves the endocytic 
pathway and subunit-A is translocated to the cytosol, where it cleaves rRNA and 
inhibits protein synthesis, which ultimately results in host cell death (Endo et al., 
1988; Mallard et al., 1998). Stx causes local damage in the colon, resulting in bloody 
diarrhea and haemorrhagic colitis; and can also travel via the bloodstream to the 
kidneys, where the induction of a cytokine response can lead to renal inflammation 
and ultimately HUS (Kaper et al., 2004). EHEC also contain the LEE pathogenicity 
island, where similarly to EPEC, the Intimin-Tir complex is important for intimate 
intestinal colonisation (Croxen & Finlay, 2009; McDaniel et al., 1995). Factors 
mediating the initial adherence of EHEC to epithelial cells are not well defined, but 
flagella and a type IV pilus called the haemorrhagic coli pilus (HCP), have been 
implicated in this process (Erdem et al., 2007; Xicohtencatl-Cortes et al., 2009) 
(Figure 1.2 C). 
 
1.5.1.4 Enteroinvasive E. coli (EIEC) 
EIEC are closely related to Shigella spp. and indeed they share identical virulence 
factors and modes of pathogenesis. The genus name Shigella will be used in this 
section. Shigella is the causative agent of Shigellosis, symptoms of which can range 
from mild watery diarrhoea to dysentery, characterised by fever, abdominal pain 
and diarrhoea containing blood and mucus (Schroeder & Hilbi, 2008). This pathovar 
differs from other pathovars of E. coli as they do not contain adhesins and are non-
motile. Shigella initiates infection by passing through microfold (M) cells, thereby 
gaining access to the underlying submucosa (Sansonetti et al., 1996). Shigella are 
then phagocytosed by macrophages, where they then escape from the phagosome 
and induce both an inflammatory response and host cell death (Sansonetti et al., 
2000; Zychlinsky et al., 1992; Zychlinsky et al., 1996). Shigella released from lysed 
macrophages can then invade the basolateral side of the colonic epithelium where 
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they are taken up within an endocytic vacuole. This vacuole subsequently lyses, 
releasing Shigella into the cytoplasm, where they can multiply (Sansonetti et al., 
1986). Shigella are capable of moving within the cytoplasm, which is mediated by 
nucleation of actin into a tail-like structure, which protrudes from one pole of the 
bacterial cell, thus propelling the bacterium through the cytoplasm. In this way, 
Shigella can spread to adjacent cells (Monack & Theriot, 2001). The virulence genes 
required by Shigella to carry out the above events are encoded on a large plasmid 
(Small & Falkow, 1988) which has been named pINV. Important genes on this 
plasmid are the mxi and spa loci, which encode the T3SS apparatus. This T3SS is 
required for the secretion of the invasion plasmid antigen (Ipa) proteins, which are 
required for virulence (Andrews et al., 1991; Venkatesan et al., 1992). The Mxi-Spa 
apparatus facilitates the insertion of a pore complex consisting of IpaB and IpaC, 
into the host cell membrane. IpaD is required for the insertion of this complex into 
the membrane. Insertion of this complex allows the translocation of the C-terminal 
domain of IpaC, which triggers actin polymerisation and membrane protrusions 
required for entry into the cell (Marquart et al., 1996). IpaA is also involved in the 
invasive process, where it mediates actin depolymerisation, closing the membrane 
protrusions around the invading bacteria (Demali et al., 2006; Ramarao et al., 
2007). IpaB, IpaC and IpaD are required for phagosomal escape, while evidence 
suggests that IpaC mediates lysis (Schroeder & Hilbi, 2008). Also encoded on the 
plasmid is the IcsA outer membrane protein which binds N-WASP and thus 
mediates actin nucleation required for intracellular bacterial motility (Egile et al., 
1999) (Figure 1.2 D). 
 
1.5.1.5 Enteroaggregative E. coli (EAEC) 
EAEC are associated with persistent diarrhoea in children and adults in both 
developed and developing populations (Lima et al., 2013; Nataro et al., 2006; 
Sarantuya et al., 2004) and EAEC is also the second most common cause of 
travellers diarrhoea, after ETEC (Shah et al., 2009). This pathovar has also been the 
cause of outbreaks in Serbia, Italy and the United Kingdom (Cobeljic et al., 1996; 
Scavia et al., 2008; Smith et al., 1997). A characteristic feature of EAEC is their 
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autoaggregative pattern of adherence to epithelial cells, where bacteria stick to 
each other in a “stacked-brick” configuration and adhere loosely to the mucosal 
surface (Nataro & Kaper, 1998). In animal models, EAEC have been observed 
embedded within a thick mucus-containing biofilm, which may promote persistent 
colonisation or nutrient malabsorption (Nataro & Kaper, 1998). The aggregative 
adherence phenotype is encoded on a plasmid called pAA (Vial et al., 1988). This 
plasmid encodes fimbrial adhesins, called aggregative adherence fimbriae (AAF) 
which facilitate mucosal colonisation, however these adhesins are not present in all 
strains (Bernier et al., 2002; Czeczulin et al., 1997; Nataro et al., 1992). The 
transcriptional regulator, AggR, has been identified as the master regulator of EAEC 
virulence (Nataro et al., 1994). A small secreted protein has also been identified on 
EAEC pAA, called dispersin, which attaches noncovalently to the bacterial cell 
surface and scanning electron microscopy (SEM) showed that AAF were collapsed 
onto the surface in null mutant strains (Sheikh et al., 2002). It has been proposed 
that dispersin neutralises the negative charge of LPS, thereby allowing the positively 
charged AAF to extend from the cell (Harrington et al., 2006). The class II SPATE 
(non-cytotoxic) protein, Pic, is another important chromosomally-encoded 
virulence factor in EAEC (Henderson et al., 1999). Pic has many functions such as 
the degradation of mucin, complement resistance and hemagglutination 
(Henderson et al., 1999). The class I SPATE (cytotoxic) protein, Pet, is encoded on 
pAA in some EAEC strains and is released into the host cell cytosol where it cleaves 
the actin binding protein spectrin, thereby disrupting the actin cytoskeleton 
resulting in cell detachment (Eslava et al., 1998; Navarro-Garcia et al., 1998). 
Several other toxins have been identified in EAEC. The EAEC heat-stable enterotoxin 
1 (EAST-1) is encoded on pAA and is a homologue of ETEC STa (Savarino et al., 
1993). Shigella enterotoxin 1 (ShET1) is a chromosomally located toxin in EAEC, 
which is present in most strains of S. flexneri 2a (Noriega et al., 1995). Although the 
precise mode of action of these toxins is not well understood, they might 
contribute to the diarrhoea induced by EAEC by damaging intestinal epithelial cells 
(Figure 1.2 E). 
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1.5.1.6 Diffusely adhering E. coli (DAEC) 
DAEC has been implicated in diarrhoeagenic disease in young children (Gunzburg et 
al., 1993; Scaletsky et al., 2002). This pathotype is characterised by its diffuse 
pattern of adherence to HEp2 epithelial cells (Kaper et al., 2004). Colonisation of 
DAEC is mediated by the action of afimbrial adhesins (Afa), fimbrial adhesins 
(F1845) and the Dr hemagglutinin, collectively referred to as Afa-Dr adhesins. Afa-
Dr adhesins bind to the receptor decay accelerating factor (DAF) (Bernet-Camard et 
al., 1996). Binding of Afa-Dr adhesins to DAF induces a cytopathic effect 
characterised by the formation of long cellular projections (called target 
mobilisation) which surround the adherent bacteria, a process which is dependent 
on Src kinase activation (Bernet-Camard et al., 1996; Queval et al., 2011). Following 
target mobilisation, host signal transduction pathways are activated resulting in the 
production of IL-8 and the recruitment of polymorphonuclear neutrophils (PMN’s) 
(Betis et al., 2003a). These events stimulate epithelial cells to upregulate pro-
inflammatory cytokine production and to upregulate DAF expression, which 
increases bacterial adhesion (Betis et al., 2003b). DAEC also express secreted 
autotransporter protein (Sat), which is a member of the SPATE subfamily of 
secreted proteins. Sat has been shown to act as a virulence factor in DAEC by 
inducing the formation of lesions in the tight junctions of epithelial cells thus 
increasing cellular permeability (Guignot et al., 2007) (Figure 1.2 F). 
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Figure 1.2 Pathogenic mechanisms of diarrhoeagenic E. coli. (A) EPEC intimately attach to 
enterocytes via the intimin-Tir complex, resulting in the characteristic attaching and 
effacing (A/E) lesions. Cytoskeletal rearrangements are accompanied by an inflammatory 
respone and diarrhoea. (B) ETEC adhere to enterocytes and secrete heat-labile (LT) and/or 
heat-stable (ST) enterotoxins, resulting in watery diarrhoea. (C) EHEC induce the A/E lesions 
and they also secrete shiga toxin (Stx) the systemic absorption of which leads to life-
threatening complications. (D) EIEC invades the basolateral side of epithelial cells, lyses the 
phagosome and moves by actin-based motility, facilitating infection of neighbouring cells. 
(E) EAEC adhere to the epithelium in a thick biofilm and secrete toxins, resulting in 
diarrhoea. (F) DAEC induces signal transduction events in epithelial cells, which result in the 
growth of long finger-like cellular projections, which wrap around the bacteria. Adapted 
from Kaper et al., 2004. 
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1.5.2 Extraintestinal pathogenic E. coli (ExPEC) 
1.5.2.1 Uropathogenic E. coli (UPEC) 
UPEC are the principal causative agents of urinary tract infections (UTI’s) such as 
cystitis in the bladder and acute pyelonephritis in the kidneys (Zhang & Foxman, 
2003). The urinary tract is normally a sterile environment, but UPEC posess an array 
of diverse virulence factors which allow it to translocate from its initial site of 
colonisation, the gut, to the periurethral area, where it then ascends the urethra to 
the bladder and kidneys (Croxen & Finlay, 2009; Kaper et al., 2004). UPEC strains 
express type 1 fimbriae, which are an important virulence factor in mediating 
bacterial attachment to uroepithelial cells. The fimbrial adhesin, FimH, which is 
located at the tip of the fimbrial shaft binds to mannose residues present on the 
receptor uroplakin (UPIa and UPIb) which is found on the surface of superficial facet 
cells in the bladder (Mulvey et al., 1998). UPEC can also use their type 1 fimbriae to 
invade the epithelium which offers them protection from the host immune 
response. They do this by binding to the host receptors α3 or β1 integrins, which 
activate signalling cascades, resulting in the localised rearrangement of the actin 
cytoskeleton and the subsequent envelopment and internalisation of the bacterium 
(Eto et al., 2007). Internalised bacteria can replicate and form intracellular bacterial 
communities (IBC’s), which are biofilm-like structures consisting of clusters of 
bacteria in a polysaccharide-rich matrix, encased in a shell of uroplakin (Anderson 
et al., 2003). The development process of IBC’s consists of four main stages. Initially 
the IBC consists of rod-shaped, non-motile, rapidly growing bacteria. In the second 
phase, the IBC consists of slow-growing cocci-shaped bacteria which fill the entire 
cytoplasm. In the third phase, bacteria switch to a motile, rod-shaped phenotype, 
which detach from the IBC and result in the flux of bacteria out of the host cell and 
into the bladder lumen. The fourth phase is characterised by the filamentation of 
bacteria, which also flux out of the infected cell and can re-enter the IBC cycle 
(Justice et al., 2004). UPEC infection stimulates innate immune defense 
mechanisms which result in shedding and apoptosis of the epithelial cell (Mulvey et 
al., 1998). However, this event temporarily exposes the underlying urothelial cells 
and permits UPEC invasion, leading to the establishment of a quiescent intracellular 
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reservoir (QIR) within bladder tissue (Mulvey et al., 2001). Bacteria invading the 
urothelium are trafficked into acidic actin-bound compartments, where they enter 
a non-replicating quiescent phase which can serve as a reservoir for long-term 
persistence of UPEC (Eto et al., 2006). In order to cause disease, UPEC must be able 
to survive and grow in urine. Iron is essential for bacterial growth but is limiting in 
the urinary tract. In order to overcome this, UPEC expresses four different 
siderophores which scavenge iron, namely enterobactin, salmochelin, 
yersiniabactin and aerobactin (Ulett et al., 2013). UPEC can also ascend to the 
kidney and cause pyelonephritis, and this is mediated by the reciprocal regulation 
of type 1 fimbriae and flagella-mediated motility (Lane et al., 2007a). P fimbriae 
may play a role in mediating UPEC colonisation of the kidney epithelium, by binding 
to Galα(1-4)Galβ residues on the surface of kidney epithelial cells (Lane & Mobley, 
2007). The secretion of toxins such as haemolysin and Sat can damage the renal 
epithelium leading to an inflammatory response, and in some cases this can result 
in a breach in the epithelial barrier, facilitating bacterial entry into the bloodstream 
and ultimately resulting in bacteraemia (Guyer et al., 2000; Trifillis et al., 1994) 
(Figure 1.3 A). 
 
1.5.2.2 Neonatal meningitis E. coli (NMEC) 
NMEC is the most frequent cause of Gram negative meningitis in newborns (May et 
al., 2005; Unhanand et al., 1993). The pathogenesis of NMEC involves the 
translocation of bacteria from the gut to the bloodstream by transcytosis through 
enterocytes, followed by entry into the central nervous system by crossing the 
blood brain barrier (BBB) (Croxen & Finlay, 2009; Kaper et al., 2004). NMEC strains 
express a K1 capsule, which essentially protects the bacteria against serum and 
opsonophagocytic killing, thereby allowing them to reach the high bacterial 
numbers required to initiate infection (Kim et al., 1992; Xie et al., 2004). However, 
NMEC can be taken up by macrophages in the absence of opsonins. Indeed, it has 
been shown that NMEC can survive and replicate within macrophages and this is 
dependent upon the expression of the outer membrane protein OmpA (Sukumaran 
et al., 2003). Again, this allows NMEC to maintain a high level of bacteremia 
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required for the onset of meningitis. NMEC can then cross the layer of brain 
microvascular endothelial cells which constitute the BBB. Attachment to this 
epithelial layer can occur by two different mechanisms, either by FimH mediated 
binding to the CD48 receptor (Khan et al., 2007), or by binding of OmpA to the 
ECGP96 receptor (Prasadarao, 2002). FimH also mediates bacterial invasion by 
inducing host cell signalling cascades which result in actin cytoskeletal 
rearrangements (Khan et al., 2007). Similarly, OmpA is also involved in the invasion 
process by binding to the GlcNAcβ1-4GlcNAc epitope on glycoprotein receptors 
(Prasadarao et al., 1996a). The toxin, cytotoxic necrotising factor 1 (CNF1) also 
mediates invasion by binding to the laminin receptor, 67LR, which mediates myosin 
rearrangements (Essler et al., 2003). Once NMEC have crossed the BBB, they can 
enter the central nervous system, where the release of toxic compounds and pro-
inflammatory compounds results in meningitis (Figure 1.3 B). 
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Figure 1.3 Pathogenic mechanisms of extraintestinal E. coli (ExPEC). (A) UPEC attaches to 
bladder superficial facet cells by FimH binding to uroplakin. Internalisation is mediated by 
FimH binding to the integrins α3/β1 resulting in the formation of intracellular bacterial 
communities (IBC’s). Exfoliation of the superficial facet cells exposes the transitional cells to 
further invasion by UPEC, resulting in the formation of quiescent intracellular reservoirs 
(QIR’s). (B) NMEC K1 capsule protects the cell from complement and opsonophagocytosis 
during transit in blood. NMEC can survive and replicate within macrophages, generating 
the high bacterial numbers required to cross the BBB. NMEC attaches to and invades the 
BBB by FimH binding to CD48 and OmpA binding to ECGP96. Internalisation is also achieved 
by CNF1 binding to 67LR. Adapted from Croxen & Finlay, 2009. 
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1.6 Molecular mechanisms of AIEC pathogenesis 
As discussed in Section 1.4.2, AIEC have been implicated in the pathogenesis of CD. 
AIEC do not posess any of the virulence factors that have been described for 
pathogenic E. coli which cause disease in the intestine i.e. diarrhoeagenic E. coli 
(Discussed in Section 1.5.1), therefore they have been designated their own 
pathogenic group. The current criteria for inclusion in the AIEC group are firstly, the 
ability to adhere to and invade the intestinal epithelium and secondly, the ability to 
replicate in macrophages (Darfeuille-Michaud, 2002). The proceeding sections 
discuss the genetic factors that have been identified to date which are important 
for the ability of AIEC to adhere to and invade the intestinal epithelium and to 
replicate in macrophages. However, it is important to highlight that nearly all of the 
molecular studies carried out to date have used only one AIEC strain i.e. LF82. This 
strain was isolated from the ileum of a patient with CD (Darfeuille-Michaud et al., 
1998), and it is possible that AIEC strains isolated from other niches, such as the 
colon, will have different pathogenic mechanisms. 
 
1.6.1 AIEC and the epithelial barrier 
Intestinal epithelial cells represent a physical barrier to prevent enteric bacteria 
from entering and interacting with immune cells in the lamina propria. Adhesion to 
the epithelium is the first step in pathogenicity for many pathogens as it limits 
bacterial clearance and facilitates colonisation (Lu & Walker, 2001). Indeed, AIEC 
have been shown to adhere to various epithelial cell lines in vitro (Darfeuille-
Michaud et al., 1998; Martin et al., 2004). AIEC has also been shown to invade 
cultured epithelial cells in vitro (Boudeau et al., 1999; Martin et al., 2004). The 
invasive process of the prototypical AIEC strain, LF82, has been well studied. 
Transmission electron microscopy (TEM) showed that the interaction of LF82 with 
HEp2 epithelial cells induced the elongation of microvillar extensions which 
protrude from the host cell membrane. These elongated membrane extensions 
then surrounded the bacteria, resulting in their internalisation into endocytic 
vacuoles (Boudeau et al., 1999). This suggests that AIEC may trigger an active 
endocytic mechanism to promote its internalisation into epithelial cells. A similar 
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invasive mechanism has been proposed for the invasive pathogens Salmonella and 
Shigella (Adam et al., 1995; Finlay et al., 1991; Francis et al., 1993). The invasive 
ability of AIEC could facilitate their translocation into deep tissues. 
 
1.6.2 Genetic factors involved in the interaction of AIEC with epithelial cells 
1.6.2.1 Type 1 fimbriae 
The binding of LF82 to mannose receptors on the host cell surface is essential for 
the subsequent invasion of LF82 as this strain was unable to invade the epithelial 
cell line Intestine-407 in the presence of mannose (Boudeau et al., 2001). Under 
these conditions, the adherence of LF82 was also impaired, but not abolished. This 
implicated type 1 fimbriae in the adherence/invasive process, as type 1 fimbriae 
bind to mannosylated receptors on the host cell surface. Indeed, screening a 
transposon mutant library of LF82 identified non-invasive mutants, all of which had 
insertions in the fim operon (Boudeau et al., 2001). Interestingly, two fim mutants 
(fimI and fimF) still adhered to the epithelium as well as the wild-type, whereas all 
the other fim mutants were also defective in adherence. This suggests that the 
FimH adhesin is required for adhesion, while the fimbrial shaft is required for 
internalisation (Boudeau et al., 2001). TEM analysis revealed that the fimI and fimF 
mutants were not able to induce host cell membrane elongations which are a 
prerequisite for invasion (Boudeau et al., 2001). In addition, expression of the LF82 
fim operon in a non-invasive K-12 strain did not confer invasiveness to this strain, 
indicating that the LF82 genetic background is required for invasion (Boudeau et al., 
2001). It also suggests that additional factors likely operate in concert with type 1 
fimbriae to mediate adherence/invasion.  
The ability of LF82 to adhere to enterocytes isolated from CD patients was 
significantly greater than its ability to adhere to enterocytes from healthy controls, 
suggesting that a receptor for LF82 may be preferentially expressed on the surface 
of enterocytes from CD patients (Barnich et al., 2007). Similarly to what was 
observed in epithelial cells, type 1 fimbriae negative mutants were unable to 
adhere to enterocytes from CD patients, and adherence of the wild-type was also 
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blocked in the presence of mannose (Barnich et al., 2007). Indeed, incubation of the 
enterocytes with concanavalin-A (ConA), which binds to mannose residues, 
revealed high levels of ConA binding to enterocytes from CD patients in comparison 
to the control enterocytes, indicating that there is high expression of a 
mannosylated molecule on the suface of enterocytes in CD patients (Barnich et al., 
2007). Subsequently, increased expression of the glycosylated receptor 
carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) was 
observed in the involved ileal mucosa in comparison to the uninvolved ileal mucosa 
of CD patients (Barnich et al., 2007). Moreover, blocking expression of CEACAM6 
with an anti-CEACAM6 monoclonal antibody reduced the ability of LF82 to adhere 
to enterocytes isolated from CD patients (Barnich et al., 2007). Taken together, 
these results indicate that LF82 adheres to the ileal mucosa of CD patients by type 1 
fimbriae mediated binding to the CEACAM6 receptor expressed on the apical 
surface of ileal enterocytes in CD patients. In vitro experiments showed that 
CEACAM6 expression was upregulated in response to infection with LF82 or in 
response to treatment with pro-inflammatory cytokines (TNF-α and IFN-Ƴ) (Barnich 
et al., 2007). Therefore, it would appear that LF82 can promote their own 
colonisation in the CD gut by directly inducing the upregulation of CEACAM6 and 
also indirectly, by inducing TNF-α secretion from infected macrophages. The role 
for the abnormal expression of CEACAM6 in mediating colonisation of AIEC was 
confirmed in vivo. Using the transgenic CEABAC10 mouse model expressing human 
CEACAM6, it was shown that LF82 was able to colonise this mouse, however, no 
colonisation was observed in the wild-type mouse (which does not express 
CEACAM6) (Carvalho et al., 2009). Moreover, LF82 colonisation of the CEABAC10 
transgenic mouse was associated with severe colitis, characterised by body weight 
loss, diarrhoea, rectal bleeding, cytokine production and a reduced survival rate 
(Carvalho et al., 2009). In contrast, transgenic mice challenged with an E. coli K-12 
strain did not result in either colonisation or colitis (Carvalho et al., 2009). In 
addition, a type 1 fimbriae negative mutant of LF82 was also unable to colonise the 
transgenic mouse (as it cannot bind CEACAM6) or induce colitis (Carvalho et al., 
2009). Overall, this study shows that the abnormal expression of CEACAM6 plays a 
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pivotal role in the pathogenesis of AIEC in CD by promoting gut colonisation and 
inflammation.  
 
1.6.2.2 Flagella 
In a screen aimed at identifying genetic determinants which co-operate with type 1 
fimbriae in the LF82 invasive process, mutants in the flagellar regulon were 
obtained (Barnich et al., 2003). Of these mutants, a disruption in fliC showed the 
greatest defect in invasion. A fliC isogenic mutant was constructed in LF82 and 
further analysed. TEM analysis showed that this mutant failed to induce membrane 
elongations at the site of contact between the bacterial cell and host cell (Barnich 
et al., 2003), like the previously mentioned fim mutants. Interestingly, the fliC 
mutant was also shown to be defective for type 1 fimbriae production (Barnich et 
al., 2003). The transcription of the flagellar master regulator flhDC was 
downregulated in the fliC mutant; and complementation of the mutant with a 
cloned copy of fliC restored the transcription of flhDC to wild-type levels, suggesting 
that flhDC may be regulating both flagella and type 1 fimbriae expression in LF82 
(Barnich et al., 2003). Therefore in LF82, flagella and type 1 fimbriae appear to be 
co-regulated. To assess the specific role of flagella, the fliC mutant was 
complemented with the entire fim operon. This strain was still defective for both 
adhesion and invasion. However, the inclusion of a centrifugation step after 
infection (which approximates bacterial cells and the epithelium) restored 
adhesion, but not invasion, of this strain. This shows that flagella play a direct role 
in adhesion via active motility and an indirect role in invasion by regulating the 
expression of type 1 fimbriae and other factors which remain to be determined 
(Barnich et al., 2003).  
The flagellar sigma factor, FliA ( 28), has been identified as a key regulatory factor 
linking flagellar motility and type 1 fimbriae expression in LF82 (Claret et al., 2007). 
The loss of type 1 fimbriae expression in a fliA mutant was shown to be as a result 
of decreased expression of the c-di-GMP phosphodiesterase YhjH. Decreased 
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expression of YhjH was related to increased intracellular levels of c-di-GMP which in 
turn inhibit motility and type 1 fimbriae expression (Claret et al., 2007). 
Additionally, LF82 flagellin has been shown to be an important mediator of 
inflammation in the DSS mouse model of colitis. Using this model, it was shown that 
LF82, but not a fliC mutant (which is unable to produce flagellin), was capable of 
aggravating the clinical symptoms of colitis (Carvalho et al., 2008). Mice challenged 
with the wild-type LF82 had a reduced survival rate and increased diarrhoea and 
rectal bleeding as well as mucosal ulcerations and an infiltration of neutrophils, in 
comparison to mice challenged with the fliC mutant. The expression of the two 
pathogen recognition receptors (PRR’s) which detect flagellin, TLR5 (which detects 
flagellin extracellularly) and NLRC4 (which detects flagellin intracellularly) were 
upregulated at the mRNA level in mice challenged with LF82 in comparison to mice 
challenged with the fliC mutant or uninfected mice (Carvalho et al., 2008). Similarly, 
genes encoding pro-inflammatory cytokines (IL-6, TNF-α and IL-1β) were also 
upregulated at the mRNA level in mice challenged with LF82, but not the fliC 
mutant (Carvalho et al., 2008). 
 
1.6.2.3 Lipoproteins, outer membrane proteins (OMP’s) and outer membrane 
vesicles (OMV’s) 
The lipoprotein NlpI is involved in the LF82 adhesion and invasion process, as an 
nlpI mutant was reduced in its ability to attach to and invade the epithelial cell line 
Intestine-407 (Barnich et al., 2004). The nlpI mutant was non-motile and was 
defective in type 1 fimbriae production, however the defect in adhesion and 
invasion was independent of the loss of these phenotypes (Barnich et al., 2004). It 
has been demonstrated that surface-exposed lipoproteins can function in virulence 
by acting as adhesins. Indeed, the surface-exposed lipoprotein, JlpA, in 
Campylobacter jejuni mediates adhesion to HEp2 epithelial cells (Jin et al., 2001). In 
E. coli, it is believed that NlpI is targeted to the outer membrane (Barnich et al., 
2004). 
38 
 
A second lipoprotein, YfgL (BamB), has been identified which is involved in the 
invasive process of LF82 (Rolhion et al., 2005). YfgL is involved in the synthesis 
and/or degradation of peptidoglycan (Eggert et al., 2001). An LF82 yfgL isogenic 
mutant was reduced in its ability to invade Intestine-407 cells (Rolhion et al., 2005). 
Although this mutant had reduced motility and type 1 fimbriae expression in 
comparison to the parent strain, the defect in invasion was shown to be 
independent of motility or type 1 fimbriae. Analysis of culture supernatants from 
LF82 and the yfgL mutant showed that the amount of two outer membrane 
proteins (OMP’s), OmpA and OmpC were much lower in the yfgL mutant 
supernatant (Rolhion et al., 2005). The presence of these integral OMP’s in the 
culture supernatant of LF82 resulted from the formation of outer membrane 
vesicles (OMV’s). Therefore, deletion of yfgL resulted in the reduced secretion of 
OmpA and OmpC by decreasing the release of OMV’s. Moreover, pre-treatment of 
epithelial cells with OMV’s from LF82, but not from an E. coli K-12 strain, increased 
the ability of the yfgL mutant to invade (Rolhion et al., 2005). Therefore, it is 
possible that the OMV’s produced by LF82 contain virulence factors which mediate 
invasion. The transport of virulence factors via OMV’s has been demonstrated for 
ETEC and EHEC (Kesty et al., 2004; Kolling & Matthews, 1999). 
In CD patients, an abnormal reactivity to E. coli OmpC (encoding an outer 
membrane porin C) has been observed, with high levels of anti-OmpC antibodies 
observed in 37% - 55% of CD patients in comparison to only 5% of control patients 
(Arnott et al., 2004; Beaven & Abreu, 2004; Mow et al., 2004). Rolhion et al., (2007) 
have demonstrated that OmpC expression is increased in LF82 under conditions of 
high osmolarity, similar to that of the gastrointestinal (GI) tract. Additionally, LF82 
had an increased ability to adhere to and invade the epithelium under high 
osmolarity conditions, suggesting a role for OmpC in the interaction of LF82 with 
epithelial cells (Rolhion et al., 2007). Indeed, deletion of ompC in LF82 decreased 
the ability of LF82 to adhere to and invade Intestine-407 cells, which was 
independent of flagella and/or type 1 fimbriae (Rolhion et al., 2007). An ompR 
mutant (which does not express OmpC or OmpF), also showed a reduced ability to 
adhere to and invade the epithelium (Rolhion et al., 2007). Interestingly, 
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overexpression of RpoE ( E; a sigma factor controlling a regulatory pathway that 
responds to envelope stress) in the ompR mutant restored the wild-type phenotype 
without restoring expression of OmpC or OmpF (Rolhion et al., 2007). In addition to 
an increased expression of OmpC at high osmolarity, increased expression of RpoE 
was also observed; suggesting a direct role of RpoE and not OmpC in the adhesion 
and invasion process (Rolhion et al., 2007). Transcriptome analysis has shown that 
E regulates genes encoding chaperones and proteases which target overexpressed 
proteins in the cell envelope for degradation; and genes involved in the synthesis, 
assembly and homeostasis of OMP’s as well as genes related to pathogenesis 
(Rhodius et al., 2006). Indeed, the E pathway has been demonstrated to be 
important for the virulence of Salmonella and Mycobacterium (Bang et al., 2005; 
Manganelli et al., 2001). 
The outer membrane protein, OmpA, is also involved in the LF82 invasive process 
(Rolhion et al., 2010). Deletion of ompA had no effect on type 1 fimbriae 
production, but resulted in a decreased ability of LF82 to invade Intestine-407 cells 
(Rolhion et al., 2010). OmpA is involved in pathogenesis as it has been shown to 
play a role in adhesion, invasion and intracellular persistence of UPEC (Nicholson et 
al., 2009), EHEC (Torres & Kaper, 2003) and NMEC (Prasadarao et al., 1996b; Weiser 
& Gotschlich, 1991). In the case of NMEC strain K1, OmpA was shown to mediate 
binding to endothelial cells via the Ecgp96 receptor (Prasadarao, 2002). A 
homologue of Ecgp96, the endoplasmic reticulum (ER) localised stress response 
chaperone Gp96, is expressed by intestinal epithelial cells. Interestingly, expression 
of this receptor was shown to be increased in the epithelium of CD patients, in 
comparison to control patients (Rolhion et al., 2010). Expression of Gp96 was 
shown to support LF82 invasion, as siRNA-mediated knockdown of this receptor 
resulted in a decreased ability of LF82 to invade; and moreover, it was 
demonstrated that LF82 OmpA binds to Gp96 (Rolhion et al., 2010). Pre-treatment 
of epithelial cells with LF82 OMV’s (but not OMV’s from the ompA mutant) rescued 
the invasion defect of the ompA mutant, which was dependent on the expression of 
Gp96 (Rolhion et al., 2010). Taken together, these results suggest a role for OmpA-
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Gp96 binding in mediating the fusion of LF82 OMV’s with the epithelium, thus 
promoting LF82 invasion. 
 
 
 
 
Figure 1.4 Transmission electron micrographs (TEM’s) of C2Bbe1 epithelial cells infected 
with AIEC strain HM605. (A) A section of the cell monolayer after a 4 h infection period, 
showing numerous intracellular HM605 cells enclosed in vacuoles. Magnification X 4,000 
(B) Septum formation shows that HM605 can survive and multiply within C2Bbe1 cells. 
Magnification X 30,000. C2Bbe1 epithelial cell infection assay was carried out by Dr Adam 
O’ Driscoll (Department of Microbiology and Alimentary Pharmabiotic Centre, University 
College Cork). Sample preparation and microscopy was carried out by Dr Don O’ Leary 
(Department of Anatomy and Neuroscience, University College Cork). 
 
(A) 
 
 
 
 
 
 
(B) 
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1.6.3 M cells as a portal of entry for AIEC 
Although AIEC are partly defined by their ability to invade cultured epithelial cells in 
vitro, they have not been directly detected within epithelial cells of CD patients in 
vivo. It is therefore probable that AIEC use M cells as a means of crossing the 
epithelial barrier of CD patients. In support of this, the earliest lesions in CD 
patients usually overlie the Peyers patches (PP) in the distal ileum and the lymphoid 
follicles in the colon (Fujimura et al., 1996; Rickert & Carter, 1980). The epithelial 
layer that overlies the PP’s and the lymphoid follicles is called the follicle-associated 
epithelium (FAE) and is also the location of M cells. M cells are similar to epithelial 
cells in that they are polarised, form tight junctions and contain two major domains, 
the apical side and the basolateral side (Kraehenbuhl & Neutra, 2000). However, a 
distinguishing feature of M cells is that they contain a basolateral pocket, 
containing macrophages, dendritic cells, B lymphocytes and T lymphocytes 
(Kraehenbuhl & Neutra, 2000). M cells also lack the uniform, densely packed brush 
border which is characteristic of epithelial cells (Kraehenbuhl & Neutra, 2000). In 
epithelial cells, the microvilli tips are coated with the filamentous brush border 
glycocalyx (FBBG). The FBBG allows the diffusion of nutrients into the cell, while 
excluding pathogens, thereby preventing contact between pathogens and the 
epithelial surface. In contrast, M cells lack glycocalyx and their main function is in 
immunological sampling (Kraehenbuhl & Neutra, 2000). That is, they facilitate the 
uptake of antigens and microbes and deliver them to the basolateral pocket by a 
process known as transcytosis. However, pathogens can exploit this immune 
surveillance function of M cells whereby they use M cells as a means of invading the 
host. Indeed, Listeria, Mycobacterium, Shigella and Salmonella cross the epithelial 
barrier via M cells (Jensen et al., 1998; Secott et al., 2004). M cells are present in 
very low numbers in the follicle associated epithelium, making them difficult to 
isolate, and in turn, hindering the study of M cells in vitro. However, an in vitro M 
cell model has been developed, involving the co-culture of the Caco-2 intestinal 
epithelial cell line with B lymphocytes, which has facilitated the study of bacterial 
transport across M cells (Gullberg et al., 2000). Using this model, it was shown that 
E. coli strains isolated from CD biopsies, including HM605, translocated through M 
cells with a greater efficiency than control strains of E. coli (Roberts et al., 2010). 
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The presence of HM605 within M cells was also confirmed by TEM (Roberts et al., 
2010). A later study showed that LF82 interacted with both human and murine PP’s, 
and that this interaction was dependent on the expression of long polar fimbriae 
(LPF) in LF82 (Chassaing et al., 2011). Interestingly, LPF were not required for LF82 
to invade intestinal epithelial cells (Chassaing et al., 2011). Similarly, using the in 
vitro M cell model, it was shown that higher numbers of LF82 translocated across M 
cells in comparison to the Caco-2 monoculture; and again translocation across M 
cells was dependent on the expression of LPF (Chassaing et al., 2011). Mutations in 
the CD-associated CARD15/NOD2 gene are associated with the abnormal 
development and function of PP’s, characterised by an increase in the number of 
PP’s and M cells (Barreau et al., 2007). Consistent with this, increased numbers of 
LF82 were found interacting with PP’s from Nod2-/- mice in comparison with wild-
type mice, and this interaction was LPF dependent (Chassaing et al., 2011). A recent 
study has shown that LPF expression is upregulated in LF82 in the presence of bile 
salts (high levels of bile salts are characteristic of the intestinal environment) 
(Chassaing et al., 2013). When LF82 was cultured with the bile salt sodium choleate, 
there was a significant increase in the number of bacteria interacting with PP’s and 
the M cell monolayer, in comparison to untreated LF82 (Chassaing et al., 2013). 
Moreover, it was demonstrated that the transcriptional regulator FhlA plays a 
pivotal role in the expression of LPF under conditions of high bile salt 
concentrations (Chassaing et al., 2013). 
LPF have also been demonstrated to mediate the invasion of M cells by Salmonella 
(Baumler et al., 1996), whilst the IpaB and IpaC effectors are required by Shigella 
(Sansonetti et al., 1996). A recent study has shown that glycoprotein 2 (GP2) is 
specifically expressed on the apical membrane of M cells where it binds to the FimH 
adhesion of type 1 fimbriated bacteria such as E. coli and Salmonella, thus 
mediating their transcytosis (Hase et al., 2009). Type 1 fimbriae are essential for the 
adhesion and invasion of LF82 into epithelial cells (Boudeau et al., 2001), however 
they are not the sole requirement for the interaction of LF82 with M cells 
(Chassaing et al., 2011). Blocking GP2 with an anti-GP2 antibody reduced the 
numbers of LF82 interacting with PP’s and decreased numbers of LF82 interacted 
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with PP’s when fimA was deleted (Chassaing et al., 2011). However, when the 
binding of type 1 fimbriae to GP2 was blocked by chemical inhibitors, LF82 still 
interacted with PP’s, suggesting that this interaction can proceed in a mannose-
independent manner i.e. type 1 fimbriae independent (Chassaing et al., 2011). 
 
1.6.4 AIEC can persist and replicate within mature phagolysosomes in 
macrophages 
Macrophages serve as the first line of defence of the innate immune system. Their 
primary function is to engulf and eliminate invading microorganisms through the 
production of an arsenal of antimicrobial features such as an acidic pH, degradative 
proteases, reactive oxygen species and reactive nitrogen species (Flannagan et al., 
2009). However, many pathogenic organisms have devised mechanisms to avoid 
killing within these phagocytic cells, thus promoting their intracellular survival and 
replication. Such evasion strategies include escaping from the phagosome (Listeria 
and Shigella), preventing phagosomal maturation (Mycobacterium and Salmonella) 
or resisting the antimicrobial environment (Coxiella) (Alpuche-Aranda et al., 1994; 
Flannagan et al., 2009; High et al., 1992). 
The second hallmark feature of AIEC is their ability to survive and replicate within 
macrophages. In the original study it was shown that a panel of AIEC strains that 
were isolated from ileal lesions of patients with CD, including the prototypical AIEC 
strain LF82, were able to survive and replicate extensively within the murine 
phagocytic cell line J774A.1 (Glasser et al., 2001). The non-pathogenic control E. coli 
strain C600 was eradicated by the same macrophages. TEM showed that LF82 
resided in small vacuoles within the macrophage, which over time were capable of 
fusing with each other, resulting in the formation of large spacious phagosomes; 
with no bacteria observed free in the cytoplasm (Glasser et al., 2001). Moreover, 
LF82 was not cytotoxic to macrophages and infection of macrophages with LF82 
resulted in the secretion of the pro-inflammatory cytokine TNF-α, but not IL-1β 
(Glasser et al., 2001). A recent study demonstrated that this TNF-α secretion from 
infected macrophages is beneficial to intracellular LF82, as it maintains their 
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intracellular replication (Bringer et al., 2012). Stimulation of macrophages with 
exogenous TNF-α resulted in a corresponding dose dependent increase in 
intracellular replication and treating macrophages with an anti-TNF-α antibody 
resulted in a significant decrease in the number of intramacrophagic LF82 (Bringer 
et al., 2012). Similar to this, TNF-α has also been shown to enhance the intracellular 
growth of Mycobacterium (Engele et al., 2002). However, TNF-α secretion can also 
have the opposite effect on bacterial replication, as has been shown for Salmonella 
(Bringer et al., 2012). 
LF82-containing phagosomes traffic along the classical endocytic pathway (Bringer 
et al., 2006). After infection, phagosomes acquired the early endosomal marker, 
early endocytic antigen 1 (EEA1), which was followed by acquisition of Rab7 GTPase 
and lysosomal-associated membrane protein-1 (Lamp-1), which are features of late 
endosomes (Bringer et al., 2006). Once phagosomes have matured, they 
accumulate Lamps and hydrolytic enzymes such as cathepsin D and continue to 
acidify to order to degrade their contents. Consistent with this, LF82-containing 
phagosomes were positive for Lamp-1, Lamp-2 and cathepsin D, and were also 
positively marked with the pH indicator LysoTracker red, indicating that they had 
matured into phagolysosomes (Bringer et al., 2006). In addition, it was 
demonstrated that LF82 requires an acidic pH in order to replicate intracellularly, as 
neutralisation of the phagosome with ammonium chloride reduced the replication 
of intracellular LF82 (Bringer et al., 2006).  
Indeed, it has also been demonstrated that E. coli strains isolated from colonic 
biopsies of CD patients are capable of replicating within macrophages 
(Subramanian et al., 2008). This group showed that eight colonic CD E. coli isolates, 
including HM605, were better able to replicate in J774A.1 macrophages than a K-12 
laboratory strain of E. coli (Subramanian et al., 2008). HM605 was also shown to 
replicate within human monocyte derived macrophages (HMDM’s) (Subramanian et 
al., 2008). TEM analysis of J774A.1 macrophages infected with HM605 showed that 
they resided in vacuoles, which had the appearance of phagolysosomes and no 
bacteria were observed free in the cytoplasm (Subramanian et al., 2008); similar to 
observations with LF82. 
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Figure 1.5 Transmission electron micrographs (TEM’s) of J774A.1 macrophages infected 
with HM605. (A) At 0 h post-infection, intracellular HM605 can be observed within 
vacuoles. Septum formation indicates that HM605 can divide within the host cell. 
Magnification X 12,000 (B) At 12 h post-infection, numerous intracellular HM605 can be 
observed within vacuoles. These are likely to be derived directly from intramacrophagic 
replication as gentamicin is present in the growth medium to kill any extracellular bacteria. 
Magnification X 12,000. Sample preparation and microscopy was carried out by Dr Don O’ 
Leary (Department of Anatomy and Neuroscience, University College Cork). 
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1.6.4.1 Genetic factors involved in the ability of AIEC to survive and replicate 
within macrophages 
Molecular studies have identified genes in LF82 which are required for its ability to 
persist and replicate in macrophages. However, it is important to note that these 
genes are also present in commensal E. coli strains, which are unable to replicate in 
macrophages and are thus not specific AIEC-associated virulence genes. Therefore 
the factors(s) that differentiate AIEC from other strains of E. coli and allow this 
group to replicate in the macrophage remain as of yet, undetected. 
A transposon mutant library in LF82 was screened in J774A.1 macrophages, in order 
to isolate mutants that had a defect in intracellular growth. One mutant had a 
transposon inserted in the htrA (degP) gene (Bringer et al., 2005). This gene 
encodes a periplasmic serine protease which is involved in the bacterial stress 
response. The htrA mutant was more sensitive to oxidative stress than the wild-
type strain and its growth was compromised in an acidic and nutrient poor medium, 
designed to mimic the phagosome (Bringer et al., 2005). The htrA gene promoter 
was cloned upstream of the lacZ gene and transformed into both LF82 and K-12. In 
this way, it was shown that the transcription of htrA was upregulated in LF82, but 
not in the K-12 strain, in macrophages, in comparison to growth in cell culture 
medium (Bringer et al., 2005). Therefore, HtrA may play an important role in the 
adaptation of this strain to the hostile conditions encountered in the macrophage. 
Indeed, htrA mutants in other bacterial pathogens such as Salmonella and 
Legionella also have reduced virulence (Johnson et al., 1991; Pedersen et al., 2001). 
Screening the LF82 transposon mutant library also identified a mutant in dsbA, 
which was defective for both survival and replication in J774A.1 macrophages 
(Bringer et al., 2007). DsbA encodes an oxidoreductase, which is responsible for 
introducing disulfide bonds into proteins, in particular membrane proteins and 
exported proteins (Heras et al., 2009). Without these disulfide bonds, proteins are 
unstable, misfolded and inactive. Indeed, a wide variety of bacterial virulence 
factors require a disulfide bond for activity, such as fimbriae of EPEC and UPEC, the 
T3SS of Salmonella and Shigella and toxins of ETEC, amongst many others; and 
deleting dsbA in these strains results in attenuation (Jacob-Dubuisson et al., 1994; 
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Miki et al., 2004; Yu et al., 2000; Yu et al., 2001; Zhang & Donnenberg, 1996). The 
LF82 dsbA mutant was shown to be defective in the expression of both type 1 
fimbriae and flagella. However, the intracellular growth defect of the dsbA mutant 
was independent of this defect (Bringer et al., 2007). Similar to the htrA mutant, 
growth of the dsbA mutant was compromised in an acidic and nutrient poor 
medium, designed to mimic the phagosome. Additionally, dsbA gene expression 
was upregulated in LF82 bacteria growing in this medium suggesting that dsbA 
expression is activated under phagolysosomal conditions (Bringer et al., 2007). 
DsbA is also important for the virulence of the Gram negative pathogen Shigella 
flexneri. Similarly to LF82, a S. flexneri dsbA mutant also grew poorly within 
macrophages in comparison to the wild-type (Yu et al., 2001). 
The RNA-binding chaperone, Hfq, has also been shown to be important for the 
intracellular survival of LF82 in cultured macrophages, as well as for its ability to 
invade cultured epithelial cells (Simonsen et al., 2011). Hfq functions as a global 
posttranscriptional regulator of gene expression by binding to small regulatory 
RNA’s (sRNA’s) and thus facilitating their interaction with their target mRNA (Chao 
& Vogel, 2010). In vitro stress tests showed that the LF82 hfq mutant had an 
increased sensitivity to low pH, reactive oxygen species and reactive nitrogen 
species, conditions which are characteristic of the mature phagolysosome. This may 
assign an important role for Hfq in promoting the adaptation of the bacterial cells 
to the hostile conditions it encounters within the macrophage. This suggests that 
sRNA molecules may play an important role in the regulation of the AIEC 
phenotype. Hfq has been previously reported to play an important role in the 
general fitness and virulence of bacterial pathogens (Chao & Vogel, 2010).  
The genetic factors identified to date which are important for the pathogenesis of 
AIEC are summarised in Table 1.2. 
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Table 1.2 A summary of virulence factors required for the pathogenesis of AIEC 
strain LF82 
Virulence 
factor 
Process Function in LF82 virulence Reference 
Type 1 
fimbriae 
Epithelial cell 
adhesion/invasion 
Bind to CEACAM6 and induce 
host cell membrane 
elongations, promoting invasion 
Boudeau et al., 2001 
Flagella Epithelial cell 
adhesion/invasion 
Promote adhesion via active 
motility; co-regulated 
expression of type 1 fimbriae 
Barnich et al., 2003 
Claret et al., 2007 
Long polar 
fimbriae 
Interaction with PP’s; 
translocation of M cells 
Promote interaction with PP’s 
and translocation across M cells 
Chassaing et al., 2011 
NlpI Epithelial cell 
adhesion/invasion 
Lipoprotein; role in virulence of 
LF82 is unknown 
Barnich et al., 2004 
YfgL 
(BamB) 
Epithelial cell invasion Lipoprotein; ∆yfgL had reduced 
secretion of OmpA/C due to 
decreased release of OMV’s 
Rolhion et al., 2005 
OmpC Epithelial cell 
adhesion/invasion 
Role of OmpC in virulence is 
indirect, direct role for sigma E 
regulatory pathway 
Rolhion et al., 2007 
OmpA Epithelial cell invasion Binds to Gp96 on epithelial cell 
surface, mediating fusion of 
OMV’s with epithelium 
Rolhion et al., 2010 
DsbA Epithelial cell 
adhesion/invasion; 
Replication in 
macrophages 
Role in adhesion/invasion is due 
to loss of flagella/type 1 
fimbriae; adaptation to harsh 
conditions of phagolysosome 
Bringer et al., 2007 
HtrA 
(DegP) 
Replication in 
macrophages 
Adaptation to harsh conditions 
of phagolysosome 
Bringer et al., 2005 
Hfq Epithelial cell invasion; 
Replication in 
macrophages 
Unknown; ∆hfq was non-motile, 
type 1 fimbriae
-
 and was 
sensitive to in vitro stress 
conditions 
Simonsen et al., 2011 
 
 
1.7 Comparative genomics 
To date, the genomes of four AIEC strains have been sequenced, namely LF82 
(Miquel et al., 2010), NRG857c (Nash et al., 2010), UM146 (Krause et al., 2010) and 
HM605 (Clarke et al., 2011) . The general consensus from these genome sequencing 
projects is that AIEC strains cluster within the B2 phylogroup and indeed, their 
genomes closely resemble that of other extraintestinal pathogenic E. coli (ExPEC) 
strains associated with neonatal meningitis, urinary tract infections and avian 
colibacillosis. However, it is important to note that phylogenetic studies have also 
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isolated AIEC strains from the A, B1 and D phylogroups, suggesting that AIEC are a 
highly diverse group (Martinez-Medina et al., 2009a; Martinez-Medina et al., 
2009b). This suggests that AIEC are not a clonal group of strains, and may have 
evolved several times, independently, over time. 
These sequencing projects revealed that AIEC strains harbour virulence-associated 
genes characteristic of ExPEC including genes involved in motility, serum resistance, 
iron uptake, capsule expression and the adhesion to, and invasion of, epithelial cells 
(Miquel et al., 2010; Nash et al., 2010). However, a recent study determined the 
frequency of the AIEC phenotype among a collection of ExPEC strains (isolated from 
patients with UTI’s, sepsis, meningitis and abcesses), by analysing the ability of 
these strains to adhere to and invade intestinal epithelial cells as well as to survive 
and replicate within macrophages (Martinez-Medina et al., 2009b). Results showed 
that the majority of ExPEC strains do not behave like AIEC, suggesting that the AIEC 
group possess distinct virulence genes that are not found in other ExPEC strains 
(Martinez-Medina et al., 2009b). Genomic comparisons were carried out between 
two AIEC strains, LF82 and NRG857c, and 29 other non-AIEC strains of pathogenic 
and commensal nature, in an attempt to identify genetic determinants unique to 
the AIEC group (Nash et al., 2010). In this study, 35 genomic islands were identified 
on the NRG857c chromosome which exhibited a high level of conservation with 
LF82, but were poorly conserved or absent among non-AIEC and commensal 
strains, suggesting that these islands could encode genes unique to AIEC. Among 
these islands, 21 sequences (coding for prophage elements and proteins involved in 
intermediary metabolism) were identified which were unique to AIEC (Nash et al., 
2010). However, phylogenetic analysis of AIEC strain HM605 showed that this strain 
is more divergent than LF82 or NRG857c, and comparisons failed to identify any 
AIEC-specific regions in HM605 (Clarke et al., 2011). The regions identified as 
specific to AIEC in the comparison between LF82 and NRG857c likely reflect the 
close relationship between these two strains that have the same serotype (083:H1) 
(Clarke et al., 2011). Therefore, although AIEC have unique pathogenic features 
there does not appear to be a specific set of genes to explain these features.  
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1.8 Pathoadaptive mutations 
The evolution of non-pathogenic bacteria to pathogenic bacteria can occur 
primarily via two major mechanisms; the acquisition of virulence genes via 
horizontal gene transfer or the modification of existing genes. The latter involves 
the selection of mutations in genes that ultimately result in a change in gene 
function. Mutations that result in a selective advantage in the virulence niche are 
referred to as pathoadaptive mutations (Sokurenko et al., 1999). As no AIEC-specific 
virulence factors have been identified to date, pathoadaptive mutations could play 
an important role in enhancing the pathogenesis of AIEC. It has previously been 
demonstrated that the FimH adhesin of type 1 fimbriae plays an important role in 
the binding of LF82 to host cell receptors (Boudeau et al., 2001). This group also 
reported that LF82 express a variant of type 1 fimbriae that is distinct from non-
invasive strains of E. coli. Nucleotide sequence analysis of the fimH gene from LF82 
revealed that it was highly homologous to fimH from other invasive E. coli such as 
MT78 (APEC) and IHE3034 (NMEC), but not to E. coli K-12 (Boudeau et al., 2001). 
Phylogenetic analysis of the FimH amino acid sequence from all of the sequenced E. 
coli strains showed that FimH clustered in two major groups, with one group 
containing all the B2 strains (except S88 and E234869) (Miquel et al., 2010). Two 
substitutions were identified N70S and S78N (Miquel et al., 2010), which have 
previously been characterised as being specific to the B2 phylogroup (Hommais et 
al., 2003). A novel substitution was also identified T158P, which has not been 
identified in any sequenced E. coli genome to date (Miquel et al., 2010). Position 
158 is in the flexible loop which links the pilin domain and the lectin domain, and 
interestingly, substitutions in this region have been previously shown to enhance 
the affinity of FimH to its receptor (Aprikian et al., 2007). Indeed, these 
substitutions endow LF82 with an increased ability to adhere to T84 intestinal 
epithelial cells (Dreux et al., 2013). In addition, replacing the polymorphic FimH of 
LF82 with FimH of an E. coli K-12 strain decreased the ability of LF82 to colonise and 
induce colitis in CEABAC10 transgenic mice expressing CEACAM6 (Dreux et al., 
2013). 
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It has been previously documented that an ompA mutant in LF82 is defective for 
invasion into host epithelial cells; and complementation of this mutant with LF82 
OmpA, but not OmpA from E. coli K-12 restored invasiveness (Rolhion et al., 2010). 
A comparison of the amino acid sequences of OmpA from LF82 and MG1655, 
revealed 2 substitutions in LF82, V110F and Y111D (Miquel et al., 2010; Rolhion et 
al., 2010). Phylogenetic analysis of the OmpA amino acid sequence from other E. 
coli strains showed that OmpA from all B2 strains (except CFT073) contain these 
substitutions and cluster on a single branch (Miquel et al., 2010). These 
substitutions are located at the top of the inflexible external L3 loop, and are 
thought to enhance recognition of host cell receptors (Miquel et al., 2010). OmpC 
and YfgL have also been reported to be important for the invasive ability of LF82 
(Rolhion et al., 2005; Rolhion et al., 2007). Again, phylogenetic analysis of the amino 
acid sequences of these proteins revealed that the amino acid sequence of these 
proteins from all B2 strains clustered together (Miquel et al., 2010). 
Therefore, there is evidence that important surface proteins have undergone 
positive selection resulting in improved interactions with host cells. Moreover, 
there is also evidence that suggests that the regulatory networks controlling the 
expression of some genes identified as virulence factors in AIEC may also have 
experienced some selection to increase the fitness of these bacteria. For example, 
the expression of htrA in LF82 (a gene required for growth in the macrophage) is 
increased in the macrophage whilst the expression of the same gene in a K-12 strain 
of E. coli is not (Bringer et al., 2005). This suggests that AIEC may have evolved its 
virulence through a combination of the positive selection of 1) specific alleles of 
important proteins and 2) specific changes in important regulatory networks. 
 
1.9 Proposed model for the role of AIEC in CD 
AIEC have been isolated in increased numbers from the guts of CD patients, 
however they are also present in the guts of healthy individuals but do not cause 
disease (Darfeuille-Michaud et al., 2004), suggesting that AIEC are pathobionts. One 
theory is that AIEC could be directly involved in initiating CD. CD patients harbour 
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an underlying genetic immunodeficiency (Hugot et al., 2001; Ogura et al., 2001; 
Rioux et al., 2007) and one possibility is that as a result of this, they are unable to 
clear AIEC that gain access to the lamina propria, resulting in chronic inflammation 
(Strober, 2011). This theory is flawed however, as it would suggest that CD patients 
would also be susceptible to infection with other intestinal pathogens such as 
Salmonella and Shigella, and indeed, this has not been reported (Strober, 2011). 
Moreover, it has been shown that NOD2-deficient mice do not develop colitis in the 
presence of AIEC (Barreau et al., 2007). 
An alternative and more likely theory is that the inflammatory conditions in the CD-
gut “licence” AIEC pathogenicity (Strober, 2011) and so AIEC are secondary to and 
not a primary cause of the inflammation. It is generally accepted that CD results 
from a hypersensitivity to the enteric gut microflora, resulting in continuous 
antigenic stimulation and activation of the mucosal immune system, leading the 
intestinal damage (Kaser et al., 2010; Xavier & Podolsky, 2007). Indeed, strong 
evidence for this stems from the observation that gnotobiotic mice only develop 
colitis when the microbiota has been re-introduced (Frank et al., 2007; Strober et 
al., 2002). Moreover, a dysbiosis has been observed in CD patients, characterised by 
an abundance of “aggressive” species such as Proteobacteria relative to 
“protective” species such as Firmicutes. These changes in the microbiota (possibly 
due to elements of a modern lifestyle and amplified by the genetic defects in CD 
patients) could stimulate a hyper-immunological response resulting in an 
inflammation that could favour the proliferation and invasion of AIEC (eg. by 
upregulating receptors such as CEACAM6 and Gp96 or by inducing ulcerations 
facilitating AIEC translocation to the lamina propria), thereby aggravating the 
inflammatory process and resulting in a positive feedback loop of invasion and 
inflammation (Carvalho et al., 2012; Craven et al., 2012; Martinez-Medina et al., 
2013). Therefore, it is likely that AIEC are involved in maintaining the inflammatory 
state, rather than being a primary cause of it. Figure 1.6 outlines a proposed model 
for the role of AIEC in the pathogenesis of CD. However, it is important to reinforce 
that this model is based on a single strain of AIEC i.e. LF82 and it is possible that 
aspects of this model may be modified depending on the AIEC strain. 
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Figure 1.6 A model for the role of AIEC in CD pathogenesis. (A) AIEC may be present as 
normal members of the microbiota. (B) Gut microbial dysbiosis due to environmental 
insults/underlying genetic susceptibility induces a pro-inflammatory response in the gut. 
This inflammatory response induces the increased expression of CEACAM6, an epithelial 
cell receptor for AIEC, thereby selecting for the proliferation of AIEC. AIEC can then invade 
epithelial cells or can be taken up through Peyers patches via the binding of long polar 
fimbriae (LPF) to Gp2 expressed on the surface of M cells. (C) AIEC are then phagocytosed 
by macrophages, either underlying the Peyers patches or patrolling the lamina propria. Like 
many intracellular pathogens AIEC engage with autophagy where they are enclosed within 
autophagosomes and are rapidly degraded, thereby resolving the infection. However, some 
CD patients exhibit defects in autophagy and AIEC are subsequently taken up into 
phagolysosomes, where they replicate, resulting in the hyper-secretion of pro-
inflammatory cytokines. 
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1.10 Objectives of this study 
The overall objective of this study was to gain a better understanding of the 
interaction between AIEC and the host cell. One of the defining features of AIEC is 
their ability to persist and replicate within macrophages and it has been proposed 
that AIEC-infected macrophages are stimulated to produce high levels of pro-
inflammatory cytokines, thus contributing to the inflammation observed in CD 
patients. Additionally, AIEC are capable of adhering to and invading intestinal 
epithelial cells. However, the molecular mechanisms underpinning these processes 
are not well understood. Therefore, the aims of this study were firstly, to determine 
the metabolic pathways which support the growth of AIEC in the macrophage; 
secondly, to uncover the mechanism(s) driving AIEC-dependent cytokine production 
and thirdly, to determine the role played by flagella and flagella-mediated motility 
in mediating the interaction between AIEC and epithelial cells. 
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Chapter 2: Materials and Methods 
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2.1 Bacterial strains and plasmids 
The bacterial strains used in this study are listed in Table 2.1 and the plasmids in 
Table 2.2. AIEC strain HM605, isolated from a colonic mucosal biopsy of a patient 
with CD and was a gift from Barry J. Campbell, Department of Medicine, Henry 
Wellcome Laboratory of Molecular and Cellular Gastroenterology, University of 
Liverpool, Liverpool, United Kingdom (Martin et al., 2004). AIEC strain LF82, isolated 
from a chronic ileal lesion of a CD patient, was a gift from Arlette Darfeuille-
Michaud, Laboratoire de Bacteriologie, Faculte de Pharmacie, Clermont-Ferrand, 
France (Darfeuille-Michaud et al., 1998). 
 
Table 2.1 List of strains relevant to this study 
Strain Relevant characteristics Source or Reference Comments 
BW25113 
∆pfkA::Km 
∆pfkA::Km knockout mutant in 
E. coli K-12 strain BW25113 
Keio Library  
(Baba et al., 2006) 
Glycolysis mutant 
BW25113 
∆pfkB::Km 
∆pfkB::Km knockout mutant in 
E. coli K-12 strain BW25113 
Keio Library 
(Baba et al., 2006) 
Glycolysis mutant 
BW25113 ∆pgi::Km ∆pgi::Km knockout mutant in E. 
coli K-12 strain BW25113 
Keio Library 
(Baba et al., 2006) 
Glycolysis mutant 
BW25113 
∆tpiA::Km 
∆tpiA::Km knockout mutant in 
E. coli K-12 strain BW25113 
Keio Library 
(Baba et al., 2006) 
Glycolysis mutant 
BW25113 
∆pgm::Km 
∆pgm::Km knockout mutant in 
E. coli K-12 strain BW25113 
Keio Library 
(Baba et al., 2006) 
Glycolysis mutant 
BW25113 ∆fbp::Km ∆fbp::Km knockout mutant in E. 
coli K-12 strain BW25113 
Keio Library 
(Baba et al., 2006) 
Gluconeogenesis 
mutant 
BW25113 
∆glpX::Km 
∆glpX::Km knockout mutant in 
E. coli K-12 strain BW25113 
Keio Library 
(Baba et al., 2006) 
Gluconeogenesis 
mutant 
BW25113 
∆pps::Km 
∆pps::Km knockout mutant in 
E. coli K-12 strain BW25113 
Keio Library 
(Baba et al., 2006) 
Gluconeogenesis 
mutant 
BW25113 
∆pck::Km 
∆pck::Km knockout mutant in 
E. coli K-12 strain BW25113 
Keio Library 
(Baba et al., 2006) 
Gluconeogenesis 
mutant 
BW25113 
∆acnA::Km 
∆acnA::Km knockout mutant in 
E. coli K-12 strain BW25113 
Keio Library 
(Baba et al., 2006) 
TCA 
cycle/Glyoxylate 
shunt mutant 
BW25113 
∆acnB::Km 
∆acnB::Km knockout mutant in 
E. coli K-12 strain BW25113 
Keio Library 
(Baba et al., 2006) 
TCA 
cycle/Glyoxylate 
shunt mutant 
BW25113 
∆aceA::Km 
∆aceA::Km knockout mutant in 
E. coli K-12 strain BW25113 
Keio Library 
(Baba et al., 2006) 
Glyoxylate shunt 
mutant 
BW25113 ∆icd::Km ∆icd::Km knockout mutant in E. 
coli K-12 strain BW25113 
Keio Library 
(Baba et al., 2006) 
TCA cycle mutant 
BW25113 
∆gnd::Km 
∆gnd::Km knockout mutant in 
E. coli K-12 strain BW25113 
Keio Library 
(Baba et al., 2006) 
Pentose Phosphate 
pathway mutant 
BW25113 
∆edd::Km 
∆edd::Km knockout mutant in 
E. coli K-12 strain BW25113 
Keio Library 
(Baba et al., 2006) 
Entner-Doudoroff 
pathway mutant 
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BW25113 
∆eda::Km 
∆eda::Km knockout mutant in 
E. coli K-12 strain BW25113 
Keio Library 
(Baba et al., 2006) 
Entner-Doudoroff 
pathway mutant 
E. coli strain 
HM605 
Amp
R
, AIEC strain isolated 
from a colonic biopsy of a CD 
patient 
Barry Campbell 
(Martin et al., 2004) 
Wild-type AIEC 
strain 
∆pfkA::Km ∆pfkA::Km knockout mutant in 
E. coli HM605 
This study Glycolysis mutant 
∆pfkB::Km ∆pfkB::Km knockout mutant in 
E. coli HM605 
This study Glycolysis mutant 
∆pfkA ∆pfkA markerless mutant in E. 
coli HM605 
This study Glycolysis mutant, 
Km
R
 cassette 
removed by FLP 
recombinase 
∆pfkAB::Km ∆pfkAB::Km knockout mutant 
in E. coli HM605 
This study Glycolysis mutant 
∆pfkAB::Km 
(pCA24N-pfkA) 
∆pfkAB::Km knockout mutant 
in E. coli HM605, 
complemented with pCA24N 
expressing a copy of pfkA (Cm
R
) 
This study Complementation 
of ∆pfkAB::Km 
∆pfkAB::Km 
(pCA24N-pfkB) 
∆pfkAB::Km knockout mutant 
in E. coli HM605, 
complemented with pCA24N 
expressing a copy of pfkB (Cm
R
) 
This study Complementation 
of ∆pfkAB::Km 
∆pgi::Km ∆pgi::Km knockout mutant in E. 
coli HM605 
This study Glycolysis mutant 
∆tpiA::Km ∆tpiA::Km knockout mutant in 
E. coli HM605 
This study Glycolysis mutant 
∆pgm::Km ∆pgm::Km knockout mutant in 
E. coli HM605 
This study Glycolysis mutant 
∆fbp::Km ∆fbp::Km knockout mutant in E. 
coli HM605 
This study Gluconeogenesis 
mutant 
∆glpX::Km ∆glpX::Km knockout mutant in 
E. coli HM605 
This study Gluconeogenesis 
mutant 
∆pps::Km ∆pps::Km knockout mutant in 
E. coli HM605 
This study Gluconeogenesis 
mutant 
∆pck::Km ∆pck::Km knockout mutant in 
E. coli HM605 
This study Gluconeogenesis 
mutant 
∆acnA::Km ∆acnA::Km knockout mutant in 
E. coli HM605 
This study TCA 
cycle/Glyoxylate 
shunt mutant 
∆acnB::Km ∆acnB::Km knockout mutant in 
E. coli HM605 
This study TCA 
cycle/Glyoxylate 
shunt mutant 
∆aceA::Km ∆aceA::Km knockout mutant in 
E. coli HM605 
This study Glyoxylate shunt 
mutant 
∆icd::Km ∆icd::Km knockout mutant in E. 
coli HM605 
This study TCA cycle mutant 
∆gnd::Km ∆gnd::Km knockout mutant in 
E. coli HM605 
This study Pentose Phosphate 
pathway mutant 
∆edd::Km ∆edd::Km knockout mutant in 
E. coli HM605 
This study Entner-Doudoroff 
pathway mutant 
∆eda::Km ∆eda::Km knockout mutant in 
E. coli HM605 
This study Entner-Doudoroff 
pathway mutant 
ilvE::Km E. coli HM605 with Km
R
 
transposon insertion in ilvE 
This study Tn5 auxotrophic 
mutant 
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panC::Km E. coli HM605 with Km
R
 
transposon insertion in panC 
This study Tn5 auxotrophic 
mutant 
trpB::Km E. coli HM605 with Km
R
 
transposon insertion in trpB 
This study Tn5 auxotrophic 
mutant 
proA::Km E. coli HM605 with Km
R
 
transposon insertion in proA 
This study Tn5 auxotrophic 
mutant 
aroE::Km E. coli HM605 with Km
R
 
transposon insertion in aroE 
This study Tn5 auxotrophic 
mutant 
metB::Km E. coli HM605 with Km
R
 
transposon insertion in metB 
This study Tn5 auxotrophic 
mutant 
pyrF::Km E. coli HM605 with Km
R
 
transposon insertion in pyrF 
This study Tn5 auxotrophic 
mutant/Tn5 
mutant from 
rapamycin screen 
pyrF::Km (pCA24N-
pyrF) 
E. coli HM605 with Km
R
 
transposon insertion in pyrF, 
complemented with pCA24N 
expressing pyrF (Cm
R
) 
This study Complementation 
of pyrF::Km 
purD::Km E. coli HM605 with Km
R
 
transposon insertion in purD 
This study Tn5 auxotrophic 
mutant 
purE::Km E. coli HM605 with Km
R
 
transposon insertion in purE 
This study Tn5 auxotrophic 
mutant 
nadC::Km E. coli HM605 with Km
R
 
transposon insertion in nadC 
This study Tn5 auxotrophic 
mutant 
argB::Km E. coli HM605 with Km
R
 
transposon insertion in argB 
This study Tn5 auxotrophic 
mutant 
trpE::Km E. coli HM605 with Km
R
 
transposon insertion in trpE 
This study Tn5 auxotrophic 
mutant 
proB::Km E. coli HM605 with Km
R
 
transposon insertion in proB 
This study Tn5 auxotrophic 
mutant 
pdxB::Km E. coli HM605 with Km
R
 
transposon insertion in pdxB 
This study Tn5 auxotrophic 
mutant 
thrB::Km E. coli HM605 with Km
R
 
transposon insertion in thrB 
This study Tn5 auxotrophic 
mutant 
aroC::Km E. coli HM605 with Km
R
 
transposon insertion in aroC 
This study Tn5 auxotrophic 
mutant 
purM::Km E. coli HM605 with Km
R
 
transposon insertion in purM 
This study Tn5 auxotrophic 
mutant 
ilvY::Km E. coli HM605 with Km
R
 
transposon insertion in ilvY 
This study Tn5 auxotrophic 
mutant 
cysG::Km E. coli HM605 with Km
R
 
transposon insertion in cysG 
This study Tn5 auxotrophic 
mutant 
carB::Km E. coli HM605 with Km
R
 
transposon insertion in carB 
This study Tn5 auxotrophic 
mutant 
ubiE::Km E. coli HM605 with Km
R
 
transposon insertion in ubiE 
This study Tn5 mutant from 
rapamycin screen 
aceE::Km E. coli HM605 with Km
R
 
transposon insertion in aceE 
This study Tn5 mutant from 
rapamycin screen 
ptsI::Km E. coli HM605 with Km
R
 
transposon insertion in ptsI 
This study Tn5 mutant from 
rapamycin screen 
kpsS::Km E. coli HM605 with Km
R
 
transposon insertion in kpsS 
This study Tn5 mutant from 
rapamycin screen 
HM605_0337::Km E. coli HM605 with Km
R
 
transposon insertion in 
HM605_0337 
This study Tn5 mutant from 
rapamycin screen 
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efp::Km E. coli HM605 with Km
R
 
transposon insertion in efp 
This study Tn5 mutant from 
rapamycin screen 
basR::Km E. coli HM605 with Km
R
 
transposon insertion in basR 
This study Tn5 mutant from 
rapamycin screen 
E. coli strain LF82 Amp
R
, E. coli isolated from a 
chronic ileal lesion of a CD 
patient 
Arlette Darfeuille-
Michaud  
(Darfeuille-Michaud 
et al., 1998) 
Wild-type AIEC 
strain 
flhC::Km E. coli LF82 with Km
R
 
transposon insertion in flhC 
This study Tn5 motility 
mutant 
fliI::Km E. coli LF82 with Km
R
 
transposon insertion in fliI 
This study Tn5 motility 
mutant 
flgE::Km E. coli LF82 with Km
R
 
transposon insertion in flgE 
This study Tn5 motility 
mutant 
flgJ::Km E. coli LF82 with Km
R
 
transposon insertion in flgJ 
This study Tn5 motility 
mutant 
dsbA::Km E. coli LF82 with Km
R
 
transposon insertion in dsbA 
This study Tn5 motility 
mutant 
dsbB::Km E. coli LF82 with Km
R
 
transposon insertion in dsbB 
This study Tn5 motility 
mutant 
ubiH::Km E. coli LF82 with Km
R
 
transposon insertion in ubiH 
This study Tn5 motility 
mutant 
bdm::Km E. coli LF82 with Km
R
 
transposon insertion in bdm 
This study Tn5 motility 
mutant 
LF82 bdm::Km 
(pBAD33-bdm) 
E. coli LF82 with Km
R
 
transposon insertion in bdm, 
complemented with pBAD33 
expressing a copy of bdm (Cm
R
) 
This study Complementation 
of bdm::Km 
LF82 (pCA24N-
bdm) 
E. coli LF82 containing pCA24N 
expressing a copy of bdm (Cm
R
) 
This study Overexpression of 
Bdm in LF82 
LF82 (pCA24N-
osmC) 
E. coli LF82 containing pCA24N 
expressing a copy of osmC 
(Cm
R
) 
This study Overexpression of 
OsmC in LF82 
LF82 (bdm-
subclone) 
E. coli LF82 containing pBR322 
expressing bdm subclone 
fragment 
This study Expression of bdm- 
subclone fragment 
in LF82 
E. coli K-12 strain 
BW25113 
F
-
, DE(araD-araB)567, 
lacZ4787(del)::rrnB-3, LAM-, 
rph-1, DE(rhaD-rhaB)568, 
hsdR514 
Lab stock Wild-type strain 
∆bdm::Km ∆bdm::Km knockout mutant in 
E. coli BW25113 
Keio Library 
(Baba et al., 2006) 
bdm mutant 
E. coli K-12 strain 
MG1655 
F
-
 λ
-
 ilvG
-
 rfb-50 rph-1 Lab stock Wild-type strain 
∆bdm::Km ∆bdm::Km knockout mutant in 
E. coli MG1655 
This study bdm mutant 
E. coli K-12 strain 
W3110 
F
-
 λ
-
 IN(rrnD-rrnE)1 rph-1 Lab stock Wild-type strain 
∆bdm::Km ∆bdm::Km knockout mutant in 
E. coli W3110 
This study bdm mutant 
E. coli K-12 strain 
ZK2686 
W3110, Δ(argF-lac) U169 Lab stock Wild-type strain 
∆bdm::Km ∆bdm::Km knockout mutant in 
E. coli ZK2686 
This study bdm mutant 
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Table 2.2 List of plasmids relevant to this study 
Plasmid Relevant characteristics Source or Reference Comments 
pFLP3 Amp
R
, Tet
R
, source of Flp 
recombinase 
Dr Jerry Reen (BIOMERIT 
Research Institute and 
Department of 
Microbiology, University 
College Cork, Ireland 
Used to excise the 
kanamycin cassette 
from HM605 
∆pfkA::Km 
pKD4 repR6KƳ Amp
R
-FRT Km
R
-FRT Lab stock Used as a template 
for amplifying Km
R
 
cassette 
pCA24N-pfkA Cm
R
, lacI
q
, pCA24N pT5-
lac::pfkA
+
 
(Kitagawa et al., 2005) Used for 
complementing 
HM605 ∆pfkAB::Km 
pCA24N-pfkB Cm
R
, lacI
q
, pCA24N pT5-
lac::pfkB
+
 
(Kitagawa et al., 2005) Used for 
complementing 
HM605 ∆pfkAB::Km 
pCA24N-pyrF Cm
R
, lacI
q
, pCA24N pT5-
lac::pyrF
+
 
(Kitagawa et al., 2005) Used for 
complementing 
HM605 pyrF::Km 
pCA24N-bdm Cm
R
, lacI
q
, pCA24N pT5-
lac::bdm
+
 
(Kitagawa et al., 2005) Used to overexpress 
Bdm in LF82 
pCA24N-osmC Cm
R
, lacI
q
, pCA24N pT5-
lac::osmC
+
 
(Kitagawa et al., 2005) Used to overexpress 
OsmC in LF82 
pBAD33 Cm
R
, paraBAD (Guzman et al., 1995) Used in 
complementation 
studies 
pBAD33-bdm Cm
R
, paraBAD-bdm This study Used for 
complementing LF82 
bdm::Km 
pBR322 Amp
R
, Tet
R
, ori colE1 (Bolivar et al., 1977) Cloning vector 
pBR322-bdm 
subclone 
Amp
R
, contains bdm subclone 
fragment 
This study Used to clone the 
bdm subclone 
fragment in LF82 
 
2.2 Bacterial culture, growth conditions and storage 
For routine culturing of E. coli, Luria-Bertani (LB) broth was used [5 g yeast extract 
(Merck), 10 g peptone from casein (Merck) and 10 g sodium chloride (Sigma-
Aldrich) per litre]. For solid LB media, 1.5% (w/v) agar (Merck) was added to LB 
broth. The composition of all growth media used in this study is summarised in 
Table 2.3. Unless otherwise stated, E. coli cultures were incubated at 37°C, either 
statically or with shaking at 200 r.p.m. Where appropriate, antibiotics were added 
to the media at the following concentrations: ampicillin (Amp): 100 µg ml-1; 
chloramphenicol (Cm): 20 µg ml-1; kanamycin (Km): 50 µg ml-1; tetracycline (Tet): 10 
µg ml-1. All antibiotics were purchased from Sigma. 
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Bacteria were spread onto the surface of solid LB media, containing antibiotics if 
necessary, using a sterile inoculating loop. After overnight incubation at 37°C, 
plates were stored at 4°C until needed. New culture plates were prepared on a 
weekly basis. Overnight cultures were prepared by picking individual colonies from 
solid media into universal tubes containing 5 ml LB broth, with antibiotics, if 
necessary. Cultures were grown overnight at 37°C, either statically, or with shaking 
at 200 r.p.m. Frozen stocks were prepared by mixing equal volumes of the 
overnight culture with 40% (v/v) glycerol in a cryovial (Nunc), followed by 
permanent storage at -80°C. 
 
2.3 Cell line maintenance and cell culture techniques 
2.3.1 J774A.1 murine macrophage cell line 
The macrophage cell line J774A.1 was purchased from the ATCC (TIB-67). This cell 
line was derived from a tumour in a female, adult, BALB/c mouse. J774A.1 cells 
were maintained at 37°C in a humidified atmosphere of 5% C02 and 95% air in 
Dulbecco’s Modified Eagle’s Medium (DMEM) containing high glucose, sodium 
pyruvate, glutaMAXTM and phenol red (GIBCO). DMEM was supplemented with 10% 
(v/v) fetal bovine serum (FBS) (Sigma), 100 U ml-1 penicillin and 100 µg ml-1 
streptomycin (GIBCO). Media was replaced 3 times weekly and sub-cultures were 
prepared by gentle physical removal using cell scrapers (Sarstedt).  
 
2.3.2 C2Bbe1 human epithelial cell line 
The human epithelial cell line C2BBe1 (a kind gift from Susan Lapthorne, Alimentary 
Pharmabiotic Centre, University College Cork, Ireland) was maintained in DMEM 
containing high glucose, sodium pyruvate, glutaMAXTM and phenol red (GIBCO), 
supplemented with 10% (v/v) fetal bovine serum (Sigma), 100 U ml-1 penicillin, 100 
µg ml-1 streptomycin (Gibco), 0.01 mg ml-1 human transferrin (Calbiochem) and 1% 
(v/v) non-essential amino acid solution (Sigma). Media was replaced 3 times weekly 
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and sub-cultures were prepared by treatment with a 0.25% (v/v) Trypsin-EDTA 
solution (Sigma). 
 
2.3.3 J774A.1 Gentamicin protection assay 
Gentamicin protection assays were performed as previously described, with minor 
modifications (Glasser et al., 2001). J774A.1 macrophages were seeded into 
triplicate 96-well tissue culture plates (Sarstedt) at a density of 1 x 105 cells/well in 
100 µl of antibiotic-free DMEM. Cells were used approximately 24 h later. Prior to 
infection of cells, bacteria were resuspended in antibiotic-free DMEM and added to 
cells at a multiplicity of infection (MOI) of 10 (equivalent to 1 x 106 cfu 100 µl-1). 
Macrophages were co-cultured with bacteria for 2 h at 37°C / 5% C02. Following the 
2 h infection period, each well was washed with 100 µl sterile 1X PBS to remove 
non-adherent bacteria and treated with 100 µl of fresh DMEM containing 50 µg ml-1 
gentamicin for 1 h to kill extracellular bacteria. After 1 h, wells of one plate were 
washed X2 with 100 µl sterile 1X PBS and subsequently lysed with 100 µl of 1% (v/v) 
Triton X-100 in sterile distilled water (sdH2O) for 5 min at room temperature, to 
release internalised bacteria. This is the basal time-point, defined as Time 0 (T0). 
Ten-fold dilutions of the cell lysates were prepared in sterile 1X PBS and 100 µl of 
each dilution was plated onto LB agar, containing antibiotics as necessary. Plates 
were incubated at 37°C overnight and cfu’s were counted, as a measure of viable 
bacteria. The duplicate and triplicate plates were maintained in DMEM containing 
50 µg ml-1 gentamicin for an additional 6 h and 24 h, respectively, to allow 
replication of internalised bacteria. These time-points are referred to as Time 6 (T6) 
and Time 24 (T24), respectively. Plates were subsequently processed exactly as 
above. 
 
2.3.4 C2Bbe1 Gentamicin protection assay 
Gentamicin protection assays were carried out as previously described, with minor 
modifications (Boudeau et al., 1999). C2Bbe1 epithelial cells were seeded into 
duplicate 24-well tissue culture plates (Sarstedt) at a density of 4 x 105 cells/well in 
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1 ml of antibiotic-free DMEM. Cells were used approximately 24 h later. Prior to 
infection of cells, bacteria were resuspended in antibiotic-free DMEM and added to 
cells at an MOI of 10 (equivalent to 4 x 106 cfu ml-1). Macrophages were co-cultured 
with bacteria for 3 h at 37°C / 5% C02. Following the 3 h infection period, one plate 
was washed twice with sterile 1X PBS to remove non-adherent bacteria and 
subsequently lysed with 1% (v/v) Triton X-100 in sdH2O for 5 min at room 
temperature. Lysates were serially diluted in sterile 1X PBS and plated onto LB agar 
plates to determine the number of colony forming units (cfu’s) corresponding to 
the total number of cell associated bacteria (adherent and intracellular bacteria). 
The second plate was washed with sterile 1X PBS and treated with fresh DMEM 
containing 100 µg ml-1 gentamicin for 1 h to kill extracellular bacteria. After the 1 h 
period, cells were washed twice with 1X PBS and lysed with 1% (v/v) Triton X-100 in 
sdH2O for 5 min at room temperature. Lysates were serially diluted in sterile 1X PBS 
and plated onto LB agar plates to determine the number of cfu’s corresponding to 
the total number of intracellular bacteria. 
 
2.4 Kits and Enzymes 
Plasmids were purified from bacterial strains using the QIAprep miniprep kit 
(Qiagen). Bacterial strains were grown overnight at 37°C with shaking and pelleted 
by centrifugation at 8,000 r.p.m for 3 min. Plasmids were subsequently extracted 
following the manufacturer’s instructions. PCR products and restriction digests 
were purified using the QIAquick PCR purification kit (Qiagen), following 
manufacturer’s recommendations. DNA was extracted from 1% (w/v) agarose gels 
using the QIAquick Gel Extraction kit (Qiagen), following the protocol provided. 
Genomic DNA was purified from bacterial cells using the GenElute Bacterial 
Genomic DNA kit (Sigma Aldrich). Bacterial strains were grown overnight at 37°C 
with shaking and pelleted by centrifugation at 8,000 r.p.m for 3 min. DNA was 
subsequently isolated following the manufacturer’s protocol. Restriction 
endonucleases were provided by New England Biolabs (NEB). 
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Table 2.3 Composition of agars and broth used in this study 
  Media Composition Purpose 
LB broth 10 g L
-1
 peptone from casein 
5 g L
-1
 yeast extract 
10 g L
-1
 NaCl 
Routine culturing 
LB agar 10 g L
-1
 peptone from casein 
5 g L
-1
 yeast extract 
10 g L
-1
 NaCl 
15 g L
-1
 agar 
Routine culturing 
LB swim motility 
agar 
LB broth supplemented with 0.3% (w/v) 
agar 
Used to determine swim 
motility 
LB Freezing broth LB broth supplemented with: 
36 mM K2HPO4 
13.2 mM KH2PO4 
1.7 mM Na3C6H5O7 
0.4 mM MgSO4 
6.8 mM (NH4)2SO4 
4.4% (v/v) glycerol 
Used for growth and 
subsequent storage of the 
HM605 mutant library, the 
KEIO library and the ASKA 
library at -80⁰C. 
LB sucrose agar 10 g L
-1
 peptone from casein 
5 g L
-1
 yeast extract 
10 g L
-1
 NaCl 
5% (w/v) sucrose 
15 g L
-1
 agar 
Used for elimination of pFLP3 
M9 minimal 
medium broth 
200 ml 5X M9 minimal salts (Difco) 
20 ml sterile 20% (w/v) glucose 
2 ml sterile 1 M magnesium sulfate 
0.1 ml sterile calcium chloride 
777.9 ml sdH2O 
 
Used for growth analysis 
experiments 
M9 minimal 
medium agar 
M9 minimal medium broth supplemented 
with 1.5% (w/v) agar 
Used for isolating auxotrophic 
mutants of HM605 
 
 
2.5 Electrophoresis 
DNA electrophoresis was carried out on 1% (w/v) agarose gels in Tris-Acetate-EDTA 
(TAE) buffer (4.84 g Tris, 1.14 ml glacial acetic acid, 2 ml 0.5 M EDTA pH 8, per litre 
of H2O). Ethidium bromide (EtBr) (Sigma) was added to gels prior to pouring at a 
final concentration of 0.5 µg ml-1. 6X DNA loading dye (Fermentas) was added to 
DNA samples prior to loading. A 1 kb DNA ladder (Fermentas) was used as a 
reference. Gels were run at 100 V, 400 mA for 30 min. 
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2.6 Primers 
Primers were purchased from MWG-Biotech (Germany). Primers were delivered in 
a lyophilised state and were resuspended in sterile HPLC-grade H2O to a final 
concentration of 100 pmol µl-1. The primers used in this study are listed in Table 
2.4. 
 
Table 2.4 List of primers used in this study 
Primer 
name 
Sequence (5’ – 3’) Tm 
(⁰C) 
Purpose 
ARB1 GGCCACGCGTCGACTAGTTACNNNNNNNNNNGATAT 72.9 Arbitrarily primed PCR 
ARB2 GGCCACGCGTCGACTTAGTTAC 64.0 Arbitrarily primed PCR 
ARB6 GGCCACGCGTCGACTAGTACNNNNNNNNNNACGCC >75.0 Arbitrarily primed PCR 
Tn5Ext CCTGATTGCCCGACATTATCGCG 64.2 Arbitrarily primed PCR 
Tn5Int GAATATGGCTCATAACACCC 55.3 Arbitrarily primed PCR 
K2pKD4 CGGTGCCCTGAATGAACTGC 61.4 Kanamycin cassette 
KtpKD4 CGGCCACAGTCGATGAATCC 61.4 Kanamycin cassette 
bdmF sacI TTATTGAGCTCCACAGACACGGAGAATCACTATGTTTAC
TTATTATCAGGC
a
 
72.6 Forward primer for 
cloning bdm into 
pBAD33 
bdmR xbaI TTATTTCTAGAGCATAGCACCTTAAAGCGTAGGGTGC
b
 69.5 Reverse primer for 
cloning bdm into 
pBAD33 
pBADF CTGTTTCTCCATACCCGTT 54.5 Sequencing cloned 
inserts in pBAD33 
pBADR CTCATCCGCCAAAACAG 52.8 Sequencing cloned 
inserts in pBAD33 
pBR322F GTCATCCTCGGCACCGTCACCCTGG 71.2 Sequencing cloned 
inserts in pBR322 
pBR322R CCAAAGCGGTCGGACAGTGCTCCGAG 71.1 Sequencing cloned 
inserts in pBR322 
EZ_Tn5_ 
biotin 
BITEG-
GCCATATTCAACGGGAAACGTCTTGCTCGAGGCCGCGA
TTAAATTCCAACATGGATGC 
>75.0 Probe for Southern 
blot 
NBbdmF BITEG-GCTGGTAGATATCACTGAGGATGTCGTTATCA 66.9 Probe for Northern 
blot (bdm-osmC IG 
region) 
NBbdmR BITEG-GCGTTTGATATCGCCTTCCCAGTGTGCC 69.5 Probe for Northern 
blot (bdm-osmC IG 
region) 
NBosmCF BITEG-ATGACAATCCATAAGAAAGGTCAGGC 61.6 Probe for Northern 
blot (osmC specific) 
NBosmCR BITEG-TTACGATTTCAACTGGTAATCCAGC 59.7 Probe for Northern 
blot (osmC specific) 
 
a
 sacI restriction site is underlined; 
b
 xbaI restriction site is underlined 
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2.7 Construction of deletion mutants in E. coli by P1 transduction 
This technique involves the transfer of genetic information from a donor strain to a 
recipient strain using the bacteriophage P1cml (a temperature sensitive lysogenic 
phage), as previously described (Silhavy, 1984). Clones from the KEIO library, a 
library of single gene knockouts in all non-essential genes in E. coli K-12 strain 
BW25113 (Baba et al., 2006), were used as donor strains for all P1 transduction 
experiments. KEIO library clones have targeted genes replaced with a Km-resistance 
cassette. 
2.7.1 Preparation of Lysogens 
To prepare a lysogen, 3 colonies of the donor strain were resuspended in 50 µl LB 
broth. 50 µl of a phage lysate from wild-type E. coli ZK2686 and 5 µl 1 M CaCl2 was 
added to the LB broth. The mixture was incubated statically at 30°C for 30 min and 
subsequently plated on an LB agar plate supplemented with Cm and Km. The plate 
was incubated at 30°C overnight. One colony from the lysogen was purified by re-
streaking on an LB plate supplemented with Cm and Km. 
2.7.2 Preparation of Lysates 
To prepare a high-titre P1cml lysate, 2 ml LB broth supplemented with Cm and Km 
was inoculated with a single colony from the lysogen and incubated at 30°C 
overnight, with shaking. 5 ml LB broth was then inoculated with the overnight 
culture to OD600 of 0.02. The culture was incubated with shaking at 30°C until the 
OD600 reached 0.1 – 0.2. The culture was heat-shocked by incubation at 42°C for 20 
min, without agitation. The flask was vigorously shaken for 3 – 4 s during this 
incubation. The culture was incubated at 37°C, with agitation, until complete cell 
lysis was observed. 100 µl chloroform was added to the culture, which was then 
vortexed. Cellular debris was pelleted by centrifugation at 4,000 r.p.m for 10 min at 
4°C. The supernatant was transferred to a tube containing 100 µl chloroform and 
stored at 4°C until needed. 
2.7.3 P1-mediated transduction 
To carry out P1 mediated transduction, 5 ml LB broth was inoculated with a single 
colony of the recipient strain (AIEC strain HM605) and incubated with shaking at 
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37°C overnight. The cells were pelleted at 4,000 r.p.m for 10 min and resuspended 
in 2.5 ml buffer (10 mM magnesium sulphate [MgSO4], 5 mM calcium chloride 
[CaCl2]). Several different volumes of phage lysate were added to 100 µl of recipient 
cells. The mixture was incubated at 37°C for 30 min, without agitation. 200 µl 1 M 
sodium citrate and 1 ml LB broth was added to the mixture, and subsequently 
incubated at 37°C for a further 1 h. The cells were pelleted by centrifugation at 
12,000 r.p.m for 1 min. Cell pellets were resuspended in 100 µl LB containing 20 
mM sodium citrate. The entire mixture was plated on an LB plate containing Km 
and incubated at 37°C overnight. Any colonies obtained were colony purified once 
by restreaking onto LB plates supplemented with Km (and 50 µl 1 M sodium citrate) 
and incubating at 37°C overnight. 
 
2.8 Colony PCR for Km-resistance cassette 
From single KmR colonies, small samples of biomass were picked using sterile 200 µl 
tips, and resuspended in 50 µl sterile HPLC-grade H2O (Sigma) by repeated 
pipetting. 1 µl of each resuspended colony was then used as a DNA template for the 
colony PCR. For the negative control, a wild-type HM605 colony was resuspended in 
50 µl H2O, as above. For the positive control, 1 µl of the plasmid pKD4, which carries 
the Km-resistance cassette, was used. The primers k2pKD4 and ktpKD4 were used 
to amplify the Km-resistance cassette (Table 2.4). Colony PCR’s were carried out 
using GoTaq® DNA polymerase (Promega) and a dNTP mix, 10 mM each (Promega). 
Each PCR reaction contained 1 µl template DNA, 10 µl of 5X green GoTaq® reaction 
buffer, 0.2 mM of each dNTP, 100 pmol of each primer, 0.4 µl GoTaq® polymerase 
and sterile HPLC-grade H2O (Sigma) to a final volume of 50 µl. PCR conditions were 
as follows: initial denaturation at 95°C for 5 min and 30 cycles of 95°C for 30 s, 56°C 
for 30 s, 72°C for 1 min, and a final extension at 72°C for 5 min. 5 µl of each PCR 
reaction was run on a 1% (w/v) agarose gel. 
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2.9 Flp recombinase-mediated excision of antibiotic resistance gene 
To create unmarked bacterial mutants, the antibiotic resistance gene can be 
excised using a helper plasmid which expresses the FLP recombinase. FLP 
recombinase acts on the FLP Recognition Target sites (FRT sites) which flank the 
antibiotic resistance gene, thus “cutting out” and eliminating the marker gene (See 
Figure 2.1). The plasmid pFLP3 was a kind gift from Dr Jerry Reen (BIOMERIT 
Research Institute and Department of Microbiology, University College Cork, 
Ireland), and was used for the excision of the Km-resistance cassette in this study. 
pFLP3 is an Amp and Tet resistant plasmid which has FLP recombinase activity. 
pFLP3 was transformed into Km-resistant HM605, containing a chromosomally 
integrated Km-resistance cassette, and Tet-resistant colonies were selected after 
incubation at 37°C. Tet-resistant colonies were re-streaked onto a plain LB agar 
plate, an LB agar plate containing Tet (to confirm uptake of the plasmid) and an LB 
agar plate containing Km (to confirm elimination of the Km-resistance cassette). 
Growth on both the plain LB plate and the Tet plate, but not on the Km plate 
indicated that cells had taken up the plasmid and lost the Km-resistance cassette. 
Km-sensitive cells which had taken up the plasmid were re-streaked onto LB agar 
plates containing 5% (w/v) sucrose to eliminate the plasmid (pFLP3 contains the 
sacB gene). Plates were incubated at 30°C. Colonies were finally re-streaked onto 
an LB agar plate, and an LB agar plate containing Tet to confirm loss of pFLP3. 
Excision of the Km-resistance cassette was finally confirmed by performing a colony 
PCR with the Km-resistance cassette specific primers, K2pKD4 and KtpKD4 (See 
Section 2.8). 
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Figure 2.1 Diagrammatic representation of FLP recombinase mediated excision of 
chromosomal markers. The kanamycin-resistance cassette is flanked by FRT sites. With the 
use of a helper plasmid expressing FLP recombinase, which acts on FRT sites, the resistance 
gene can be eliminated from the chromosome. Modified from (Datsenko & Wanner, 2000). 
 
2.10 Preparation of electrocompetent E. coli 
Single colonies of E. coli strains were inoculated into 5 ml LB broth containing 
antibiotics if necessary, and grown overnight at 37°C, with shaking. Overnight 
cultures were diluted 1:500 into fresh LB broth containing the appropriate 
antibiotics and grown until an OD600 of 0.5 – 0.7 was obtained. Cells were harvested 
by centrifugation at 4,000 r.p.m for 10 min at 4°C in pre-chilled falcon tubes. 
Supernatants were discarded and the pellets were resuspended in 100 ml ice-cold 
sterile HPLC-grade H2O. Cells were harvested as above and resuspended in 50 ml 
ice-cold sterile HPLC-grade H2O. Cells were again harvested as above and 
resuspended in 1.6 ml ice-cold sterile 20% (v/v) glycerol. Finally, cells were 
harvested again, and resuspended in 160 µl ice-cold sterile 20% (v/v) glycerol. Cells 
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were aliquoted into 50 µl volumes in 1.5 ml eppendorf tubes and stored at -80°C 
until needed. 
 
2.11 Transposon mutagenesis 
Random transposon mutants were made in AIEC strain HM605 and in AIEC strain 
LF82 using an EZ-Tn5™ <KAN-2> Tnp Transposome™ kit (Epicentre). 
Electrocompetent E. coli cells (See Section 2.10) were stored at -80°C and thawed 
on ice just before use. Electroporation cuvettes (BTX model no. 620, 2 mm gap) 
were either stored at -20°C or chilled on ice prior to use.  
For electroporations, 50 µl of electrocompetent cells and 1 µl of the transposome 
were mixed gently in an eppendorf tube and transferred to the pre-chilled 
electroporation cuvette. Cuvettes were tapped gently on the surface of the bench 
to ensure that the mixture was spread evenly across the bottom of the cuvette and 
that no air bubbles were present. Cells were pulsed using a micro-pulser (Bio-Rad) 
on setting EC2. Immediately after electroporation, 900 µl pre-warmed (to 37°C) LB 
broth was added to the cuvette and mixed gently. The mixture was transferred to a 
15 ml sterilin tube and incubated, with shaking, at 37°C for 60 min. 250 ml LB agar 
supplemented with Amp and Km was poured into 500 cm2 Q-Trays (Genetix) and 
the entire electroporation mixture was spread across each Q-Tray. Q-Trays were 
incubated at 37°C overnight. Colonies were picked (either by hand or using a robot) 
into well plates containing 150 µl LB freezing media [LB broth supplemented with 
36 mM K2HPO4, 13.2 mM KH2PO4, 1.7 mM sodium citrate, 0.4 mM MgSO4, 6.8 mM 
(NH4)2SO4, 4.4% (v/v) glycerol] and supplemented with Amp and Km. Plates were 
incubated at 37°C overnight, then transferred to -80°C, where they were 
permanently stored. Although the electroporation efficiency for HM605 is quite 
low, a library was constructed consisting of approximately 5,500 mutants. In LF82, a 
library was constructed consisting of approximately 16,500 mutants. 
71 
 
2.12 Screening the transposon mutant libraries 
2.12.1 For auxotrophic mutants in HM605 
The HM605 Tn5 mutant library, consisting of approximately 5,500 mutants, was 
screened in order to identify auxotrophic mutants. On the day of the experiment, 
the library plates were defrosted at room temperature. Plates were hand-replicated 
onto Q-Trays (Genetix) containing 200 ml M9 minimal medium agar, supplemented 
with 0.4% (w/v) glucose (sterile-filtered) (and Amp and Km), using a 96-pin 
replicator. Plates were incubated at 37°C overnight. Mutants that failed to grow on 
the M9 glucose minimal medium (but which exhibited growth in the original library) 
were classified as auxotrophs. Potential auxotrophs were noted and were re-
examined in secondary and tertiary screens. Transposon insertion sites were 
identified in each mutant by arbitrarily-primed PCR (Section 2.13). 
 
2.12.2 For mutants in HM605 which induce less pyroptosis than the wild-type in 
the presence of rapamycin 
Approximately 2,500 HM605 transposon mutants were screened in order to 
identify mutants which induced less pyroptosis than the wild-type in the presence 
of the autophagy-inducer, rapamycin. On the day of the experiment, library plates 
were defrosted at room temperature. Library Plates were replicated by hand into 
new 96-well plates containing LB broth supplemented with Amp and Km, using a 
96-pin replicator. The plates were incubated at 37°C overnight. Macrophages were 
seeded in 96-well plates as described previously (Section 2.3.3). The following day, 
mutants were diluted in DMEM to give 1 x 106 cells 100 µl-1 (corresponding to an 
MOI of 10). Macrophages were infected with the mutants as described previously 
(Section 2.3.3). Rapamycin (LC Laboratories) was added to the cells at the 
gentamicin step, at a final concentration of 40 µM. The rapamycin was maintained 
in the culture media for the duration of the experiment. At T6, macrophage cell-
death was assessed visually using an inverted microscope. Mutants which failed to 
induce macrophage cell-death were noted and were re-examined in a secondary 
screen. In the secondary screen, cell-death was assessed both visually and in a 
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quantitative cell-death assay, by measuring the amount of LDH released from the 
cells (See Section 2.21). Transposon insertion sites were identified in each mutant 
by arbitrarily-primed PCR (Section 2.13). 
 
2.12.3 For mutants in LF82 which are affected in motility 
The library, consisting of approximately 16,500 mutants, was stored in 384-well 
plates at -80°C. On the day of the experiment, plates were defrosted at room 
temperature and replicated into LB broth containing Amp and Km in 96-well plates, 
using robotics. Plates were incubated at 37°C statically overnight. Plates were 
subsequently hand-replicated onto Q-Trays (Genetix) containing 250 ml of swim 
motility agar [LB broth containing 0.3% (w/v) agar], using a 96-pin replicator. Q-
Trays were incubated overnight at 37°C. Motility was assessed visually as a circular 
halo of cells surrounding the site of initial inoculum. Mutants showing defective 
motility were noted and were re-examined in secondary and tertiary screens. 
Transposon insertion sites were identified in each mutant by arbitrarily-primed PCR 
(Section 2.13). 
 
2.13 Arbitrarily primed PCR 
Transposon insertion sites were determined by amplifying the region within the 
genome surrounding the transposon using two rounds of arbitrarily primed PCR 
(Figure 2.2). In the first PCR (PCR 1), the random primers ARB1 and ARB6 were 
paired with an external Tn5 specific primer, Tn5ext (Table 2.4). The products from 
PCR 1 were purified and used as a template for the second PCR (PCR 2), using the 
internal Tn5 specific primer, Tn5int and the random primer ARB2 (Table 2.4). ARB2 
was designed to match the 5’ (non-random) sequence of ARB1 and ARB6. Arbitrary 
PCR’s were carried out using the Velocity™ PCR kit (Bioline). 
Genomic DNA was isolated from the mutant strains using the GenElute Bacterial 
Genomic DNA kit (Sigma), as per manufacturer’s instructions. Genomic DNA was 
diluted 1:10 in sterile HPLC-grade H2O. Each reaction in arbitrary PCR 1 contained 1 
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µl of diluted genomic DNA, 10 µl of 5X Hi-Fi buffer, 0.2 mM of each dNTP, 50 pmol 
of each primer, 1 µl Velocity DNA polymerase and sterile HPLC-grade H2O (Sigma) to 
a final volume of 50 µl. PCR conditions were as follows: initial denaturation at 98°C 
for 2 min and 30 cycles of 98°C for 30 s, 56°C for 30 s, 72°C for 1 min, and a final 
extension at 72°C for 5 min. PCR products were purified using the QIAquick PCR 
purification kit (Qiagen) and eluted in 35 µl sterile HPLC-grade H2O. The reaction 
mix for arbitrary PCR 2 was identical to that used in PCR 1, except 5 µl of the 
purified PCR product from round 1 was used as a template. Cycling conditions were 
also identical to round 1, except an annealing temperature of 50°C was used. 
Products were purified and eluted as above. Samples were sequenced using the 
internal Tn5 specific primer, Tn5int by GATC Biotech (Germany). To determine 
which gene was disrupted, sequences obtained from the PCR products were 
compared to sequences in the HM605 genome or the NCBI database using a BLAST 
search. 
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Figure 2.2 Diagrammatic representation of the process of arbitrarily primed PCR. The 
transposon specific primer Tn5ext and the arbitrary primers ARB1 and ARB6 were used in 
round 1. PCR products were purified and subjected to a second round of PCR using the 
transposon specific primer Tn5int, which lies just inside Tn5ext; and ARB2, which is 
complementary to the 5’ sequence of ARB1/ARB6. Tn5int was used as a sequencing primer, 
allowing the chromosome-junction to be sequenced. 
 
 
2.14 Plasmid based complementation  
2.14.1 Using pCA24N 
To validate gene knock-outs, where appropriate, the gene in question was re-
introduced into the mutant strain using a plasmid based complementation method. 
The ASKA library, obtained from the Nara Institute of Science and Technology, 
Japan, was utilised for this purpose (Kitagawa et al., 2005). The ASKA library is a 
complete set of cloned individual open reading frames (ORF’s) in E. coli. Each ORF 
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was amplified by PCR and cloned into the high copy-number vector pCA24N. 
Expression of cloned genes is driven by the IPTG-inducible PT5-lac promoter 
(Kitagawa et al., 2005). The ASKA library was delivered on solid media in a 96-spot 
layout. Clones were hand-replicated into 96-well plates containing LB freezing-
media supplemented with Cm, using a 96-pin replicator. Plates were incubated at 
37°C overnight and subsequently frozen at -80°C. When required, the plate 
containing the required clone was defrosted at room temperature. The clone was 
inoculated into LB broth containing Cm and incubated overnight at 37°C, with 
shaking. Plasmids were purified using the QIAprep miniprep kit (Qiagen) and 
electroporated (Section 2.11) into the required strain. IPTG was added to the 
growth medium at a final concentration of 0.1 mM to induce expression of the 
cloned gene, where indicated. However, it was observed that supplementation of 
the medium with IPTG was not necessary to induce gene expression. 
 
2.14.2 Using pBAD33 
The bdm gene was amplified by PCR from LF82 genomic DNA, using the primers 
bdmF-sacI and bdmR-xbaI (Table 2.4). The PCR reaction contained 1 µl of genomic 
DNA, 10 µl of 5X Hi-Fi buffer, 0.2 mM of each dNTP, 50 pmol of each primer, 1 µl 
Velocity DNA polymerase and sterile HPLC-grade H2O (Sigma) to a final volume of 
50 µl. PCR conditions were as follows: initial denaturation at 98°C for 2 min and 30 
cycles of 98°C for 30 s, 63°C for 30 s, 72°C for 15 s, and a final extension at 72°C for 
5 min. The PCR product was purified using the QIAquick PCR purification kit 
(Qiagen) and eluted in 35 µl sterile HPLC-grade H2O. The PCR product and pBAD33 
were digested at 37°C for 4 h with XbaI and SacI, as follows: 10 U of each enzyme, 2 
µl 10X buffer, 17 µl DNA and sterile HPLC-grade H2O to a final volume of 20 µl. 
Reactions were purified using the QIAquick PCR purification kit and subsequently 
ligated. Ligation reaction consisted of 1 U T4 DNA ligase (Promega), 1 µl 10X buffer, 
4 µl plasmid DNA and 4 µl bdm PCR product. Ligations were incubated at 16°C 
overnight. The ligation mix was electroporated (Section 2.11) into 
electrocompetent E. coli EC100 cells (Epicentre) and CmR colonies were selected 
after overnight incubation at 37°C. Random colonies were chosen and plasmids 
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were extracted using the QIAprep miniprep kit (Qiagen) to confirm the presence of 
the bdm insert. Plasmids were screened by PCR using the pBAD33-specific primers 
pBADF and pBADR (Table 2.4). PCR reactions contained 1 µl of plasmid DNA, 10 µl 
of 5X GoTaq® reaction buffer, 0.2 mM of each dNTP, 50 pmol of each primer, 1 µl 
GoTaq®DNA polymerase and sterile HPLC-grade H2O (Sigma) to a final volume of 50 
µl. PCR conditions were as follows: initial denaturation at 95°C for 5 min and 30 
cycles of 95°C for 30 s, 47°C for 30 s, 72°C for 1 min, and a final extension at 72°C 
for 5 min. One plasmid containing the bdm insert was chosen and sequenced using 
the primers pBADF and pBADR to confirm its integrity. The plasmid was then 
electroporated (Section 2.11) into electrocompetent LF82 bdm::Km cells (Section 
2.10). To induce the expression of the cloned gene, 0.2% (w/v) arabinose was 
added to the culture media. 
 
2.15 bdm subcloning 
2.15.1 Genomic DNA extraction and DNA digestion 
Genomic DNA was extracted from LF82 bdm::Km, using the GenElute Bacterial 
Genomic DNA kit (Sigma Aldrich). Genomic DNA and the vector pBR322 were 
digested at 37°C for 3 h with EcoRV (NEB), as follows: 20 U of EcoRV, 2 µl 10X 
buffer, 17 µl DNA and sterile HPLC-grade H2O to a final volume of 20 µl.  
2.15.2 DNA purification 
Restricted plasmid DNA was purified using the QIAquick PCR purification kit 
(Qiagen). Restricted LF82 bdm::Km genomic DNA was purified by 
phenol:chloroform:isoamyl alcohol extraction and ethanol precipitation, to prevent 
loss of small fragments. Equal volumes of phenol:chloroform:isoamyl alcohol 
solution (Sigma) and DNA sample were mixed in an eppendorf tube, followed by 
centrifugation at maximum speed for 5 min. The aqueous (upper) phase was 
transferred to a new tube, while the interphase and organic phase were discarded. 
This process was repeated twice more. Purified DNA was transferred to a new tube 
and concentrated using the ammonium acetate/ethanol precipitation method 
described in Section 2.25.2. 
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2.15.3 DNA ligations and electroporation 
Inserts were ligated into pBR322 using T4 DNA ligase (Promega) at 25°C overnight. 
The ligation mix was electroporated into electrocompetent EC100 cells (Epicentre) 
(Section 2.11) and KmR colonies were selected by plating the electroporation mix 
onto LB agar supplemented with Km.  
2.15.4 Sequencing inserts 
Random colonies were chosen, the plasmids were extracted using the QIAprep 
miniprep kit (Qiagen) and the inserts were amplified by PCR using the primers 
pBR322F and pBR322R (Table 2.4), which sequence from the plasmid backbone into 
the cloned sequence. The PCR reaction contained 1 µl of plasmid DNA, 10 µl of 5X 
Hi-Fi buffer, 0.2 mM of each dNTP, 50 pmol of each primer, 1 µl Velocity DNA 
polymerase and sterile HPLC-grade H2O (Sigma) to a final volume of 50 µl. PCR 
conditions were as follows: initial denaturation at 98°C for 2 min and 30 cycles of 
98°C for 30 s, 65°C for 30 s, 72°C for 1 min, and a final extension at 72°C for 5 min. 
PCR products were sequenced by GATC using the above mentioned primers, to 
confirm their integrity. One plasmid was chosen and was electroporated (Section 
2.11) into electrocompetent LF82 cells or electrocompetent MG1655 cells (Section 
2.10).  
 
2.16 Bacterial growth experiments 
2.16.1 Monitoring growth using MWG Sirius HT plate reader 
Bacterial strains were grown in LB broth overnight at 37°C, with agitation. Cells 
were pelleted by centrifugation at 8,000 r.p.m for 3 min, washed and resuspended 
in either fresh LB broth or DMEM (supplemented with 10% v/v FBS) to a final OD600 
of 0.01. 200 µl of the diluted cultures were inoculated into the wells of a 96-well 
plate (Genetix). Each well was overlayed with 50 µl of mineral oil to prevent 
evaporation of the culture. Plates were incubated at 37°C in the MWG Sirius HT 
plate reader, which was programmed to take OD600 readings every 15 min for a 
period of 24 h. 
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2.16.2 Measuring final growth yields in M9 minimal medium 
E. coli cultures were first grown in LB broth overnight at 37°C with shaking. Cells 
were harvested by centrifugation at 8,000 r.p.m for 3 min, washed and 
resuspended in M9 minimal medium broth (containing no carbon source) to an 
OD600 of 0.4. 5 µl of each culture was added to 200 µl M9 minimal medium 
supplemented with an appropriate carbon source in a 96-well plate, resulting in a 
standard starting OD600 of 0.01. The carbon sources used in this study were glucose 
(C6H12O6), glycerol (C3H8O3), sodium acetate (C2H3O2Na) sodium gluconate 
(C6H11O7Na) and proline (C5H9NO2). All carbon sources were used at a final 
concentration of 0.4% (w/v). Carbon sources were sterile-filtered and added to the 
M9 medium after autoclaving. Inoculated plates were incubated at 37°C statically. 
OD595 was recorded after overnight incubation using a GENios (Tecan) microtitre 
plate reader. 
 
2.16.3 Auxotrophic mutants rescue experiments 
Individual auxotrophies were verified by supplementing M9 glucose minimal 
medium broth with the appropriate nutrients. One or more of the following 
supplements were added at a final concentration of 1 mM: L-ornithine 
hydrochloride (Fisher), L-proline (Fisher), L-phenylalanine (Fisher), L-isoleucine 
(Sigma), L-arginine (Fisher), L-leucine (Sigma), L-methionine (Fisher), L-tryptophan 
(Fisher), L-valine (Fisher), L-tyrosine (Fisher), guanine (Sigma), adenine (Sigma), 
cytosine (Sigma) and thymine (Sigma). Supplements were sterile-filtered and added 
to the M9 medium after autoclaving. Bacterial strains were grown overnight in LB 
broth at 37°C, with agitation. Cultures were washed and resuspended to an OD600 of 
0.05 in either M9 glucose minimal medium broth or M9 glucose minimal medium 
broth supplemented with one or more of the above supplements. 100 µl of each 
diluted culture was inoculated into the wells of a 96-well plate, which was 
subsequently incubated statically at 37°C overnight, in a humidified environment. 
The OD595 of each well was measured using a GENios (Tecan) microtitre plate 
reader. 
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2.17 Bacterial stress tolerance tests 
2.17.1 Sensitivity to reactive nitrogen species (RNS) and low pH 
Bacterial strains were grown overnight in LB broth at 37°C, with shaking. Cells were 
pelleted by centrifugation at 8,000 r.p.m for 3 min and resuspended in 1X PBS to an 
OD600 of 0.1. For each culture, a series of 10-fold dilutions in 1X PBS were prepared. 
LB agar plates were prepared, containing the following stress agents: 100 mM 2-(N-
morpholino) ethanesulfonic acid [MES] pH 5.0 (to test for sensitivity to low pH); 100 
mM MES pH 5.0 and 1 mM sodium nitrite [NaNO2] (to test for sensitivity to RNS). 5 
µl of each dilution was spotted onto the surface of the prepared plates and the 
plates were incubated at 37°C overnight.  
 
2.17.2 Sensitivity to reactive oxygen species (ROS) 
To determine sensitivity to (ROS), an agar overlay diffusion method was used, as 
previously described (Bertrand et al., 2010), with some modifications. Bacterial 
cultures grown overnight in LB broth were adjusted to an OD600 of 0.5. 100 µl of 
each culture was suspended in 4 ml of LB broth containing 0.3% (w/v) agar. The 
mixture was poured over pre-prepared LB agar plates. Sterile blank discs were 
added to the surface of the solidified overlays and 10 µl of a 30% (v/v) solution of 
hydrogen peroxide (H2O2) was spotted onto the discs. Plates were incubated at 
37°C overnight and diameters of inhibition zones were measured using a ruler. 
 
2.17.3 Acid sensitivity in the presence of iron  
LB agar was autoclaved and allowed to cool before adding 1.5 mM sterile-filtered 
FeSO4. The pH of the agar was adjusted to 5.5 with sterile-filtered MES buffer, at a 
final concentration of 100 mM. Bacterial strains were grown overnight in LB broth 
at 37°C, with shaking. Cultures were centrifuged at 8,000 r.p.m for 3 min, washed in 
1X PBS and the OD600 was adjusted to 1. Ten-fold serial dilutions of each culture 
were prepared in 1X PBS and 5 µl volumes were spotted onto the surface of 
prepared agar plates. Plates were incubated at 37°C overnight. 
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2.18 Bacterial phenotypic characterisation 
2.18.1 Swimming motility assay 
Motility agar [LB broth containing 0.3% (w/v) agar] was routinely used to assess 
swimming motility. Motility agar was prepared fresh on the day of the experiment. 
The agar was allowed to cool to below 50°C before being poured into petri-dishes. 
This reduced the amount of condensation formed on the inside of the lid. Plates 
were poured and left to solidify on the bench. To prevent loss of moisture from 
plates, plates were not left to dry in a laminar-flow hood. Overnight bacterial 
cultures were adjusted to an OD600 of 1 and 5 µl of the culture was spotted onto the 
surface of the motility agar plate. Inoculated plates were left to dry on the bench 
before transferring them to a 37°C incubator. After overnight incubation, swim 
motility was assessed visually as a circular halo of cells extending from the site of 
the initial inoculum. 
 
2.18.2 Mannose-sensitive yeast aggregation assay 
A mannose-sensitive yeast aggregation assay was performed to test for the 
production of type 1 fimbriae. Bacteria are capable of binding to mannosylated 
proteins on the yeast cell surface via their type 1 fimbriae, resulting in visual 
aggregation. Bacterial cultures were grown overnight at 37°C, statically, to enhance 
type 1 fimbriae expression. Cultures were centrifuged at 8,000 r.p.m for 3 min and 
pellets were resuspended in PBS to an OD600 of 0.5. Commercial baker’s yeast 
(Saccharomyces cerevisiae) was suspended in PBS to a final concentration of 4 mg 
(dry weight) ml-1. Equal volumes (250 µl) of bacterial culture and yeast suspension 
were mixed in a 24-well polystyrene plate (Sarstedt). Bacterial samples were 
prepared in duplicate and mannose was added to one set at a final concentration of 
3% (v/v). The plate was swirled gently at room temperature until aggregation was 
observed visually. 
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2.18.3 Curli assay 
Curli production was assessed on Congo red agar plates. Congo red agar was 
prepared by supplementing LB agar with 20 µg ml-1 congo-red and 10 µg ml-1 
Coomassie blue. Bacterial strains were grown statically overnight at 37°C. Cells 
were pelleted by centrifugation and resuspended in fresh LB to an OD600 of 0.5. 5 µl 
of each culture was spotted onto a Congo red agar plate. Plates were incubated 
overnight at either 30°C or 37°C. Strains which are producing curli bind Congo red 
and therefore form a pink colony on the Congo red agar. 
 
2.18.4 Biofilm formation assay 
The ability of LF82 and LF82 motility-minus mutants to form biofilms was assayed as 
previously described (Ferrieres & Clarke, 2003), with some modifications. Statically-
grown overnight cultures were diluted 1:100 in fresh YESCA broth (10 g L-1 
casamino acids, 1 g L-1 yeast extract in sdH20) and aliquots of 150 µl were 
inoculated into the wells of a polystyrene 96-well plate. The plate was incubated at 
30°C in a humidified environment for 24 h. The planktonic bacteria were removed 
by aspiration and the wells were thoroughly washed with PBS. To visualise biofilm 
formation, the wells were stained with 200 µl of a 1% (w/v) crystal violet solution, 
for 5 min at room temperature. The wells were thoroughly washed under running 
tap water. In order to quantify biofilm formation, the crystal violet entrapped in the 
cells was dissolved in 200 µl of ethanol and the OD595 of each well was measured in 
a GENios (Tecan) microplate reader. Specific-biofilm formation was calculated by 
the following formula: (OD595 of the attached and stained bacteria / OD595 of cell 
growth). 
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2.19 Preparation of Heat-killed E. coli 
Overnight cultures of E. coli were centrifuged at 8,000 r.p.m for 3 min. Cell pellets 
were resuspended in antibiotic-free DMEM to give a final cell density of 1 x 106 cells 
100 µl-1. Diluted cultures were heated to 60°C for 1 h. Aliquots of each heat-killed 
culture were plated onto LB agar plates and incubated at 37°C overnight, to assess 
the efficacy of killing. Heat-killed cells were prepared the evening before the 
experiment and were stored at 4°C until use. 
 
2.20 Cytokine analysis 
J774A.1 macrophages were seeded and infected as described above (Section 2.3.3). 
At the indicated time-points, supernatants were collected and centrifuged at 250 x 
g for 4 min. Cell-free supernatants were stored at -80°C until needed. Cytokine 
levels in culture supernatants were determined using mouse cytokine assays (MSD® 
Meso Scale Discovery), according to the manufacturer’s instructions. Briefly, 25 µl 
of each sample or calibrator solution was dispensed into a separate well of the MSD 
plate. Calibrators were prepared by serially diluting a 1 µg ml-1 stock calibrator 
solution in standard tissue culture growth medium containing 10% (v/v) serum, 
generating a calibration curve from 10,000 pg ml-1 to 0 pg ml-1. The plate was sealed 
and incubated for 2 h at room temperature with vigorous shaking (1,000 r.p.m). 25 
µl of a 1X detection antibody solution was dispensed into each well and the plate 
was incubated for a further 2 h at room temperature with vigorous shaking (1,000 
r.p.m). The plate was washed three times with 1X PBS containing 0.05% (v/v) 
Tween-20 and 150 µl of 2X Read Buffer T was added to each well. The plate was 
analysed on a SECTOR®Imager. 
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2.21 Cytotoxicity assay (LDH assay) 
The CytoTox 96® Non-Radioactive Cytotoxicity assay kit (Promega) was used to 
determine % cytotoxicity. This assay quantitatively measures the levels of lactate 
dehydrogenase (LDH) in culture supernatants. LDH is a stable cytoplasmic enzyme 
which is released upon cell lysis. Addition of a tetrazolium salt to culture 
supernatants results in the formation of a red formazan product, in the presence of 
LDH. Therefore, the amount of red colour formed (by measurement of OD490) is 
proportional to the number of lysed cells. In brief, macrophage infection assays 
were performed as described previously (Section 2.3.3). At T0, T6 and T24, culture 
supernatants were collected, centrifuged at 250 x g for 4 min and stored at -80°C 
until needed. Supernatants were used in the cytotoxicity assay as per 
manufacturer’s instructions. Percentage cytotoxicity was calculated using the 
following formula: [(experimental release – spontaneous release) / (maximum 
release – spontaneous release)] x 100. Spontaneous release is the amount of LDH 
released from uninfected macrophages and maximum release is the amount of LDH 
present in whole-cell lysates from uninfected macrophages. 
 
2.22 Caspase inhibitor studies 
Macrophages were seeded in 96-well plates and infected with HM605 as described 
previously (Section 2.3.3). The caspase-1 inhibitor, Z-WEHD-FMK (R&D Systems) or 
the pan-caspase inhibitor, Q-VD-OPh (R&D Systems), were added to cells at a final 
concentration of 50 µM 1 h prior to infection. The inhibitors were maintained in the 
culture medium for the duration of the experiment. At T0, T6 and T24, culture 
supernatants were collected and stored at -80°C until needed. 
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2.23 Western blotting 
2.23.1 For caspase-1 activation 
J774A.1 macrophages were seeded in 6-well tissue culture plates (Sarstedt) at a 
density of 1 x 106 cells in 2 ml of antibiotic-free DMEM. Cells were used 
approximately 24 h later and were infected with HM605, HM605 ∆pfkAB::Km or 
MG1655 as described previously (Section 2.3.3). At T0, T12 and T24, macrophages 
were washed twice with ice-cold 1X PBS and lysed with Radio Immunoprecipitation 
assay (RIPA) buffer containing a 1X protease and phosphatase inhibitor cocktail 
(Thermo Scientific). Whole cell lysates were clarified by centrifugation at 13,000 
r.p.m for 10 min at 4°C. Supernatants were transferred to new tubes and stored at -
80°C until needed. The protein concentration in each sample was determined using 
Bradford Reagent (Sigma), following the manufacturer’s protocol. 20 µg of each 
protein sample was mixed with 6X sample buffer [9% (w/v) SDS, 60% (v/v) glycerol, 
375 mM Tris-HCl pH 6.8, 0.015% (w/v) bromophenol blue, 12% (v/v) β-
mercaptoethanol] and heated to 90°C for 5 min. Samples were loaded onto a 12.5% 
sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) gel and 
run in 1X running buffer [25 mM Tris base, 190 mM glycine, 0.1% (w/v) SDS; pH 8.3] 
at 180 V for approximately 1 h. Fractionated protein samples were transferred to a 
0.45 µm nitrocellulose membrane (Sigma) in 1X transfer buffer [48 mM Tris base, 
39 mM glycine, 20% (v/v) methanol] at 100 V for 30 min. The membrane was 
stained with Ponceau S solution (Sigma) for 5 min at room temperature to verify 
the success of transfer. Ponceau S dye was removed from the membrane by 
soaking in 0.1 M NaOH for 30 sec. The membrane was blocked with 5% (w/v) 
skimmed milk (Marvel) in PBST [PBS with 0.05% (v/v) Tween-20] for 1 h at room 
temperature. The membrane was probed with a mouse anti-rabbit caspase-1 
antibody (Abcam; ab17820) diluted to 1 µg ml-1 in blocking buffer, overnight at 4°C. 
The membrane was subjected to 3 x 10 min washes in PBST to remove any 
unbound antibody. A goat anti-rabbit horse-radish peroxidase (HRP) conjugated 
secondary antibody (Santa Cruz Biotechnology; sc-2004) was diluted to 50 ng ml-1 in 
PBST and incubated with the membrane for 1 h at room temperature. The 
membrane was subjected to a further 3 x 10 min washes in PBST. Bound antibody 
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was detected by enhanced chemiluminescence, using the SuperSignal West Pico 
Chemiluminescent substrate (Thermo Scientific), following the manufacturers 
recommendations. Membranes were stripped of bound antibodies by incubation in 
stripping buffer [100 mM β-mercaptoethanol, 2% (w/v) SDS, 62.5 mM Tris-HCl pH 
6.8] at 50°C for 30 min, with rotation. Stripped membranes were subjected to 3 x 
10 min washes in PBST, re-blocked and re-probed with an anti-β-actin antibody 
(Santa Cruz Biotechnology), as a loading control. 
 
2.23.2 For the detection of E. coli flagellin H1 
Bacterial strains were grown overnight in LB broth at 37°C, with agitation. Cultures 
were standardised to an OD600 of 0.35 ml
-1. Standardised cultures were pelleted by 
centrifugation at 3,500 r.p.m for 10 min. Whole-cell lysates were prepared by 
resuspending pellets in 15 µl of sterile H2O and 7 µl of 6X sample buffer [9% (w/v) 
SDS, 60% (v/v) glycerol, 375 mM Tris-HCl pH 6.8, 0.015% (w/v) bromophenol blue, 
12% (v/v) β-mercaptoethanol]. Samples were heated to 90°C for 10 min. Western 
blotting was carried out as described previously (Section 2.23.1), using a 1:500 
dilution of a rabbit polyclonal antiserum to H1 flagella (Statens Serum Institute, 
Copenhagen, Denmark). 
 
2.24 Southern Blotting 
2.24.1 Probe synthesis 
The probe was a single-stranded oligonucleotide probe (EZ-Tn5-biotin) (Table 2.4), 
complementary to a 58 bp region of the transposon. The probe was end-labelled at 
the 5’ end with biotin and was synthesised by MWG Biotech (Germany). This 58 bp 
segment of DNA does not appear anywhere in the LF82 genome. 
2.24.2 Preparation of a positive control 
As a positive control for the Southern blot, the transposon was amplified by PCR, 
using the primers ME F and ME R. PCR was carried out using the Velocity™ PCR kit 
(Bioline). The PCR reaction contained 1 µl of the EZ-Tn5 <KAN-2> Tnp transposome 
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(Epicentre) as a template, 10 µl of 5X Hi-Fi buffer, 0.2 mM of each dNTP, 50 pmol of 
each primer, 1 µl Velocity DNA polymerase and sterile HPLC-grade H2O (Sigma) to a 
final volume of 50 µl. PCR conditions were as follows: initial denaturation at 98°C 
for 2 min and 30 cycles of 98°C for 30 s, 58°C for 30 s, 72°C for 1 min, and a final 
extension at 72°C for 5 min. The PCR product was purified using the QIAquick PCR 
purification kit (Qiagen) and eluted in 35 µl sterile HPLC-grade H2O. 
2.24.3 Genomic DNA extraction, DNA digestion and gel electrophoresis 
Genomic DNA was isolated from the strains using the GenElute Bacterial Genomic 
DNA kit (Sigma). DNA was eluted in a total volume of 80 µl of elution solution and 
quantified using a nano-drop. 6 µg of each genomic DNA sample was fragmented 
using the restriction endonuclease, EcoRV (New England Biolabs, NEB) at 37°C for 
16 h. EcoRV was chosen because it does not cut within the transposon. Samples (6 
µg total DNA per well) were subsequently run on a 1% (w/v) agarose gel containing 
0.5 µg ml-1 ethidium bromide. 2.5 ng of the positive control was also included. The 
gel was run at 150 V, 400 mA for 90 min. 
2.24.4 Southern analysis 
Southern blotting was carried out according to standard techniques (Sambrook & 
Russell, 2006). Briefly, immediately after electrophoresis, the gel was depurinated 
by incubation in a solution of 0.2 M hydrochloric acid (HCl) at room temperature, 
with gentle agitation, for 30 min. The gel was rinsed briefly under running tap 
water, followed by incubation in denaturation solution (1.5 M sodium chloride, 0.5 
M sodium hydroxide) for 30 min, at room temperature, with gentle agitation. The 
pH of the gel was finally neutralised by incubating in neutralisation solution (1.5 M 
sodium chloride, 1 M Tris-base, pH 7.5) for 30 min, at room temperature, with 
gentle agitation. DNA was transferred to a positively-charged nylon membrane 
(Ambion) overnight, by capillary transfer using 20X SSC transfer buffer (3 M sodium 
chloride, 0.3 M sodium citrate). The efficiency of transfer was assessed by staining 
the gel with 0.5 µg ml-1 EtBr and viewing under a transilluminator. DNA was 
permanently fixed to the membrane by baking at 80°C for 2 h. Hybridisation was 
carried out using ULTRAhyb® Ultrasensitive Hybridisation buffer (Ambion), 
following manufacturer’s instructions. The biotin-labelled probe was detected using 
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the Chemiluminescent Nucleic Acid Detection Module (Thermo Scientific), following 
manufacturer’s instructions exactly. Light was detected by exposing the blot to x-
ray film (Thermo Scientific) for 30 s. The film was developed manually in a dark-
room, using developer and fixer solutions (Kodak). 
 
2.25 Small RNA Northern blotting 
2.25.1 Probe preparation 
Probes for Northern analysis were prepared by amplifying osmC or the bdm-osmC 
intergenic region (plus flanking DNA) from wild-type LF82, using the primer pairs 
NBosmCF / NBosmCR and NBbdmF / NBbdmR, respectively (Table 2.4). Reaction 
mixtures consisted of 1 µl of LF82 genomic DNA, 10 µl of 5X Hi-Fi buffer, 0.2 mM of 
each dNTP, 50 pmol of each primer, 1 µl Velocity DNA polymerase and sterile HPLC-
grade H2O (Sigma) to a final volume of 50 µl. The PCR cycle was run under the 
following conditions: initial denaturation at 98°C for 2 min and 30 cycles of 98°C for 
30 s, 56°C for 30 s, 72°C for 1 min, and a final extension at 72°C for 5 min. The PCR 
products were purified using the QIAquick PCR purification kit (Qiagen) and eluted 
in 35 µl sterile HPLC-grade H2O. 
2.25.2 RNA purification 
Bacterial strains were grown in LB broth overnight at 37°C, with shaking. The next 
day, 100 µl of each culture was inoculated into 50 ml fresh LB broth and the 
cultures were incubated at 37°C with shaking until they reached mid-exponential 
phase. Each culture was mixed with double the volume of RNAlater [20 mM EDTA, 
25 mM sodium citrate, 70% (w/v) ammonium sulfate] to halt bacterial transcription. 
The cells were pelleted by centrifugation at 4,000 r.p.m for 10 min at 4°C. Residual 
supernatant was removed by gently tapping inverted tubes on a paper towel. 
RNA extraction was carried out using the miRNeasy® mini kit (Qiagen), with some 
modifications. Briefly, cell pellets were resuspended in 100 µl sterile RNase-free 
H2O and quickly transferred to 800 µl of QIAzol lysis reagent in an eppendorf tube. 
Tubes were incubated at room temperature for 5 min. 160 µl chloroform was 
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added to each tube and tubes were vigorously shaken for 15 s and incubated at 
room temperature for 3 min. Tubes were centrifuged at 13,000 r.p.m for 15 min at 
4°C. This centrifugation step allows the samples to separate into three phases: an 
aqueous phase on top, a white interphase and a red organic phase at the bottom. 
The aqueous phase of each sample was transferred to new tubes. Ethanol was 
added to the tubes (1.5 volume) and the contents were mixed thoroughly by 
pipetting. The mixture was transferred to an RNeasy spin column and centrifuged at 
13,000 r.p.m for 30 s at room temperature. The flow-through was discarded and 
350 µl of buffer RWT was added to the columns which were then centrifuged at 
13,000 r.p.m for 15 s at room temperature. Another 350 µl volume of buffer RWT 
was added to each column and columns were spun at 13,000 r.p.m for 15 s at room 
temperature. Two 500 µl volumes of buffer RPE was added to each column which 
were again spun at 13,000 r.p.m for 15 s and 2 min, respectively, at room 
temperature. Finally, RNA was eluted in RNase-free H2O which was pre-heated to 
50°C.  
To produce concentrated RNA samples, the RNA was precipitated following the 
protocol in Ambion’s NorthernMax® manual for ammonium acetate/ethanol 
precipitation. Briefly, ammonium acetate was added to each sample to give a final 
concentration of 0.5 M. Samples were mixed well, and 2.5 volumes of ice-cold 200-
proof ethanol was added to each sample. Samples were mixed well and chilled at -
80°C for 30 min. RNA was pelleted by spinning samples for 15 min at maximum 
speed in a centrifuge pre-chilled to 4°C. RNA pellet was resuspended in RNase-free 
H2O and stored at -20°C. Contaminating DNA was removed from the RNA samples 
using the TURBO DNA-free™ kit (Ambion).  
2.25.3 Northern analysis 
Northern analysis for sRNA’s was carried out as previously described (De Lay & 
Gottesman, 2012). RNA samples were quantified using a nano-drop. 5 µg of each 
sample was mixed with an equal volume of TBE (Tris Borate EDTA)-Urea sample 
buffer (BioRad), followed by boiling the samples for 5 min. A 5% TBE-Urea precast 
gel (BioRad) was pre-run in 1X TBE running buffer at 55 V for 30 min. Samples were 
loaded into the gel and the gel was run at 55 V for approximately 3 h. The gel was 
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stained with 4 µg ml-1 EtBr and briefly viewed under a transilluminator to assess the 
quality of the RNA. The gel was rinsed in 0.5X TBE to remove all traces of EtBr. The 
fractionated RNA was transferred to a Zeta-Probe GT membrane (BioRad) in 0.5X 
TBE transfer buffer at 200 mA for 2 h. The gel was re-stained with 4 µg ml-1 EtBr and 
viewed under a transilluminator to assess the efficiency of transfer. The RNA was 
crosslinked to the membrane by UV irradiation and baked dry in an oven for 30 min 
at 80°C. The membrane was probed with the indicated probe (100 ng ml-1) in 
ULTRAhyb solution (Ambion) at 42°C overnight. The probe was detected using the 
Chemiluminescent Nucleic Acid Detection Module (Thermo Scientific). 
 
2.26 Transmission Electron Microscopy (TEM) 
TEM was carried out by Dr Don O’ Leary (Department of Anatomy, University 
College Cork, Ireland). J774A.1 macrophages were seeded and infected as described 
previously (Section 2.3.3). Cross sections of infected cultured cells were prepared as 
follows. The cells were fixed for 90 min in a primary fixative that consisted of 2% 
glutaraldehyde and 2.5% paraformaldehyde in 0.165 M phosphate buffer. After 
primary fixation, the cells were washed in 0.165 M phosphate buffer for 30 min and 
post-fixed in 2% osmium tetroxide in 0.165 M phosphate buffer for 90 min. After 
dehydration in a graded series of ethanol, the samples were embedded in 
polymerised araldite and polymerised at 50°C for 48 h. Araldite embedded 
specimens were sectioned using a Reichert-Jung Ultracut E ultramicrotome. 
Samples were then stained with uranlyl acetate and lead citrate. Sections were 
examined in a JEOL JEM-2000FXII transmission electron microscope and 
photographed using a Mega View Soft Imaging System digital camera. Calibration 
grid to determine real as distinct magnification: Agar Scientific cross grating, 2160 
lines/mm. = 2159 intervals per 1000 microns for average spacing between lines. 
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2.27 Phylogenetic analysis 
Nucleotide sequences of the bdm-osmC intergenic regions from 36 sequenced E. 
coli strains were obtained from the NCBI databases and phylogenetic analysis was 
performed on the Phylogeny.fr platform (http://www.phylogeny.fr) using the “one 
click” mode which provides ready-to-use pipeline chaining programmes. Sequences 
were aligned with MUSCLE, ambiguous regions were removed with Gblocks and the 
phylogenetic tree was constructed using the maximum likelihood method 
implemented in the PhyML program and graphically represented using TreeDyn. 
Reliability for internal branches was assessed using the aLRT statistical test and the 
resulting branch support values are indicated next to each branch on the tree 
(Anisimova & Gascuel, 2006; Castresana, 2000; Chevenet et al., 2006; Dereeper et 
al., 2008; Dereeper et al., 2010; Edgar, 2004; Guindon & Gascuel, 2003). 
 
2.28 Statistical analysis 
All statistical analysis was performed using the GraphPad Prism 5.03 software. All 
experiments were performed in triplicate, unless otherwise stated. The students T-
Test was used to compare two groups of data. Differences were considered to be 
significant if P≤0.05. 
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Chapter 3: The metabolic requirements of AIEC 
strain HM605 when growing in the macrophage 
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3.1 Introduction 
There is a tremendous wealth of information available regarding the virulence 
factors of pathogenic bacteria and how these virulence factors function in the 
pathogenesis of an organism (Flannagan et al., 2009; Ray et al., 2009; Valdez et al., 
2009). However, in addition to expressing specialised virulence factors, a bacterium 
must also be capable of obtaining all of the nutrients it requires for growth and 
proliferation from the site of infection within the host. The ability of a bacterium to 
replicate within its host is a key factor in the virulence of a pathogen, and therefore 
understanding the genes and metabolic pathways that support the intracellular 
multiplication of pathogens may serve as an important strategy to combat their 
pathogenesis (Abu Kwaik & Bumann, 2013; Eisenreich et al., 2010; Munoz-Elias & 
McKinney, 2006). Intracellular bacteria are heterotrophs, meaning that they require 
at least one carbon source in order to generate energy and to produce the catabolic 
intermediates necessary to produce anabolic monomers which are then converted 
into proteins, nucleic acids and cell envelope components (Eisenreich et al., 2010). 
The intracellular metabolism of bacterial pathogens has been relatively under-
studied and our knowledge in this area is limited. However, in the past few years, 
studies analysing the growth of metabolic mutants in host cells and in animal 
models, in combination with more sophisticated techniques such as differential 
gene expression profiling (DGEP) and 13C-isotopologue profiling analysis (13C-IPA), 
have revealed the importance of central carbon metabolic pathways in supporting 
the growth and virulence of many pathogens (Eisenreich et al., 2010). 
 
3.1.1 The role of central catabolic pathways in supporting the intracellular growth 
of pathogens 
3.1.1.2 Sugar catabolism 
There are three primary routes of sugar catabolism in bacteria: glycolysis, the 
Entner-Doudoroff (ED) pathway and the pentose-phosphate (PP) pathway (Figure 
3.1). These central metabolic pathways function to convert glucose and other 
monosaccharides into pyruvate, generating energy in the form of ATP and reducing 
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power in the form of NAD(P)H. These pathways are also important for the 
generation of precursor metabolites which are required for various cellular 
functions (Romano & Conway, 1996). The glycolytic pathway is perhaps the better 
known of the three and is indeed the major pathway for sugar metabolism in 
enteric bacteria, including E. coli, when grown in vitro (Conway, 1992). However, 
certain groups of bacteria, such as the pseudomonads have an incomplete 
glycolytic pathway, due to a lack of the enzyme phosphofructokinase (Pfk) and rely 
on the ED pathway for the catabolism of sugars (Conway, 1992; Velazquez et al., 
2004).  
These sugar catabolic pathways have been demonstrated to play important roles in 
the in vivo nutrition of pathogens. DGEP of Salmonella Typhimurium growing in 
J774A.1 macrophages and HeLa cells, showed that genes encoding enzymes of 
glycolysis and the ED pathway were upregulated in comparison to cells grown in LB 
broth, whereas genes encoding enzymes of the TCA cycle were repressed, 
suggesting that sugar metabolism may be important for intracellular Salmonella 
(Hautefort et al., 2008; Lucchini et al., 2005). Indeed, using a mutagenesis 
approach, it has been shown that S. Typhimurium requires glucose and the 
glycolytic pathway to replicate within the Salmonella containing vacuole (SCV) of 
macrophages and for full virulence in mice (Bowden et al., 2009). In good 
correlation with this, a recent study using 13C-IPA coupled with mutational analysis, 
showed that S. Typhimurium growing in the SCV in cells of the epithelial cell line 
Caco-2, utilised glucose as a sole carbon source for growth (Gotz et al., 2010). This 
study also demonstrated that enteroinvasive E. coli (EIEC), which replicates in the 
cytoplasm of host cells, also utilised glucose (Gotz et al., 2010). A S. Typhimurium 
zwf mutant, that is incapable of carrying out the first step in the PP pathway, is also 
avirulent in mice (Lundberg et al., 1999). However, S. Typhimurium does not have a 
metabolic requirement for the PP pathway when growing in mice, rather, the 
pathway plays an important role in anti-oxidant and anti-nitrosative defences, by 
providing reducing equivalents in the form of NADPH (Lundberg et al., 1999). A 
recent study demonstrated the importance of glycolysis in the intracellular life-
cycle of Mycobacterium tuberculosis. The group showed that a glucokinase mutant, 
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which is unable to phosphorylate glucose to glucose-6-phosphate, established an 
infection in mice similarly to the wild-type strain, however, the mutant failed to 
persist normally in mouse lungs during the chronic phase of infection (Marrero et 
al., 2013).  
 
3.1.1.3 The Tricarboxylic acid (TCA) cycle, gluconeogenesis and anaplerotic 
reactions 
The TCA cycle is a pathway involved in the final steps of the oxidation of 
carbohydrates and fatty acids (Figure 3.1). The pathway begins with the activated 
form of acetate (Acetyl Co-A), which is derived from sugars or fatty acids. Acetyl Co-
A is oxidised to carbon dioxide (CO2) in a series of enzymatic reactions, resulting in 
the production of reducing equivalents for respiration-mediated ATP synthesis and 
precursors for various biosynthetic pathways. Metabolic flux through the TCA cycle 
is generally essential for cell survival. The glyoxylate pathway is a shunt that by-
passes many of the reactions of the TCA cycle and the main function of this 
pathway is to permit bacterial growth on C2 compounds e.g. acetate (Kornberg, 
1966). The TCA cycle, with its two decarboxylation steps, does not allow the 
assimilation of these simple compounds. The glyoxylate pathway bypasses these 
two decarboxylation steps, thereby allowing simple carbon compounds to feed into 
gluconeogenesis, where they can be incorporated into glucose and subsequently 
into amino acids and nucleotides (Figure 3.1). 
In systemically infected mice, it has been shown that, while gluconeogenesis is not 
required for the intracellular growth of S. Typhimurium, full cyclic operation of the 
TCA cycle is required (Tchawa Yimga et al., 2006). This is in good correlation with 
the observation that glucose and glycolysis are also required by S. Typhimurium for 
virulence in mice (Bowden et al., 2009), highlighting the important role of sugar 
metabolism in supporting the intracellular lifestyle of this pathogen. Interestingly, it 
has also been demonstrated that the glyoxylate pathway plays a role in the 
persistence of S. Typhimurium during chronic infection. In the acute murine S. 
Typhimurium infection model, an aceA mutant, which is unable to metabolise fatty 
95 
 
acids via the glyoxylate pathway, was not attenuated for virulence (Fang et al., 
2005). Likewise, this mutant was not attenuated for growth in murine macrophages 
after 18 h of infection. However, in a chronic murine model of infection, the wild-
type strain was detectable two months after infection, whereas the aceA mutant 
was eliminated (Fang et al., 2005). 
DGEP of Mycobacterium tuberculosis growing in murine bone marrow derived 
macrophages (BMDM) and in the lungs of mice and tuberculosis patients revealed 
the upregulation of genes involved in fatty acid metabolism, the glyoxylate shunt 
and gluconeogenesis (Dubnau et al., 2005; Schnappinger et al., 2003; Timm et al., 
2003) and indeed this has also been confirmed in mutational studies. A M. 
tuberculosis strain mutated for the icl gene (which encodes isocitrate lyase (ICL), an 
essential enzyme of the glyoxylate pathway), displayed a reduced ability to survive 
in the lungs of mice during the persistent phase of infection and hence, was 
attenuated for virulence (McKinney et al., 2000). In contrast, the icl mutant 
displayed a similar growth pattern to the wild-type strain during the acute phase of 
infection. This work also established a direct link between the immune status of the 
host and the requirement for the glyoxylate pathway, as infecting interferon-Ƴ 
knockout mice (which are immune deficient) with ∆icl cells restored virulence to 
the bacteria. This link was also established at the macrophage level, suggesting that 
expression of ICL enhances the survival of Mycobacterium within inflammatory 
macrophages. A further study demonstrated that M. tuberculosis requires the Mce4 
transporter, which encodes a cholesterol import system, for growth in mice during 
the chronic phase of infection and for growth in IFN-Ƴ activated macrophages 
(Pandey & Sassetti, 2008). Mycobacterium can degrade the acyl side chain of 
cholesterol by β-oxidation to give rise to propionyl-CoA and the group hypothesised 
that this production of propionyl-CoA could explain the previous observations of an 
attenuated virulence of a ∆icl mutant (Pandey & Sassetti, 2008). It has been shown 
that icl mutants are defective for growth when propionate is the sole carbon 
source. Therefore, the group speculated that the attenuated virulence of the icl 
mutant could be due to an inability to fully catabolise cholesterol (Pandey & 
Sassetti, 2008). The view that M. tuberculosis primarily relies on gluconeogenic 
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substrates such as fatty acids for intracellular survival was further supported by 
work which demonstrated the importance of PckA (an enzyme which catalyses the 
first committed step of gluconeogenesis) for the virulence of Mycobacterium during 
both active and latent stages of the disease (Marrero et al., 2010). When bacteria 
solely metabolise fatty acids, they must produce sugars from TCA cycle 
intermediates to support cell growth. Therefore, the growth attenuation of the 
pckA mutant suggests that sugars are not available to Mycobacterium during 
infection and strengthens the notion that Mycobacterium relies on gluconeogenic 
substrates for persistence. 
DGEP of Listeria monocytogenes growing in epithelial or macrophage cell lines has 
shown the upregulation of genes involved in gluconeogenesis and the uptake and 
catabolism of glycerol, while genes involved in glycolysis were downregulated 
(Chatterjee et al., 2006; Joseph et al., 2006). Indeed, a study involving 13C-IPA 
coupled with mutational analysis, showed that C3 compounds such as glycerol may 
serve as important carbon sources for L. monocytogenes growing in macrophages 
(Eylert et al., 2008). Similarly, it has been shown that mutants in L. monocytogenes 
which are defective in the metabolism of glycerol are attenuated for growth in both 
macrophage and epithelial cell lines (Joseph et al., 2008). Interestingly, intracellular 
metabolism and virulence of L. monocytogenes are co-regulated. The 
transcriptional regulator of virulence gene expression in L. monocytogenes, PrfA, is 
activated when cells are growing on C3 compounds (as encountered inside the host 
cell) and inactivated when cells are growing on C6 substrates (as encountered 
extracellularly), suggesting that the available nutrients act as a signal to L. 
monocytogenes, determining whether the bacteria should live as a pathogen or as a 
saprophyte (Freitag et al., 2009). 
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3.1.2 The role of biosynthetic pathways in supporting the growth of intracellular 
pathogens 
In addition to central metabolic pathways, biosynthetic pathways play an important 
role in the intracellular growth and virulence of many pathogens. Auxotrophic 
mutants have been traditionally used to probe the biosynthetic requirements of a 
pathogen in vivo. In addition, the study of auxotrophic mutants also provides a 
means of uncovering the range of host cell nutrients that are accessible to 
intracellular microbes. By definition, auxotrophic mutants are bacterial strains in 
which one or more genes of a biosynthetic pathway have been deleted or 
inactivated. The resulting mutant requires supplementation of the growth media 
with the required substrate in order for it to grow. Therefore, if an auxotrophic 
mutant is capable of growing in a host cell, it can be deduced that the required 
substrate is present and available to the microbe within the host cell. Alternatively, 
if the auxotrophic mutant is not able to grow within the host cell, then it can be 
deduced that the host is limited for the particular substrate. 
A genetic study in Salmonella to identify genes important for intracellular survival 
isolated purine, pyrimidine, histidine and aromatic amino acid auxotrophic mutants 
which were attenuated for survival in the macrophage and were avirulent in a 
mouse model (Fields et al., 1986). A later study confirmed these results and 
demonstrated that aroA, purA or purE auxotrophs (aromatic amino acid and purine 
biosynthesis, respectively) were effective live vaccines against Salmonella 
(O'Callaghan et al., 1988). Therefore, there has been considerable interest in 
studying Mycobacterium auxotrophs, as these strains have the potential to serve as 
candidates for new live attenuated vaccines. It has been demonstrated that 
Mycobacterium proC  (proline biosynthesis) and trpD (tryptophan biosynthesis) 
mutants are attenuated in macrophage and mouse models (Smith et al., 2001), an 
argB (arginine biosynthesis) mutant is attenuated in a mouse model (Gordhan et 
al., 2002), a mutant in alanine biosynthesis was impaired for intramacrophagic 
growth (Chacon et al., 2009), and a purC (purine biosynthesis) mutant is impaired 
for growth in mice (Brown et al., 2005). In addition to providing insights into the 
intracellular metabolic requirements of Mycobacterium, these studies also highlight 
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that the Mycobacterium vacuole appears to be a nutrient-poor environment. It is 
noteworthy to mention, however, that intravacuolar pathogens such as Legionella  
and Chlamydia lack biosynthetic pathways, including those for certain amino acids, 
yet they are capable of growth in the phagosome, indicating that the nutrient 
composition of the phagosome may vary depending on the pathogen in question 
(Chien et al., 2004; Kalman et al., 1999b). 
In summary, it is clear that knowledge of the metabolic requirements of microbes 
when growing in their host cells is critical to building a comprehensive 
understanding of the virulence of an organism. In addition, these metabolic and 
biosynthetic pathways may serve as prospective therapeutic targets to control the 
intracellular growth of pathogens. 
 
3.2 Objectives 
The in vivo metabolism of pathogenic bacteria is a fundamental, yet insufficiently 
studied aspect of microbe-host interactions. Increasing our knowledge of the 
metabolic pathways and nutrients involved in the multiplication of these pathogens 
may serve as an effective strategy to combat their pathogenesis. The in vivo 
metabolism of AIEC has not been examined previously, and therefore, the objective 
of this study was to determine the role played by both central metabolic pathways 
and biosynthetic pathways in supporting the growth of AIEC strain HM605 in the 
macrophage. 
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Figure 3.1 The major central metabolic pathways of E. coli. The best characterised 
pathways of carbohydrate metabolism in bacteria are glycolysis, the Pentose phosphate 
(PP) pathway, the Entner Doudoroff (ED) pathway, gluconeogenesis, the TCA cycle and the 
glyoxylate shunt. Arrows indicate the physiological direction of the reactions. Genes 
encoding the enzymes for each reaction are indicated in red beside each reaction and 
pathway names are written in purple boxes. 
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3.3 Results 
3.3.1 AIEC strain HM605 replicates inside J774A.1 macrophages 
One of the characteristic features of AIEC is their ability to replicate in macrophages 
(Glasser et al., 2001; Subramanian et al., 2008). In this study, we use a strain of AIEC 
called HM605, which was isolated from a colonic biopsy taken from a patient with 
CD (Martin et al., 2004). Using the gentamicin protection assay, it is evident that 
HM605 is capable of replicating approximately 4-fold in J774A.1 macrophages over 
a 6 h period, whereas the non-pathogenic laboratory K-12 strain MG1655 is unable 
to replicate (Figure 3.2). MG1655 is thought to closely resemble the original K-12 
strain isolated from the faeces of a convalescing diptheria patient in Palo Alto in 
1922 and this strain is often used as a non-pathogenic control in murine studies. 
 
 
Figure 3.2 HM605 replicates inside J774A.1 macrophages. J774A.1 macrophages were 
infected with the indicated strains at an MOI of 10. Intracellular bacteria were quantified 
using the gentamicin protection assay at T0 and at T6. The fold replication is expressed as 
the number of intracellular bacteria at T6 / the number of intracellular bacteria at T0. 
Results shown are the mean of three experiments and the error bars represent the 
standard deviation. *: P≤0.05. 
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3.3.2 The role of central metabolic pathways in supporting the intramacrophagic 
growth of HM605 
3.3.2.1 Construction of metabolic mutants in AIEC strain HM605 
In order to determine the metabolic pathway(s) which support the intracellular 
growth of AIEC strain HM605, deletion mutants were constructed in all the major 
pathways of central metabolism, namely, glycolysis, gluconeogenesis, the ED 
pathway, the PP pathway, the TCA cycle and the glyoxylate pathway. Deletion 
mutants were constructed using bacteriophage P1-mediated transduction, with 
mutants from the KEIO library as the donors (Baba et al., 2006). The KEIO library is a 
collection of single gene knockouts in all non-essential genes in E. coli K-12 strain 
BW25113. The deletions in the donor strains were constructed by replacing the 
gene of interest with a Km-resistance cassette, however, the native start codon and 
the last 18 C-terminal nucleotides were retained, in order to minimise polar effects 
on downstream gene expression. The kanamycin cassette is flanked with FRT (FLP 
recombinase target) sites, which enable excision of the resistance gene by plasmids 
expressing Flp recombinase activity, if needed. The required KEIO alleles were 
transferred into HM605 using P1 phage, and by selecting for Km resistant colonies. 
The presence of the Km-resistance cassette in the genome of each mutant was 
verified by PCR (data not shown). In total, 13 metabolic mutants were constructed 
in HM605 (Table 3.1). The growth of each mutant was assessed in both LB broth 
and DMEM over a 24 h period. All of the mutants grew at a rate comparable to the 
wild-type (data not shown), with the exception of ∆pps::Km and ∆pfkA::Km (which 
are discussed further in Section 3.3.2.5 and Figure 3.9). 
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Table 3.1 Metabolic mutants constructed in AIEC strain HM605 
Mutant Pathway Function 
∆pfkA::Km Glycolysis Catalyses the phosphorylation of fructose-
6-phosphate to fructose-1,6-bisphosphate 
∆pfkB::Km Glycolysis As above 
∆fbp::Km Gluconeogenesis Catalyses the conversion of fructose-1,6-
bisphosphate to fructose-6-phosphate 
∆glpX::Km Gluconeogenesis As above 
∆pps::Km Gluconeogenesis Catalyses the conversion of pyruvate to 
phosphoenolpyruvate 
∆pck::Km Gluconeogenesis Catalyses the conversion of oxaloacetate to 
phosphoenolpyruvate 
∆edd::Km ED pathway Catalyses the conversion of 6-phospho-D-
gluconate to 2-dehydro-3-deoxy-D-
gluconate-6-phosphate 
∆eda::Km ED pathway Catalyses the conversion of 2-dehydro-3-
deoxy-D-gluconate-6-phosphate to D-
glyceraldehyde-3-phosphate 
∆icd::Km TCA cycle Catalyses the conversion of isocitrate to 2-
oxoglutarate 
∆acnB::Km TCA cycle/Glyoxylate 
pathway 
Catalyses the reversible isomerisation of 
citrate and iso-citrate 
∆acnA::Km TCA cycle/Glyoxylate 
pathway 
As above 
∆aceA::Km Glyoxylate pathway Catalyses the reversible conversion of 
isocitrate to glyoxylate and succinate 
∆gnd::Km PPP Catalyses the reversible conversion of 6-
phospho-D-gluconate to D-ribulose-5-
phosphate 
 
 
3.3.2.2 In vitro characterisation of the HM605 metabolic mutants 
To confirm the integrity and expected metabolic defect of each metabolic mutant, 
the strains were grown in M9 minimal medium supplemented with glucose, 
glycerol, acetate or gluconate as the sole carbon source. 
Isocitrate lyase (encoded by aceA) catalyses the first step in the glyoxylate pathway, 
a pathway that allows cells to grow on simple C2 compounds as sole carbon 
sources. As expected, the ∆aceA::Km mutant was capable of using glucose or 
glycerol, but not sodium acetate, as a sole carbon source (Figure 3.3).  
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Isocitrate dehydrogenase (encoded by icd) is a key enzyme in the TCA cycle, where 
it catalyses the oxidative decarboxylation of isocitrate to α-ketoglutarate, resulting 
in the generation of NADPH. α-ketoglutarate can be further oxidised within the 
cycle or it can serve as a precursor for the synthesis of amino acids such as 
glutamate. It has been shown that E. coli icd mutants have a glutamate auxotrophy 
(Aoshima et al., 2003; Helling & Kukora, 1971; Lakshmi & Helling, 1976), and 
therefore must be supplied with the amino acid (which is metabolised into α-
ketoglutarate) in order for it to grow. Consistent with this observation, the HM605 
∆icd::Km mutant failed to grow in M9 minimal medium with either glucose, glycerol 
or acetate as the sole carbon source (Figure 3.3). However, the mutant grows well 
in LB broth (data not shown), where peptides provide a source of glutamate. 
There are two aconitase enzymes in E. coli (encoded by acnA and acnB) which 
catalyse the reversible isomeration of citrate and isocitrate (Gruer & Guest, 1994). 
Therefore, aconitase mutants are unable to carry out the TCA cycle or the 
glyoxylate pathway and would therefore be expected to be unable to grow in M9 
minimal medium supplemented with any of the carbon sources used in this study. 
However the HM605 ∆acnA mutant was able to grow as well as the wild-type strain 
in M9 minimal medium supplemented with glucose, glycerol or acetate as the sole 
carbon source (Figure 3.3). Indeed, an acnA mutant in E. coli K-12 strain W3110 was 
also capable of growing in glucose and acetate minimal media (Gruer et al., 1997). 
It has been reported that acnB functions as the main catabolic enzyme 
(Cunningham et al., 1997). Therefore, the acnB gene would be expected to 
complement the acnA defect. In contrast, the HM605 ∆acnB::Km mutant was 
unable to grow in M9 minimal medium with acetate as a sole carbon source and 
growth was severely impaired with glucose or glycerol as the carbon source (Figure 
3.3). Similarly, an E. coli W3110 acnB mutant also exhibited no growth in acetate 
minimal media and a slow growth rate in glucose minimal media (Gruer et al., 
1997). This suggests that the acnA gene may compensate for the acnB defect, albeit 
with a very low efficiency.  
Fructose-1,6-bisphosphatase (encoded by fbp) is specific for gluconeogenesis as the 
enzyme catalyses the irreversible conversion of fructose-1,6-bisphosphate to 
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fructose-6-phosphate. An fbp mutant, although able to carry out glycolysis 
normally, is not able to carry out gluconeogenesis above fructose-1,6-bisphosphate. 
Consistent with this, HM605 ∆fbp::Km was able to grow as well as the wild-type in 
glucose minimal media, but was not able to grow on the gluconeogenic carbon 
sources, glycerol and acetate (Figure 3.3). This result is in agreement with studies 
on fbp in E. coli (Fraenkel & Horecker, 1965) and in Salmonella (Tchawa Yimga et al., 
2006). 
In E. coli, a second fructose-1,6-bisphosphatase has been characterised, which is 
encoded by glpX (Donahue et al., 2000). The HM605 ∆glpX::Km mutant grew as well 
as the wild-type strain in glucose, glycerol and acetate minimal media (Figure 3.3); 
suggesting that fbp is the major fructose-1,6-bisphosphatase in this background. It 
has been reported that glpX is only functional in E. coli when overexpressed, and 
that chromosomal glpX does not compensate for a loss of fbp expression (Donahue 
et al., 2000). 
The HM605 ∆fbp::Km mutant is blocked for gluconeogenesis above fructose-1,6-
bisphosphate. Gluconeogenesis can be blocked earlier by mutating either pps or 
pck. Phosphoenolpyruvate synthetase (encoded by pps) catalyses the conversion of 
pyruvate to phosphoenolpyruvate (PEP); and phosphoenolpyruvate caboxykinase 
(encoded by pck) catalyses the conversion of oxaloacetate to PEP. As expected, 
both HM605 ∆pps::Km and HM605 ∆pck::Km were able to grow in glucose minimal 
media (Figure 3.3). However, the mutants were also still able to grow as well as the 
wild-type on the gluconeogenic carbon sources, glycerol and acetate (Figure 3.3). 
Completely blocking the production of PEP, by creating a ∆pps ∆pck double 
knockout, would be required to block gluconeogenesis above pyruvate i.e. to block 
growth on TCA cycle intermediates and gluconeogenic substrates. 
Phosphofructokinase catalyses the irreversible conversion of fructose-6-phosphate 
to fructose-1,6-bisphosphate, and therefore is a key committing step in the 
glycolytic pathway. In E. coli, phosphofructokinase is encoded by two genes, pfkA 
and pfkB; where over 90% of the phosphofructokinase activity can be attributed to 
pfkA (Kotlarz et al., 1975). Indeed, both HM605 ∆pfkA::Km and HM605 ∆pfkB::Km 
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were able to grow as well as wild-type on glucose minimal media (Figure 3.3), 
showing a functional redundancy in these genes. In agreement with this, it has been 
shown that pfkA and pfkB single mutants in Salmonella were able to grow on 
glucose as a sole carbon source (Bowden et al., 2009).  
The ED pathway is one of the major pathways used for gluconate metabolism in E. 
coli (Eisenberg & Dobrogosz, 1967). The pathway consists of two enzymes; 
phosphogluconate dehydratase (encoded by edd), and 2-keto-3-deoxy-6-
phosphogluconate aldolase (encoded by eda). It has been reported that an edd 
mutant in E. coli grows with wild-type kinetics on glucose, however, growth of this 
mutant is impaired, but not abolished, on gluconate (Zablotny & Fraenkel, 1967). 
Similar to this, HM605 ∆edd::Km exhibited no growth defects in glucose minimal 
media, but did have a slight growth defect in gluconate minimal media (Figure 3.4). 
The ability of these mutants to grow (albeit poorly) on gluconate can be attributed 
to residual flux through the PP pathway (Zablotny & Fraenkel, 1967). On the other 
hand, HM605 ∆eda::Km was not able to grow on gluconate minimal medium (Figure 
3.4). This phenotype of an eda mutant has been reported previously for E. coli 
(Fradkin & Fraenkel, 1971). It has been demonstrated that the accumulation of 2-
keto-3-deoxy-6-phosphogluconate in an eda mutant is toxic, resulting in a 
bacteriostatic effect on the cells (Fuhrman et al., 1998). HM605 ∆eda::Km also 
exhibited a slight (statistically significant, P≤0.05) growth defect in glucose media 
(Figure 3.4). This phenotype has not been previously reported in E. coli.  
The pentose phosphate pathway represents another major pathway for sugar 
catabolism in bacteria. A key enzyme in this pathway is 6-phosphogluconate 
dehydrogenase (encoded by gnd). It has been demonstrated that gnd mutants in E. 
coli grow normally on both glucose and gluconate medium (Fraenkel, 1968), as the 
glycolytic and ED pathways can be utilised. Similarly, HM605 ∆gnd::Km grew on 
glucose and gluconate minimal medium, albeit the growth on gluconate was slightly 
impaired in comparison to the wild-type strain (Figure 3.4). However, it has been 
reported that gnd null mutations in E. coli do indeed inactivate the pentose 
phosphate pathway, resulting in a significant re-routing of carbon flux (Jiao et al., 
2003). 
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In summary, the carbon utilisation experiments outlined above verified that the 
TCA cycle was blocked in ∆icd::Km, the glyoxylate pathway was blocked in 
∆aceA::Km, gluconeogenesis was blocked in ∆fbp::Km and the ED pathway was 
blocked in ∆eda::Km. Although the ∆gnd::Km mutation did not have any impact on 
the growth of HM605 (as has been reported in the literature for E. coli), it has been 
shown that a ∆gnd mutation does inactivate the PP pathway (Jiao et al., 2003). 
However, glycolysis was not blocked in either the ∆pfkA::Km or ∆pfkB::Km mutants.  
 
 
 
Figure 3.3 Growth of HM605 metabolic mutants in minimal media with various carbon 
sources. The indicated strains were inoculated into M9 minimal medium to a starting OD600 
of 0.05 and supplemented with 0.4% (w/v) glucose, 0.4% (w/v) glycerol or 0.4% (w/v) 
acetate, as the sole carbon source. After overnight incubation at 37°C, final growth yields 
were obtained by measuring OD595. Results shown are the mean of three experiments. The 
error bars represent the standard deviation. 
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Figure 3.4 Growth of HM605 metabolic mutants in minimal media with various carbon 
sources. The relevant bacterial strains were grown overnight at 37°C in M9 minimal 
medium supplemented with 0.4% (w/v) glucose or 0.4% (w/v) sodium gluconate, as the 
sole carbon source. Final growth yields were obtained by measuring OD595.  The data 
represents the mean of three experiments. The error bars represent the standard 
deviation. *: P≤0.05. 
 
3.3.2.3 The metabolic mutants are not defective for replication in murine 
macrophages 
As shown by the carbon utilisation experiments outlined in Section 3.3.2.2, mutants 
were constructed in HM605 which blocked the TCA cycle (icd::Km), the glyoxylate 
pathway (aceA::Km), gluconeogenesis (fbp::Km), the ED pathway (eda::Km) and the 
PP pathway (gnd::Km). Glycolysis was not blocked in either pfkA::Km or pfkB::Km. 
Regardless of this, it was decided to test these mutants for their ability to replicate 
inside J774A.1 macrophages. Although there was some variation in the level of 
replication, no significant defects in the numbers of intracellular bacteria were 
observed for any of the metabolic mutants, in comparison to the wild-type strain 
(Figure 3.5). This result suggests that all of the metabolic mutants were able to 
multiply at a similar rate as wild-type HM605 in J774A.1 cells.  
0
0.2
0.4
0.6
0.8
1
1.2
1.4
HM605 ∆edd::Km ∆eda::Km ∆gnd::Km 
O
D
5
9
5 
re
la
ti
ve
 t
o
 H
M
6
0
5
 
M9 (Glucose) M9 (Sodium Gluconate)
* 
108 
 
 
Figure 3.5 The HM605 metabolic mutants are not attenuated for replication in murine 
macrophages. J774A.1 macrophages were infected with the relevant bacterial strains at an 
MOI of 10. Intracellular bacterial numbers were assayed using the gentamicin protection 
assay at T0 and at T6. The data represents the number of intracellular bacteria at T6 / the 
number of intracellular bacteria at T0, relative to that obtained for HM605, taken as 100%. 
The data represents the mean of three experiments. The error bars represent the standard 
deviation. 
 
3.3.2.4 Construction of a phosphofructokinase double mutant in HM605 
The HM605 pfkA and pfkB mutants were still able to grow as well as the wild-type 
strain when glucose was provided as a sole carbon source (Figure 3.3), indicating 
that the glycolytic pathway was not inactivated in these mutants, likely due to a 
functional redundancy in the pfkA and pfkB genes. To ensure that the glycolytic 
pathway was completely inactivated, it was necessary to construct a double mutant 
strain, which lacked both the pfkA and pfkB genes. Considering that both of the 
single mutants had the gene of interest replaced by a Km-resistance cassette, it was 
first necessary to remove the Km-resistance marker from HM605 ∆pfkA::Km, before 
transducing in the ∆pfkB::Km allele. The Km-resistance cassette is flanked by two 
FRT sites, a property which allows the antibiotic marker to be eliminated from the 
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strain, with the help of a plasmid expressing Flp recombinase. To achieve this, the 
plasmid pFLP3 (which expresses Flp recombinase) was transformed into HM605 
∆pfkA::Km. Elimination of the Km-resistance cassette from the resulting colonies 
was verified by PCR (in addition to streaking onto agar containing Km) (data not 
shown) and the plasmid was cured from the strain by streaking onto agar 
containing 5% (w/v) sucrose. Following this the ∆pfkB::Km allele was transduced 
into the markerless HM605 ∆pfkA strain using P1 phage, resulting in the double 
knock-out strain (HM605 ∆pfkA ∆pfkB::Km, referred to as ∆pfkAB::Km). The in vitro 
growth of the double knock-out strain was then tested in M9 minimal medium with 
various carbon sources. As expected, HM605 ∆pfkAB::Km lost its ability to utilise 
glucose as a sole carbon source, while its growth in glycerol or acetate was 
unaffected (Figure 3.6), indicating successful inactivation of the glycolytic pathway. 
 
 
Figure 3.6 HM605 ∆pfkAB::Km is unable to grow with glucose as a sole carbon source. The 
indicated strains were inoculated into M9 minimal medium supplemented with 0.4% (w/v) 
glucose, 0.4% (w/v) glycerol or 0.4% (w/v) acetate, as the sole carbon source. Final growth 
yields were obtained by measuring OD595 after overnight incubation at 37°C. Results shown 
are the mean of three experiments and the error bars represent the standard deviation. 
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3.3.2.5 Glycolysis is required for replication of HM605 in murine macrophages 
In J774A.1 macrophages, neither the pfkA nor the pfkB single mutants were 
attenuated for intracellular replication (Figure 3.5). In contrast, ∆pfkAB::Km was 
severely attenuated for intramacrophagic replication (Figure 3.7). Whereas the 
number of wild-type strain bacteria increased approximately 4-fold over the 6 h 
period, the number of ∆pfkAB::Km bacteria actually decreased approximately 0.15-
fold. This result strongly suggests that a functional glycolytic pathway is required for 
active intracellular growth of HM605 in J774A.1 macrophages. Although 
∆pfkAB::Km cannot replicate, this strain does persist in the macrophage  and, after 
6 h, is found at levels that are approximately 2 orders of magnitude higher than 
what was observed for MG1655 (Figure 3.8).   
HM605 ∆pfkAB::Km grows with slower kinetics than the wild-type in vitro in both LB 
broth and DMEM (Figure 3.9).  It has been documented that an E. coli pfkAB double 
mutant is not able to grow under oxygen limiting conditions (Edwards & Palsson, 
2000). When oxygen is not present, the TCA cycle does not operate as a full cycle, 
but instead operates a branched version, which does not yield ATP (Wolfe, 2005). 
Therefore, ATP must be provided by glycolysis (Wolfe, 2005). The growth curves 
presented below were generated under static growth conditions, which would limit 
oxygen availability to the bacterial cells, thereby explaining the reduced growth rate 
of ∆pfkAB::Km. However, the reduced growth rate of ∆pfkAB::Km in vitro is not 
likely to be the reason for the defects in intracellular growth, as other mutants 
(∆pps::Km and ∆pfkA::Km) also exhibited slow-growth kinetics in vitro (Figure 3.9), 
but these mutants were unaffected for growth in the macrophage (Figure 3.5).  
 
 
111 
 
 
Figure 3.7 Glycolysis is required by HM605 for growth in J774A.1 macrophages. J774A.1 
macrophages were infected with bacterial strains at an MOI of 10. Using the gentamicin 
protection assay, intracellular bacterial numbers were enumerated at T0 and at T6. Bars 
represent the number of intracellular bacteria at T6 / the number of intracellular bacteria at 
T0, compared to HM605 (which is taken as 100%). Results shown are the average of three 
experiments. The error bars represent the standard deviation. *: P≤0.05. 
 
 
Figure 3.8 HM605 ∆pfkAB::Km persists to higher levels than MG1655 within the 
macrophage. J774A.1 macrophages were infected with the indicated bacterial strains at an 
MOI of 10. The numbers of intracellular bacteria were quantified at T6, using the 
gentamicin protection assay. The results are represented as the mean log (cfu ml-1) for each 
strain recovered from the macrophage at T6. Results shown are the mean of three 
experiments and the error bars represent the standard deviation. *: P≤0.05. 
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Figure 3.9 Growth of HM605 metabolic mutants in LB broth and DMEM. The indicated 
bacterial strains were inoculated into either (A) LB broth or (B) DMEM (supplemented with 
10% FBS) and were grown at 37°C for 24 h without agitation. Each curve is the average of 
three experiments. Error bars were omitted for clarity. 
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3.3.2.6 Complementation of HM605 ∆pfkAB::Km restores intramacrophagic 
growth 
To confirm the role for the glycolytic pathway in supporting the intramacrophagic 
replication of HM605, plasmids containing the pfkA and pfkB genes were isolated 
from the ASKA library and individually transformed into HM605 ∆pfkAB::Km. To 
confirm that expression of pfkA and pfkB from the plasmid was sufficient to restore 
the glycolytic pathway, the complemented strains were tested for their ability to 
utilise glucose as a sole carbon source. As shown in Figure 3.10, the cloned copy of 
either pfkA or pfkB fully complemented the growth defect of ∆pfkAB::Km in glucose 
in vitro. 
The complemented strains were then tested for their ability to replicate in J774A.1 
macrophages. Similar to what was observed for in vitro growth, expression of either 
pfkA or pfkB from a plasmid resulted in a significant increase in the intracellular 
growth of ∆pfkAB::Km (Figure 3.11). Indeed, the complemented strains were able 
to replicate at a level comparable to the wild-type. A slight growth attenuation was 
observed for ∆pfkAB::Km (pCA24N-pfkA) in comparison to both the wild-type 
(P=0.0599) and ∆pfkAB::Km (pCA24N-pfkB) (P≤0.05) (Figure 3.11). This may indicate 
that excessive Pfk activity is toxic to the cell (as pfkA is the major isozyme) or it may 
reflect plasmid instability as it was not possible to include the plasmid selection 
antibiotic, chloramphenicol, in the infection media. 
 
 
 
 
114 
 
 
Figure 3.10 Complementation of HM605 ∆pfkAB::Km restores in vitro growth on glucose. 
The indicated bacterial strains were grown overnight at 37°C in M9 minimal media 
supplemented with 0.4% (w/v) glucose as the sole carbon source. Cm was added where 
appropriate. Final growth yields were determined by measuring the OD595 of each culture. 
The data represents the average of three experiments. The error bars represent the 
standard deviation. 
 
 
Figure 3.11 Complementation of HM605 ∆pfkAB::Km restores replication in J774A.1 
macrophages. J774A.1 macrophages were infected with the relevant strains at an MOI of 
10. Intracellular bacterial numbers were quantified, using the gentamicin protection assay, 
at T0 and at T6. The data shows the % of the number of bacteria inside the macrophage at 
T6 / the number of bacteria inside the macrophage at T0, compared to HM605. Results 
shown are the mean of three experiments and the error bars represent the standard 
deviation. *: P≤0.05. 
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3.3.2.7 Confirmation of sugar-negative phenotype using Biolog Phenotype 
Microarrays (PM’s) 
To confirm the sugar auxotrophies of HM605 ∆pfkAB::Km, Biolog Phenotype 
Microarray (PM) technology (Biolog Inc., Hayward, CA) was employed, which allows 
the examination of microbial cellular phenotypes in a high-throughput fashion 
(Bochner et al., 2001; Bochner, 2003). PM assays measure nearly 2,000 phenotypes 
in a set of 20 96-well microtitre plates, where each well measures a different 
phenotype. Plates 1 - 10 measure basic cellular metabolism and stress functions, 
whereas plates 11 – 20 measure susceptibility to inhibitors at four different 
concentrations. PM’s exploit bacterial respiration and redox chemistry as a reporter 
system. The assays employ a tetrazolium dye (tetrazolium violet) which is reduced 
by the action of succinate dehydrogenase, thereby allowing the quantification of 
respiration. Reduction of tetrazolium violet results in the formation of a purple 
colour. Therefore, if a bacterial strain is positive for a certain phenotype, the cells 
actively respire and reduce tetrazolium violet, forming a strong colour. This reaction 
is irreversible, therefore the colour accumulates in the well over the incubation 
period. If a bacterial strain is weakly positive or negative for a phenotype, 
respiration is slowed or stopped completely and less colour or no colour is formed. 
Incubation and phenotype quantification are performed using the OmniLog 
instrument which captures a digital image of the microarray every 15 min for a 
duration of 24 h. To compare the phenotypes of two different strains, one is 
recorded in red and the other is recorded in green. The resulting graphs are then 
overlaid by bioinformatics software to detect differences. Any areas of overlap are 
highlighted in yellow i.e. where growth of the two strains was similar. PM’s are 
particularly useful for detecting the effects of gene-knockouts on the phenotype of 
a cell (Bochner et al., 2001; Bochner, 2003). 
Biolog PM plates 1 and 2 were employed to assess the ability of ∆pfkAB::Km to 
grow on various carbon sources in comparison to the wild-type. The kinetic curves 
are shown in Figure 3.12. Results confirmed that ∆pfkAB::Km has lost the ability to 
utilise a number of carbon sources including N-acetyl-D-glucosamine, D-trehalose, 
D-mannose, D-sorbitol, D-xylose, D-mannitol, D-glucose, D-glucose-1-phosphate, β-
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methyl-D-glucoside, Dextrin, N-acetyl-D-galactosamine, β-D-allose, 3-0-β-D-
galactopyranosyl-D-arabinose and D-glucosamine (Figure 3.12). These PM’s also 
showed that the use of other carbon sources was unaffected in ∆pfkAB::Km. 
 
 
 
Biolog PM plate # Location on Biolog PM plate Sugar 
1 3A N-acetyl-D-glucosamine 
 10A D-Trehalose 
 11A D-Mannose 
 2B D-sorbitol 
 8B D-Xylose 
 11B D-Mannitol 
 9C D-Glucose 
 3E D-Glucose-1-phosphate 
 8E β-methyl-D-Glucoside 
2 6A Dextrin 
 1B N-acetyl-D-galactosamine 
 3B β-D-Allose 
 12B 3-0-β-D-Galactopyranosyl-D-arabinose 
 5E D-Glucosamine 
 
Figure 3.12 Carbon utilisation phenotypic changes for ∆pfkAB::Km in PM assays. (A) The 
kinetic curves represent substrate oxidation vs. time. Significant changes are enclosed with 
black boxes. Red indicates growth of the wild-type HM605, green indicates growth of 
HM605 ∆pfkAB::Km and yellow indicates that growth of the wild-type and the mutant were 
similar. Experiments were carried out in duplicate. (B) The sugar sources which ∆pfkAB::Km 
is unable to utilise. 
(A) 
 
 
 
 
 
 
 
(B) 
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3.3.2.8 Deletion of pfkAB in HM605 does not affect stress tolerance in vitro 
Many bacterial pathogens can survive intracellularly in macrophages by either 
escaping from the phagosome or by preventing fusion of the phagosome with 
lysosomes. In contrast, it has been shown that the prototypical AIEC strain LF82 is 
capable of residing and replicating within the mature phagolysosome, where the 
bacteria are exposed to hostile conditions such as low pH and oxidative stress 
(Bringer et al., 2006). Indeed, it has also been demonstrated that HM605 replicates 
within macrophage vacuoles, which have the appearance of phagolysosomes 
(Subramanian et al., 2008). It is a possibility that the attenuated replication of 
HM605 ∆pfkAB::Km may reflect a reduced tolerance of the bacterial cells to acidic 
conditions and reactive oxygen and nitrogen species, which are characteristic of the 
mature phagolysosome. Therefore, the ability of HM605 ∆pfkAB::Km to grow on LB 
agar plates containing various chemical stress conditions was assessed. As can be 
seen in Figure 3.13 A, acidification of the LB agar with 100 mM MES pH 5, did not 
affect the growth of HM605 ∆pfkAB::Km. The addition of 1 mM acidified sodium 
nitrite (to mimic nitrosative stress) also did not impair the growth of HM605 
∆pfkAB::Km (Figure 3.13 B). Similarly, HM605 ∆pfkAB::Km also had a similar 
sensitivity to hydrogen peroxide (H2O2) (oxidative stress) as the wild-type strain in 
an agar overlay diffusion assay (Figure 3.13 C). The halo size in centimetres (cm) of 
HM605 (3.2 ± 0.1) was not significantly different from that of HM605 ∆pfkAB::Km 
(3.3 ± 0.2). These results demonstrate that HM605 ∆pfkAB::Km is not more 
sensitive to stress conditions than the wild-type in vitro. Therefore, the replication 
defect of HM605 ∆pfkAB::Km in vivo is unlikely to be due to an increased sensitivity 
to stress conditions, pointing to a metabolic requirement for glycolysis during 
growth in the macrophage.  
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Figure 3.13 Stress tolerance of HM605 ∆pfkAB::Km in vitro. HM605 and ∆pfkAB::Km 
cultures were adjusted to an OD600 of 1.0 in PBS. A series of 10-fold dilutions were prepared 
and 5 µl of each dilution was spotted onto LB plates containing (A) 100 mM MES pH 5  or 
(B) 100 mM MES pH 5 + 1 mM NaNO2. Cells were also spotted onto plain LB plates as a no-
stress control. (C) Sensitivity to H2O2 using the agar overlay diffusion method. The plates 
were incubated overnight at 37°C. Experiments were carried out in triplicate with similar 
results and a representative image is shown. 
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3.3.3 The role of anabolic pathways in supporting the intramacrophagic growth of 
HM605 
3.3.3.1 HM605 transposon mutant library screen for the isolation of auxotrophic 
mutants 
A transposon mutant library of HM605 was screened in order to identify 
auxotrophic mutants. Identification of auxotrophic mutants in HM605, and 
subsequently testing their ability to grow in macrophages would serve two 
purposes. Firstly, it would allow the identification of nutrients that contribute to 
HM605 intramacrophagic growth; and secondly, it would provide a means of 
uncovering the range of host cell nutrients that are accessible to HM605 residing in 
the phagosome.  
The mutant bank was prepared using an Epicentre EZ-Tn5 <Kan2> transposome kit, 
according to manufacturer’s instructions. Approximately 5,500 mutants were 
grown in LB broth, arrayed in 96-well plates and frozen at -80°C. On the day of the 
experiment, the library plates were left to defrost at room temperature. The 
mutants were then hand-replicated onto Q-trays (Genetix) containing M9 minimal 
medium agar supplemented with 0.4% (w/v) glucose as a sole carbon source, using 
a 96-pin replicator. Plates were incubated overnight at 37°C. Mutants that 
displayed no growth (but which exhibited growth in the original library on LB agar 
plates) were noted. See Figure 3.14 for an example of a typical plate from the 
screen. In the primary screen, 112 mutants (out of 5,513 screened) were identified 
that were unable to grow on the M9 glucose agar and re-screening of these 
mutants resulted in the retention of 39 mutants which consistently showed no 
growth. The position of the transposon in each of the 39 mutants was identified by 
amplifying the DNA fragment flanking the transposon using arbitrarily-primed PCR. 
PCR products were sequenced by GATC and nucleotide sequences generated were 
matched to sequences in the HM605 genome. For eleven of the mutants, the 
sequencing reactions did not yield any results and were discarded from the study. 
Table 3.2 outlines the transposon insertion site for each mutant and the 
corresponding gene disrupted. 
120 
 
 
Figure 3.14 A transposon mutant library of HM605 screened for auxotrophic mutants. 
5,513 mutants were replica-plated onto M9 minimal medium agar supplemented with 0.4% 
(w/v) glucose as a sole carbon source. Plates were incubated at 37°C overnight. Mutants 
showing no growth (indicated with an arrow) were noted. 
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Table 3.2 The transposon insertion site for each auxotrophic mutant and the corresponding gene disrupted 
 
Mutant 
(Plate#:Well#) 
 Localisation of Tn5  
 Scaffold  
# 
Gene 
ID 
Gene name Gene Function Gene location  
in scaffold 
Tn5 location  
within gene 
44:8G 1 2257 ilvE Catalyses the final step in valine, leucine and 
isoleucine biosynthesis 
2206979 - 2207908 800bp/930bp 
47:11D 1 2257 ilvE As above 2206979 - 2207908 389bp/930bp 
10:9B 1 2256 ilvD Catalyses the penultimate step in isoleucine and 
valine biosynthesis 
2205064 - 2206914 892bp/1851bp 
2:5H 1 2254 ilvY Transcriptional regulator; isoleucine and valine 
biosynthesis 
2202630 - 2203520 571bp/891bp 
27:6C 1 5028 trpB The tryptophan synthase complex catalyses the last 
two steps in the biosynthesis of tryptophan 
4966965 - 4968158 555bp/1194bp 
27:10F 1 5028 trpB As above 4966965 - 4968158 555bp/1194bp 
42:4H 1 5028 trpB As above 4966965 - 4968158 555bp/1194bp 
27:7E 1 5028 trpB As above 4966965 - 4968158 555bp/1194bp 
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58:7E 1 5025 trpE Catalyses the first step in the tryptophan 
biosynthetic pathway 
4962434 - 4963996 626bp/1563bp 
23:10B 1 1055 proA Catalyses the second reaction in proline 
biosynthesis 
1025785 - 1027038 141bp/1254bp 
23:7D 1 1055 proA As above 1025785 - 1027038 141bp/1254bp 
33:2E 1 1056 proB Catalyses the first step in the biosynthesis of proline 1027050 - 1028153 527bp/1104bp 
52:1H 1 3872 aroC Shikimate pathway- biosynthesis of aromatic amino 
acids (phenylalanine, tyrosine, tryptophan) 
3825073 - 3826161 914bp/1089bp 
34:7G 1 2788 aroE As above 2733778 - 2734596 635bp/819bp 
58:6E 1 2061 metB Involved in the methionine biosynthetic pathway 2014196 - 2015410 665bp/1215bp 
11:6D 1 2036 argB Catalyses the second step in the biosynthesis of 
ornithine and arginine 
1980080 - 1980856 47bp/777bp 
33:9H 1 1333 thrB Involved in the threonine biosynthetic pathway 1318231 - 1319163 55bp/933bp 
37:3H 1 5007 pyrF Catalyses the last essential step in the de novo 
biosynthesis of pyrimidines 
4942737 - 4943534 104bp/798bp 
19:1D 1 5007 pyrF As above 4942737 - 4943534 104bp/798bp 
5:9C 1 3714 purM Catalyses the fifth step in the de novo biosynthesis 3673251 - 3674288 523bp/1038bp 
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of purines 
8:2A 1 N/A IG region (42bp 
before purE start 
codon) 
Likely to have polar effect on purE (and purK) 
expression 
N/A N/A 
40:12E 1 1304 carB Catalyses the first committed step in the 
biosynthesis of arginine and pyrimidine nucleotides 
1286033 - 1289254 3060bp/3222bp 
9:1F 1 190 panC Catalyses the synthesis of pantothenate from β-
alanine and pantoate 
1165511 - 1166362 110bp/852bp 
53:2F 1 3929 pdxB Catalyses the second reaction in pyridoxine 
5’phosphate (vitamin B6) biosynthesis 
3870280 - 3871437 968bp/1158bp 
14:6B 1 1219 nadC Catalyses the third step in the de novo biosynthesis 
of NAD from L-aspartate 
1199345 - 1200238 401bp/894bp 
22:7A 1 2701 cysG Involved in the siroheme biosynthetic process 2664956 - 2666329 834bp/1374bp 
21:3H 1 2701 cysG As above 2664956 - 2666329 834bp/1374bp 
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3.3.3.2 In vitro characterisation of the HM605 auxotrophic mutants 
Where possible, the HM605 auxotrophic mutants were further characterised in a 
series of in vitro growth experiments, where M9 minimal medium was 
supplemented with the appropriate nutrient/nucleobase in order to rescue the 
phenotype of each auxotrophic mutant.  
Methionine biosynthesis. In E. coli, methionine biosynthesis is catalysed by the 
metJBLF gene cluster, where metBL forms an operon (Duchange et al., 1983). In the 
auxotrophic screen, a mutant in metB was obtained. The gene metB encodes an O-
succinylhomoserine(thiol)-lyase, which catalyses a reaction which produces L-
cystathionine and succinate from the substrates O-succinylhomoserine and L-
cysteine. The addition of methionine (1 mM) restored the growth of HM605 
metB::Km to wild-type levels in M9 minimal medium (Figure 3.15 A). 
Arginine/Ornithine biosynthesis. Arginine and ornithine are biosynthesised in E. 
coli from glutamate. The synthesis of these amino acids occurs via the action of nine 
enzymes (argA, argB, argC, argD, argE, argF, argG, argH and argI), which are 
scattered in several transcriptional units around the genome. The argB gene 
encodes a protein that catalyses the second reaction in the biosynthetic pathway – 
the conversion of N-acetyl-L-glutamate to N-acetylglutamyl-phosphate. A HM605 
mutant in argB failed to grow in M9 glucose medium and supplementation of the 
medium with both ornithine and arginine (either individually or together) restored 
growth of the mutant to wild-type levels (Figure 3.15 B). 
Isoleucine/Leucine/Valine biosynthesis. In the HM605 auxotrophic screen, 4 
mutants in the branched chain amino acid biosynthetic pathway were identified. 
Two separate mutants were independently recovered with disruptions in the ilvE 
gene, one mutant was recovered with a disruption in the ilvD gene and one mutant 
was recovered with a disruption in the ilvY gene. The gene ilvE (transaminase B) 
carries out the final step in the biosynthesis of these amino acids, and was chosen 
as a representative for the pathway. Of the supplements tested, the addition of 
isoleucine (1 mM) restored growth of HM605 ilvE::Km to wild-type levels in M9 
minimal medium, whereas the addition of valine or leucine did not (Figure 3.15 C), 
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suggesting that the mutation is specific to isoleucine biosynthesis. Indeed, it has 
been reported that ilvE mutants have an absolute requirement for isoleucine, as 
alternative transaminases exist (transaminase C and A) which can catalyse the last 
step in valine and leucine biosynthesis, respectively, in the absence of ilvE 
(McGilvray & Umbarger, 1974). 
Pyrimidine biosynthesis. Two separate mutants were identified with disruptions in 
the pyrF gene. The gene pyrF is annotated as orotidine-5’-phosphate-
decarboxylase, which catalyses the last essential step in the de novo biosynthesis of 
pyrimidines. The addition of thymine (1 mM) restored the growth of HM605 
pyrF::Km to wild-type levels in M9 glucose minimal media, whereas the addition of 
cytosine did not (Figure 3.15 E). A mutant was also identified with a disruption in 
the carB gene. The gene carB encodes a carbamoyl phosphate synthetase, which 
catalyses the first committed step in two separate biosynthetic pathways – 
pyrimidine biosynthesis and arginine biosynthesis. The addition of arginine (1 mM) 
restored the growth defect of HM605 carB::Km in M9 glucose minimal medium, 
whereras the addition of the pyrimidine bases thymine or cytosine had no effect 
(Figure 3.15 D). Arginine is an important amino acid for E. coli as it serves as a 
precursor for polyamine biosynthesis. Arginine can also be metabolised to 
glutamate by E. coli, which can subsequently be used by the cell to make pyrimidine 
nucleotides, which explains why the addition of arginine rescued the growth defect 
of carB::Km in M9-glucose medium. 
Purine biosynthesis. Two mutants were identified with disruptions in the purine 
biosynthetic pathway, purM::Km and purN::Km. HM605 purM::Km was chosen as a 
representative of the pathway. The purM encodes 
phosphoribosylformylglycinamide-cyclo-ligase, which catalyses the 5th step in the 
de novo purine biosynthetic pathway. The addition of the purine nucleobases 
adenine (1 mM) and guanine (1 mM) individually restored the growth of HM605 
purM::Km in M9 glucose minimal medium (Figure 3.15 F). 
Phenylalanine/Tyrosine/Tryptophan biosynthesis. The biosynthesis of the 
aromatic amino acids (phenylalanine, tyrosine and tryptophan) are catalysed by the 
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aro genes. One mutant was recovered which had a disruption in the aroE gene and 
another mutant was recovered which had a disruption in the aroC gene. The 
aroE::Km mutant was chosen to represent the aromatic amino biosynthetic 
pathway. The gene aroE catalyses the conversion of 3-dehydroshikimate to 
shikimate. Addition of each of the 3 aromatic amino acids (either individually or in 
combination) was not sufficient to restore growth of HM605 aroE::Km to wild-type 
levels in M9 glucose minimal medium (Figure 3.15 G). An aroE mutant is unable to 
make chorismate, which is the common precursor for the synthesis of the essential 
compounds tetrahydrofolate, ubiquinone, menaquinone and enterobactin; in 
addition to the amino acids phenylalanine, tyrosine and tryptophan. Therefore, an 
aroE mutant may have to be supplied with chorismate in order to restore growth. 
In the auxotrophic screen, 4 separate mutants were independently recovered with 
disruptions in the trpB gene and one mutant was recovered with a disruption in the 
trpE gene. The gene trpB is annotated as tryptophan synthase (β-subunit), which 
catalyses the final step in tryptophan biosynthesis i.e. the conversion of indole to 
tryptophan. HM605 trpB::Km was chosen as a representative of the pathway. 
Addition of tryptophan (1 mM) restored growth of the mutant to a level 
comparable to the wild-type in M9 minimal media (Figure 3.15 H). 
A summary of these auxotrophies is presented in Table 3.3. 
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Figure 3.15 The phenotypes of the HM605 auxotrophic mutants can be rescued by the 
addition of the appropriate supplements in vitro. The HM605 auxotrophic mutants are 
unable to grow in M9 minimal medium supplemented with 0.4% (w/v) glucose as a sole 
carbon source, after 24 h incubation at 37°C. Addition of the indicated amino 
acids/nucleobases to the medium restored growth of the mutants to levels comparable to 
the wild-type strain. Results represent the mean of three independent experiments and the 
error bars represent the standard deviation. Glu, Glucose; Met, Methionine; Orn, 
Ornithine; Arg, Arginine; Val, Valine; Leu, Leucine; Ile, Isoleucine; Phe, Phenylalanine; Tyr, 
Tyrosine; Trp, Tryptophan; T, Thymine; C, Cytosine; A, Adenine; G, Guanine. 
 
 
Table 3.3 A summary of the growth requirements of the selected auxotrophs 
Mutant Auxotrophy 
metB::Km methionine 
argB::Km ornithine or arginine 
ilvE::Km isoleucine 
carB::Km arginine 
pyrF::Km cytosine 
purM::Km adenine or guanine 
aroE::Km N/D 
trpB::Km tryptophan 
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3.3.3.3 The HM605-containing phagosome appears to be a nutrient-rich 
environment, where pyrimidines are limiting 
The HM605 auxotrophic mutants were analysed for their ability to replicate inside 
J774A.1 macrophages, using the gentamicin protection assay. Surprisingly, all of the 
auxotrophic mutants (with the exception of pyrF::Km) were able to grow in the 
macrophage at a similar level to the wild-type strain (Figure 3.16 A). This result 
suggests that HM605 has access to a wide range of nutrients inside the phagosome 
that can support the growth of the bacterium. Significantly less HM605 pyrF::Km 
cells were recovered from the macrophage at T6 relative to that obtained at the 
basal time-point, in comparison to the wild-type strain. This suggests that 
pyrimidine nucleotides might not be available or accessible to HM605 in the 
macrophage, and are therefore a limiting factor in its growth. Interestingly, less 
argB::Km and carB::Km cells were recovered from the macrophage (although the 
data was non-significant (P=0.1944 and P=0.3557, respectively) at T6 relative to that 
obtained at the basal time-point, in comparison to the wild-type strain. The in vitro 
rescue experiments showed that both argB::Km and carB::Km had an absolute 
growth requirement for arginine (Figure 3.15 D and F), suggesting that HM605 
might also be growing on a limited supply of arginine in the macrophage. The % fold 
replication for HM605 trpB::Km was not included on this graph, as the number of 
cfu’s recovered for the mutant at T0 was significantly less (5-times less) than that 
recovered for the wild-type, suggesting  that the mutant is defective for uptake into 
the macrophage or it has an initial survival defect. However, the mutant is capable 
of replicating, and at T6, comparable cfu counts were obtained for HM605 and 
trpB::Km (Figure 3.16 B). 
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Figure 3.16 Replication of HM605 auxotrophic mutants in J774A.1 macrophages. J774A.1 
macrophages were infected with the relevant strains at an MOI of 10. The numbers of 
intracellular bacteria were enumerated at T0 and T6, using the gentamicin protection assay. 
(A) Results are expressed as the number of intracellular bacteria at T6 / the number of 
intracellular bacteria at T0; relative to that obtained for HM605, taken as 100%. (B) 
Comparison of the colony forming units (cfu) of HM605 and the trpB::Km mutant during 
growth in the macrophage. The data shows the mean cfu ml-1 for each strain recovered 
from the macrophage at T0 and T6. Results shown are the mean of three experiments. The 
error bars represent the standard deviation. *: P≤0.05. 
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3.3.3.4 Disrupting trpB, aroE, purM and pyrF affects growth in vitro in DMEM 
Growth curves were generated for the auxotrophic mutants in both LB broth and 
DMEM. While all of the mutants grew at a comparable rate to the wild-type in LB 
broth (data not shown), some of the mutants, namely, trpB::Km, aroE::Km, 
purM::Km and pyrF::Km did exhibit a defect in growth in DMEM (Figure 3.17). 
Although DMEM contains phenylalanine, tyrosine, tryptophan and folic acid, which 
should support the growth of trpB::Km and aroE::Km, these nutrients may not be in 
sufficient quantity to support the growth of these mutants over the 24 h 
experimental period. Similarly, purine and pyrimidine nucleotides are not supplied 
directly in DMEM, explaining the reduced growth of purM::Km and pyrF::Km. 
However, as described previously for the central metabolic mutants, this is unlikely 
to be the reason for the fitness defect of pyrF::Km, as trpB::Km, aroE::Km and 
purM::Km can replicate normally in macrophages, despite the observed growth 
defect in vitro. 
 
3.3.3.5 Complementation of HM605 pyrF::Km restores intramacrophagic 
replication 
To confirm the requirement for pyrF during growth in the macrophage, the plasmid 
harbouring the pyrF gene was isolated from the ASKA library and transformed into 
HM605 pyrF::Km. As shown in Figure 3.18, the cloned copy of the pyrF gene fully 
complemented the pyrF::Km growth defect in M9-Glucose minimal medium in vitro. 
The complemented strain was then tested for its ability to replicate in J774A.1 
macrophages. Similar to the in vitro growth, the cloned copy of the pyrF gene 
complemented the pyrF::Km defect during growth in the macrophage (Figure 3.19). 
This result confirms that the reduced intracellular fitness of HM605 pyrF::Km is 
specifically associated with the loss of pyrF, and not due to a polar effect on 
downstream genes. 
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Figure 3.17 Growth of the HM605 auxotrophic mutants in DMEM. The indicated bacterial 
strains were inoculated into DMEM containing 10% FBS and incubated at 37°C without 
agitation for 24 h. OD600 was recorded at 15 min intervals. Results shown are the mean of 
three experiments. Error bars were omitted for clarity. 
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Figure 3.18 Complementation of HM605 pyrF::Km restores in vitro growth on glucose. 
The indicated bacterial strains were inoculated into M9 minimal medium containing 0.4% 
(w/v) glucose as a sole carbon source. After overnight incubation at 37°C, final growth 
yields were determined by measuring the OD595 of each culture. The data represents the 
mean of three experiments. The error bars represent the standard deviation. 
 
 
 
Figure 3.19 Complementation of HM605 pyrF::Km restores replication in J774A.1 
macrophages. J774A.1 macrophages were infected with the indicated bacterial strains at 
an MOI of 10. Using the gentamicin protection assay, the levels of intracellular bacteria at 
T0 and at T6 were quantified. Bars represent the % of the number of intracellular bacteria at 
T6 / the number of intracellular bacteria at T0, compared to HM605. Results shown are the 
mean of three experiments. The error bars represent the standard deviation. *: P≤0.05. 
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3.3.3.6 Deletion of pyrF in HM605 does not affect stress tolerance in vitro 
As previously discussed in Section 3.3.2.8, the macrophage phagosome represents a 
hostile environment, where bacteria are exposed to low pH, degradative proteases 
and reactive oxygen and nitrogen species. Therefore, to assess if the reduced 
intracellular fitness of pyrF::Km could be due to an increased sensitivity of the 
mutant to conditions encountered within the phagosome, pyrF::Km was grown on 
LB agar plates containing various chemical stressors. Results showed that pyrF::Km 
is not any more sensitive to low pH (Figure 3.20 A) or nitrosative stress (Figure 3.20 
B) than the wild-type (Figure 3.20 B). Similarly, the agar overlay diffusion assay 
showed that pyrF::Km is not any more sensitive to oxidative stress than the wild-
type (Figure 3.20 C). The halo size of HM605 (3.2 cm ± 0) was not significantly 
different from HM605 pyrF::Km (3.07 ± 0.058). From these results it can be 
concluded that pyrF::Km is not any more or less tolerant than HM605 to stress 
conditions in vitro. Therefore, it is likely that the reduced intracellular fitness of 
pyrF::Km in the macrophage is due to a requirement for pyrimidine nucleotides, 
which are limiting in the macrophage. 
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Figure 3.20 Stress tolerance of HM605 pyrF::Km in vitro. A series of 10-fold dilutions were 
prepared from standardised bacterial cultures and 5 µl volumes were spotted onto LB agar 
plates containing (A) 100 mM MES pH 5 or (B) 100 mM MES pH 5+1 mM NaNO2. Cultures 
were also spotted onto plates containing no stress (LB). (C) Sensitivity to H2O2 using the 
agar overlay diffusion method. Plates were incubated overnight at 37°C. Experiments were 
carried out in triplicate with similar results and a representative image is shown. 
 
 
 
 
137 
 
3.4 Discussion 
The in vivo metabolism of pathogenic bacteria is a fundamental, yet insufficiently 
studied aspect of microbe-host interactions. It has recently emerged that central 
carbon metabolism plays an important role in supporting the intracellular growth, 
and thus virulence, of many intracellular pathogens such as Salmonella, 
Mycobacterium and Listeria (Eisenreich et al., 2010; Munoz-Elias & McKinney, 
2006). The in vivo metabolism of AIEC has not been examined previously, and 
therefore, the objective of this study was to uncover the metabolic pathways (both 
catabolic and anabolic) which support the growth of AIEC strain HM605 in the 
macrophage. 
To this end, mutations were constructed in the following central metabolic 
pathways of HM605: glycolysis, gluconeogenesis, the TCA cycle, the glyoxylate 
pathway, the Entner-Doudoroff (ED) pathway and the Pentose phosphate (PP) 
pathway. The disruption in each pathway was confirmed by growing the mutant 
strains in M9 minimal medium supplemented with glucose, glycerol, acetate or 
gluconate. Although ∆gnd::Km was not affected for growth with any of the carbon 
sources tested, it has been shown that a gnd null mutation in E. coli does inactivate 
the PP pathway and results in a significant re-routing of carbon flux (Jiao et al., 
2003). 
One of the characteristic features of AIEC (and one which differentiates them from 
commensal E. coli) is their ability to replicate in macrophages (Glasser et al., 2001; 
Subramanian et al., 2008). Therefore, the metabolic mutants were tested for their 
ability to replicate in murine J774A.1 macrophages. While gluconeogenesis, the TCA 
cycle, the glyoxylate pathway, the ED pathway and the PP pathway were found to 
be dispensable for HM605 intramacrophagic replication, glycolysis was found to be 
essential in supporting the growth of HM605 in macrophages. The key committing 
step in glycolysis – the irreversible conversion of fructose-6-phosphate into 
fructose-1,6-bisphosphate – catalysed by the enzyme phosphofructokinase (pfk) 
was shown to be necessary for intracellular replication of HM605 in macrophages. 
Moreover, the replication defect of HM605 pfkAB::Km was fully complemented by 
the expression of pfkA or pfkB in trans from a plasmid, confirming the important 
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role played by the glycolytic pathway in the intramacrophagic replication of HM605. 
Interestingly, this is similar to what has been observed recently for the closely 
related pathogen, S. Typhimurium, which also requires the glycolytic pathway and 
the sugar glucose in order to replicate in the phagosome of macrophages and for 
full virulence in the mouse typhoid infection model (Bowden et al., 2009). 
Bacteria residing within phagosomes encounter harsh environmental conditions, 
and indeed, this has also been shown to be the case for AIEC (Bringer et al., 2006; 
Subramanian et al., 2008). Bacterial primary metabolism has been linked to 
oxidative stress survival, as reducing equivalents (NAD[P]H) provide an electron 
source for detoxifying superoxides (Carmel-Harel & Storz, 2000; Chavarría et al., 
2013). For this reason, the sensitivity of ∆pfkAB::Km to various chemical stressors 
was assessed in vitro. However, it was demonstrated that HM605 pfkAB::Km does 
not exhibit an increased sensitivity in vitro to stress conditions likely encountered 
by HM605 in the macrophage, such as low pH and exposure to oxidative and 
nitrosative stress, pointing to a metabolic requirement for glycolysis. Although it is 
unlikely that increased susceptibility to stress caused the in vivo phenotype, this 
possibility cannot be ruled out completely. Blocking the oxidative burst in 
macrophages using chemical inhibitors and analysing the effect on the intracellular 
growth of HM605 pfkAB::Km would be one strategy to address this issue. 
We have shown that the glycolytic pathway is important for the ability of HM605 to 
replicate in macrophages. Many different carbon sources can be catabolised by the 
glycolytic pathway, raising the question as to what sugars are available to HM605 
during infection. In Chapter 5, we isolate a mutant in ptsI, which encodes a key 
component of the phosphotransferase (PTS) sytem and we show that this mutant is 
also unable to replicate in the macrophage. Therefore, it would appear that the 
specific sugar utilised by HM605 is a PTS-imported sugar. We have shown, by 
means of Biolog PMs, that ∆pfkAB::Km is unable to use a number of  carbohydrate 
carbon sources including N-acetyl-D-glucosamine, D-trehalose, D-mannose, D-
sorbitol, D-xylose, D-mannitol, D-glucose, D-glucose-1-phosphate, β-methyl-D-
Glucoside, dextrin, N-acetyl-D-galactosamine, β-D-allose, 3-0-β-D-galactopyranosyl-
D-arabinose and D-glucosamine. However, it would be necessary to carry out a 
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systematic analysis of mutants defective in the transport of each of the fore-
mentioned sugars in order to identify the specific sugar source used by HM605 in 
the macrophage. Despite this, Bowden et al., (2009), showed by means of 
constructing specific sugar transport mutants, that glucose was the sugar source 
required by S. Typhimurium for growth in the macrophage. Considering that both 
HM605 and S. Typhimurium occupy similar niches in the macrophage, it is likely 
that glucose will also be important for HM605. 
Another question that arises is how phagosomally-residing HM605 would have 
access to sugars such as glucose? As previously mentioned, EIEC relies on glucose to 
support its intracellular growth. However, this pathogen replicates in the host cell 
cytoplasm and would therefore have direct access to glucose that is transported 
from the external environment into the cytosol by the facilitated glucose 
transporter family, GLUT and by the sodium-dependent D-glucose co-transporter 
family, SGLT (Zhao & Keating, 2007). The utilisation of glucose by HM605, and 
indeed by S. Typhimurium, which both reside in the membrane-bound phagosome 
is not as easy to explain, as glucose would have to be transported across the 
phagosome membrane in order to reach the bacteria. It has been reported that 
most of SGLT1 in enterocytes is present intracellularly, on the surface of 
endosomes, which can be rapidly and reversibly incorporated into the plasma 
membrane in order to regulate glucose uptake into the cell (Khoursandi et al., 2004; 
Kipp et al., 2003). Therefore one possibility is that fusion of the phagosome with 
endosomes may provide a route for glucose transport from the cytosol into the 
HM605-containing phagosome. The Leishmania parasite has been shown to require 
amino sugars (such as glucosamine) for growth within the phagolysosme of 
macrophages, and it has been suggested that these sugars are most likely derived 
from the endocytic pathway, from the internalisation and degradation of host 
glycans, glycoproteins and proteoglycans (McConville & Naderer, 2011; Naderer et 
al., 2010). Alternatively, it has been shown that phagosomes containing bacteria 
exhibit an intrinsic leakiness (Sander et al., 2011) and it is possible that this property 
may allow the diffusion of nutrients from the cytosol into the phagosome. In any 
regard, our data suggests that the nutrients used by HM605 are unlikely to be an 
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artefact of the growth medium used to culture the cells, which may be taken up 
with the bacteria during phagocytosis, as we have shown that some of our 
metabolic mutants which have a growth defect in DMEM are able to replicate 
normally in the macrophage. Therefore, it seems likely that HM605 is utilising host-
derived nutrients. 
Colonisation is a prerequisite to the virulence of enteric pathogens. An important 
factor in colonising a host is the ability to compete with commensal organisms for 
nutrients in the intestine. In a study aimed at identifying the metabolic pathways 
which allow E. coli K-12 strain MG1655 to colonise the streptomycin-treated mouse 
intestine, it was found that only mutations in sugar metabolic pathways affected 
colonisation and not mutations in gluconeogenesis, the TCA cycle or the pentose 
phosphate pathway (Chang et al., 2004). A later study compared the carbon sources 
preferentially used by MG1655 and EHEC strain EDL933 and it was found that both 
strains could use arabinose, fucose and N-acetylglucosamine (Fabich et al., 2008). 
However, EDL933 also used galactose, mannose and ribose, whereas MG1655 used 
gluconate and N-acetylneuraminic acid (Fabich et al., 2008). The fact that these two 
strains use different carbon sources in vivo, suggests that pathogenic strains may 
establish an infection by exploiting nutrients which are not used by commensals. 
Preliminary experiments carried out by Dr Emma Smith (Department of 
Microbiology and Alimentary Pharmabiotic Centre, University College Cork) suggest 
that both HM605 ∆eda::Km and HM605 ∆pfkAB::Km are defective in their ability to 
colonise the cecum of the streptomycin-treated mouse after 5 days. Interestingly, 
Biolog PM’s showed that ∆pfkAB::Km is unable to use mannose. Like EHEC, this may 
suggest that AIEC strains may also use carbon sources which commensal strains do 
not use, thereby allowing them to effectively colonise and initiate infection in the 
host. However, the effect of these mutations on the ability of HM605 to contribute 
to inflammation in the gut of model animals has not been tested. 
In addition, the role of biosynthetic pathways in supporting the intracellular growth 
of HM605 was analysed. A transposon mutant library of HM605 was screened for 
auxotrophic mutants, which were subsequently tested for their ability to grow in 
macrophages. This strategy allows the identification of nutrients that contribute to 
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HM605 intramacrophagic growth; and also provides a means of uncovering the 
range of host cell nutrients that are accessible to phagosomally-residing HM605. 
Twenty-eight mutants were isolated which were auxotrophic for various amino 
acids, vitamins and nucleobases. Surprisingly, all of the auxotrophic mutants tested 
(with the exception of HM605 pyrF::Km) were able to grow in macrophages as well 
as the wild-type strain. This suggests that phagosomally-residing HM605 has access 
to all the nutrients it requires to support its growth. However, pyrimidines might 
not be available or accessible to HM605. Indeed, the importance of the pyrimidine 
biosynthetic pathway has been demonstrated in Francisella, where a pyrF mutant 
was unable to replicate in primary human macrophages and mutants in pyrB, carA 
and carB were defective for growth in neutrophils and monocyte derived 
macrophages (Horzempa et al., 2010; Schulert et al., 2009).  
Our data clearly assigns a role for the glycolytic pathway and pyrimidine 
biosynthesis in supporting the replication of HM605 in macrophages. However, it is 
also important to highlight that our experiments were carried out using a cell line, 
which are known to exhibit an altered metabolism, characterised by an increased 
uptake of glucose and an enhanced glycolytic pathway, known as the Warburg 
effect (Eisenreich et al., 2010). Further studies using primary cells and animal 
models will be required to complement the findings presented here. However, it is 
evident from the literature (as discussed in the Introduction, Section 3.1), that 
studies involving cell lines, animal models, DGEP and 13C-IPA all give a similar 
picture regarding the intracellular metabolism of pathogens such as Salmonella, 
Mycobacterium and Listeria. 
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Chapter 4: Activation of the inflammasome by 
AIEC strain HM605 is dependent on bacterial 
metabolism 
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4.1 Introduction 
The innate immune system provides the first line of defence against invading 
microbes and noxious insults. Activation of the innate immune response occurs 
through the recognition of conserved microbial components called microbial-
associated molecular patterns (MAMP’s) or endogenous host-derived signals called 
damage-associated molecular patterns (DAMP’s) by germline encoded pattern-
recognition receptors (PRR’s) (Chen & Nunez, 2010; Ishii et al., 2008). Once PRR’s 
have been engaged, they initiate a cascade of signalling events resulting in 
inflammatory reactions which serve to eliminate the infectious agent or clear 
damaged cells (Akira et al., 2006). Two important families of PRR’s are the Toll-like 
receptors (TLR’s) located on the plasma membrane and on internal membranes; 
and the Nod-like receptors (NLR’s) located in the cell cytosol. Therefore, TLR’s sense 
PAMP’s and DAMP’s outside the cell, whereas NLR’s sense PAMP’s and DAMP’s that 
have gained access to the cell cytoplasm. A subset of NLR proteins respond to 
infection and stress by assembling inflammasomes (Franchi et al., 2009a). 
Inflammasomes are multi-protein complexes located in the cell cytosol which 
function in the activation of the cysteine protease, caspase-1. Once activated, 
caspase-1 can proteolytically cleave the immature forms of the pro-inflammatory 
cytokines IL-1β (pro-IL-1β) and IL-18 (pro-IL-18) into their mature, bioactive form. 
Therefore, IL-1β and IL-18 production is regulated in a two-step process. Firstly, TLR 
stimulation by PAMP’s or DAMP’s induces the synthesis of pro-IL-1β and pro-IL-18. 
Secondly, an intracellular signal, which can be of microbial origin, results in 
inflammasome activation, which catalyses the post-translational processing 
required for the secretion of the mature cytokine. In addition, inflammasome 
activation can also trigger a form of cell death called pyroptosis. Therefore, 
inflammasomes are a major driver of inflammation and antimicrobial responses in 
mammals, which serve to protect the host. Dysregulated or excessive activation of 
the inflammasome, however, can be detrimental to the host (Strowig et al., 2012). 
The best characterised inflammasome complexes, named after the associated NLR 
(or PYHIN family) protein, are discussed below. 
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4.1.1 NLRC4  
NLRC4 (also referred to as IPAF) consists of an N-terminal CARD domain (caspase-
recruitment domain), a central NBD (nucleotide binding domain) and a C-terminal 
LRR (leucine-rich repeat) domain (Figure 1 A). Due to its CARD domain, NLRC4 can 
directly recruit pro-caspase-1, without the need for the adaptor protein ASC. 
However, it has been shown that ASC enhances the efficiency of NLRC4-mediated 
IL-1β processing (Broz et al., 2010; Mariathasan et al., 2004). 
The activation of caspase-1 in macrophages infected with pathogens such as 
Salmonella , Legionella (Amer et al., 2006), Pseudomonas (Franchi et al., 2007b; 
Miao et al., 2008; Sutterwala et al., 2007) and Shigella (Suzuki et al., 2007) has been 
shown to depend on the NLRC4 inflammasome. Studies aimed at uncovering the 
molecular mechanisms of NLRC4 activation in response to these pathogens 
revealed that a functional virulence-associated bacterial type III secretion system 
(T3SS) or type IV secretion system (T4SS) was essential (Amer et al., 2006; Franchi 
et al., 2007b; Miao et al., 2008; Ren et al., 2006a; Ren et al., 2006b). These 
secretion systems are complex macromolecular structures spanning bacterial 
membranes which inject effector molecules into the cytoplasm of host cells by 
forming a needle-like pore through the cell membrane. In addition, it has been 
shown that bacterial flagellin is required for NLRC4 activation (Amer et al., 2006; 
Franchi et al., 2007b; Miao et al., 2008; Ren et al., 2006b). Indeed, cytosolic delivery 
of flagellin is sufficient to activate NLRC4 (Franchi et al., 2006; Miao et al., 2006), 
suggesting that leakage of small amounts of flagellin via bacterial secretion systems 
during infection may be the trigger for NLRC4 activation. Interestingly, Shigella 
engages the NLRC4 inflammasome through its T3SS even though it is aflagellate 
(Suzuki et al., 2007), suggesting that factors other than flagellin can activate NLRC4. 
It has been reported that proteins that form the inner rod of the bacterial T3SS, 
such as Salmonella PrgJ (which has regions structurally homologous to the C-
terminal portion of flagellin), can also activate NLRC4 (Miao et al., 2010b). PrgJ 
homologs, such as BsaK (Burkholderia pseudomallei), EprJ (EHEC), EscI (EHEC and 
EPEC), MxiI (Shigella flexneri) and PscI (Pseudomonas aeruginosa) were all capable 
of activating NLRC4 (Miao et al., 2010b). Direct interactions between flagellin (or 
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T3SS rod proteins) and NLRC4 have not been detected, suggesting the possibility of 
an intermediate receptor that binds these proteins. Indeed, it has recently been 
discovered that the Naip subfamily of NLR’s mediate cytosolic recognition of 
flagellin and T3SS rod proteins and distinct Naip proteins link flagellin and T3SS rod 
proteins to NLRC4. Specifically, flagellin binds to Naip5 and Naip6, whereas PrgJ-like 
proteins bind to Naip2 (Kofoed & Vance, 2011; Zhao et al., 2011). The mechanism 
by which Naip proteins subsequently activate NLRC4 is unknown, although it has 
been proposed that binding of flagellin or PrgJ-like proteins to the LRR domain of 
Naip proteins induces a conformational change in the protein, which then 
stimulates the activation of NLRC4. 
 
4.1.2 AIM2  
One of the initial reports of a DNA-sensing inflammasome arose from a study that 
demonstrated caspase-1 activation and IL-1β and IL-18 secretion from macrophages 
when double-stranded DNA (dsDNA) of viral or bacterial origin was transfected into 
the cytosol (Muruve et al., 2008). This IL-1β processing occurred independently of 
all known NLR’s, however, the adaptor protein ASC was critical. Subsequent to this, 
AIM2 (Absent in melanoma 2) was identified by numerous groups as the 
inflammasome which detects dsDNA (Burckstummer et al., 2009; Fernandes-
Alnemri et al., 2009; Hornung et al., 2009; Roberts et al., 2009). AIM2 is a member 
of the interferon-inducible PYHIN family (PYRIN and HIN-domain containing 
proteins). The carboxy-terminal HIN-200 domain of AIM2 binds directly to dsDNA, 
whereas the amino-terminal PYD (pyrin domain) is required for the association with 
ASC and to activate caspase-1 (Burckstummer et al., 2009; Fernandes-Alnemri et al., 
2009; Hornung et al., 2009) (Figure 1 A). However, AIM2 is structurally distinct from 
the other inflammasomes as it lacks a nucleotide-binding domain (NBD) and 
contains a HIN-200 domain instead of a leucine-rich repeat (LRR). Despite these 
differences, AIM2 induces the assembly of an inflammasome complex and the 
resulting downstream processes of IL-1β secretion and pyroptosis are 
indistinguishable from those mediated by the NBD-LRR proteins. 
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The cytosolically-replicating pathogen, Francisella tularensis, engages the AIM2 
inflammasome. It has been demonstrated that this bacterium is capable of cleaving 
caspase-1 and secreting IL-1β from Aim2+/+ macrophages, however, this response 
was abrogated in Aim2-/- cells (Rathinam et al., 2010). These results were confirmed 
in another study, which also demonstrated (through labelling and microscopy) that 
Francisella DNA colocalises with AIM2 and ASC, thereby directly implicating 
Francisella DNA in the AIM2 activation process (Fernandes-Alnemri et al., 2010). 
This study also demonstrated the critical role played by AIM2 in mediating the host 
defense against Francisella, evidenced by the dramatically higher mortality rate of 
Aim2-/- mice infected with Francisella in comparison to wild-type mice (Fernandes-
Alnemri et al., 2010).  
Inflammasome activation by Listeria monocytogenes, which also replicates in the 
cell cytosol, is partly dependent on AIM2. Infection of Aim2-/- macrophages with 
Listeria resulted in a lower level of caspase-1 activation and IL-1β cleavage than was 
observed in wild-type macrophages, suggesting that other pathways, in addition to 
AIM2 contribute to IL-1β activation (Rathinam et al., 2010). At the same time, 
another study demonstrated that both AIM2 and NLRP3 (Section 4.1.3) are engaged 
by Listeria, evidenced by a complete loss of caspase-1 activation when AIM2 
expression was knocked-down in NLRP3-deficient macrophages (Kim et al., 2010). 
Similar to Francisella, bacteriolysis of Listeria in the cytoplasm, with the 
concomitant release of dsDNA, was identified as the AIM2-activating signal (Sauer 
et al., 2010). 
 
4.1.3 NLRP3  
NLRP3 (also known as Nalp3 or cryopyrin) consists of an N-terminal PYD domain, a 
central NBD and a C-terminal LRR domain (Figure 1 B). Despite being the most 
studied inflammasome, the mechanism of activation of NLRP3 remains elusive.  
Unlike other NLR’s, NLRP3 is expressed at very low levels in resting macrophages. 
This base-line expression of NLRP3 is not sufficient for caspase-1 cleavage in 
unprimed macrophages. Therefore, upregulation of NLRP3 transcription (a process 
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known as priming) via NFKB mediated signalling is a prerequisite for activation of 
this inflammasome (Bauernfeind et al., 2009). Priming also induces the expression 
of pro-IL-1β. A second signal is then required for NLRP3 activation. Therefore, 
stimuli involved in NLRP3 activation can be subdivided into NLRP3 “primers” and 
NLRP3 “activators”. NLRP3 “primers” include TLR ligands such as LPS, peptidoglycan 
and MDP (Bauernfeind et al., 2009); as well as endogenous cytokines such as TNF-α 
and IL-1β (Franchi et al., 2009b). 
Once primed, NLRP3 activation can be triggered in response to a large number of 
diverse stimuli. Many bacterial pathogens activate NLRP3 through the secretion of 
pore-forming toxins, notably the α-, β- and Ƴ-hemolysins of Staphylococcus aureus 
(Munoz-Planillo et al., 2009), pneumolysin of Streptococcus pneumonia (McNeela et 
al., 2010; Witzenrath et al., 2011), streptolysin-O of Streptococcus pyogenes 
(Harder et al., 2009), the B-subunit of cholera toxin from Vibrio cholera (Kayagaki et 
al., 2011) and listeriolysin-O of Listeria monocytogenes (Meixenberger et al., 2010). 
It has recently been demonstrated that bacterial RNA can also mediate activation of 
NLRP3 (Kanneganti et al., 2006; Sander et al., 2011). Mycobacterium tuberculosis 
activates caspase-1 cleavage via the NLRP3 inflammasome through the expression 
of the ESAT-6 protein, which is exported through the ESX-1 secretion system 
(Mishra et al., 2010). Bacterial pathogens such as Citrobacter rodentium (Kayagaki 
et al., 2011), Chlamydia pneumoniae (He et al., 2010) and Neisseria gonorrhoea 
(Duncan et al., 2009) have also been reported to activate NLRP3 through 
unidentified ligands. Fungi such as Candida albicans (Hise et al., 2009; Joly et al., 
2009) and Aspergillus fumigatus (Said-Sadier et al., 2010) can activate NLRP3, 
although the effector mechanisms are generally not known. Studies have also 
shown that NLRP3 can be activated by viruses. In particular, activation of NLRP3 by 
Influenza-A virus has been shown to depend on viral RNA and an intracellular M2 
ion channel (Allen et al., 2009; Ichinohe et al., 2010). 
An unusual feature of the NLRP3 inflammasome is that it can induce sterile 
inflammation. In addition to microbial activators, NLRP3 can also be activated by 
non-microbial signals, i.e. DAMPs. Indeed, DAMPs such as ATP (Mariathasan et al., 
2006), amyloid-β (Halle et al., 2008), uric-acid crystals (Martinon et al., 2006), 
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hyaluronan (Yamasaki et al., 2009), aluminium (Eisenbarth et al., 2008), asbestos 
and silica (Dostert et al., 2008) are all capable of activating NLRP3. 
Given the diversity of NLRP3 activators, the general hypothesis is that NLRP3 does 
not interact directly with any of its activators. Instead, it is believed that all of these 
stimuli induce an intermediate cellular signal or a disruption in host cell physiology, 
which in all cases results in activation of a cytoplasmic protein, which subsequently 
becomes a direct NLRP3 ligand. Although a number of theories have been 
proposed, a unifying mechanism for NLRP3 activation has not been elucidated. A 
change in intracellular potassium (K+) levels is one such theory. Some NLRP3 
activators such as ATP, nigericin and pore-forming toxins result in K+ efflux from the 
cell (Franchi et al., 2007a). Moreover, the addition of 130 mM K+ to the culture 
media results in inhibition of NLRP3 activation by known NLRP3 stimuli (Petrilli et 
al., 2007). However, particulate matter has not been reported to cause K+ efflux 
from the cell. Additionally, the addition of high concentrations of K+ to culture 
media has also been reported to block the AIM2, NLRP1 and NLRC4 inflammasomes 
(Bauernfeind et al., 2011a). A second model proposes that reactive oxygen species 
(ROS) activate NLRP3. Evidence for this stems from the fact that NLRP3 agonists 
induce ROS production in macrophages (Cruz et al., 2007). However, it has been 
shown that ROS mediates NLRP3 priming, rather than activation (Bauernfeind et al., 
2011b). Thirdly, it has been proposed that the release of cathepsins due to 
phagosomal disruption could mediate NLRP3 activation. Indeed, phagocytosis of 
silica and other particles can mediate phagosomal damage with the release of 
cathepsin B, which mediates NLRP3 activation (Hornung et al., 2008). However, this 
is unlikely to be a unifying mechanism as there is no evidence that ATP, for 
example, induces the release of cathepsins. None of the above mentioned 
hypotheses provide an adequate explanation for the mechanism of NLRP3 
activation and further studies will be required to assess how these observations 
integrate into a complete picture of NLRP3 activation. 
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4.1.4 NLRP1  
The original inflammasome was identified on the basis of the assembly of the 
human NLRP1 (Nalp1) inflammasome (Martinon et al., 2002). NLRP1 differs from 
other NLR proteins in its domain organisation. Like other NLR proteins, it has an N-
terminal PYD domain, followed by a centrally located NBD and LRR domain. 
However, in contrast to other NLR proteins, it has a C-terminal domain consisting of 
a CARD and FIND (function-to-find) domain (Figure 1 B). Therefore, it differs from 
other NLR’s by having two signal transduction domains (a PYD and a CARD domain). 
The human NLRP1 inflammasome was the only inflammasome complex 
reconstituted in vitro using purified components (Faustin et al., 2007). This revealed 
that the minimum components for NLRP1 inflammasome assembly were NLRP1, 
caspase-1 and a triphosphate ribonucleotide (rNTP). Bacterial MDP was identified 
as the activating ligand. It was proposed that caspase-1 was activated in a two-step 
manner. Firstly, MDP induces a conformational change in the LRR of NLRP1, which 
allows it to bind to nucleotide and oligmerise, resulting in caspase-1 activation. 
However, there is no evidence that MDP binds directly to NLRP1, so its mechanism 
of activation is unclear. Humans have a single NLRP1 gene, however, mice have 
three paralogs (which lack the N-terminal PYD domain) – NLRP1a, NLRP1b and 
NLRP1c. Different strain-specific alleles exist for NLRP1b, which is the best 
understood NLRP1 inflammasome. Bacillus anthracis lethal toxin (LT) has been 
shown to activate NLRP1b in murine macrophages (Nour et al., 2009). LT is 
composed of two protein subunits, protective antigen (PA) and lethal factor (LF). 
The PA forms a pore in the membrane which allows the translocation of the LF (a 
zinc metalloprotease) into the cell cytosol, thereby activating caspase-1 (Nour et al., 
2009). Caspase-1 activation, IL-1β production and pyroptosis require the 
susceptible NLRP1b allele (Boyden & Dietrich, 2006). It has been demonstrated that 
LT-mediated activation of caspase-1 via NLRP1b is protective to the host, as mice 
deficient in caspase-1 or NLRP1b were more susceptible to infection than wild-type 
mice (Terra et al., 2010). However, the precise mechanism by which anthrax LT 
activates NLRP1b remains unknown. 
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Figure 4.1 (A) The NLRC4 and AIM2 inflammasomes. Activation of NLRC4 occurs in 
response to bacterial flagellin or PrgJ-like proteins. These stimuli activate NLRC4 by binding 
to Naip proteins. Upon activation, NLRC4 recruits pro-caspase-1 directly; the adaptor 
protein ASC plays an unidentified role. AIM2 is directly activated in response to dsDNA. 
Upon activation AIM2 directly recruits pro-caspase-1. Activation of pro-caspase-1 within 
the inflammasome results in IL-1β secretion and pyroptotic cell death. 
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Figure 4.1 (B) The NLRP3 and NLRP1b inflammasomes. Activation of NLRP3 occurs in 
response to a wide variety of stimuli including bacterial RNA, bacterial toxins, fungi, viruses 
and endogenous danger signals. Upon activation, NLRP3 recruits pro-caspase-1 via 
interactions with the adaptor protein ASC. NLRP1b is activated in response to anthrax lethal 
toxin. Upon activation it can directly recruit pro-caspase-1. The role of ASC is currently 
unknown. Direct binding of stimuli to NLRP3 or NLRP1b has not been demonstrated; rather 
these stimuli elicit a common cellular response which in turn activates NLRP3 or NLRP1. 
Activation of pro-caspase-1 within the inflammasome results in IL-1β secretion and 
pyroptosis. 
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4.1.5 Major Effector functions of Inflammasomes 
4.1.5.1 Pyroptosis 
Eukaryotic cells can die through many distinct biochemical pathways, such as 
apoptosis, necrosis and pyroptosis (Miao et al., 2011). Pyroptosis is described as a 
caspase-1 dependent programmed cell death resulting in the rapid lysis of the 
infected cell (Miao et al., 2011). These modes of cell death have a distinct set of 
morphological and biochemical features, some of which are shared (Table 4.1). The 
molecular mechanisms leading to pyroptosis are unknown, however, it is thought to 
result from osmotic pressure generated from caspase-1 dependent pore formation 
in the cell membrane. This results in rupture of the plasma membrane and the 
release of danger signals into the extracellular environment (Fink & Cookson, 2006). 
The in vivo relevance of pyroptosis has been documented for Salmonella. 
Salmonella infection is lethal to mice, as during the systemic phase of infection, 
Salmonella downregulates flagellin and T3SS expression, resulting in evasion of 
NLRC4 recognition (Miao et al., 2010a). It has been demonstrated that a Salmonella 
strain which constitutively expresses flagellin is attenuated in mice due to 
recognition by NLRC4. This attenuation was shown to be independent of IL-1β 
secretion, and dependent on pyroptosis (Miao et al., 2010a). Pyroptotic cell death 
promoted the release of Salmonella, which were consequently engulfed by 
neighbouring neutrophils (Miao et al., 2010a). Therefore, pyroptosis appears to be 
an innate immune effector mechanism that serves to clear infection by eliminating 
the niche that bacterial pathogens exploit for intracellular replication. 
 
4.1.5.2 Cytokine processing 
A major function of the inflammasome is to mediate the processing of the related 
pro-inflammatory cytokines IL-1β and IL-18. Production of these cytokines causes a 
variety of biological effects in the cell. IL-1β coordinates local and systemic 
responses to infection and injury by generating fever, activating lymphocytes and 
by promoting the migration of leukocytes to the site of infection or injury 
(Dinarello, 2009; Sims & Smith, 2010). IL-18 is principally known for its ability to 
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induce IFN-Ƴ production from activated T cells and natural killer (NK) cells, in 
conjunction with IL-12, thereby mediating T helper 1 (TH1) cell polarisation 
(Dinarello, 2009; Sims & Smith, 2010). In conjunction with IL-23, IL-18 drives TH17 
responses by promoting IL-17 production from TH17 cells (Weaver et al., 2006). In 
the absence of IL-12 and IL-23, IL-1  can drive TH2 responses by stimulating the 
production of IL-4, IL-5 and IL-10 (Dinarello, 2009; Nakanishi et al., 2001). 
 
Table 4.1 Characteristics of Apoptosis, Pyroptosis and Necrosis. Modified from 
(Miao et al., 2011) 
 Apoptosis Pyroptosis Necrosis 
Initiation Programmed Programmed Accidental 
Caspase 
involvement 
Yes, (3, 6 and 7) Yes, (1) No 
Morphological 
effects 
Cell shrinkage, 
membrane 
blebbing 
Membrane swelling and 
rupture 
Membrane 
swelling and 
rupture 
Terminal event Non-Lytic Lytic Lytic 
Effect on tissue Non-inflammatory Inflammatory Inflammatory 
Cell type All Macrophages/Dendritic 
cells 
All 
 
 
4.2 Objectives 
A characteristic feature of AIEC is their ability to persist and replicate within 
macrophages. In Chapter 3, we described a mutant in HM605 in the glycolytic 
pathway that was shown to persist but not replicate in J774A.1 macrophages. 
Therefore, the aim of this chapter was to use HM605 ∆pfkAB::Km as a tool to probe 
the consequences of AIEC replication on the J774A.1 macrophage. 
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4.3 Results 
4.3.1 Response of the macrophage to infection with HM605, HM605 ∆pfkAB::Km 
and MG1655 
Macrophages are phagocytic cells that are capable of destroying internalised 
microorganisms, through the production of an arsenal of antimicrobial features 
(Flannagan et al., 2009). Most microbes are successfully internalised and degraded 
by macrophages, however, many pathogens have devised mechanisms to interfere 
with phagocytosis and/or the phagosomal maturation process, thereby promoting 
their survival within these cells (Flannagan et al., 2009). However, a characteristic 
feature of AIEC is their ability to persist and replicate within macrophages, where 
they reside in vacuoles which exhibit phagolysosome-like properties (Glasser et al., 
2001; Subramanian et al., 2008). Indeed, this feature of AIEC differentiates them 
from commensal strains of E. coli, which are effectively eradicated by macrophages. 
Therefore, as part of our studies to characterise the molecular mechanisms 
underpinning the AIEC phenotype, it was of interest to us to determine the 
consequences of AIEC replication on the macrophage response. The transcriptional 
response of the macrophage to infection with different strains of E. coli was 
determined in the laboratory by Mr. John Catchpole (Department of Microbiology, 
University College Cork, Ireland). Three E. coli isolates were chosen for this analysis 
– the AIEC strain HM605 (Martin et al., 2004); HM605 ∆pfkAB::Km, an isogenic 
mutant of HM605 which is not able to replicate, but does persist within the 
macrophage (Described in Chapter 3); and MG1655, a non-pathogenic laboratory K-
12 strain.  
J774A.1 macrophages were infected with each of the three E. coli strains at an MOI 
of 10, for 2 h. Gentamicin was added to the cells for 1 h after the infection period to 
kill extracellular bacteria. Total RNA was then extracted from the cells 6 h later (at 
T6) and subjected to microarray analysis. Transcriptome data was analysed by Ms. 
Ailis Fagan (Alimentary Pharmabiotic Centre, University College Cork, Ireland). 
When the macrophage transcriptomes were compared, the gene expression 
patterns induced in response to HM605, HM605 ∆pfkAB::Km and MG1655 were 
identical (data not shown). This suggests, that at the transcriptional level, the 
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macrophage responds identically to different strains of E. coli and is not affected by 
the replication of AIEC within the phagosome. The Gram negative cell wall contains 
LPS, an important MAMP that is recognised by TLR4, a membrane localised 
signalling protein that controls the expression of the transcriptional regulator NFKB. 
Many of the macrophage genes which exhibited the largest increase in expression 
in response to infection were genes which are known to be regulated by NFKB; e.g. 
Tnf, Il6, Il12a and Il1b, encoding the cytokines TNF-α, IL-6, IL-12 and Il-1β, 
respectively (Table 4.2). 
 
Table 4.2 Genes which were differentially regulated by infection with HM605, 
HM605 ∆pfkAB::Km and MG1655. 
Gene name Designation Fold Regulation* in HM605-infected cells in comparison 
to 
 Uninfected HM605 ∆pfkAB::Km MG1655 
NFKB Nfkb1 2
1.274 
(p=0.000649) 
20.212 (p=0.9998) 20.011 
(p=0.999974) 
Caspase 1 Casp1 21.416 
(p=0.000778) 
20.101 (p=0.9998) 20.062 
(p=0.999974) 
Caspase 11 Casp11 22.391 
(p=0.000123) 
20.233 (p=0.9998) 20.096 
(p=0.999974) 
NLRP3 Nlrp3 22.095 (p=7.5E-
05) 
20.383 (p=0.9998) 20.043 
(p=0.999974) 
Tumor necrosis 
factor alpha 
Tnf 23.685 
(p=3.8E-05) 
20.629 
(p=0.9998) 
20.649 
(p=0.999974) 
Interleukin 1 
beta 
Il1b 28.502 
(p=1.5E-05) 
20.364 
(p=0.9998) 
2-0.319 
(p=0.999974) 
Interleukin 12  Il12 29.395 
(p=8E-06) 
20.839 
(p=0.9998) 
21.042 
(p=0.999974) 
Interleukin 6 Il6 29.856 
(p=8E-06) 
20.589 
(p=0.9998) 
2-0.062 
(p=0.999974) 
*Positive values indicate fold induction and negative values indicate fold repression 
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4.3.1.1 Verification of the microarray data 
To independently confirm and validate the microarray results for gene induction by 
E. coli, we measured the level of cytokines (TNF-α, IL-1β, IL-12 and IL-6) produced in 
infected macrophages. J774A.1 macrophages were infected with each of the three 
E. coli strains at an MOI of 10 for 2 h. Gentamicin was added to the cells after the 
infection period to kill extracellular bacteria. Culture supernatants were collected at 
T0, T6 and T24. Although microarray analysis was only performed at T6, a 24 h time-
point was also included here, as Glasser et al., (2001) observed high levels of TNF-α 
secretion from LF82-infected macrophages at 24 h post-infection. At each indicated 
time-point, macrophages were also lysed to release intracellular bacteria. Lysates 
were serially diluted and plated to determine the number of viable bacteria. As 
expected, viable counts for HM605 increased over the 6 h period, whereas viable 
counts for HM605 ∆pfkAB::Km remained relatively constant whilst MG1655 levels 
were lower (Figure 4.2 A). It is also important to note that between T6 and T24 viable 
counts also decrease for HM605, which might be a reflection of HM605-induced 
macrophage cytotoxicity at this time (Figure 4.2 F). 
TNF-α, IL-12 and IL-6 were detected in the supernatants of HM605, HM605 
∆pfkAB::Km and MG1655 infected macrophages (at all time-points tested), whereas 
negligible levels of these cytokines were detected in uninfected cell supernatants. 
In addition, all of these cytokines were produced at similar levels by the three 
strains at T6, confirming the results of the microarray. However, at T24, MG1655 
induced the secretion of significantly less of these cytokines than either HM605 or 
HM605 ∆pfkAB::Km. The increased level of cytokine production at T24 may indicate 
a late-acting signal produced by AIEC bacteria or it may simply be a consequence of 
the persistence and/or replication of HM605 and HM605 ∆pfkAB::Km in the 
macrophage (Figure 4.2 B-D). 
IL-1β was also detected in the supernatants of HM605, HM605 ∆pfkAB::Km and 
MG1655 infected macrophages (at all time-points tested), whereas negligible levels 
of this cytokine was detected in uninfected cell supernatants. However, contrary to 
the transcriptome data, HM605 ∆pfkAB::Km and MG1655 induced the secretion of 
significantly less IL-1β than HM605 at T6. At T24, this difference became more 
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pronounced, with large quantities of IL-1β detected in culture supernatants of 
HM605-infected macrophages, in comparison to the other two strains. In addition, 
at this time-point, significant differences were also observed between HM605 
∆pfkAB::Km and MG1655, with HM605 ∆pfkAB::Km inducing the secretion of 
significantly more IL-1β than MG1655 (Figure 4.2 E). As already explained IL-1β 
production requires 2 signals: an initial priming signal that is necessary for the 
expression of the il1b gene and a second danger signal that activates the 
inflammasome, required for the maturation of IL-1β. The microarray would be 
measuring the priming step of IL-1β production whereas the immunoassay is 
measuring levels of the mature, secreted cytokine (and is therefore likely reporting 
on inflammasome activation). Therefore a distinguishing feature of a replicating 
AIEC strain appears to be its ability to activate the inflammasome to higher levels 
than a laboratory E. coli strain and thus process pro-IL-1β into its bioactive cytokine. 
In this way, AIEC can be considered to be more pro-inflammatory than non-AIEC 
strains. Inflammasome activation is also associated with pyroptosis and, consistent 
with this, as measured by the release of the cytoplasmic enzyme LDH into culture 
supernatants, HM605 was significantly more cytotoxic to macrophages than HM605 
∆pfkAB::Km or MG1655 at T24 (Figure 4.3 F).  
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Figure 4.2 AIEC strain HM605 induces a pro-inflammatory response in J774A.1 
macrophages. J774A.1 macrophages were infected with the indicated strains at an MOI of 
10. (A) Using the gentamicin protection assay, the numbers of intracellular bacteria were 
enumerated at T0, T6 and T24. Results are expressed as the mean cfu ml
-1 for each strain 
recovered from the macrophage at these time-points. (B) – (E) At T0, T6 and T24, culture 
supernatants were collected and cytokine levels (TNF-α, IL-12, IL-6 and IL-1β) in the 
supernatants were quantified using a mouse cytokine assay kit. (F) Host cell death was 
assessed by measuring the level of the cytosolic enzyme LDH released into culture 
supernatants at T0, T6 and T24. Results shown are the mean of four experiments. The error 
bars represent the standard deviation. *: P≤0.05. 
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4.3.2 Caspase-1 activation by HM605, HM605 ∆pfkAB::Km and MG1655 
Activation of the cysteine protease caspase-1 is critical for processing pro-IL-1β into 
its biologically active form and this takes place in the context of the inflammasome. 
Upon activation by binding a ligand, the inflammasome recruits the 45 kDa pro-
caspase-1 (p45) to the complex, and this is subsequently self-activated by 
proteolytic cleavage into an enzymatically active heterodimer composed of a 10 
kDa (p10) and 20 kDa (p20) subunit. Enzymatically active caspase-1 can then 
proteolytically cleave pro-IL-1β into its bioactive form. 
The transcriptome data shows that there was an increase in caspase-1 mRNA in all 
infected J774A.1 cells (Table 4.2); and this is also reflected at the protein level 
(Figure 4.3 A). Immunoblotting showed an increased production of caspase-1 p45 in 
all infected macrophage in comparison to uninfected samples (Figure 4.3 A). 
However, activation of caspase-1 was observed in HM605-infected macrophage, as 
determined by Western blot detection of the p20 cleavage product (Figure 4.3 A). 
No caspase-1 cleavage was observed in uninfected (UI) cells (Figure 4.3 A), showing 
that the cleavage was due to microbial infection. In contrast, infection of 
macrophages with HM605 ∆pfkAB::Km resulted in significantly less caspase-1 
activation compared with the wild-type HM605 strain (Figure 4.3 A), as measured 
by densitometric analysis (Figure 4.3 B). No detectable caspase-1 activation was 
observed when macrophages were infected with MG1655 (Figure 4.3 A). These 
results reflect the diminished abilities of HM605 ∆pfkAB::Km and MG1655 to induce 
IL-1β secretion from macrophages (Figure 4.2 E). 
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Figure 4.3 HM605 infection stimulates caspase-1 cleavage in J774A.1 macrophages. (A) 
J774A.1 macrophages were infected with the relevant bacterial strains at an MOI of 10. At 
T12 and T24, whole-cell lysates were prepared and were immunoblotted with an anti-
caspase-1 antibody. Arrows indicate the full-length caspase-1 (p45) and the p20 subunit. 
Membranes were stripped and immunoblotted with an anti-β-Actin antibody to confirm 
equal loading. Experiments were carried out in triplicate with similar results and a 
representative image is shown. (B) Band densities for cleaved caspase-1 p20 were 
determined using ImageJ software. The densitometry values were normalised to the β-
Actin level in each lane. Bars represent the normalised densitometry values relative to that 
obtained for HM605 at T12. *:P≤0.05. UI, uninfected cells. 
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4.3.3 HM605 induced IL-1β secretion is dependent on caspase-1 
To determine whether HM605-induced IL-1β secretion is dependent on the activity 
of caspase-1, the ability of a general caspase inhibitor (Q-VD-OPH) and a caspase-1 
inhibitor (Z-WEHD-FMK) to block IL-1β secretion was assessed. Q-VD-OPH and Z-
WEHD-FMK are irreversible, cell-permeable peptide based caspase inhibitors. The 
caspase inhibitor binds to the active site of the protease, thus inhibiting its activity. 
Blocking caspase-1 activity with the caspase-1 specific inhibitor (Z-WEHD-FMK) or 
the general caspase-inhibitor (Q-VD-OPH) resulted in a significant decrease in IL-1β 
secretion in response to infection with HM605 (Figure 4.4), suggesting that the IL-
1β is produced in a caspase-1 dependent manner.  
 
 
Figure 4.4 HM605-induced IL-1β secretion by J774A.1 macrophages is reduced in the 
presence of caspase inhibitors. J774A.1 cells were either untreated or pre-treated with 50 
µM Z-WEHD-FMK (caspase-1 inhibitor) or 50 µM Q-VD-OPH (pan-caspase inhibitor) for 1 h 
prior to infection. Macrophages were then infected with HM605 and at T24, culture 
supernatants were collected and assayed for IL-1β production. The caspase inhibitors were 
maintained in the culture medium for the duration of the experiment. Experiments were 
carried out in triplicate and the error bars represent the standard deviation. *: P≤0.05. 
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4.3.4 Live bacteria are required for IL-1β release from HM605 infected 
macrophages 
To determine whether inflammasome activation is dependent on an active bacterial 
process, J774A.1 macrophages were infected as described previously with live and 
killed bacteria. Killed bacteria were prepared by heating bacterial cells to 60°C for 1 
h. The efficacy of killing was determined by plating aliquots of the killed bacterial 
cultures onto LB agar plates and incubating at 37°C overnight. The absence of any 
bacterial growth confirmed effective killing (data not shown).  
At 24 h post-gentamicin treatment, culture supernatants were collected and 
assayed for the presence of IL-1β. Viable HM605 and viable HM605 ∆pfkAB::Km 
induced significantly greater levels of IL-1β release than their heat-killed 
counterparts (Figure 4.5). It has recently been shown that bacterial mRNA can act 
as a vita-PAMP, enabling the NLRP3 inflammasome to distinguish between viable 
and non-viable bacteria (Sander et al., 2011). Therefore, the difference in IL-1β 
production between macrophages infected with viable ∆pfkAB::Km and dead 
∆pfkAB::Km is likely due to the presence of mRNA in viable cells (which is absent in 
dead cells). However, viable HM605 stimulated the macrophage to release 
significantly higher levels of IL-β release than viable ∆pfkAB::Km (Figure 4.5), 
suggesting that there is an additional, and synergistic signal produced from HM605, 
which is absent in ∆pfkAB::Km. 
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Figure 4.5 Infection with viable bacteria is required for efficient IL-1β secretion by J774A.1 
macrophages. J774A.1 cells were infected with viable and heat-killed bacteria at an MOI of 
10. At T24, culture supernatants were collected and IL-1β levels in the supernatants were 
quantified using a mouse cytokine assay kit. Results shown are the mean of three 
experiments. The error bars represent the standard deviation. *: P≤0.05. 
 
4.3.5 Inflammasome activation by HM605 is not dependent on bacterial 
replication 
Considering that HM605 ∆pfkAB::Km is able to persist, but not replicate within 
macrophages (see Chapter 3), and it induces significantly less IL-1β release from 
infected macrophages than the wild-type strain (Figure 4.2 E), it seemed reasonable 
to speculate that intracellular replication may be the driving force behind the high 
levels of IL-1β release from HM605-infected macrophages. To explore this idea 
further, a panel of HM605 mutants which were unable to grow, or grew to much 
lower levels in the macrophage, were analysed for their ability to induce IL-1β 
secretion from macrophages. These mutants were isolated from our HM605 
transposon mutant library through various genetic screens, as detailed below.  
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HM605 pyrF::Km was isolated from the HM605 mutant bank during a screen aimed 
at isolating auxotrophic mutants (see Chapter 3). This gene is annotated as 
orotidine-5’-phosphate decarboxylase, which catalyses the last essential step in the 
de novo biosynthesis of pyrimidines. There is a 16.4% (± 7.63%) drop in the 
numbers of intracellular HM605 pyrF::Km between T0 and T6, showing that this 
mutant strain is unable to grow in the macrophage (Figure 4.6 A). 
HM605 tolA::Km and HM605 surA::Km were isolated from the HM605 mutant bank 
during a screen aimed at identifying mutants which were sensitive to SDS. The 
product of the gene surA encodes an isomerase which is required for the proper 
folding of outer membrane proteins, whereas the product of tolA is an inner 
membrane protein which forms part of the Tol-Pal cell-envelope complex. The main 
function of the Tol-Pal system is to mainatin cell-envelope integrity. There is a 
47.18% (± 12.89%) drop in the numbers of intracellular HM605 tolA::Km between T0 
and T6, again showing that this mutant strain is unable to grow in the macrophage 
(Figure 4.6 A). In the case of HM605 surA::Km, there is a 3,081.86% (± 643.25%) 
increase in the numbers of intracellular bacteria between T0 and T6, showing that 
this strain is capable of replicating in the macrophage (Figure 4.6 A). However, the 
% of surA::Km cells recovered from the macrophage at T0 was only 1.32% (± 0.03%) 
compared to that of the wild-type (Figure 4.6 A), suggesting that surA::Km might 
have an initial survival defect in the macrophage, which it recovers from. In order 
for the bacterial numbers to increase to such an extent, it must suggest that the 
surA::Km cells are present at T0, but they are just not culturable. Due to the nature 
of the mutation, it may be that the cells are too stressed to form colonies early in 
infection, but they adapt and recover over the course of the experiment. Even 
though surA::Km is capable of replicating in the macrophage, the bacterial load 
recovered from the macrophage at T6 is only 19.01% (± 4.34%) compared to that of 
the wild-type (Figure 4.6 A).  
HM605 uvrD::Km was isolated from the HM605 mutant bank during a screen aimed 
at identifying mutants which were sensitive to hydrogen peroxide (H2O2) ie. 
oxidative stress (Dr Adam O’Driscoll, personal communication). The product of the 
gene uvrD is a DNA helicase II which is involved in nucleotide excision repair. There 
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is a 213.64% (± 70.45%) increase in the number of intracellular uvrD::Km cells 
between T0 and T6, showing that this strain is capable of replicating within the 
macrophage (Figure 4.6 A). However, the % of uvrD::Km cells recovered from the 
macrophage at T0 was only 29.77% (± 12.01%) compared to that of the wild-type 
(Figure 4.6 A), suggesting that uvrD::Km (like surA::Km) might have an initial survival 
defect in the macrophage, from which it recovers. Even though uvrD::Km is capable 
of replicating in the macrophage, the bacterial load recovered from the 
macrophage at T6 is only 27.16% (± 1.36%) compared to that of the wild-type 
(Figure 4.6 A). 
At T24, culture supernatants were collected and analysed for the presence of IL-1β. 
Surprisingly, all of the mutants, with the exception of ∆pfkAB::Km, stimulated the 
macrophages to induce similar amounts of IL-1β as the wild-type (Figure 4.6 B). 
However, surA::Km and uvrD::Km did stimulate significantly higher levels of IL-1β 
release from infected macrophages, than did the wild-type (Figure 4.6 B). As 
previously mentioned, these mutants possibly experience an initial survival defect 
in the macrophage, which could be correlated with RNA release from these 
mutants due to membrane damage/bacterial lysis. Bacterial RNA is a known 
activator of the NLRP3 inflammasome (Sander et al., 2011). Therefore, RNA release 
from these mutants could the reason for the higher levels of IL-1β observed from 
macrophages infected with these strains.  
Overall, these results suggest that IL-1β secretion does not correlate with the level 
of bacterial replication, or indeed bacterial numbers, within the macrophage. 
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Figure 4.6 Intramacrophagic replication of HM605 is not required for IL-1β secretion. 
J774A.1 macrophages were infected with the indicated bacterial strains at an MOI of 10. (A) 
Using the gentamicin protection assay, intracellular bacterial numbers were quantified at T0 
and T6. Results are expressed as the mean cfu ml
-1 for each strain recovered from the 
macrophage at the indicated time-points. (B) IL-1β levels in culture supernatants were 
quantified at T24. Results shown are the mean of three experiments and the error bars 
represent the standard deviation. *: P≤0.05 
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4.3.6 Complementation of HM605 ∆pfkAB::Km restores IL-1β secretion from 
infected macrophages 
Results from Chapter 3 showed that complementation of HM605 ∆pfkAB::Km with 
plasmids expressing cloned copies of both pfkA (pCA24N-pfkA) and pfkB (pCA24N-
pfkB) restored the ability of the mutant to utilise glucose as a sole carbon source 
(Figure 3.10) and also restored the ability of the mutant to replicate in macrophages 
(Figure 3.11).  
Indeed, complementation of ∆pfkAB::Km with pCA24N-pfkA or pCA24N-pfkB also 
resulted in an increase in IL-1β secretion from infected macrophages (Figure 4.7). 
Complementation with pCA24N-pfkA restored IL-1β levels to that of the wild-type 
strain. However, although complementation with pCA24N-pfkB resulted in a 
significant increase in IL-1β secretion compared to ∆pfkAB::Km, IL-1β levels induced 
by this complemented strain were still significantly lower than that induced by the 
wild-type strain (Figure 4.7). This could be due to expression differences. As 
previously mentioned, pfkA is the major isozyme, with only 5% of Pfk activity 
attributed to pfkB (Kotlarz et al., 1975). In the absence of pfkA, slow-growth on 
sugars depends on pfkB. So therefore, although complementation of pfkAB::Km 
with pfkB did restore intracellular replication, it is possible that the inflammasome-
activating signal is being produced with slower kinetics in this strain, thereby 
resulting in lower levels of IL-1β production. Previous results have demonstrated 
that IL-1β secretion occurs independently of bacterial replication (Figure 4.6). 
Therefore, the ability of ∆pfkAB (pCA24N-pfkA) to induce IL-1β secretion to wild-
type levels is unlikely due to the fact that intracellular replication is also restored in 
this complemented strain (Chapter 3, Figure 3.11). Therefore, it may suggest that a 
functional glycolytic pathway is required by HM605 to interact with the 
inflammasome and stimulate IL-1β secretion. 
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Figure 4.7 Complementation of HM605 ∆pfkAB::Km restores IL-1β secretion by J774A.1 
macrophages. J774A.1 cells were infected with the relevant bacterial strains at an MOI of 
10. At T24, culture supernatants were collected and IL-1β levels in the supernatants were 
quantified using a mouse cytokine assay kit. Results shown are the mean of two 
experiments. The error bars represent the standard deviation. *: P≤0.05. 
 
4.3.7 The role of bacterial glycolysis in inflammasome activation by HM605 
4.3.7.1 Construction of additional mutants in the glycolytic pathway 
HM605 ∆pfkAB::Km is compromised in its ability to induce caspase-1 activation and 
IL-1β secretion in macrophages, however, this defect appears to be independent of 
its inability to replicate in macrophages. Intrigueingly, this may suggest that the 
HM605 glycolytic pathway plays a role in inflammasome activation by AIEC ie. a 
bacterial metabolite produced via glycolysis may be the inflammasome-activating 
signal.  
To explore this idea further, additional deletion mutants were constructed in the 
glycolytic pathway, with the aim of pin-pointing the signal to a specific step in the 
pathway. Deletion mutants were constructed using bacteriophage P1-mediated 
transduction, using the KEIO library as a source of the donor strains (Baba et al., 
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2006) (Table 4.3). The integration of the Km-resistance cassette into the 
chromosome of each mutant was verified by PCR (data not shown). It is important 
to note that not all steps in glycolysis were successfully inactivated. As detailed 
below, a number of mutants in glycolysis are not culturable on LB medium due to a 
requirement for gluconeogenesis on this medium (although it would have been 
possible to supply glucose exogenously). However, the KEIO library is maintained in 
LB broth and these alleles were, therefore, not present in the library.  
The interconversion of fructose-1-bisphosphate and dihydroxyacetone-phosphate is 
catalysed by two enzymes (fbaA and fbaB) (Figure 4.8). It has been demonstrated 
that fbaA is absolutely required for glycolysis, whereas fbaB functions in 
gluconeogenesis and is not expressed when cells are grown on glucose. An fbaA 
mutant has a general growth defect and is unable to grow on LB medium. The 
conversion of glyceraldehyde-3-phosphate to glycerate-1,3-bisphosphate is 
catalysed by glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Figure 4.8) 
which is encoded by three enzymes in E. coli (gapA, gapB and gapC). It has been 
shown that gapA plays an essential role in glycolysis, whereas gapB and gapC are 
dispensable (Seta et al., 1997). A gapA mutant is unable to grow on LB medium. The 
interconversion of 2-phosphoglycerate and PEP is catalysed by enolase (eno) (Figure 
4.8). Again, an eno mutant is not viable on LB medium. 
Additionally, there is a high level of functional redundancy among the glycolysis 
enzymes. The interconversion of 3-phospho-glycerate and 2-phospho-glycerate is 
catalysed by two enzymes gpmM and gpmA (Figure 4.8), with gpmA being the 
major enzyme. The conversion of PEP to pyruvate is catalysed by pyruvate kinase, 
encoded by pykA and pykF (Figure 4.8). Both pykA and pykF play an active role in 
pyruvate biosynthesis from PEP, but it has been demonstrated that the pykF 
isoenzyme contributes to a greater extent (Ponce et al., 1995). Although these 
alleles are present within the KEIO library, time constraints did not permit the 
construction of the double-knockouts required to block these steps. Therefore, it 
was only possible to block three additional steps in the glycolytic pathway (Table 
4.3); that is, the conversion of glucose-6-phosphate to fructose-6-phosphate by pgi; 
the conversion of glyceraldehyde-3-phosphate to dihydroxyacetone-phosphate by 
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tpiA; and the conversion of glucose-1-phosphate to glucose-6-phosphate by pgm. 
The reaction catalysed by pgm is not strictly part of the glycolytic pathway, but it is 
required in order to feed exogenous glucose-1-phopshate (e.g. derived from 
glycogen degradation) into the pathway (Figure 4.8). 
 
 
Figure 4.8 An overview of the central metabolic pathway of glycolysis. 
 
Table 4.3 Additional mutations constructed in the glycolytic pathway in HM605 
Mutant Annotation Function 
∆pgi::Km Phosphoglucose isomerase Interconversion of glucose-6-
phosphate and fructose-6-phosphate 
∆tpiA::Km Triose phosphate isomerase Interconversion of glyceraldehyde-3-
phosphate and dihydroxyacetone-
phosphate 
∆pgm::Km Phosphoglucomutase Interconversion of glucose-1-
phosphate and glucose-6-phosphate 
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4.3.7.2 Phenotypic characterisation of ∆pgi::Km, ∆tpiA::Km and ∆pgm::Km 
(i) The ability to utilise glucose as a sole carbon source 
All of the mutants were tested for their ability to grow with glucose as a sole carbon 
source (Figure 4.9). In addition to ∆pfkAB::Km, the only other mutant which was 
defective for growth in glucose was ∆pgi::Km (Figure 4.9). However, ∆pgi::Km grew 
to significantly higher levels than ∆pfkAB::Km, suggesting that it is able to grow 
slowly on glucose. Indeed, the slow-growth phenotype of an E. coli pgi mutant has 
been previously documented, where it has been reported that it utilises glucose 
primarily through the PP pathway (Fraenkel & Levisohn, 1967). 
 
(ii) The ability to replicate within J774A.1 macrophages 
The ability of these mutants to replicate in macrophages was also assessed. As can 
be seen in Figure 4.10, no significant differences were observed in the % fold 
replication of the glycolysis mutants (with the exception of the control mutant 
∆pfkAB::Km) in comparison to the wild-type strain. There are some interesting 
differences between the in vitro and in vivo growth capabilities of the glycolysis 
mutants. Although both ∆pfkAB::Km and ∆pgi::Km are defective for growth in 
glucose in vitro (Figure 4.9), ∆pfkAB::Km is also defective for growth in the 
macrophage, whereas ∆pgi::Km can replicate at similar levels to the wild-type 
(Figure 4.10). The growth of ∆pgi::Km in glucose in vitro is significantly higher than 
that of ∆pfkAB::Km (Figure 4.9), as it has been shown that a pgi mutant can re-route 
and utilise glucose (albeit more slowly) through the PP pathway (Fraenkel & 
Levisohn, 1967). Therefore, it would appear that HM605 does not have a 
requirement for glycolysis per se for intramacrophagic growth, but rather it must be 
capable of re-routing its metabolic flux to metabolise the available glucose. 
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Figure 4.9 Growth of HM605 glycolysis mutants in minimal medium containing glucose as 
a sole carbon source. Bacterial strains grown overnight in LB broth were washed and 
diluted to an OD600 of 0.05 in M9 minimal medium supplemented with 0.4% (w/v) glucose. 
Cultures were incubated overnight at 37°C and the final growth yield of each strain was 
determined by measuring OD595. Results shown are the mean of three experiments and the 
error bars represent the standard deviation. *: P≤0.05. 
 
 
Figure 4.10 Replication of the HM605 glycolysis mutants in J774A.1 macrophages. J774A.1 
cells were infected with bacterial strains at an MOI of 10. The numbers of intracellular 
bacteria were determined at T0 and T6 using the gentamicin protection assay. The 
replication of each mutant in the macrophage (T6 / T0) was compared to HM605 and 
presented as the % fold replication. Results shown are the mean of three experiments. The 
error bars represent the standard deviation. *: P≤0.05. 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
HM605 ∆pfkAB::Km ∆pgi::Km ∆tpiA::Km ∆pgm::Km 
O
D
5
9
5
 r
e
la
ti
ve
 t
o
 H
M
6
0
5
 
* 
0
20
40
60
80
100
120
HM605 ∆pfkAB::Km ∆pgi::Km ∆tpiA::Km ∆pgm::Km 
%
 F
o
ld
 R
e
p
lic
at
io
n
 a
ft
e
r 
6
 h
 
re
la
ti
ve
 t
o
 H
M
6
0
5
 
* 
175 
 
(iii) The ability to induce IL-1β secretion from murine macrophages 
At 24 h post-gentamicin treatment (T24), culture supernatants were collected and 
IL-1β levels were quantified. Interestingly infection of the macrophage with either 
∆pgi::Km and ∆pgm::Km resulted in levels of IL-1β production that were equivalent 
to ∆pfkAB::Km infected macrophages and therefore significantly lower than 
macrophages infected with the wild-type strain (Figure 4.11). These results re-
enforce our previous observation that intracellular bacterial replication and IL-1β 
secretion are not tightly linked. These results also suggest that although carbon flux 
(and not glycolysis per se) appears to be important for the intracellular growth of 
HM605, glycolysis might be important for IL-1β processing and secretion. 
 
4.3.8 The role of other central metabolic pathways in inflammasome activation by 
HM605 
As outlined in Chapter 3, mutations were constructed in HM605 in all of the 
pathways of central carbon metabolism i.e. the TCA cycle, the ED pathway, the PP 
pathway, gluconeogenesis and the glyoxylate shunt. These mutants were also 
tested for their ability to stimulate IL-1β secretion from infected macrophages. This 
served to determine if the inflammasome-activating signal was glycolysis-specific, 
or if general perturbations in central metabolism were sufficient to block 
inflammasome activation. Interestingly, in addition to ∆pfkAB::Km, mutants in the 
TCA cycle (∆icd::Km) and the ED pathway (∆eda::Km) also resulted in the decreased 
secretion of IL-1β from infected macrophages when compared to the wild-type 
(Figure 4.12). Therefore, the inflammasome-activating signal is not glycolysis-
specific. Rather, a general perturbation in the central metabolic pathways of 
HM605 affects inflammasome activation. Therefore, we propose that bacterial 
metabolism is required for the production of a signal, which is then sensed by the 
inflammasome. 
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Figure 4.11 IL-1β secretion by J774A.1 macrophages infected with the HM605 glycolysis 
mutants. J774A.1 macrophages were infected with the indicated strains at an MOI of 10 
and at T24 culture supernatants were collected and IL-1β levels were quantified. Results 
shown are the mean of three experiments and the error bars represent the standard 
deviation. *: P≤0.05. 
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Figure 4.12 IL-1β secretion by J774A.1 macrophages infected with HM605 mutants in 
central metabolism. J774A.1 cells were infected with the indicated strains at an MOI of 10. 
At T24, the level of IL-1β in culture supernatants was assayed. Results shown are the mean 
of three experiments. The error bars represent the standard deviation. *: P≤0.05. 
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4.4 Discussion 
A characteristic and distinguishing feature of AIEC is their ability to replicate within 
phagocytic cells such as macrophages (Glasser et al., 2001; Subramanian et al., 
2008). Therefore, as part of our studies on AIEC, it was of interest to us to 
determine the consequences of AIEC replication on the macrophage. Therefore, 
transcriptional profiling was carried out by Mr. John Catchpole, of macrophages 
infected with E. coli strains exhibiting distinct intramacrophage replication 
characteristics i.e. HM605, an AIEC strain which is capable of replicating within 
macrophages; HM605 ∆pfkAB::Km, a mutant of HM605 which is able to persist, but 
not replicate within macrophages; and MG1655, a K-12 strain of E. coli, which is 
effectively eradicated by macrophages. Transcriptomic analyses of gene expression 
patterns of J774A.1 macrophages infected with these E. coli strains revealed genes 
associated with a common macrophage antibacterial response. Indeed, no specific 
“virulence-associated signature” was identified for HM605, nor was a “persistence-
associated signature” identified for HM605 ∆pfkAB::Km. Therefore, at least at the 
transcriptional level, the macrophage is responding in exactly the same way when 
faced with HM605, HM605 ∆pfkAB::Km or MG1655.  
The integrity of the array data was verified by selecting a small number of pro-
inflammatory cytokines (TNF-α, IL-6, IL-12 and IL-1β), which were induced in 
response to infection, for further analysis. The induction of these cytokines was 
assessed using immunoassays and, consistent with the array, similar levels of TNF-
α, IL-6 and IL-12 were produced by all 3 strains. However, J774A.1 macrophages 
infected with HM605 produced significantly higher levels of IL-1β than those 
infected with HM605 ∆pfkAB::Km or MG1655. This result was also replicated in the 
human monocyte cell-line THP-1 by Dr Emma Smith, Department of Microbiology 
and Alimentary Pharmabiotic Centre, UCC (personal communication). 
While the production of most pro-inflammatory cytokines (including TNF-α, IL-6 and 
IL-12p70) is regulated at the transcriptional level, IL-1β requires a second, and 
critical, proteolytic step. This proteolytic processing is mediated by caspase-1, 
which itself, must be activated to carry out this function. Activation of caspase-1 
occurs within protein complexes in the cell cytosol, termed inflammasomes. 
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Therefore, signalling through TLR’s induces the synthesis of an inactive precursor, 
pro-IL-1β, and a second intracellular signal is required for inflammasome activation 
with the concomitant activation of caspase-1 and cleavage of pro-IL-1β into the 
mature, secreted cytokine (Franchi et al., 2009a).  
Consistent with this, infection of J774A.1 macrophages with HM605 resulted in 
activation of caspase-1, as determined by immunoblot detection of the p20 
cleavage product. Significantly less caspase-1 activation was observed in J774A.1 
macrophages after infection with HM605 ∆pfkAB::Km, and no detectable caspase-1 
activation was observed after infection with MG1655. Caspase-1 activation is also 
associated with a form of inflammatory cell death called pyroptosis. Indeed, HM605 
was cytotoxic to macrophages after 24 h of infection. In contrast, HM605 
∆pfkAB::Km and MG1655 induced significantly less macrophage cell death in 
comparison to the wild-type strain. Moreover, the pharmacological inhibition of 
caspase-1 abolished IL-1β secretion from HM605-infected macrophages, thus 
confirming the involvement of the inflammasome complex.  
At this point, two major conclusions can be drawn from these results. Firstly, the 
AIEC strain HM605 activated the inflammasome to much higher levels than the 
laboratory E. coli strain MG1655. This suggests that AIEC are inherently more pro-
inflammatory than non-AIEC strains. In support of this, Dr Adam O’ Driscoll 
(Department of Microbiology and Alimentary Pharmabiotic Centre, UCC) isolated a 
number of E. coli strains from the ECOR72 reference collection which were able to 
replicate in macrophages and these were also capable of inducing the secretion of 
IL-1β from infected J774A.1 macrophages, to a level comparable to that of HM605 
(personal communication). Therefore, activation of the inflammasome may be a 
conserved feature of AIEC. High levels of the pro-inflammatory cytokine IL-1β have 
been detected in mucosal biopsies from CD patients (Brynskov et al., 1992; 
Ligumsky et al., 1990; Mahida et al., 1989; Reimund et al., 1996); and indeed it is 
well recognised that AIEC are present in the guts of CD patients at a higher 
frequency than in healthy subjects, thereby implicating AIEC in the initiation and/or 
maintenance of the CD-associated inflammation. Therefore, this study provides a 
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potential molecular link between AIEC and the inflammation observed in CD 
patients.  
Secondly, a non-replicating mutant of HM605 (∆pfkAB::Km) did not activate the 
inflammasome to the same extent as the wild-type. Macrophages infected with 
either HM605 or the ∆pfkAB::Km mutant produced more IL-1β than non-viable 
(heat-killed) cells. Indeed, it has recently been shown that bacterial mRNA can act 
as a vita-PAMP to allow the NLRP3 inflammasome to distinguish between viable 
and non-viable cells, thereby enabling the macrophage to scale the level of threat 
and mount an appropriate response (Sander et al., 2011). Therefore, the difference 
in IL-1β production induced by viable ∆pfkAB::Km and non-viable ∆pfkAB::Km is 
likely due to the presence of mRNA in the viable cells. However, viable HM605 cells 
induce the production of significantly higher levels of IL-1β than viable ∆pfkAB::Km 
cells, suggesting that in addition to viability signals (mRNA), an additional, and 
synergistic signal is produced by HM605. One possibility is that intracellular 
replication may be the driving force behind the high levels of IL-1β release observed 
in HM605-infected macrophages. A panel of HM605 mutants (surA::Km, tolA::Km, 
uvrD::Km and pyrF::Km) which were unable to grow in the macrophage (or grew to 
much lower levels) were used to test the role of bacterial replication in mediating 
IL-1β secretion from infected macrophages. Surprisingly, all of these mutants 
stimulated the macrophage to produce similar levels of IL-1β as the wild-type 
strain, suggesting that bacterial replication is not the signal required for 
inflammasome activation. Whether bacterial growth is required for inflammasome 
activation in macrophages has not been well studied. However, it has been 
demonstrated that Chlamydia muridarum-induced IL-1β secretion occurs 
independently of bacterial growth (Prantner et al., 2009). Similarly, it has been 
shown that mutants in Legionella which are unable to replicate within the 
macrophage are still able to induce a level of IL-1β secretion from macrophages 
that was comparable to the wild-type (Zamboni et al., 2006). Therefore, it would 
appear that intracellular bacterial growth is dispensable for inflammasome 
activation.  
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Complementation of HM605 ∆pfkAB::Km with plasmids expressing cloned copies of 
both the pfkA and pfkB genes, restored the ability of the mutant to induce IL-1β 
secretion. Although complementation also restored the ability of the mutant to 
replicate in the macrophage, it has been established that HM605-induced IL-1β 
secretion can proceed independently of bacterial growth. Therefore, it may indicate 
that HM605 has a requirement for a functional glycolytic pathway in order to 
successfully activate the inflammasome i.e. a bacterial metabolite generated via 
glycolysis may be the inflammasome activating signal. Further mutations were 
constructed in the glycolytic pathway in order to try and localise the signal to a 
particular step in the pathway. There is a high level of functional redundancy 
among the enzymes involved in glycolysis. Coupled with the fact that all enzymes 
below pfkA and pfkB are essential for growth on LB because they are required for 
gluconeogenesis, it was only possible to successfully inactivate three additional 
steps in glycolysis involving the proteins encoded by pgi, tpiA and pgm. While 
growth on glucose as a sole carbon source was only reduced (but not completely 
blocked) in ∆pgi::Km, all three of the mutants were able to replicate in the 
macrophage as well as the wild-type. However, both ∆pgi::Km and ∆pgm::Km (but 
not ∆tpiA::Km) stimulated the macrophage to secrete less IL-1β than the wild-type. 
Interestingly, pgi, pfkAB and pgm function consecutively during glycolysis. The 
conversion of glucose-6-phosphate to fructose-6-phosphate is catalysed by pgi; the 
conversion of fructose-6-phosphate to fructose-1,6-bisphosphate is catalysed by 
pfkAB; and pgm feeds into the glycolytic pathway, where it converts glucose-1-
phosphate (from exogenous sources) to glucose-6-phosphate. This implicates any 
metabolite below fructose-1,6-bisphosphate as an important metabolite for 
inflammasome activation. HM605 mutants in other central metabolic pathways i.e. 
the TCA cycle, the Entner-Doudoroff pathway, the pentose phosphate pathway, 
gluconeogenesis and the glyoxylate shunt, were also tested for their ability to 
stimulate IL-1β secretion from infected macrophages. Interestingly, mutants in the 
TCA cycle (∆icd::Km) and the Entner-Doudoroff pathway (∆eda::Km) resulted in the 
decreased secretion of IL-1β from infected macrophages when compared to the 
wild-type. Therefore, perturbing the central metabolic pathways of HM605 affects 
inflammasome activation.  
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The specific inflammasome engaged by HM605 has not been determined. Although 
NLRC4, NLRP1b and AIM2 all respond to a specific set of stimuli (flagellin and PrgJ-
like proteins; anthrax lethal toxin and dsDNA, respectively), NLRP3 is promiscuous 
in nature, responding to a diverse set of stimuli such as bacterial RNA and pore-
forming toxins as well as endogenous danger signals like ATP, amyloid-β, uric-acid 
crystals, hyaluronan, aluminium, asbestos and silica. Recently, a relationship has 
been established between the NLRP3 inflammasome and the metabolic status of 
the host (Vandanmagsar et al., 2011; Wen et al., 2011). Of particular relevance is 
the link between NLRP3 activation and obesity, which is mediated through the 
metabolism of lipids. Consumption of a high-fat diet associated with obesity results 
in elevated levels of free fatty acids which are scavenged by adipose-tissue 
macrophages; the metabolism of these fatty acids leads to the accumulation of 
ceramide and palmitate resulting in the activation of NLRP3 and IL-1β release. The 
mechanism of action has also been proposed - high levels of these molecules lead 
to lower activity of the kinase AMPK (5’adenosine monophosphate-activated 
protein kinase), resulting in defective autophagy of mitochondria and an 
accumulation of ROS, which in turn results in NLRP3 activation (Vandanmagsar et 
al., 2011; Wen et al., 2011). This suggests that NLRP3 is capable of sensing and 
responding to the accumulation of certain metabolic products, which does make 
good immunological sense as it provides a mechanism whereby the immune system 
can respond to metabolic imbalances. Moreover, it has also been shown that small 
bacterial-derived metabolites are capable of stimulating the innate immune system. 
For example, L. monocytogenes secretes cyclic diadenosine monophosphate (c-di-
AMP) via a multi-drug efflux pump (MDR), which can trigger a cytosolic host 
response resulting in the induction of IFN-β (Woodward et al., 2010). Similarly, the 
bacterial secondary messenger cyclic dinucleotide guanosine monophosphate (c-di-
GMP) can be sensed within the cytosol of immune cells, resulting in the induction of 
an IFN-β response (McWhirter et al., 2009).  
Although these molecules have been shown to induce an interferon response, and 
not an inflammasome-mediated response, it has been shown recently that IFN-β is 
involved in the activation of a non-canonical inflammasome (caspase-11 
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dependent) in response to enteric pathogens such as EHEC, V. cholera and C. 
rodentium (Kayagaki et al., 2011). This non-canonical inflammasome requires TLR4-
mediated TRIF signalling, which ultimately results in the production of IFN-β 
(Rathinam et al., 2012). IFN-β upregulates caspase-11 expression, which is both 
necessary, and sufficient, for its autoactivation. Simultaneously, an intracellular 
signal of microbial origin results in the assembly of the NLRP3 inflammasome. 
Active caspase-11 then synergises with this assembled NLRP3 inflammasome to 
license caspase-1 processing. In this non-canonical inflammasome, pyroptosis is 
entirely caspase-11 dependent, whilst IL-1β production is caspase-1 dependent 
(Rathinam et al., 2012). Therefore, the IL-1β production and pyroptosis induced by 
infection with HM605 may involve the non-canonical inflammasome. Although 
attempts were made in this study to assess the involvement of caspase-11 in 
inflammasome activation by HM605, results were inconclusive. Experiments are 
currently underway in the laboratory to address this issue. 
In summary, we have shown that AIEC can activate the inflammasome to higher 
levels than non-AIEC strains, thereby resulting in the secretion of higher levels of 
the pro-inflammatory cytokine IL-1β. This may have important consequences in 
terms of CD pathology. We have also shown that whilst HM605-induced IL-1β 
secretion is independent of bacterial replication, it is dependent on bacterial central 
metabolism. The inflammasome can distinguish between viable and non-viable cells 
through the detection of vita-PAMPs (such as mRNA) and here we have shown that 
bacterial metabolism may represent a signal, possibly conserved, which allows the 
innate immune system to distinguish between viable cells which can and cannot 
metabolise (and thus survive) within the macrophage. Many pathogens are known 
to down-regulate virulence factor expression during certain stages of infection, 
thereby allowing them to evade recognition by the host immune system. Therefore, 
the sensing of vita-PAMPs as well as bacterial metabolic signals (indicative of 
bacterial survival) may provide a fail-safe mechanism for the innate immune system 
to protect the host. 
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Chapter 5: The development of a screen to 
isolate mutants in AIEC strain HM605 which do 
not activate the inflammasome 
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5.1 Introduction 
Autophagy is a broadly conserved membrane trafficking pathway which functions 
to target and degrade cytoplasmic material such as damaged or redundant 
organelles (Levine et al., 2011). These organelles are captured in a double-
membrane vacuole called the autophagosome. Subsequent fusion of 
autophagosomes with lysosomes results in the degradation of its contents. 
Autophagy also plays a role in the capture and elimination of invasive 
microorganisms, a process referred to as xenophagy. Indeed, autophagy has been 
demonstrated to play a role in the elimination of intracellular pathogens such as 
Salmonella (Birmingham et al., 2006), Mycobacterium (Singh et al., 2006) and 
Streptococcus (Nakagawa et al., 2004). Importantly, genome-wide association 
studies have identified polymorphisms in autophagy genes such as NOD2, ATG16L1 
and IRGM as susceptibility factors for Crohn’s disease (Hampe et al., 2007; Hugot et 
al., 2001; Ogura et al., 2001; Parkes et al., 2007; Rioux et al., 2007).  
Recently, evidence has emerged that AIEC may exploit these CD-associated defects 
in autophagy in order to survive and replicate within host cells (Lapaquette et al., 
2009; Lapaquette et al., 2012). It has been shown that autophagy targets a 
subpopulation of intracellular LF82 in a number of human epithelial cell lines such 
as HeLa, Hep-2 and Intestine-407 (Lapaquette et al., 2009). Furthermore, the 
induction of autophagy with rapamycin decreased the number of intracellular LF82, 
whereas intracellular bacterial numbers were enhanced in cells deficient for Atg5 
(Lapaquette et al., 2009). The impact of altered expression of the two autophagy-
related genes (ATG16L1 and IRGM), which have been identified as susceptibility 
factors for CD, was assessed in terms of their effect on intracellular AIEC growth. 
Functional knock-down of ATG16L1 resulted in an increase in the number of 
intracellular LF82 in comparison to that observed in wild-type cells. Importantly, 
this phenotype was rescued by expression of ATG16L1, but not of the CD-
associated variant ATG16L1 T300A (Lapaquette et al., 2009); suggesting that the 
presence of this allele in a CD patient may result in a diminished ability to respond 
to intracellular bacteria. Functional knock-down of IRGM also resulted in a 
significant increase in the numbers of intracellular LF82 (Lapaquette et al., 2009). 
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Moreover, confocal microscopy showed that IRGM knock-down was also associated 
with large clusters of intracellular LF82 which resided in non-acidic compartments, 
indicating that this protein may play a role in phagosome maturation as well as 
autophagy (Lapaquette et al., 2009).  Similar results were obtained in a recent 
study, which looked at the role of autophagy in controlling AIEC replication within 
macrophages (Lapaquette et al., 2012). Specifically, the group showed that LF82 
induces the autophagic pathway in macrophages upon phagocytosis, an event 
which serves to rapidly degrade intracellular LF82. However, a subset of LF82 
bacteria were able to escape uptake by autophagosomes and instead resided in 
phagolysosomes, where they could multiply. Knock-down of autophagy-related 
genes such as ATG16L1, IRGM or NOD2, resulted in increased levels of intracellular 
LF82 and cytokine secretion; and conversely, activation of autophagy using 
rapamycin resulted in a decrease in both the numbers of intracellular LF82 and 
cytokine secretion (Lapaquette et al., 2012). Taken together, these results suggest 
that CD-associated polymorphisms in autophagy genes, in combination with AIEC 
colonisation of the mucosa, may lead to functional alterations in the ability of host 
cells to control intracellular replication of AIEC, a scenario which could be linked to 
the persistent and chronic inflammation observed in CD patients. Therefore, 
stimulating autophagy in CD patients could be a potential therapeutic strategy. 
However, considering that AIEC are phylogenetically diverse, it would be imperative 
to confirm this role for autophagy using AIEC strains other than LF82. Therefore, 
our laboratory is interested in studying the interaction of AIEC strain HM605 with 
the autophagic pathway, to assess if CD-associated defects in autophagy could play 
a global role in the pathogenesis of AIEC. Although studies are still in the 
preliminary stage, one interesting observation, relevant to our previous work with 
the inflammasome, was established. The induction of autophagy using rapamycin 
resulted in a dramatic increase in HM605-mediated macrophage cytotoxicity at T6, 
in comparison to untreated macrophages (Figure 5.1). Induction of autophagy in 
macrophages infected with HM605 ∆pfkAB::Km or MG1655, also resulted in a 
significant increased cytotoxicity at T6, in comparison to untreated macrophages 
(Figure 5.1). However, HM605 induced significantly more cytotoxicity than either 
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∆pfkAB::Km or MG1655 in the presence of rapamycin; and ∆pfkAB::Km induced 
significantly more cytotoxicity than MG1655 (Figure 5.1). Importantly, inducing 
autophagy in uninfected cells did not result in a significant increase in cytotoxicity, 
showing that the presence of intracellular E. coli is required for this response 
(Figure 5.1). Moreover, experiments carried out by Mr. John Catchpole (personal 
communication) showed that the levels of IL-1β secretion in rapamycin-treated 
infected cells positively correlated with the levels of cytotoxicity (data not shown). 
 
Figure 5.1 Induction of autophagy enhances cytotoxicity in infected macrophages. 
J774A.1 macrophages were infected with the indicated bacterial strains at an MOI of 10, 
both with (40 µM rapamycin) and without autophagic induction. Host cell death was 
assessed by measuring the release of the cytosolic enzyme LDH into culture supernatants 
at T6. Results shown are the mean of three experiments. The error bars represent the 
standard deviation. *: P≤0.05. 
 
5.2 Objectives 
Although the molecular mechanisms underpinning the observed increase in 
cytotoxicity are not currently known, it does appear that the inflammasome and 
autophagy can act synergistically to mediate HM605-induced cytotoxicity. In this 
chapter, this increased level of cell cytotoxicity was used as the basis for a genetic 
screen aimed at the identification of bacterial mutants that do not activate the 
inflammasome. 
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5.3 Results 
5.3.1 HM605 transposon mutant library screen for the isolation of mutants which 
cause less rapamycin-induced cytotoxicity than the wild-type 
The HM605 mutant library was screened in order to isolate mutants that, when 
infected in the presence of rapamycin, induced reduced levels of cytotoxicity 
compared to HM605. The level of cytotoxicity observed in macrophages infected 
with wild-type HM605 was such that cell death could be rapidly assessed 
qualitatively by eye and selected mutants could then be further analysed using 
cytotoxicity and IL-1β assays. Briefly, on the day of the experiment, the HM605 
transposon mutant library was diluted in DMEM to give approximately 1 x 106 
bacteria per well, which corresponds to an MOI of 10. J774A.1 cells were then 
infected with the mutants for 2 h. Following the infection period, the culture media 
in each well was replaced with media containing gentamicin for 1 h in order to kill 
any extracellular bacteria. Rapamycin (40 µM) was also added to this media to 
induce autophagy. Plates were incubated in this media for a further 6 h and at this 
time (T6) each well was visually inspected for macrophage cell death using an 
inverted microscope at 10,000 X magnification. Wells in which there was little, or 
significantly reduced, macrophage cytotoxicity were noted for further analysis.  
In the primary screen, 244 mutants (out of 3,168 screened) were identified with 
reduced rapamycin-induced macrophage cytotoxicity. HM605 ∆pfkAB::Km was used 
as a positive control (as it activates the inflammasome to lower levels than the wild-
type) and this strain induced approximately 50% less macrophage cell death than 
the wild-type (see Figure 5.1). For this reason, a threshold of approximately 50% 
was applied when selecting mutants for further study. To quantify the reduction in 
cytotoxicity, culture supernatants were collected and assayed for the release of the 
cytoplasmic enzyme LDH, which is a direct measure of cell death. Therefore re-
screening of these mutants resulted in the retention of 15 mutants that consistently 
caused reduced (≤50%) rapamycin-induced macrophage cytotoxicity (Figure 5.2).  
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Figure 5.2 HM605 transposon mutants with reduced rapamycin-induced cytotoxicity. 
J774A.1 macrophages were infected with HM605 transposon mutants at an MOI of 10 for 2 
h. Following the infection period, gentamicin was added to the cells for 1 h to kill 
extracellular bacteria. Rapamycin was also included in the gentamicin media at a final 
concentration of 40 µM. Cytotoxicity was assessed by measuring the release of the 
cytosolic enzyme LDH into culture supernatants at T6. Results shown are the mean of two 
biological replicates. The error bars represent the standard deviation.  
 
5.3.1.1 Identification of mutants from the rapamycin screen 
The disrupted gene and the position of the transposon in each of the 15 mutants 
was identified by amplifying the DNA fragment flanking the transposon using 
arbitrarily-primed PCR. PCR products were sequenced by GATC and nucleotide 
sequences generated were matched to sequences in the HM605 genome. For 2 of 
the mutants (50:10F and 50:10D), the sequencing reactions did not yield any results 
(possibly due to the presence of multiple copies of the transposon within the 
genome), and these mutants were discarded from the study. Table 5.1 outlines the 
transposon insertion site for each mutant and the corresponding gene disrupted 
and Figure 5.3 is a diagrammatic representation of the genomic context and 
localisation of the transposon in each mutant. 
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Table 5.1 The transposon insertion site for each mutant and the corresponding gene disrupted 
Mutant 
(Plate#:Well#) 
Localisation of Tn5  
 Scaffold  
# 
Gene ID Gene name Gene location  
in scaffold 
Tn5 location  
within gene 
50:8D 1 1838 basR 1773756 - 1774424 429bp/669bp 
45:11C 1 1718 efp 1667980 - 1668546 118bp/567bp 
37:3H 1 5007 pyrF 4942737 - 4943534 104bp/798bp 
51:4D 1 3133 kpsS 3085543 - 3086748 531bp/1206bp 
42:4H 1 3778 ptsI 3735737 - 3737464 727bp/1728bp 
52:8B 1 1210 aceE 1188405 - 1191044 35bp/2640bp 
54:8E 1 2169 ubiE 2116003 - 2116758 242bp/756bp 
50:10H 1 2596 Putative PTS enzyme IID 2557860 - 2558714 320bp/855bp 
50:8F 1 3376 Hypothetical protein; homology to T6SS protein, EvpB 3335101 - 3336645 170bp/1545bp 
49:8B 1 0337 Unknown; Located between putP and putA 288039 - 288248 183bp/210bp 
42:9F 1 3851 Unknown; Endo-alpha-sialidase; phage head protein 3802227 - 3805172 885bp/2946bp 
51:3H 4 5307 Unknown; conserved hypothetical protein in UPEC containing a 
pyocin/colicin endonuclease-like domain 
(Usp-like) 
238 - 1722 782bp/1485bp 
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Figure 5.3 Genomic organisation of the transposon insertion sites in mutants isolated 
from the rapamycin screen. The position of the transposon in each mutant was identified 
by arbitrarily primed PCR, sequencing and subsequent BLAST analysis against the HM605 
genome. The triangles indicate the approximate position of the transposon in each mutant. 
Diagrams were modified and re-drawn from xBASE. 
 
5.3.1.2 Description and verification of mutants 
Mutant 50:8D 
Mutant 50:8D had a transposon inserted within the gene basR, which encodes a 
response regulator involved in the two-component BasS/BasR signal transduction 
system. It has been demonstrated that the BasS/BasR signal transduction system of 
E. coli functions in the response to elevated levels of iron (Hagiwara et al., 2004). 
Transcriptome analysis revealed that all of the BasS/BasR dependent genes were 
associated with acidic and/or anaerobic growth conditions (Hagiwara et al., 2004). 
The BasS/BasR system controls the expression of a wide range of genes, including 
genes involved in the formation and modification of the cell membrane, genes 
involved in the stress response and also a number of metabolic genes (Hagiwara et 
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al., 2004; Ogasawara et al., 2012). Indeed, an E. coli basS/basR mutant is sensitive 
to mild-acid conditions in the presence of iron (Hagiwara et al., 2004). A basR 
mutation would be expected to be polar on basS, therefore the phenotype of 
HM605 basR::Km was analysed with respect to acidic growth conditions in the 
presence of iron. Both HM605 and HM605 basR::Km were capable of growing on LB 
agar at pH 7.0 which contained a high concentration of FeSO4 (1.5 mM) (Figure 5.4). 
However, when the pH of the medium was lowered to 5.5, HM605 basR::Km was 
no longer able to grow, while growth of HM605 was unaffected (Figure 5.4). 
Therefore, the BasS/BasR system may be of particular relevance in terms of 
colonisation and/or infection of mammalian hosts, where bacteria are likely to 
encounter high iron concentrations in addition to anaerobic and acidic 
environments.  
 
 
Figure 5.4 Acid sensitivity of HM605 basR::Km on LB agar plates containing a high 
concentration of iron. The indicated strains were standardised to an OD600 of 1 in PBS and 
serially diluted. The standardised cultures were spotted (5 µl) onto the surface of LB agar 
plates containing 1.5 mM FeSO4, both at pH 7 and pH 5.5. Plates were incubated overnight 
at 37°C. The experiment was carried out in triplicate with similar results and a 
representative image is shown. 
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Mutant 45:11C 
Mutant 45:11C had a transposon inserted within efp. The efp gene is predicted to 
encode a protein chain elongation factor called EF-P. Recently, two independent 
studies demonstrated that EF-P is post-translationally modified by two enzymes, 
PoxA (YjeA) and YjeK, whereby a unique β-amino acid is attached onto a highly 
conserved lysine residue in EF-P (Navarre et al., 2010; Yanagisawa et al., 2010). 
Modified EF-P was proposed to regulate the synthesis of a subset of proteins 
required for bacterial virulence and stress survival. Recently, the precise function of 
EF-P was described (Doerfel et al., 2013; Ude et al., 2013). EF-P enhances the 
translation of polyproline-containing proteins; without EF-P, ribosomes stall at 
stretches of three or more proline residues. Therefore, the observed pleiotropic 
effects of efp mutants (or indeed poxA or yjeK mutants) can be explained by the 
impaired synthesis of proteins containing proline stretches.  
 
Mutant 37:3H 
Mutant 37:3H had a transposon inserted within the gene pyrF, which is annotated 
as orotidine-5’-phosphate decarboxylase. This enzyme is involved in the de novo 
synthesis of pyrimidines. The pathway consists of six enzymatic reactions which 
culminates in the decarboxylation of orotidine-5’-phosphate to uridine-5-
monophosphate, which is catalysed by pyrF (Shambaugh, 1979). HM605 pyrF::Km 
was previously described in Chapter 3 as an auxotrophic mutant, which must be 
supplied with cytosine in order to grow in M9 minimal medium containing glucose 
(Figure 3.15 E). HM605 pyrF::Km has also previously been shown to be unable to 
replicate in the macrophage, although it is capable of stimulating the macrophage 
to secrete similar levels of IL-1β as the wild-type (Figure 4.6 A and B). 
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Mutant 51:4D 
Mutant 51:4D had a transposon inserted in kpsS. The gene kpsS is predicted to 
encode a polysialic acid capsule synthesis protein. Capsules are protective 
structures composed of high molecular weight polysaccharides, on the surface of 
many bacteria (Whitfield, 2006). Capsular polysaccharides have been well studied in 
E. coli, where the 80 different capsular serotypes (K antigen) are divided into 4 
major groups (1-4), according to a number of biochemical and genetic criteria 
(Whitfield, 2006). Group 1 and 4 capsules are characteristic of E. coli that cause 
intestinal infections, such as EPEC, ETEC and EHEC; whereas group 2 and 3 capsules 
are characteristic of extraintestinal pathogenic E. coli (ExPEC) (Whitfield, 2006). 
KpsS is believed to be part of the polysaccharide export pathway, which functions 
to transport group 2 capsular polysaccharides to the cell surface. It has been 
proposed that KpsS (in concert with KpsC) attaches phosphatidyl-KDO to the 
reducing end of the polysaccharide chain, which thereby allows the entry of the 
polysaccharide molecule into the export pathway, however the function of KpsS has 
not been biochemically defined (Rigg et al., 1998; Whitfield & Roberts, 1999).  
The group 2 capsule gene locus is divided into 3 regions: region 1 and 3 are 
conserved among group 2 capsule-expressing strains and consist of the genes 
kpsFEDUCS and kpsMT, respectively, which are involved in capsule assembly and 
export (Whitfield, 2006). However, region 2 is unique to each serotype and contains 
genes involved in polysaccharide biosynthesis (Whitfield, 2006). An analysis of the 
capsule gene locus in HM605 shows that region 2 consists of the neu genes, which 
are characteristic of strains of the K1 serotype (Whitfield, 2006) (Figure 5.5). 
However, a comparison of this region with other E. coli strains of the K1 serotype, 
namely, the NMEC strains S88 and IHE3034, the UPEC strain IAI39 and the avian 
pathogenic E. coli (APEC) strain APEC O1, reveal that while regions 1 and 3 appear 
to be intact in HM605, there is considerable degradation in the neu region (Figure 
5.5). Therefore, it is unknown whether HM605 encodes a functional K1 operon. 
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Figure 5.5 Syntenic analysis of the K1 locus. Schematic representation of the predicted 
gene order and orientation of the K1 locus in the HM605 genome, aligned with the most 
similar regions in E. coli S88, E. coli APEC O1, E. coli IHE3034 and E. coli IAI39. Comparisons 
were generated using the nucmer algorithm in Xbase. Open reading frames (ORF’s) are 
coloured by GC content. 
 
Mutant 42:4H 
Mutant 42:4H had a transposon inserted in ptsI. The product of ptsI is a cytoplasmic 
protein which forms part of the phosphoenolpyruvate (PEP)-dependent 
phosphotransferase system (PTS). The function of the PTS system is to transport 
glucose and related carbohydrates such as fructose, mannose, amino-hexoses and 
hexitols into the bacterial cell, with the concomitant phosphorylation of such sugars 
(Postma & Lengeler, 1985). Transport and phosphorylation through the PTS system 
is mediated by a number of cytoplasmic phosphoprotein carriers. The first two 
steps of the PTS system are common to all sugars. Firstly, a phosphoryl group is 
transferred from PEP to enzyme I (encoded by ptsI). Phosphorylated PtsI can then 
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mediate the reversible transfer of a phosphoryl group to HPr (encoded by ptsH). 
Phosphorylated PtsH subsequently transfers the phosphoryl group to any one of 
the membrane-bound sugar-specific enzymes, which are collectively referred to as 
enzymes II (Postma & Lengeler, 1985). Therefore, the general PTS enzymes PtsI and 
PtsH are not directly involved in sugar transport. Their role is in phosphoryl group 
transfer, which indirectly affects transport. It has been demonstrated that ptsI 
mutants are unable to grow on PTS sugars such as glucose (Simoni et al., 1976). 
However, ptsI mutants are also unable to grow on certain non-PTS sugars such as 
glycerol (Simoni et al., 1976), due to PTS-mediated repression i.e. ptsI mutants are 
unable to synthesise the required catabolic systems and permeases for uptake and 
utilisation of such sugars. Consistent with this, HM605 ptsI::Km was unable to grow 
in M9 minimal media when either glucose or glycerol was provided as the sole 
carbon source; while growth on acetate as the sole carbon source was unaffected 
by this mutation (Figure 5.6).  
 
 
Figure 5.6 HM605 ptsI::Km is unable to grow using either glucose or glycerol as a sole 
carbon source. The indicated bacterial strains were inoculated into M9 minimal medium 
supplemented with 0.4% (w/v) glucose, 0.4% (w/v) glycerol or 0.4% (w/v) acetate, as the 
sole carbon source. Cultures were grown overnight at 37°C. Final growth yields were 
determined by measuring the OD595 of each culture. Results shown are the average of three 
experiments. The error bars represent the standard deviation. 
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Mutant 52:8B 
Mutant 52:8B had a transposon inserted in aceE. The gene aceE is annotated as 
pyruvate dehydrogenase. Pyruvate dehydrogenase is an enzyme complex that, 
under aerobic conditions, catalyses the oxidative decarboxylation of pyruvate to 
acetyl Co-A, which can then enter the TCA cycle. In this way, the pyruvate 
dehydrogenase complex (PDHC) connects the glycolytic pathway with the TCA 
cycle. In addition, the PDHC can perform anabolic functions by providing acetyl-CoA 
for biosynthetic purposes. Therefore, mutants in the PDHC must be supplied with 
acetate to support their growth (Abdel-Hamid et al., 2001). Consistent with this, 
HM605 aceE::Km was unable to grow when glucose or glycerol was provided as a 
sole carbon source, but grew as well as the wild-type when acetate was provided as 
the sole carbon source (Figure 5.7). The complex consists of multiple copies of 3 
enzymatic components; pyruvate dehydrogenase, AceE (E1), dihydrolipoamide 
acetyltransferase, AceF (E2) and lipoamide dehydrogenase, LpdA (E3) (Stephens et 
al., 1983). Therefore, both the entire enzyme complex and AceE are referred to as 
pyruvate dehydrogenase. It has recently been demonstrated that the PDHC can also 
function during anaerobic fermentation, where its primary role is to generate CO2, 
which is required by bacterial cells for the biosynthesis of small molecules, fatty 
acids and precursor metabolites (Murarka et al., 2010).  
 
Mutant 54:8E 
Mutant 54:8E had a transposon inserted in ubiE. The product of the ubiE gene is a 
C-methyltransferase, which catalyses reactions in ubiquinone (Q) and menaquinone 
(MK) biosynthesis. Q is an isoprenoid quinone which is an essential component in 
the aerobic respiratory electron transport chain of eukaryotes and most bacteria 
(Lee et al., 1997). Q biosynthesis requires a C-methylation step, which is carried out 
by ubiE. Therefore, ubiE catalyses the conversion of 2-polyprenyl-6-methoxy-1,4-
benzoquinol (DDMQH2) to 2-polyprenyl-3-methyl-6-methoxy-1,4-benzoquinol 
(DMQH2) (Young et al., 1971). The ubiE gene is also required for the biosynthesis of 
MK. MK is an isoprenoid naphthoquinone which is a component of the anaerobic 
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respiratory electron transfer chain in some bacteria (Lee et al., 1997). The Q and 
MK biosynthetic pathways are identical up to the formation of chorismate, at which 
point they diverge into two separate pathways. However, both pathways require 
the C-methylation step catalysed by ubiE (Lee et al., 1997). In MK biosynthesis, ubiE 
catalyses the conversion of demethylmenaquinone (DMK) to MK (Lee et al., 1997). 
Therefore, ubiE mutants cannot make Q or MK, but can make DMK. Q serves as the 
redox mediator in aerobic respiration, whereas MK and DMK serve as the redox 
mediators in anaerobic respiration. A ubiE mutant is unable to undergo aerobic 
respiration but is capable of respiring anaerobically using fumarate or 
trimethylamine N-oxide (TMAO) as electron acceptors (Lee et al., 1997). 
 
 
Figure 5.7 HM605 aceE::Km is unable to grow using either glucose or glycerol as a sole 
carbon source. The indicated strains were grown in M9 minimal medium supplemented 
with 0.4% (w/v) glucose, 0.4% (w/v) glycerol or 0.4% (w/v) acetate as the sole carbon 
source, overnight at 37°C. Final growth yields were determined by measuring OD595. Bars 
represent the mean of three independent experiments. The error bars represent the 
standard deviation. 
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Mutant 50:10H 
Mutant 50:10H had a transposon inserted in HM605_2596, which is annotated as a 
putative PTS enzyme IID. The genomic region surrounding this gene shares a high 
level of synteny with APEC O1 and UM146 (another AIEC strain), but this region is 
absent from CFT073 (UPEC strain), LF82 (AIEC strain) and the K-12 strain MG1655 
(Figure 5.8). BLAST analysis of the surrounding genes show that they encode 
putative components of the PTS as well as a gene encoding a putative 
dihydrodipicolinate synthase, involved in lysine biosynthesis and a gene encoding a 
putative phosphoglycerate dehydrogenase, involved in serine biosynthesis (Figure 
5.8). As previously mentioned, the core components of the PTS are enzyme I and 
HPr, which function in the transfer of phosphoryl groups. Each system then differs 
with respect to the individual sugar-specific permeases. PTS permeases consist of 2 
peripheral membrane proteins, IIA and IIB; and an integral membrane protein, IIC 
(Tchieu et al., 2001). One exception to this, however, is the mannose family. The 
mannose family consists of three enzyme II complexes, which transport mannose, 
fructose and N-acetylgalactosamine; and these enzyme complexes also consist of a 
second integral membrane protein, IID (Tchieu et al., 2001). The biochemical 
function of protein IID is unknown.  
 
Mutant 50:8F 
Mutant 50:8F had a transposon inserted in HM605_3376, which is predicted to 
encode a hypothetical protein. Subsequent BLAST analysis revealed that this gene 
had a 98% identity to a type VI secretion system (T6SS) protein, EvpB (TssC), from E. 
coli KO11. The T6SS is a protein export machine found in Gram negative bacteria 
which targets effector proteins to both prokaryotic and eukaryotic cells in a contact 
dependent manner (Silverman et al., 2012). A model has recently emerged 
suggesting that the T6SS components form 2 substructures consisting of a 
bacteriophage-like structure and a membrane complex, which interact to form an 
inverted bacteriophage-like structure which is attached to the cell envelope 
(Silverman et al., 2012). A set of 13 genes comprise the core constituents of the 
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T6SS, which encode needle apparatus components and inner and outer membrane 
proteins and indeed all of these core constituents are required for T6SS functioning 
(Silverman et al., 2012). Two proteins, Hcp (hemolysin-coregulated protein) and 
VgrG (valine-glycine repeat protein) are hallmark features of the T6SS and 
constitute the extracellular components of this system. These proteins are 
structurally similar to the bacteriophage tail-tube and tail-spike proteins, 
respectively. Current studies suggest that Hcp forms a tubular structure which 
spans the bacterial membrane, with the tip of this tube harbouring a trimer of the 
VgrG protein, which functions as a target cell puncturing device (Leiman et al., 
2009; Mougous et al., 2006). TssB and TssC assemble into tubular structures which 
form a contractile sheath, believed to propel effector proteins out of the cell (Basler 
et al., 2012). TssE is believed to form a baseplate-like structure in the cytoplasm 
(Lossi et al., 2011). The inner membrane proteins TssL and TssM and the outer 
membrane lipoprotein TssJ form a membrane complex which anchors the T6SS in 
the cell envelope (Aschtgen et al., 2010). TssH encodes a ClpV ATPase which 
functions to remodel the TssB/C tubes (Basler et al., 2012). The remaining core 
components have not been functionally characterised but are predicted to be 
cytoplasmic (Coulthurst, 2013). The function of some T6SS effector proteins has 
recently emerged. The P. aeruginosa T6SS delivers 2 effector proteins (Tse1 and 
Tse3) to the periplasm of recipient cells, where they hydrolyse peptidoglycan, 
thereby resulting in host cell lysis (Russell et al., 2011). Similarly, Tse2 has been 
identified as a toxin secreted by the P. aeruginosa T6SS, which arrests the growth of 
target bacteria, but not eukaryotes (Hood et al., 2010). Therefore, the T6SS may 
play a role in competition for a specific niche, thereby facilitating efficient 
colonisation. VasX has been identified as a protein secreted by the V. cholerae T6SS, 
which is cytotoxic to amoebae by means of binding to host membrane lipids and 
disrupting host cell signalling (Miyata et al., 2011). Some VgrG proteins contain C-
terminal extensions which function as effector domains which can target eukaryotic 
hosts modifying host-cell actin (Pukatzki et al., 2007; Suarez et al., 2010). 
The surrounding genetic region shows a high level of synteny with other 
AIEC/ExPEC strains, but notably, this region is absent from the K-12 strain MG1655 
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(Figure 5.9). BLAST analysis revealed that this genetic region in HM605 contains 
genes which encode the conserved core elements of the secretion apparatus. The 
Vgr protein was 100% identical to a Vgr family protein of IHE3034; the Clp ATPase 
was 100% identical to a ClpA/B family protein of IHE3034 and UTI89 and 96% 
identical to a ClpV protein of KO11. The Hcp protein had 100% identity to Hcp from 
UTI89 and the DotU family protein had 100% identity to a DotU family protein from 
UM146 and IHE3034. 
 
 
 
Figure 5.8 Alignment of the HM605_2596 locus with that of other E. coli strains. Using the 
nucmer algorithm in Xbase, this genetic region in HM605 was aligned with the most similar 
regions in E. coli APEC O1, E. coli UM146, E. coli CFT073, E. coli MG1655 and E. coli LF82. 
ORF’s are coloured by GC content.  
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Figure 5.9 Comparison of the T6SS locus of HM605 with the most similar regions in E. coli 
UM146, E. coli LF82, E. coli APEC O1, E. coli CFT073 and E. coli MG1655. Comparisons were 
generated using the nucmer algorithm in Xbase and ORF’s are coloured by GC content. 
 
Mutant 49:8B 
Mutant 49:8B had a transposon inserted in HM605_0337. This gene is located in 
the intergenic (IG) region between putA and putP. A comparison of this genetic 
region with other E. coli genomes reveals that while there is no ORF predicted in 
the IG region between putA and putP in MG1655, APEC O1 and LF82, there is a 
predicted ORF in this IG region in both UM146 and CFT073 (Figure 5.10). However, 
BLAST analysis reveals that this ORF encodes a hypothetical protein of unknown 
function. PutA catalyses the conversion of proline to glutamate, which is then 
further degraded to α-ketoglutarate, an intermediate of the TCA cycle. PutP is a 
sodium/proline symporter which is involved in the transport of proline (Keseler et 
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al., 2009). Indeed, mutant 49:8B was defective for growth in M9 minimal medium 
containing proline as the sole carbon source (Figure 5.10). Therefore, it is possible 
that HM605_0337 also has a role in the transport or metabolism of proline. 
However, it is also possible that the insertion simply disrupts a promoter and thus 
blocks the transcription of putA and/or putP.  
 
Mutant 42:9F 
Mutant 42:9F had a transposon inserted in HM605_3851, which is annotated as an 
endo-alpha-sialidase, phage head protein. A comparison of this region with other E. 
coli genomes revealed that it only has a low level of synteny with UM146 and LF82, 
whereas this region is absent in APEC O1, CFT073 and MG1655. This region largely 
codes for phage elements (Figure 5.11). 
 
Mutant 51:3H 
Mutant 51:3H had a transposon inserted in HM605_5307, which is homologous to a 
conserved hypothetical protein in UPEC, containing a pyocin/colicin endonuclease-
like domain.  
 
Mutant 50:8E 
Finally, mutant 50:8E had a transposon inserted in insertion sequence IS2, which is 
a small transposable element present in multiple copies in enteric bacteria. 
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Note: efeB, efeO and efeU are synonyms for ycdB, ycdO and ycdN 
           rutR, rutA and rutB are synonyms for ycdC, ycdM and ycdL 
 
 
Figure 5.10 Characterisation and analysis of mutant 49:8B. (A) Synteny between the 
HM605_0337 locus and the corresponding regions in E. coli UM146, E. coli LF82, E. coli 
APEC O1, E. coli CFT073 and E. coli MG1655. Comparisons were generated using the 
nucmer algorithm in Xbase. ORF’s are coloured by GC content. (B) Mutant 49:8B was grown 
in M9 minimal medium supplemented with 0.4% (w/v) proline, as the sole carbon source. 
Cultures were grown overnight at 37°C and final growth yields were determined by 
measuring OD595. Results shown are the mean of three experiments and the error bars 
represent the standard deviation. 
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Figure 5.11 Syntenic analysis of HM605_3851. A schematic representation of the predicted 
gene order and orientation in the HM605 genome and compared with the most similar 
regions in E. coli UM146, E. coli LF82, E. coli APEC O1, E. coli CFT073 and E. coli MG1655. 
Alignments were generated in Xbase using the nucmer algorithm. ORF’s are coloured by GC 
content.  
 
5.3.2 Phenotypic characterisation of the mutants 
The annotated mutants (and mutant 49:8B) from the rapamycin screen were 
characterised in terms of their ability to replicate in macrophages and to induce IL-
1β secretion from infected macrophages. 
(i) The ability to replicate within murine macrophages 
J774A.1 macrophages were infected with the mutant strains as described 
previously. Using the gentamicin protection assay, the numbers of bacteria inside 
the macrophage were quantified at T0 and at T6 and the % fold replication of each 
mutant in comparison to the wild-type was calculated. As can bee seen in Figure 
5.12 A, there were no significant difference in the % fold replication of kpsS::Km, 
207 
 
basR::Km or efp::Km, in comparison to the wild-type. However, ptsI::Km was unable 
to replicate (Figure 5.12 A). While HM605 replicated approximately 3-fold over the 
6 h period, the numbers of intracellular ptsI::Km actually decreased by 
approximately 0.1-fold. Similarly, although mutant 49:8B was capable of replicating 
at a comparable level to the wild-type over the 6 h period, the ability of ubiE::Km 
and aceE::Km to replicate was reduced in comparison to the wild-type (Figure 5.12 
B). In this experiment, while the wild-type replicated approximately 7-fold during 
the 6 h period, ubiE::Km only replicated approximately 1.3-fold and aceE::Km only 
replicated approximately 1.5-fold during this time. Although HM605 pyrF::Km was 
not included in this analysis, it has previously been shown to be defective for 
intracellular replication (Chapter 4, Figure 4.6 A). 
 
(ii) The ability to induce IL-1β secretion from murine macrophages 
At 24 h post-gentamicin treatment (T24), culture supernatants were collected and 
IL-1β levels were quantified. All of the mutants stimulated the macrophage to 
secrete significantly less IL-1β than the wild-type strain (Figure 5.13). This lends 
support to our previous observation that activation of the inflammasome by 
HM605 is not dependent on intracellular bacterial replication. These results also 
support the hypothesis that the level of cytotoxicity induced by the addition of 
rapamycin correlates with the level of inflammasome activation. However, pyrF::Km 
was previously shown to induce similar levels of IL-1β release as the wild-type strain 
(Chapter 4, Figure 4.6 B), suggesting that additional mechanisms may also be 
involved. 
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Figure 5.12 Replication of the HM605 mutants isolated from the rapamycin screen in 
J774A.1 macrophages. J774A.1 macrophages were infected with the indicated strains at an 
MOI of 10. Using the gentamicin protection assay, the numbers of bacteria inside the 
macrophage at T0 and T6 were determined. The data represents the number of intracellular 
bacteria at T6 / the number of intracellular bacteria at T0; relative to that obtained for wild-
type HM605, taken as 100%. Results shown are the mean of three experiments. The error 
bars represent the standard deviation. *: P≤0.05. 
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Figure 5.13 IL-1β secretion by J774A.1 macrophages infected with each of the HM605 
mutants isolated from the rapamycin screen. J774A.1 macrophages were infected with the 
indicated strains at an MOI of 10. At T24, culture supernatants were collected and IL-1β 
levels were quantified using a mouse cytokine assay kit. Results shown are the mean of 
three experiments. The error bars represent the standard deviation. *: P≤0.05. 
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5.4 Discussion 
The precise molecular mechanisms governing the interaction of autophagy, the 
inflammasome and cytotoxicity during HM605 infection of macrophages is 
unknown. However, it is emerging that autophagy plays a pivotal role in regulating 
inflammasome activation and the secretion of IL-1β. As discussed below, autophagy 
has been shown to play a negative role in inflammasome activation. It has been 
demonstrated that the inhibition of autophagy leads to an accumulation of 
damaged ROS-producing mitochondria, which in turn activates the NLRP3 
inflammasome (Zhou et al., 2011). Likewise, it has also been demonstrated that an 
accumulation of damaged mictochondria (due to defects in the autophagy 
machinery) allows the translocation of mictochondrial DNA into the cytoplasm, 
thereby resulting in NLRP3 activation (Nakahira et al., 2011). In addition to 
preventing NLRP3 inflammasome activation by mitochondrial ROS, it has also been 
shown that autophagy limits IL-1β secretion in LPS-stimulated cells by sequestering 
pro-IL-1β to autophagosomes resulting in its degradation (Harris et al., 2011). 
Therefore, in the absence of an intracellular inflammasome stimulating factor, 
autophagy serves to eliminate intracellular pools of pro-IL-1β. It has been shown 
that stimuli which activate the inflammasome (such as ATP, dsDNA and nigericin), 
also result in the activation of autophagy (Shi et al., 2012). Upon stimulation of 
NLRP3 or AIM2, the inflammasome adaptor protein ASC is ubiquitinated and can 
therefore be recognised by the autophagic cargo protein, p62, that delivers 
substrates to the autophagosome. In this way, inflammasome components are 
directed to autophagosomes, which merge with lysosomes, resulting in their 
destruction. In the context of a minor insult, this simultaneous activation of the 
inflammasome and autophagy acts to limit inflammasome activity and thus 
inflammation, thereby allowing cells to return to a basal state. However, in the 
presence of persistent inflammasome-activating stimuli, autophagy would only 
serve to temper inflammation (Shi et al., 2012). In a recent study, it was shown that 
macrophages can gauge the level of threat and correspondingly adjust their 
inflammasome-mediated resposne by either inducing autophagy or pyroptosis 
(Byrne et al., 2013). Specifically, in uninfected macrophages, NLRC4 is bound to the 
211 
 
autophagic protein Beclin-1/Atg6, thus inhibiting autophagy. Upon infection with 
Legionella, flagellin-mediated activation of NLRC4 results in the release of the 
bound autophagy protein and activation of the autophagic pathway which serves to 
clear the infection and remove the active inflammasome. However, when the 
capacity for autophagy to eliminate the insult is exceeded, the inflammasome 
complex activates caspase-1 which initiates pyroptosis and inflammation. In 
summary, autophagy negatively regulates inflammasome activation in order to 
protect the host through the following mechanisms: the removal of  endogenous 
irritants, the elimination of intracellular pools of pro-IL-1β in the absense of 
inflammasome-activating signals, and by raising the threshold of stimulus required 
to activate the inflammasome. 
Conversely, autophagy can play a positive role in the delivery of IL-1β into the 
external environment (Dupont et al., 2011). IL-1β lacks a leader peptide and cannot 
be secreted via the conventional protein secretion pathway. Therefore, until now 
the mechanism of IL-1β secretion from the cell has been unclear. A recent study has 
shown that stimulation of autophagy in bone marrow derived macrophages 
(BMDM’s) enhanced IL-1β secretion in response to various NLRP3 agonists such as 
nigericin, silica amyloid-β and alum (Dupont et al., 2011). This enhancement of IL-
1β secretion associated with autophagy induction was dependent on the 
inflammasome as IL-1β secretion was abolished in NLRP3 knock-down cells (Dupont 
et al., 2011). Interestingly, this group also noted an increased level of cytotoxicity 
under these conditions. However, there was a kinetic lag between the IL-1β 
secretion and LDH release, suggesting that the increased IL-1β secretion is not a 
direct consequence of the increased cytotoxicity (Dupont et al., 2011). 
Therefore, in our system, it is likely that activation of the inflammasome by HM605 
results in a simultaneous activation of the autophagic pathway, which serves to 
secrete IL-1β from the cell. The observed increase in IL-1β secretion in infected cells 
in the presence of the autophagy inducer rapamycin (data not shown) likely reflects 
an amplification in the secretion of IL-1β. However the reason for the 
corresponding increase in cytotoxicity is unknown. One possibility is that the 
increased IL-β secretion is directly mediating cell death. The extent of cytotoxicity 
212 
 
and IL-1β secretion was lower when autophagy was induced in MG1655 or HM605 
∆pfkAB::Km infected macrophages. Subsequently, this led to the development of a 
screen, whereby identifying mutants in HM605 which do not cause (or cause lower) 
rapamycin-induced cell death, may inadvertantly also identify mutants which are 
compromised in their ability to activate the inflammasome.  
In this way, 15 mutants were isolated which caused significantly less rapamycin-
induced cytotoxicity than the wild-type. Eight of these mutants were further 
characterised and all, with the exception of pyrF::Km, resulted in lower levels of IL-
1β production. This suggests that the decrease in IL-1β production is only a 
consequence of what is really reducing cell death. It is possible that all mutants are 
affecting autophagy and one consequence of this can be reduced IL-1β production. 
Four of the characterised mutants had insertions in genes relating to metabolism, 
namely ptsI, which is an integral component of a sugar transport system called the 
PTS (Postma & Lengeler, 1985); aceE, which catalyses the oxidative decarboxylation 
of pyruvate to acetyl Co-A under aerobic conditions; ubiE, which is involved in the 
synthesis of the quinones ubiquinone (Q) and menaquinone (MK) (Lee et al., 1997); 
and mutant 49:8B, which had a transposon inserted in an ORF (of unknown 
function) located immediately downstream of putA, and has been shown in this 
study to be putatively involved in the transport and/or metabolism of proline. All of 
these mutants stimulated the macrophage to secrete less IL-1β than the wild-type 
strain. Additionally, while mutant 49:8B was capable of replicating in the 
macrophage at a comparable level to the wild-type, ptsI::Km, aceE::Km and 
ubiE::Km were unable to replicate in the macrophage. These results also confirm 
and support our previous observations that glucose metabolism is important for the 
ability of HM605 to grow intracellularly and that successful inflammasome 
activation by HM605 is dependent on bacterial metabolism. These genes have also 
been shown to be important in supporting the intracellular lifestyle and/or 
pathogenesis of other bacteria. Salmonella requires glucose and glycolysis for 
replication in macrophages and virulence in a mouse model (Bowden et al., 2009). 
Sugar transport via the PTS was also a requirement and indeed a ptsIH mutant was 
also defective in virulence (Bowden et al., 2009). An aceE mutant in Salmonella 
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enterica serovar Enteritidis (S. Enteritidis) was shown to be defective for invasion 
into epithelial cells, less resistant to reactive oxygen species (ROS) than the wild-
type and defective for survival within chicken macrophages as well as having a 
reduced ability to colonise young chicks in comparison to the wild-type (Pang et al., 
2011). Moreover, young chicks vaccinated with the aceE mutant were protected 
from subsequent challenge with the wild-type (Pang et al., 2011). In a recent study 
aimed at analysing the anaerobic respiration of E. coli in the mouse intestine, it was 
shown that both EHEC and MG1655 primarily use nitrate, followed by fumarate as 
anaerobic electron acceptors (Jones et al., 2011). In keeping with this, ubiE mutants 
in these strains were unable to colonise the streptomycin treated mouse in 
competition with the wild-type (Jones et al., 2011). The inability of ubiE::Km to 
grow intracellularly could be due to defects in aerobic respiration and ATP 
synthesis. Similarly, the reduced ability of this mutant to activate the 
inflammasome could be as a result of a reduced synthesis of ATP. Indeed, 
extracellular ATP is a well characterised activator of the NLRP3 inflammasome 
(Mariathasan et al., 2006) , and it has recently been demonstrated that reduced 
levels of intracellular ATP can activate NLRP1b (Liao & Mogridge, 2013). This raises 
the possibility that elevated levels of intracellular ATP may also activate the 
inflammasome. 
The remaining characterised mutants had a transposon inserted in the following 
genes: basR, which encodes a response regulator involved in the two-component 
BasS/BasR signal transduction system (Hagiwara et al., 2004); efp, which encodes a 
protein chain elongation factor EF-P that enhances the translation of polyproline-
containing proteins (Doerfel et al., 2013; Ude et al., 2013); and kpsS, which encodes 
a polysialic acid capsule synthesis protein (Rigg et al., 1998; Whitfield & Roberts, 
1999). These mutants also stimulated the macrophage to secrete less IL-1β than the 
wild-type strain, even though they were all capable of intramacrophagic replication. 
Indeed, these genes have also been implicated in the virulence of other organisms.  
The BasS/BasR system has not been well studied and therefore the potential role 
played by this system during the infection of a host is unknown. However, the 
equivalent signal transduction system in Salmonella, PmrA/PmrB has been better 
214 
 
studied. PmrA/PmrB is involved in antimicrobial peptide resistance and virulence in 
Salmonella by altering LPS, specifically through the introduction of aminoarabinose 
and phosphoethanolamine to the lipid A portion and by modifying O-antigen 
synthesis (Gunn et al., 1998; Gunn et al., 2000; Lee et al., 2004; Pescaretti Mde et 
al., 2011). 
Mutants in efp, and indeed in poxA and yjek (which work in concert with efp) have 
been shown to have defects in virulence, stress survival, membrane integrity, 
motility and fitness (Kaniga et al., 1998; Navarre et al., 2010; Yanagisawa et al., 
2010; Zou et al., 2011; Zou et al., 2012). 
Polysaccharide capsules have been shown to be important virulence factors in 
bacteria. Traditionally, capsules have been viewed as extracellular virulence factors, 
protecting pathogens from complement-mediated killing and phagocytosis (Allen et 
al., 1987; Pluschke et al., 1983; Van Dijk et al., 1979). Recently, more diverse roles 
for capsular polysaccharide during pathogenesis have been uncovered. It has been 
reported that the NMEC K1 capsule prevents the fusion of E. coli-containing 
vacuoles with lysosomes in human brain microvascular endothelial cells (HBMEC), 
thereby enhancing intracellular survival (Kim et al., 2003). A K1 capsule assembly 
mutant in UPEC strain UT189 had a fitness defect in mice and also had a reduced 
ability to form biofilm-like communities called intracellular bacterial communities 
(IBC’s), which is a key step in the pathogenesis of UTI’s (Anderson et al., 2010). 
Additionally, the K5 capsule of E. coli Nissle is capable of stimulating TLR5 
expression resulting in the upregulation of TRIF, MyD88, the MAP kinase pathway 
and IL-8 (Hafez et al., 2010). Despite this, why a capsule synthesis mutant in HM605 
would stimulate the macrophage to secrete less IL-1β than the wild-type is not 
clear. It is unlikely due to defects in TLR stimulation (and hence reduced levels of 
pro-IL-1β), as our microarray data show that similar levels of pro-IL-1β are produced 
by both HM605 and MG1655 (an acapsular strain). However, considering the 
diverse roles that capsules can play in the virulence of pathogens, it is quite 
possible that the capsule in HM605 is playing a novel, and previously undescribed 
role in this organism. On the other hand, given the apparent degradation of the neu 
region in HM605, it is also possible that this strain is not producing a capsule. If this 
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is the case, it could be possible that kpsS has an alternative function in HM605, 
which is affecting IL-1β production. 
Interestingly, links can be established between the mutants obtained in this screen. 
Transcriptomics has shown that both aceE and putA/putP are positively regulated 
by the BasS/BasR signal transduction system (Hagiwara et al., 2004; Ogasawara et 
al., 2012), suggesting that the reduced ability of basR::Km to stimulate IL-1β 
secretion from infected macrophages might be due to a decreased expression of 
aceE and/or putA/putP. Additionally, it has recently been shown that PutA can 
transfer electrons to ubiquinone to generate energy from proline assimilation 
(Moxley et al., 2011), thereby potentially establishing a link between BasR, PutA 
and UbiE. As already mentioned, the biological function of efp is to prevent 
ribosomes from stalling at stretches of 3 or more proline residues (Doerfel et al., 
2013; Ude et al., 2013).  Approximately 270 proteins in E. coli contain polyproline 
residues and interestingly, metabolic enzymes are the most highly represented 
among these proteins (Doerfel et al., 2013). Notably, Icd, PutA and the PTS system 
mannose-specific EIIAB component were among these enzymes (Doerfel et al., 
2013). Indeed, it has been shown in Chapter 4 that a mutant in icd stimulated the 
macrophage to secrete less IL-1β than the wild-type. Therefore, the reduced ability 
of efp::Km to stimulate IL-1β secretion could be due to defects in the expression of 
metabolic enzymes. 
In summary, the screen was successful in isolating mutants in HM605 which 
activate the inflammasome less than the wild-type. The results presented in this 
chapter also lend support to our earlier findings, reinforcing that sugar metabolism 
is important for the intracellular growth of HM605 and that inflammasome 
activation by HM605 is dependent on an active bacterial metabolism, but 
independent of bacterial growth within the macrophage. 
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Chapter 6: The role of motility in the 
pathogenesis of AIEC strain LF82 
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6.1 Introduction 
Flagella mediated motility is a common phenomenon among microbial species. The 
ability to move has many potential benefits for the organism – it allows cells to 
access nutrients, avoid detrimental conditions and toxic substances, to translocate 
to preferred hosts, to access preferred niches within the host and to successfully 
compete with other microorganisms. Although diverse bacterial species possess 
flagella, variability does exist in the number, structure and arrangement of these 
organelles on the cell surface, reflecting environmental adaptations of different 
species. The molecular mechanisms of flagellar assembly, structure and function 
have been best studied in the Gram negative organisms Salmonella and Escherichia 
coli, which will be discussed below. 
 
6.1.1 Assembly of the flagellum in Gram negative bacteria 
The bacterial flagellum is a complex macromolecular structure requiring the 
expression of more than 50 genes for its assembly and function (Chilcott & Hughes, 
2000). The flagellum can be broadly divided into three components: the basal body, 
the hook and the filament. Flagellar assembly begins with the formation of the MS 
(membrane and supramembrane) ring (Ueno et al., 1992). The MS-ring, comprised 
of FliF, is the base structure from which all other flagellar components are 
assembled and also functions to firmly secure the flagellum in the cytoplasmic 
membrane (Kubori et al., 1997). FliG, FliM and FliN comprise the flagellar motor 
switch, required for flagellar rotation and switching. Following incorporation of FliF 
into the membrane, FliG binds to the cytoplasmic side of the MS-ring, followed by 
binding of FliM and then FliN (Francis et al., 1992; Kubori et al., 1997). FliM and FliN 
constitute the c (cytoplasmic) ring. The rod is a component of the flagellar basal 
body which is located across the outer membrane and peptidoglycan layers. The 
rod functions to transmit the force generated by the motor to the filament, thereby 
allowing flagellar movement (Jones et al., 1990). FlgB, FlgC, FlgF, flgG and FliE are 
the five components of the rod (Apel & Surette, 2008). The flagellar type III 
secretion system (fTTSS), also known as the flagellar export apparatus, functions in 
the export of flagellar components across the cytoplasmic membrane where they 
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can then be assembled into various extracellular flagellar components. The flagellar 
export apparatus consists of three cytoplasmic proteins (FliH, FliI and FliJ) and six 
integral membrane proteins (FlhA, FlhB, FliO, FliP, FliQ and FliR) (Macnab, 2003). 
FliO, FliP, FliQ and FliR comprise the protein-conducting channel of the flagellar 
export apparatus (Minamino & Macnab, 1999). Protein binding studies have shown 
that FlhA interacts with FliF as well as with FlhB, creating a docking station for the 
FliH-FliI-FliJ complex (McMurry et al., 2004). FliI functions as an ATPase, providing 
the energy required to translocate substrates across the cytoplasmic membrane 
(Fan & Macnab, 1996). FlgI comprises the P (peptidoglycan) ring of the flagellar 
basal body. The P-ring lies within the peptidoglycan layer and is assembled around 
the flagellar rod (Jones et al., 1990). The lipoprotein FlgH comprises the L 
(lipopolysaccharide) ring of the flagellar basal body. The L-ring lies within the outer 
membrane and is assembled around the flagellar rod (Berg, 2003). The flagellar 
hook is a flexible structure which connects the rotary motor to the rigid flagellar 
filament. It plays an important role in the motility of the organism by transmitting 
the energy generated by the motor into force, which allows the rigid filament to 
move (Ferris & Minamino, 2006). Monomers of FlgE polymerise into α-helices to 
form the hook structure (Vonderviszt et al., 1992). Upon hook assembly, the rod 
cap, FlgJ, is replaced with the hook cap, FlgD (Macnab, 2003). FlgD remains bound 
to the distal end of the hook during the assembly process, but is absent from the 
mature flagella (Kubori et al., 1992). The hook grows to a specific length of 55 nm. 
In terms of its function, the need for such stringent length-control is 
understandable. However, how the flagellar export apparatus knows when this 
length has been achieved, remains an enigma. Two proteins are involved, the 
flagellar hook-length control protein, FliK; and FlhB, a component of the flagellar 
export apparatus. Once the hook has reached the required length, FliK interacts 
with FlhB, resulting in a switch in specificity from the export of hook substrates to 
filament substrates (Makishima et al., 2001). The hook cap is shed once the hook 
has reached its required length, and is replaced by three proteins. These proteins, 
FlgK, FliD and FlgL, are referred to as the hook-associated proteins (Macnab, 2003). 
FlgK and FlgL function to connect the flagellar filament to the hook. FliD is attached 
to the distal growing end of the filament and plays a crucial role in the assembly of 
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FliC monomers into the growing filament (Yonekura et al., 2000). The flagellar 
filament is a long helical structure composed of approximately 20,000 FliC subunits 
(Macnab, 2003). Unlike the hook, there is no length-control mechanism for this 
structure. Flagellar filaments can grow to different lengths, resulting in better 
motility (Macnab, 2003). The stator is the non-rotating component of the motor 
and is made from two integral membrane proteins, MotA and MotB (Macnab, 
2003). These proteins function in the initial stages of torque generation, which 
drives rotation of the mature flagella (Lloyd & Blair, 1997). They are not required 
for flagellum assembly. Mot mutants constructed in E. coli are capable of producing 
mature flagella, but these flagella are paralysed. A diagrammatic representation of 
the structure of the bacterial flagellum can be seen in Figure 6.1. 
 
6.1.2 Regulation of flagella gene expression in Gram negative bacteria 
The metabolic cost of motility is quite significant for the cell. Approximately 2% of 
the cells total energy is required for the synthesis and functioning of flagella. 
Therefore, the expression of flagellar genes is tightly controlled at several levels. In 
E. coli and Salmonella, flagella genes are organised into a transcriptional hierarchy, 
consisting of three classes – class I, class II and class III. The flagellar master regulon 
flhDC is at the top of this hierarchy (class I). The flhDC operon is responsible for 
making the final decision as to whether to make flagella or not, and is controlled by 
a range of environmental signals such as temperature, osmolarity, pH and global 
regulators (Bertin et al., 1994; Li et al., 1993; Soutourina et al., 1999; Soutourina et 
al., 2002). The flhDC operon controls the transcription of the class II genes. Class II 
genes primarily encode components of the flagellar basal body and export 
apparatus. The sigma factor FliA, which positively regulates class III genes, is also 
part of the class II genes. The anti-sigma factor FlgM negatively regulates class III 
genes, ensuring that they are not transcribed until functional basal body and hook 
structures have been completed. Class III genes encode components of the flagellar 
filament, hook proteins, chemotaxis proteins and motor proteins (Soutourina & 
Bertin, 2003). 
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Figure 6.1 Structure of the flagellum in Gram negative bacteria. The flagellum from E. coli 
and Salmonella consists of three main parts: the basal body, the hook and the filament. The 
basal body, consisting of the MS ring, rod and L and P rings, is embedded within the 
bacterial cell wall. Connected to the basal body are two axial structures, the hook and the 
filament, which are joined by the hook-filament junction. Diagram was modified and re-
drawn from KEGG. 
 
6.1.3 Role of flagella in bacterial pathogenesis 
Historically, flagella have been considered as important mediators in microbe-host 
interactions, mainly because they provide a means of bacterial movement. 
However, it is now emerging that the role of flagella in virulence extends far beyond 
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that of locomotion. Recent evidence shows that flagella are also involved in cell 
adhesion, cell invasion, host colonisation and modulation of the immune system. 
The adhesive properties of flagella have been widely demonstrated. It has recently 
been shown that the EtpA adhesin of ETEC interacts with highly conserved regions 
of bacterial flagellin (Roy et al., 2009). These conserved residues are present on the 
tip of the mature flagellum, where they capture EtpA molecules and this anchors 
bacteria to host cells. These interactions are essential for mediating initial 
adherence and intestinal colonisation of ETEC (Roy et al., 2009). It has been 
demonstrated that the flagella of EPEC are directly involved in the adhesion of 
these bacteria to host cells (Giron et al., 2002). Moreover, the same study showed 
that flagella expression is upregulated upon interaction with epithelial cells, due to 
secretion of a yet uncharacterised molecule of eukaryotic origin (Giron et al., 2002). 
Both EHEC H7 flagella and EPEC H6 flagella are capable of binding mucin and mucus 
isolated from bovine intestine, while EPEC flagella are also capable of binding to the 
extracellular-matrix proteins collagen, laminin and fibronectin (Erdem et al., 2007). 
EHEC strains are also capable of agglutinating rabbit red blood cells via their flagella 
(Erdem et al., 2007). In a further investigation, the flagella of EHEC strain 0157:H7 
were shown to mediate attachment to bovine terminal primary rectal epithelial 
cells via motility and as a primary attachment organelle (Mahajan et al., 2009). The 
molecular mechanisms underpinning the binding of flagella to epithelial cells are 
unknown but these findings support the notion that bacterial flagella possess 
adhesive properties. 
The involvement of flagella in the invasion of host cells has also been well 
documented. A recent study demonstrated that NMEC K1 requires flagella for 
adherence to, and invasion of, human brain microvascular endothelial cells 
(Parthasarathy et al., 2007). This requirement is independent of motility as motAB 
deletion mutants (which produce flagella but are non-motile) exhibited no defects 
in cell association or invasion (Parthasarathy et al., 2007). Flagellin contributes to 
the virulence of shiga-toxigenic E. coli (STEC) 0113:H21 in the streptomycin-treated 
mouse model of disease. Mice were challenged with wild-type cells and a fliC 
deletion mutant. Although no differences were observed in gut colonisation or 
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cytokine secretion, the fliC mutant was less able to associate with and penetrate 
the gut epithelium, thus reducing the uptake of shiga-toxin by mice (Rogers et al., 
2006). In further support of this finding, it was shown that deletion of fliC in STEC 
0113:H21 results in a significant reduction in the ability of this strain to invade 
colonic HCT-8 epithelial cells (Luck et al., 2006). A recent study uncovered the 
molecular mechanisms underlying this process, showing that STEC flagellin interacts 
with the host lipid raft-associated cell surface receptor, asialo-GM1 (Rogers et al., 
2012). UPEC strain AL511 is capable of invading renal collecting duct cells, and is 
was demonstrated that flagellin acts as an invasin in this process (Pichon et al., 
2009). 
Colonisation of the urinary tract by UPEC strains has been linked to the expression 
of flagella. While flagella and flagella-mediated motility are not essential for 
colonisation, these features greatly enhance the competitive fitness of the 
organism (Lane et al., 2005; Wright et al., 2005). Expanding on this, UPEC flagellin 
gene expression during ascending urinary-tract infection (UTI) was monitored in 
real-time using biophotonic imaging, in an attempt to understand how flagella 
confer UPEC with a fitness advantage in vivo. Data revealed that UPEC express and 
use flagella during UTI to facilitate movement from the bladder to the kidneys and 
to subsequently spread throughout the host (Lane et al., 2007a). 
 
6.1.4 Role of flagella in the pathogenesis of AIEC 
The role of flagella in the pathogenesis of AIEC has previously been discussed in 
Chapter 1 (Section 1.6.2.2). 
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6.2 Objectives 
It has been well documented that flagella-mediated motility plays an important role 
in the pathogenesis of many bacteria. Although the role of flagella and motility in 
the pathogenesis of AIEC strain LF82 has previously been investigated, it was 
confounded by the observation that flagella and type 1 fimbriae are coregulated in 
this strain i.e. LF82 flagellar mutants also do not express type 1 fimbriae (Barnich et 
al., 2003). Therefore, the aim of this study was to further assess the role of flagella 
in the pathogenesis of LF82 by identifying mutants which are defective for 
flagella/flagella-mediated motility, but positive for type 1 fimbriae. 
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6.3 Results 
6.3.1 LF82 transposon mutant library screen for the isolation of mutants affected 
in motility 
In order to define the role of flagella and flagella mediated motility in the 
interaction of LF82 with epithelial cells, a transposon mutant library of LF82 was 
screened for mutants that were defective in motility. The mutant bank was 
prepared using an Epicentre EZ-Tn5 <Kan2> transposome kit, according to 
manufacturer’s instructions. Approximately 16,500 mutants were arrayed in 384-
well plates and frozen at -80°C. To facilitate high-throughput analysis, 
approximately 4,000 mutants were replicated into 96-well polystyrene plates and 
grown overnight at 37°C. The mutants were subsequently hand-replicated onto Q-
trays (Genetix) containing 250 ml of motility agar, using a 96-pin replicator. Plates 
were incubated overnight at 37°C and motility was assessed visually by examining 
the circular, swimming motion of the cells. Colonies showing no motility were noted 
(Figure 6.2). In the primary screen, 178 motility mutants (out of 4000 screened) 
were identified. Re-screening of these mutants resulted in the retention of 10 
mutants that were consistently defective for motility. 
 
 
Figure 6.2 The LF82 transposon mutant library was screened for mutants with defects in 
motility. The library was replica-plated onto motility agar and motility was assessed 
visually, after overnight incubation at 37°C. Colonies indicated with an arrow are examples 
of motility minus mutants from the initial screen, which were selected for further analysis. 
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6.3.2 Southern analysis of LF82 motility mutants  
Considering that the LF82 mutant library was constructed using a transposon, it is 
possible that multiple copies of the transposon inserted within a given genome. To 
evaluate the presence and copy-number of the integrated transposons within the 
genome of each mutant, Southern analysis was performed. Chromosomal DNA was 
extracted from each mutant and digested with the endonuclease EcoRV, which 
does not cleave the transposon DNA. DNA samples were electrophoresed, 
transferred to a nylon membrane and hybridised with a biotinylated 
oligonucleotide probe specific for the transposon. All samples produced a single 
prominent band (Figure 6.3). Negative control DNA from wild-type LF82 did not 
produce any bands. Transposon DNA was amplified by PCR and included as a 
positive control. These results indicate that a single copy of the transposon DNA is 
present in the genome of all the motility-minus mutants.  
 
Figure 6.3 Southern analysis of LF82 transposon mutants. Genomic DNA’s were digested 
with EcoRV and fragments were electrophoresed and transferred to a nylon membrane 
using standard techniques. The membrane was hybridised with a biotin labelled 
oligonucleotide probe specific for the Km-resistance cassette. Detection was achieved by 
chemiluminescence followed by a 30 s exposure to x-ray film.  
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6.3.3 Identification of the LF82 motility minus mutants 
The disrupted gene and the position of the transposon in each mutant was 
identified by amplifying the genomic DNA flanking the transposon using arbitrarily-
primed PCR. PCR products were sequenced by GATC and nucleotide sequences 
generated were matched to sequences in the NCBI database. All of the sequences 
generated exactly matched sequences in the LF82 complete genome. Table 6.1 
outlines the transposon insertion site for each mutant and the corresponding gene 
disrupted and Figure 6.4 is a diagrammatic representation of the genomic context 
and localisation of the transposon in each mutant.  
 
Table 6.1 The transposon insertion site for each motility mutant and the 
corresponding gene disrupted 
Mutant ID  
(plate#:well#) 
Tn5 Insertion  
(bp) 
Gene disrupted 
10:13G 1,980,962 fliI 
11:15P 1,939,964 flhC 
11:4H 1,109,486 flgE 
11:4J 1,114,533 flgJ 
5:8K 4,111,826 dsbA 
8:10J 4,111,721 dsbA 
9:15K 1,241,072 dsbB 
10:5H 1,521,570 bdm 
3:23M 3,052,750 ubiH 
7:15D 3,724,106 yhjH 
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Figure 6.4 The genetic loci important for motility in AIEC strain LF82. The position of the 
transposon in each mutant was identified by arbitrarily primed PCR, sequencing and 
subsequent BLAST analysis against the LF82 genome. The triangles indicate the 
approximate position of the transposon in each mutant. Diagrams were modified and re-
drawn from xBASE. 
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6.3.3.1 A description of each motility mutant 
Mutant 10:13G 
Mutant 10:13G had a transposon inserted at 1,980,962 bp, which lies within the 
gene fliI. FliI is a flagellum-specific ATP synthase, located in the cytoplasm of the 
cell, which functions to provide energy for the export of flagellar components. FliI 
contains two domains: the C-terminal domain, which is responsible for the 
enzymatic activity of the protein; and the N-terminal domain, which is required for 
binding to FliH, which negatively regulates FliI activity (Fan & Macnab, 1996; 
Minamino & MacNab, 2000). 
 
Mutant 11:15P 
Mutant 11:15P had a transposon inserted at 1,939,964 bp, which lies within the 
gene flhC. FlhC is part of the class I transcriptional group, which encodes the master 
regulator of the flagellar regulon. Along with FlhD and 70, FlhC directly activates 
the transcription of class II flagellar genes (Soutourina & Bertin, 2003). 
 
Mutant 11:4H 
In mutant 11:4H, the transposon inserted at 1,109,486 bp, thus inactivating the flgE 
gene. About 120 copies of FlgE make up the flagellar hook (Macnab, 2003), which is 
a flexible tubular structure located outside the cell, connecting the motor to the 
filament. Its flexibility has important implications for flagellar movement, as it 
allows it to transmit torque from the motor to the filament (Ferris & Minamino, 
2006). 
 
Mutant 11:4J 
In mutant 11:4J, the transposon inserted at 1,114,533 bp, which lies within the flgJ 
gene. FlgJ has a dual role in the flagellum assembly process. Its N-terminal domain 
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functions as a rod capping protein; and its C-terminal domain functions as a 
muramidase, which breaks down the peptidoglycan layer, thereby allowing rod 
assembly to proceed through the peptidoglycan layer and into the periplasm 
(Hirano et al., 2001).  
 
Mutants 5:8K and 8:10J 
Mutants 5:8K and 8:10J had a transposon inserted at 4,111,826 bp and 4,111,721 
bp, respectively, both of which lie within the gene dsbA. DsbA is a disulfide 
oxidoreductase, found in the bacterial periplasm, which plays a key role in a process 
called oxidative protein folding. Disulfide bonds are covalent bonds formed 
between two cysteine residues and are vital for the functioning and stability of 
many proteins. In E. coli, DsbA is the main protein which catalyses disulfide bond 
formation in newly synthesised proteins. It oxidises free thiols in the protein 
resulting in disulfide bond formation. DsbA is subsequently released in the reduced 
form (Heras et al., 2009). One consequence of a dsbA mutation is that it renders the 
bacterial cell non-motile. DsbA catalyses the formation of a disulfide bond between 
two cysteine residues in FlgI, the flagellar P-ring motor protein. Hence, dsbA 
mutants are lacking a P-ring and therefore do not form functional flagella (Dailey & 
Berg, 1993), presumably due to knock-on effects for L-ring and flagellin assembly. 
 
Mutant 9:15K 
In mutant 9:15K, the transposon inserted at 1,241,072 bp, thereby disrupting the 
dsbB gene. DsbB is a membrane-bound protein, which also functions in the 
oxidative protein folding pathway. Its main function is to reoxidise the two 
cysteines in DsbA, thus restoring the oxidising function of DsbA (Heras et al., 2009). 
Similar to a dsbA mutant, a dsbB mutant is also non-motile for the same reasons as 
discussed above (Dailey & Berg, 1993). 
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Mutant 10:5H 
Mutant 10:5H had a transposon inserted at 1,521,570 bp, which lies within the 
gene bdm, which encodes a biofilm-dependent modulation protein. Bdm is a 
member of the Rcs regulon, where it is positively regulated by this signalling system 
(Hagiwara et al., 2003). The Rcs phosphorelay is a complex signalling pathway 
common among the Enterobacteriacae and is involved in capsule synthesis 
(Gottesman et al., 1985), multidrug resistance (Hirakawa et al., 2003), biofilm 
formation (Ferrieres & Clarke, 2003) and recovery from chlorpromazine-induced 
stress (Conter et al., 2002). In a study aimed at characterising the regulation of bdm 
by the Rcs phosphorelay, it was shown that bdm is activated by osmotic shock, and 
this regulation is dependent on RcsB (Francez-Charlot et al., 2005). Interestingly, a 
role for bdm in motility has not been reported. 
 
Mutant 3:23M 
Mutant 3:23M had a transposon inserted at 3,052,750 bp, which lies within the 
gene ubiH, which encodes a 2-octaprenyl-6-methoxphenol hydroxylase involved in 
the ubiquinone biosynthetic pathway. Ubiquinone, also referred to as coenzyme Q, 
has important functions in the respiratory electron transport chain of microbes, in 
addition to roles in gene regulation and the oxidative stress response (Inoue et al., 
2007). Prokaryotes synthesise ubiquinone de novo from chorismate (forming the 
nucleus) and polyprenyldiphosphate (forming the prenyl side chain), followed by a 
series of ring modifications, decarboxylation, hydroxylation and methylation 
reactions (Soballe & Poole, 1999). Flagellation in E. coli and Salmonella has been 
shown to require ubiquinone (Bar-Tana et al., 1980; Bar Tana et al., 1977). Indeed, 
in a genome wide screen for genes required for motility in E. coli K-12, a mutant in 
ubiH was found to be strongly repressed for both swimming and swarming motility 
(Inoue et al., 2007). This defect is most likely due to defects in energy production 
(proton motive force/proton gradient) required for flagella-mediated motility. The 
motility defect may also be due to the requirement of the DSB system for 
ubiquinone (as previously mentioned dsb mutants are non-motile)  
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Mutant 7:15D 
Mutant 7:15D had a transposon inserted at 3,724,106 bp, which lies within the 
gene yhjH, which encodes a c-di-GMP phosphodiesterase. c-di-GMP functions as a 
secondary messenger in bacteria controlling the switch from the motile planktonic 
phase to the sessile biofilm phase, in addition to playing a role in controlling the 
virulence of pathogens. YhjH is under the direct control of the flagellar sigma factor 
FliA (Hengge, 2009). YhjH promotes motility by degrading c-di-GMP, which 
subsequently suppresses the activity of the motility effector protein, YcgR (Hengge, 
2009). It has been shown that although yhjH mutants are impaired for motility, they 
still express flagella. The defect in motility is attributed to the fact that this mutant 
can only move in the counter-clockwise (CCW) direction i.e. the cells are tumbling 
(Girgis et al., 2007). Flagellar motor switching between the clockwise (CW) and CCW 
direction is essential for directional movement i.e. taxis in E. coli. 
The motility phenotypes of the 10 mutants mentioned above can be seen in Figure 
6.5. All of the mutants showed a complete abolition in motility, with the exception 
of ubiH::Km, which was severely reduced in motility in comparison to wild-type. 
 
 
Figure 6.5 Motility phenotypes of LF82 transposon mutants isolated from the motility 
screen. Bacterial strains were grown overnight in LB broth and diluted to an OD600 of 1.0 in 
fresh LB before 5 µl was spotted onto the surface of motility agar plates. Plates were 
incubated at 37 °C overnight.  
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6.3.4 Phenotypic analysis of the LF82 motility minus mutants 
6.3.4.1 Type 1 fimbriae production 
Type 1 fimbriae are proteinaceous, non-flagellar, filamentous surface appendages 
involved in adhesion to host cells or environmental surfaces. This adhesive 
structure is encoded by the fim operon (fimA – fimH). FimA is the main structural 
subunit, which forms a long helical rod of 1 – 2 µm. The rod is connected to a short 
tip fibrillum via FimF. The fibrillum is composed of FimG and the adhesin, FimH 
(Hahn et al., 2002). FimH binds to mannose-containing receptors expressed by host-
cells. Type 1 fimbriae are assembled via the chaperone-usher pathway. Fimbrial 
subunits secreted into the periplasm are bound by the chaperone FimC. FimC 
mediates protein folding and subsequently delivers folded proteins to the usher 
FimD, located in the outer membrane. The subunits are released from the 
chaperone and are assembled into the fimbrial structure (Jones et al., 1993). Type 1 
fimbriae are prevalent throughout the family Enterobacteriacae. In particular, they 
are the most common type of pilus expressed by UPEC, where they contribute to 
the pathogenesis of bladder infections. UPEC attach to host cells of the urinary tract 
via FimH, allowing bacterial colonisation and persistence (Mulvey et al., 1998; Wu 
et al., 1996). FimH also directly facilitates the invasion of UPEC into bladder 
epithelial cells (Martinez et al., 2000). Moreover, in LF82, type 1 fimbriae have been 
shown to be important mediators of the adhesion to, and invasion of, epithelial 
cells. The adhesin FimH mediates the initial binding of LF82 to epithelial cells, 
whereas the fimbrial shaft protein, FimA, is required to induce membrane 
elongations which surround the bacteria at sites of contact, thus allowing bacterial 
internalisation (Boudeau et al., 2001). Surprisingly, in a later study, the group 
showed that the flagella and type 1 fimbriae of LF82 are regulated in a co-ordinate 
manner, demonstrated by a low level expression of type 1 fimbriae in both a fliC 
and a motB deletion mutant (Barnich et al., 2003). 
Taking on board the observation of a down-regulation of type 1 fimbriae in LF82, 
caused by the absence of flagella, the fimbriation status of our motility minus 
mutants was assessed by a mannose-sensitive yeast agglutination assay. This assay 
tests for the ability of type 1 fimbriated cells to bind to mannosylated receptors on 
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the surface of yeast cells. Equal volumes of Saccharomyces cerevisiae and bacterial 
cultures were mixed in a 24-well plate and aggregation was monitored visually. As a 
control in each case, mannose was added to the bacterial culture at a final 
concentration of 3% (w/v), as this blocks type 1 fimbriae mediated binding of 
bacterial cells to yeast cells. Images of each well were taken under a light 
microscope at 10,000 X magnification (Figure 6.6).  
Wild-type LF82 strongly aggregated yeast cells, indicating the expression of type 1 
fimbriae (Figure 6.6). The non-motile mutants (flhC::Km, fliI::Km, flgE::Km, flgJ::Km, 
yhjH::Km and bdm::Km) also aggregated yeast cells (Figure 6.6). Therefore there 
does not appear to be a strong link/correlation between motility and type 1 
fimbriae production as previously reported (Barnich et al., 2003). However, the 
original mutants obtained by Barnich et al., (2003) were isolated from a mutant 
library screen and were type 1 fimbriae positive. Following re-construction of the 
mutations by the lambda red phage recombination method, the resulting isogenic 
mutants were no longer expressing type 1 fimbriae (Barnich et al., 2003). The 
reason(s) for these contradictory phenotypes are unclear.   
The dsbA::Km, dsbB::Km and ubiH::Km mutant strains were unable to aggregate 
yeast cells (Figure 6.6), indicating that these strains do not express type 1 fimbriae. 
These strains are also non-motile (or at least exhibit greatly decreased motility) and 
the type 1 fimbriae defect is more likely due to an inability of these strains to form 
disulfide bonds, which are required for pilus biogenesis. A recent study in UPEC 
showed that DsbA-mediated disulfide bond formation in the unfolded FimA 
subunits was required for recognition and subsequent folding of the subunits by 
FimC (Crespo et al., 2012). DsbA is re-oxidised by DsbB which is re-oxidised by 
donating electrons to ubiquinone (Bader et al., 1999). As ubiH is required for the 
biosynthesis of ubiquinoine it is not surprising that the ubiH mutant would display a 
similar phenotype to the dsbA and dsbB mutants, in terms of type 1 fimbriae 
production. 
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Figure 6.6 Type 1 fimbriae production by the LF82 motility mutants. A yeast aggregation 
assay was performed to test for the production of type 1 fimbriae. Standardised bacterial 
cultures were mixed with equal volumes of commercial baker’s yeast (Saccharomyces 
cerevisiae) in a 24-well plate. Mannose was added to the bacterial cultures in a replicate 
experiment, at the indicated concentration. The plates were swirled gently until 
aggregation was observed visually. Wells were observed with a light microscope (Olympus 
BX51, Olympus, Hamburg, Germany). The experiment was carried out in triplicate with 
similar results and a representative picture is shown. 
 
6.3.4.2 Curli production 
Curli are proteinaceous amyloid fibers which are part of the extracellular matrix of 
enteric bacteria such as E. coli and Salmonella. They play important roles in biofilm 
formation, attachment to and invasion of host cells and induction of an 
inflammatory response (Barnhart & Chapman, 2006). Curli are encoded by two 
operons in E. coli, csgBA and csgDEFG. CsgA is the major structural subunit, CsgB is 
a nucleator protein important for curli assembly and CsgDEFG are accessory 
proteins also required for the assembly of curli fibres (Barnhart & Chapman, 2006). 
In addition to curli, the extracellular matrix of E. coli and Salmonella also contains 
cellulose and poly-β-1,6-N-acetylglucosamine (PGA) (Barnhart & Chapman, 2006; 
Wang et al., 2004). Enteric bacteria display different morphotypes, which 
correspond to the extracellular matrix that they produce. Morphotypes can be 
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determined by plating bacteria on agar plates incorporating Congo red. Four 
morphotypes have been described to date: rdar (red, dry and rough), pdar (pink, 
dry and rough), bdar (brown, dry and rough) and saw (smooth and white) (Barnhart 
& Chapman, 2006). Both curli and cellulose production is indicated by the rdar 
morphotype, cellulose production is indicated by the pdar morphotype, curli 
production is indicated by the bdar morphotype and neither curli nor cellulose 
production is indicated by the saw morphotype (Bokranz et al., 2005; Zogaj et al., 
2003). To examine the extracellular matrix components produced by LF82 and the 
LF82 motility mutants, strains were spotted onto Congo red indicator plates. It has 
been previously demonstrated that growth at temperatures at, or below, 30°C 
promotes curli expression. However, many clinical strains of E. coli produce curli at 
37°C (Bian et al., 2000). Therefore, plates were prepared in duplicate and incubated 
at either 30°C or 37°C. 
Results showed that wild-type LF82 displayed the saw morphotype at 30°C, 
indicating that this strain does not produce curli or cellulose at this temperature. In 
contrast, LF82 produced curli at 37°C, indicated by the bdar morphotype (Figure 
6.7). This perhaps reflects an adaptation of LF82 to growth in the human intestine. 
Similarly, the flhC::Km, fliI::Km, flgE::Km, flgJ::Km, bdm::Km and yhjH::Km mutants 
only produced curli at 37°C (Figure 6.7).  
It has recently been shown that DsbA negatively controls curli and cellulose 
expression in Pseudomonas putida (Lee et al., 2009). Deletion of dsbA in this strain 
stimulated the production of cellulose (which was not produced by the wild-type) 
and also enhanced curli expression (Lee et al., 2009). In this study, curli appear to 
be constitutively expressed in both dsbA::Km and dsbB::Km and cellulose 
production was also observed in these mutants at 37°C, as indicated by the rugose 
(wrinkled) colony morphotype (Figure 6.7). This suggests that the Dsb proteins may 
also negatively regulate extracellular matrix components in LF82, as has been 
reported for P. putida. 
The ubiH::Km mutant appears to be constitutively expressing cellulose, but not curli 
(Figure 6.7). A direct link between UbiH and curli expression has not been 
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documented in the literature. However, it has been shown that the ArcB sensor 
kinase is active in an ubiCA mutant (Georgellis et al., 2001; Malpica et al., 2004). 
Active ArcB directly activates the response regulator RssB which targets the 
alternative sigma factor, RpoS ( S), for proteolysis (Mika & Hengge, 2005). The 
expression of genes involved in curli biosynthesis is dependent upon RpoS (Arnqvist 
et al., 1994). Therefore, a potential decreased expression of RpoS in ubiH::Km, may 
help to explain the inability of this mutant to express curli.  
The reason for the constitutive expression of cellulose in ubiH::Km is also unknown. 
However, ubiquinones are involved in the Dsb protein folding pathway (Heras et al., 
2009). Considering that it has been shown that a dsbA mutant in P. putida 
constitutively expresses cellulose (Lee et al., 2009), it may be reasonable to 
speculate that a ubi mutant would also constitutively express cellulose. 
 
 
Figure 6.7 Morphotypes of LF82 motility mutants on Congo red indicator agar. Bacterial 
strains were grown statically overnight at 37°C in LB broth and diluted to an OD600 of 0.5 in 
fresh LB before spotting 5 µl onto the surface of Congo red indicator plates. Plates were 
incubated overnight at either 30°C or 37°C. Plates were examined visually and the 
morphotypes were categorised as: saw (smooth and white; no curli or cellulose); pdar 
(pink, dry and rough; cellulose); bdar (brown, dry and rough; curli); rdar (red, dry and 
rough; curli and cellulose). The experiment was carried out in triplicate with similar results. 
A representative picture is shown. 
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6.3.4.3 Biofilm formation 
A biofilm is defined as a community of microorganisms which are attached to a 
solid surface and surrounded by a self-produced polymeric matrix. Biofilm 
formation is a pathogenic feature of many organisms. UPEC invasion of bladder 
cells is followed by the formation of protrusions on the cell surface which contain 
bacteria surrounded by a polysaccharide-rich matrix enclosed by a shell of uroplakin 
(Anderson et al., 2003). These biofilm-encased cells can serve as a reservoir for 
recurrent infection. Similarly, EAEC adheres to the epithelium of the small and large 
intestine by forming a thick biofilm, thereby allowing toxin secretion into the cell 
(Kaper et al., 2004). Moreover, it has recently been reported that in vitro biofilm 
formation may be a phenotypic trait of AIEC (Martinez-Medina et al., 2009c).  
LF82 and the LF82 motility minus mutants were analysed for their ability to form 
biofilms in vitro. Overnight cultures were diluted in YESCA (yeast extract, casamino 
acids) broth and inoculated into the wells of a 96-well plate. Following overnight 
incubation at 30°C, the cells were removed and the wells were washed with PBS. 
Wells were subsequently stained with crystal violet and the amount of biofilm 
formed in each well was determined by measuring the OD595 of the solution with a 
microtitre plate reader. All readings were standardised to the growth OD595 of the 
particular well. As expected, wild-type LF82 formed a biofilm (Figure 6.8). However, 
unexpectedly, all the motility minus mutants (with the exception of ubiH::Km) 
formed biofilms at a comparable level to the wild-type (Figure 6.8). It has been 
reported that motility is a crucial factor in biofilm formation in E. coli K-12 (Pratt & 
Kolter, 1998). Indeed, it has been shown that a fliC deletion mutant in LF82 has a 
reduced capacity to form biofilms in comparison to the wild-type strain (Martinez-
Medina et al., 2009c). The reason for the discrepancy between results is unclear, 
however, it could be due to experimental differences. Even though the type of 
plastic used and incubation temperatures were the same, Martinez-Medina et al., 
(2009) used M63 minimal medium supplemented with glucose as a growth medium 
for their biofilm assays; whereas YESCA broth was used in this study, emphasising 
the sensitivity of biofilm assays to environmental differences. It is also interesting to 
note that EAEC form a biofilm on plastic which is distinct from that formed by non-
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pathogenic E. coli strains, in that flagella, curli and type 1 fimbriae are not required 
(Sheikh et al., 2001). Notably, biofilm formation by a ∆fliC mutant in EAEC was 
indistinguishable from that of the wild-type (Sheikh et al., 2001). 
 
 
Figure 6.8 Biofilm formation by the LF82 motility mutants. Bacterial cultures were diluted 
1:100 in YESCA broth and aliquots of 150 µl were added to the wells of a polystyrene 96-
well plate. The plate was incubated in a moist environment at 30°C without agitation. After 
24 h, the wells are stained with crystal violet to quantify bacterial attachment. Results 
shown are the mean of three independent experiments and the error bars represent the 
standard deviation. Specific Biofilm Formation (SBF) = OD595 of the attached and stained 
bacteria / OD595 of cell growth in broth. *: P≤0.05. 
 
6.3.4.4 The role of flagella and flagella mediated motility in the interaction of LF82 
with epithelial cells 
It has previously been reported that motility and type 1 fimbriae production are co-
regulated in LF82 (Barnich et al., 2003). As a result, it has not been possible to 
determine the role played by flagella alone in the pathogenesis of LF82. Therefore, 
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the initial aim of this study was to isolate a mutant in LF82 that was non-motile but 
still retained the ability to produce type 1 fimbriae. Several such mutants were 
isolated, including the different flg::Km mutants and the bdm::Km mutant. 
Therefore in order to determine the role of flagella in the interaction between LF82 
and epithelial cells we choose the flhC::Km and bdm::Km mutants. Both of these 
mutants are non-motile but express type 1 fimbriae. The flhC::Km mutant is non-
motile as this strain does not produce flagellin, whilst the bdm::Km mutant 
produces flagellin suggesting that the assembled flagella are non-functional (Figure 
6.9). The dsbA::Km mutant; which is non-motile and does not express flagellin or 
type 1 fimbriae was also included as a control. These characteristics are 
summarised in Table 6.2. 
 
 
Figure 6.9 Flagellin expression by LF82 motility mutants. Bacterial whole-cell lysates were 
prepared, electrophoresed onto a 10% SDS-PAGE gel and subjected to Western blot 
analysis with an antiserum to H1 flagella. The arrow denotes the FliC protein and molecular 
weight markers are shown on the left. The experiment was carried out in triplicate with 
similar results and a representative image is shown. 
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Table 6.2 Summary of the phenotypic characteristics of flhC::Km, bdm::Km and 
dsbA::Km 
 Motility Flagellin* Type 1 fimbriae 
LF82 + + + 
flhC::Km - - + 
bdm::Km - + + 
dsbA::Km - - - 
 
* The ability of LF82, flhC::Km and bdm::Km to produce flagellin (FliC) was assessed in this study 
(Figure 6.9). Although the ability of dsbA::Km to produce flagellin was not determined in this study, it 
has been documented that a dsbA mutant in LF82 is unable to synthesise flagellin (Bringer et al., 
2007). 
 
The ability of these mutants to attach to epithelial cells was initially assessed. 
Bacterial strains were incubated with C2Bbe1 epithelial cells at an MOI of 10 for 3 h. 
After this incubation period, the cells were lysed and the numbers of intracellular 
bacteria were enumerated. Quantification of bacterial colony forming units (cfu’s) 
revealed that flhC::Km and bdm::Km were significantly less well able to attach to 
the epithelium in comparison to the wild-type strain (Figure 6.10 A). In the case of 
dsbA::Km, cfu counts were too low to be included in the analysis; therefore 
dsbA::Km is marked as not detected (denoted as # on the graph). This suggests an 
important role for motility (and type 1 fimbriae) in mediating LF82 adherence to 
epithelial cells. To confirm the role for motility in adherence to the epithelium, the 
adhesion assay was repeated, but a centrifugation step was included directly after 
infection. This served to force contact between the bacterial cells and the epithelial 
cells. Indeed, centrifugation resulted in a significant increase in the ability of 
flhC::Km and bdm::Km to adhere to the epithelium (Figure 6.10 A). The 
centrifugation step restored the adherence of bdm::Km to approximately 75% of 
that of the wild-type. However, centrifugation only restored the adherence of 
flhC::Km to approximately 40% of that of the wild-type (although the difference was 
not statistically significant). Again, counts were not obtained for dsbA::Km. As 
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outlined in Table 6.2, bdm::Km expresses flagellin, whereas flhC::Km does not. 
Therefore the results presented here suggest, that in addition to allowing bacterial 
cells to move towards the epithelium, flagella may also play a role in the adhesion 
of LF82 to the host cell. Indeed, it has been previously reported that flhD or fliA 
mutants in LF82 (engineered to produce type 1 fimbriae) had adherence defects, 
even when a centrifugation step was included. As outlined in Table 6.2, dsbA::Km is 
defective for both type 1 fimbriae and flagellin production, which would explain the 
drastic inability of this mutant to attach. Indeed, the essential role of type 1 
fimbriae in mediating the attachment to LF82 to epithelial cells has previously been 
documented (Barnich et al., 2003; Boudeau et al., 2001). 
To determine the number of intracellular bacteria, assays were carried out as 
described above (including the centrifugation step), except gentamicin was added 
to each well and incubated for an additional 1 h, in order to kill extracellular 
bacteria. Cells were then lysed and intracellular bacteria were quantified. No 
significant differences were observed in the ability of flhC::Km or bdm::Km to 
invade C2Bbe1 cells in comparison to the wild-type strain (Figure 6.10 B). These 
mutants express type 1 fimbriae, an essential requirement for LF82 to invade 
epithelial cells. No viable counts were obtained for dsbA::Km. However, this is not 
surprising as this mutant does not express type 1 fimbriae and hence did not attach 
to the epithelial cells. 
In summary, flagella-mediated motility plays a role in the ability of LF82 to adhere 
to the epithelium via active motility. The flagella filaments may also play a role in 
mediating the binding of LF82 to the epithelium. In contrast, flagella do not appear 
to play a role in the invasive process.  
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Figure 6.10 Adhesion to, and Invasion of, C2Bbe1 epithelial cells by LF82 motility mutants 
(A) Cell-associated bacteria were quantified after a 3 h infection period. Results are 
expressed as the numbers of cell-associated bacteria relative to that obtained for LF82, 
taken as 100%. (B) The numbers of bacteria which invaded the epithelium were quantified 
after gentamicin treatment for an additional hour. Results are expressed as the number of 
bacteria which invaded relative to that obtained for LF82, taken as 100%. The experiment 
was carried out in triplicate. The error bars represent the standard deviation. #: not 
detected; *: P≤0.05. 
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6.3.5 Role of bdm in LF82 motility 
6.3.5.1 Complementation of LF82 bdm::Km 
The non-motile phenotype of the bdm::Km mutant was intriguing. A survey of the 
literature failed to establish any link between Bdm and motility in any organism. In 
fact, there is limited knowledge on the biological role of this protein. This led us to 
investigate the potential role of Bdm in the motility of LF82. To confirm that the 
motility defect observed in the bdm::Km mutant was in fact due to deletion of bdm, 
and not as a result of a polar effect, bdm was expressed in trans in the mutant. The 
bdm gene was amplified from genomic DNA extracted from LF82 and ligated 
between the SacI and XbaI sites of the plasmid pBAD33. Expression of the bdm 
transcript is therefore driven by the arabinose-inducible promoter PBAD. The 
integrity of the cloned bdm gene was confirmed by sequencing before transforming 
the clone into LF82 bdm::Km. The ability of the trans-complemented mutant to 
swim was assessed on motility agar (Figure 6.11). Surprisingly, the expression of 
bdm in trans was not sufficient to restore motility to the mutant. This result 
suggests that the motility defect in LF82 bdm::Km is not due to the mutation in 
bdm. 
 
6.3.5.2 Construction of bdm mutants in other E. coli strains 
To assess the role played by Bdm in motility throughout the E. coli genus, bdm 
deletion mutants were constructed in other E. coli strains, namely MG1655, W3110 
and ZK2686. A bdm mutant in BW25113 was directly obtained from the KEIO 
library. Deletion mutants were constructed using bacteriophage P1-mediated 
transduction, using the KEIO library as a source of the donor strains (Baba et al., 
2006). Attempts to transduce the bdm allele into LF82 were unsuccessful due to an 
innate resistance of LF82 to phage P1. The motility of the corresponding mutants 
was assessed on motility agar. The original LF82 bdm::Km mutant was also included 
as a control. As can be seen from Figure 6.12, deletions in the bdm gene in 
MG1655, W3110, ZK2686 and BW25113 did not have any impact on the motility of 
these strains.  
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Figure 6.11 Complementation of bdm::Km does not restore motility. Bacterial strains were 
grown overnight and spotted onto motility agar, containing Cm and arabinose, where 
appropriate. Plates were incubated at 37°C overnight. The experiment was carried out in 
triplicate with similar results. A representative picture is shown. 
 
 
Figure 6.12 Bdm does not play a role in motility in E. coli. The bdm::Km allele from the 
KEIO library was transduced into E. coli strains MG1655, W3110, ZK2686 and BW25113. 
The resulting mutants, along with the respective wild-type strains were grown overnight in 
LB broth and spotted onto the surface of a motility agar plate. Plates were incubated at 
37°C overnight. The experiment was carried out in triplicate with similar results. A 
representative image is shown. 
 
 
245 
 
6.3.5.3 Subcloning the bdm fragment 
The fact that the motility phenotype of the bdm::Km mutant could not be 
complemented by heterologous expression of the bdm gene from a plasmid, 
suggested that the phenotype might be due to a second transposon insertion. 
However, previous Southern analysis of the bdm::Km mutant revealed the presence 
of a single insertion in this strain (Figure 6.3). Therefore, we looked more closely at 
the localisation of the transposon within the genome of this mutant (Figure 6.13 A). 
The transposon inserted within the bdm gene, at 1,521,570 bp, which is 47 bp 
downstream from the bdm start codon. Moreover, the transposon is in the 
opposite orientation to bdm and faces a large intergenic region of 344 bp between 
bdm and osmC (using the direction of transcription of the Km-resistance gene as a 
marker). Taking this into account, we hypothesised that the transposon may be 
driving transcription of the intergenic region between bdm and osmC, thus 
producing a molecule that is affecting motility. To test this, chromosomal DNA was 
extracted from LF82 bdm::Km, cut with EcoRV (which does not cut in the 
transposon sequence) and the resulting fragments were ligated into pBR322, which 
was cleaved with the same enzyme. Clones were transformed into E. coli EC100 
cells and Km-resistant colonies were selected. In the vicinity of bdm, EcoRV cuts the 
LF82 chromosome at 1,521,453 bp and 1,522,002 bp, so essentially the transposon 
and the flanking DNA were cloned into pBR322 (referred to as “bdm-subclone”) 
(Figure 6.13 A). This clone was transformed into wild-type LF82 and motility was 
assessed on motility agar. Surprisingly, introduction of the bdm-subclone into LF82 
gave the same phenotype as the LF82 bdm::Km mutant – a complete inhibition of 
motility (Figure 6.13 B). Therefore the motility phenotype associated with the 
bdm::Km mutant is dominant, suggesting that the transposon insertion had induced 
the production of a molecule, perhaps driven by a promoter within the transposon, 
which was affecting motility. 
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Figure 6.13 The effect of the bdm::Km mutation on motility is dominant. (A) 
Diagrammatic representation of the genes surrounding bdm and the position of the 
transposon within the bdm gene. The transposon is represented by a black triangle and the 
red arrow denotes the direction of transcription. LF82 bdm::Km genomic DNA was cut with 
EcoRV, which cuts the E. coli genome in the vicinity of bdm as indicated by the green dotted 
lines. Cleaved DNA was ligated into pBR322 and subsequently transformed into EC100 cells. 
A KmR colony was selected. This colony contains pBR322 with the fragment of DNA 
indicated by the green dotted lines and is referred to as bdm-subclone. (B) Bacterial strains 
were grown overnight and standardised to an OD600 of 0.5 before spotting 5 µl onto the 
surface of motility agar plates. Plates were incubated at 37°C overnight. The experiment 
was carried out in triplicate with similar results and a representative image is shown. 
(A) 
 
 
 
 
 
 
 
 
 
 
 
 
(B) 
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6.3.5.4 Expressing the bdm-subclone in E. coli K-12 strain MG1655 has no effect 
on motility in this strain 
Expressing the bdm-subclone in LF82 completely abolished the motility of this 
strain. Therefore, it was of interest to see if expressing this plasmid in a K-12 strain 
of E. coli would have the same effect. Therefore, the bdm-subclone was 
transformed into MG1655 and the motility phenotype of the resulting strain was 
assessed on motility agar. However, expressing the bdm-subclone in MG1655 did 
not affect the motility of this strain (Figure 6.14), suggesting that the effect may be 
specific for LF82. 
 
6.3.5.5 Overproduction of Bdm and OsmC in LF82 does not affect the motility of 
this strain 
Considering that the bdm-subclone fragment includes the start of both the bdm and 
osmC genes, it is possible that the transposon could be hyper-activating these 
genes, resulting in a loss of motility. To test this, both bdm and osmC were over-
expressed in LF82, to determine if these strains would phenocopy the LF82 
bdm::Km mutant. The ASKA library was utilised for this purpose (Kitagawa et al., 
2005). Plasmids containing cloned copies of bdm and osmC were transformed into 
LF82 and motility was assessed on motility agar. Results indicate that 
overproduction of Bdm or OsmC have no effect on the motility of LF82 (Figure 
6.15). 
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Figure 6.14 Expressing the bdm-subclone in MG1655 does not affect motility. MG1655 
was transformed with the bdm-subclone. Strains were grown overnight and optical 
densities were adjusted to 0.5. 5 µl of each culture was spotted onto motility agar plates 
and plates were incubated at 37°C overnight. The experiment was carried out in triplicate 
with similar results and a representative image is shown. 
 
 
 
Figure 6.15 Overproduction of Bdm or OsmC does not affect motility in LF82. LF82 was 
transformed with plasmid pCA24N, expressing cloned copies of either bdm or osmC. Strains 
were grown overnight and diluted to an OD600 of 0.5. Motility was assessed by spotting 5 µl 
of each culture onto motility agar plates (containing Cm and IPTG where appropriate). 
Plates were incubated at 37°C overnight. 1, wild-type LF82; 2, LF82 (pCA24N-bdm); 3, LF82 
(pCA24N-osmC). The experiment was carried out in triplicate with similar results. A 
representative picture is shown. 
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6.3.5.6 Detection of a small RNA (sRNA) by Northern analysis 
Considering the recent identification of sRNA molecules which modulate motility in 
E. coli (De Lay & Gottesman, 2012; Thomason et al., 2012), it seemed possible that 
the motility defect we were observing in LF82 bdm::Km and LF82 (bdm-subclone) 
was due to the expression of a sRNA. To determine whether the transposon 
insertion induced the expression of a sRNA, Northern analysis was performed with 
a probe specific for the bdm-osmC IG region, plus flanking DNA (as outlined in 
Figure 6.13 A). Interestingly, results showed the presence of an extra band in both 
LF82 bdm::Km and LF82 (bdm-subclone) which was not present in the wild-type 
strain (indicated by an arrow in Figure 6.16 A). As outlined in Figure 6.13 A, this 
probe also covers the start of the flanking genes bdm and osmC, in addition to 
covering the IG region between these genes. Therefore, the 2 upper bands in Figure 
6.16 could be related to bdm and osmC. In an attempt to identify these bands, a 
duplicate gel was probed with a probe specific for the full osmC gene. As shown in 
Figure 6.16 B, the upper 2 bands seem to be specific for the osmC probe, indicating 
that bdm does not appear to be expressed under these experimental conditions. 
To conclude, this result indicates that the transposon may be activating a putative 
sRNA in LF82 bdm::Km, which is repressing motility in this strain.  
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Figure 6.16 The bdm::Km mutation results in the production of a putative sRNA. RNA was 
isolated from mid-exponential phase bacterial cultures and fractionated on 5% TBE-Urea 
polyacrylamide gels before transferring the fractionated RNA to a nylon membrane. 
Membranes were then probed with (A) a probe specific for the IG region between bdm and 
osmC (and parts of the flanking genes), as outlined in Figure A.13 A and (B) a probe specific 
for osmC. The experiment was carried out in triplicate with similar results. A representative 
image is shown. The arrow indicates the putative sRNA. 
 
6.3.5.7 Bioinformatic analysis of the bdm-osmC intergenic region 
As previously mentioned, although bdm::Km is non-motile, it still produces flagellin 
(Figure 6.9). This indicates that the potential sRNA regulation must be after flagella 
have been assembled. Although numerous sRNA’s have been identified in E. coli, 
there have been no published reports of a sRNA in the vicinity of bdm. However, 
nearly all sRNA studies have been done in the E. coli K-12 background. Therefore, it 
was of interest to compare the intergenic (IG) region (between bdm and osmC) of 
LF82 with that of other E. coli strains. MG1655 (a K-12 strain from the A 
phylogroup), S88 (a NMEC strain from the B2 phylogroup) and UMN026 (a UPEC 
strain from the D phylogroup) were chosen for this analysis. Nucleotide sequences 
for the IG regions were obtained from the NCBI database and subsequently aligned 
using the Clustal W multiple sequence alignment tool. The alignment report is 
shown in Figure 6.17, where any differences in the sequences are highlighted in 
red. A certain number of polymorphisms were unique to UMN026, and are 
highlighted in green. The results of this alignment show that this piece of DNA in 
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LF82 is 100% identical to that of S88, but only has a 93.9% identity to that of 
MG1655 and only a 90.99% identity to that of UMN026. LF82 and S88 are both 
members of the B2 phylogroup, suggesting that these polymorphisms could be 
specific to this group. Interestingly, all of the polymorphisms specific to LF82 and 
S88 (21 in total) were clustered within a 140 bp region of the sequence. In light of 
these differences, although a sRNA has not been identified in this region in K-12, it 
may be possible that there is a sRNA in this region in LF82. It is also interesting to 
note that there is a predicted ORF of 141bp in this IG region in several B2 E. coli 
strains, such as HM605, CFT073, UTI89 and IHE3034. Therefore, if this ORF encodes 
a functional protein, it is also a possibility that the transposon insertion in bdm::Km 
could be somehow affecting expression of this protein, resulting in the non-motile 
phenotype.  
Due to the differences in this nucleotide sequence between LF82 and S88, in 
comparison to both MG1655 and UMN026, we evaluated the polymorphic nature 
of the bdm-osmC IG region by constructing a phylogenetic tree with the nucleotide 
sequences of the bdm-osmC IG region from E. coli strains with sequenced genomes. 
Nucleotide sequences were obtained from the NCBI databases and phylogenetic 
analysis was performed on the Phylogeny.fr platform (http://www.phylogeny.fr), as 
described in Materials and Methods. The phylogenetic tree shows that there is a 
strong correlation between the sequence of the bdm-osmC IG region and 
phylogroup (Figure 6.18), suggesting that this region may be under some sort of 
selection pressure. All of the E. coli strains clustered within their respective 
phylogroups, except for IAI1 (a B1 strain) and ATCC_8739 (an A strain), which are 
indicated by green stars on the tree (Figure 6.18). LF82 clustered within a group 
that contained all of the B2 strains. This may suggest that this putative sRNA is 
specific for B2 strains of E. coli and may help to explain why the bdm-subclone did 
not affect motility when transformed into the K-12 strain MG1655, which is a 
member of the A phylogroup. It might also lead to the suggestion that the bdm-
osmC IG region from MG1655 might repress motility in MG1655. 
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UMN026    AGCGATTCTCCGTGTCTGTGTATTTTTGGTGTCTGCTACGGATCGCAGATATATAAAGCA 60 
MG1655    AGTGATTCTCCGTGTCTGTGTATTTATGGTGTCTGCTACGGATCGCAGATTTATAAAGCA 60 
LF82      AGTGATTCTCCGTGTCTGTGTATTTATGGTGTCTGCTACGGATCGCAGATTTATAAAGCA 60 
S88       AGTGATTCTCCGTGTCTGTGTATTTATGGTGTCTGCTACGGATCGCAGATTTATAAAGCA 60 
                 
 
UMN026    CATTCAGCATGGCAAATATTTGCCGCTTCGTTGTTAAGATTAGTCCTGGTTGATAATTTT 120 
MG1655    CATTCAGCATGGCAAATATTTGCCGCTTCGTTGTTAAGATTAGTCCTGGTTGATGATTTT 120 
LF82      CATTCAGCATGGCAAATATTTGCCGCTTCGTTGTTAAGATTAGTCCTGGTTGATGATTTT 120 
S88       CATTCAGCATGGCAAATATTTGCCGCTTCGTTGTTAAGATTAGTCCTGGTTGATGATTTT 120 
 
UMN026    TATATTATAACACCATGATATTCATAGGGATTGTAATTGGGGCGATCCGATTAATATTGA 180 
MG1655    TATATTTTAACACCATGATATTCATAGGGATTGTGATTGGTATGATCCGATTAATATTGA 180 
LF82      TATATTTTAACTCCATGATATTGATAGGTATTATTATTGTGATGAGTTGATTGATATTGA 180 
S88       TATATTTTAACTCCATGATATTGATAGGTATTATTATTGTGATGAGTTGATTGATATTGA 180 
 
UMN026    TACAATATCTTTTGGATTATATATTCCCCGTTATCTATTGTGGGAATTTAATTTAAGTAC 240 
MG1655    TACAATATCTTTTGGGTTATATATTCCCGGTAATCTATTGTGGGAATTTAATTTAAGTGC 240 
LF82      TGCAATATCTCTTGAGTTATATATTTCCGGTTATCTATTGTGGAAATTTAATTTAAGTGC 240 
S88       TGCAATATCTCTTGAGTTATATATTTCCGGTTATCTATTGTGGAAATTTAATTTAAGTGC 240 
                 
 
UMN026    AGAGATAATGTTTTCGCCGGATTTTATTCGGAATATCCTGCTTATCCTCGTGCGGTTTCT 300 
MG1655    AGAAGTAATATTTTCGCCGGATTTTATTCGGAATATCCTGCTTATCCTCGTGCTGTTTCT 300 
LF82      AGGAATTATATTTTCGCCGGATTTTATTCGGATTATCCTGCTTATCCTCGTGCTGTTTCT 300 
S88       AGGAATTATATTTTCGCCGGATTTTATTCGGATTATCCTGCTTATCCTCGTGCTGTTTCT 300 
                 
 
UMN026    CACGTAGTCTATAATTTCCTTTTTAAGCCCACAGGAGAGCAACA 344 
MG1655    CACGTAGTCTATAATTTCCTTTTTAAGCCCACAGGAGAGCAACA 344 
LF82      CACGTAGTCTATAATTTCCTTTTTAAGCCCACAGGAGAGCAACA 344 
S88       CACGTAGTCTATAATTTCCTTTTTAAGCCCACAGGAGAGCAACA 344 
                 
 
 
Figure 6.17 Clustal W alignment of the bdm-osmC intergenic region. Nucleotide sequences 
of the bdm-osmC intergenic region from the E. coli strains UMN026 (D phylogroup), 
MG1655 (A phylogroup) and S88 (B2 phylogroup) were compared to that of LF82 (B2 
phylogroup), using the Clustal W 2.1 Multiple Sequence Alignment tool 
(http://www.ebi.ac.uk). Differences are highlighted in red, with differences only found in 
UMN026 highlighted in green. 
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Figure 6.18 Phylogenetic tree of the bdm-osmC intergenic region in E. coli. A phylogenetic 
tree based on this DNA sequence from 36 sequenced E. coli strains was constructed using 
the PhyML program and displayed by the web service Phylogeny.fr 
(http://www.phylogeny.fr) using the “one click” mode, and was rooted to Escherichia 
fergusonni. PhyML was run with the aLRT statistical test of branch support and branch 
support values are indicated in red, next to each branch. The phylogroup of each strain is 
listed on the right. 
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6.4 Discussion 
Flagella are cell surface appendages expressed by many bacteria. Although they 
function primarily in locomotion, they are also important in the virulence of many 
pathogens, where they play roles in adhesion to, and invasion of, host cells, biofilm 
formation and elicitation of a host immune response. Although the role of flagella 
and flagella-mediated motility in the adhesion and invasion process of LF82 has 
been assessed previously, results were confounded by the finding that flagella 
mutants in LF82 are also defective in the production of type 1 fimbriae  (Barnich et 
al., 2003). Therefore, the initial aim of this chapter was to assess the role of flagella 
by themselves in the adhesion and invasion process of LF82, by identifying flagellar 
mutants that still express type 1 fimbriae. 
To achieve this aim, a random mutant library was constructed in LF82, by 
transposon mutagenesis. After screening approximately 4,000 mutants on motility 
agar, a total of 10 mutants were identified which exhibited defective motility. 
Arbitrarily primed PCR and bioinformatic analysis was used to determine the 
mutated gene in each mutant. Three mutants identified had transposons inserted in 
genes encoding structural subunits of the flagellum (fliI::Km, flgE::Km and flgJ::Km), 
one mutant had a transposon inserted in one of the flagellar master regulator 
genes (flhC::Km) and another mutant had a transposon inserted in the c-di-GMP 
phosphodiesterase encoding gene, yhjH, which affects the flagellar motor bias. The 
remaining mutants were involved in the chaperone-usher pathway, which is a 
pathway important for introducing disulfide bonds into newly synthesised proteins 
(dsbA::Km, dsbB::Km and ubiH::Km). The final mutant had a transposon inserted 
within the bdm gene. A link between Bdm and bacterial motility has not previously 
been established. 
Considering that it has been shown previously that motility and type 1 fimbriae are 
co-regulated in LF82 (Barnich et al., 2003), the next step was to determine if our 
identified motility mutants were expressing type 1 fimbriae. This was achieved 
through a mannose-sensitive yeast agglutination assay. Results showed that all of 
the motility mutants were type 1 fimbriae positive (with the exception of dsbA::Km, 
dsbB::Km and ubiH::Km, which are defective for type 1 fimbriae production due to 
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an inability of these mutants to form the disulfide bonds required for fimbriae 
biogenesis). It is interesting to note that the flagellar mutants obtained by Barnich 
et al. (2003) were transposon mutants and were type 1 fimbriae positive. When 
they constructed clean-deletions of the flagellar genes, the strains were no longer 
expressing type 1 fimbriae. When using the lambda red recombination method to 
construct deletion mutants, it is common practice to transduce the allele back into 
the wild-type strain, as residual lambda Red activity in the cell could induce 
mutations in the genome. However, Barnich et al., (2003) did not carry out this 
additional step, suggesting that the discrepancy between the two mutants could be 
due to possible Red-stimulated mutations in the clean deletion mutant. 
Alternatively, transposon mutants are known to exhibit polar effects, which can 
affect the expression of downstream genes. This could be another possible reason 
for the observed differences between the transposon and lambda red mutants. 
The downregulation of type 1 fimbriae synthesis caused by the absence of flagella 
in LF82 is the first report of the co-regulation of flagella and type 1 fimbriae 
(Barnich et al., 2003). However, it seems both counter-intuitive and energy costly 
for the bacterial cell to produce appendages required for sticking and swimming at 
the same time. Moreover, the reciprocal regulation of motility and type 1 fimbriae 
production has been well documented for numerous bacteria, including UPEC and 
the E. coli K-12 strain MG1655 (Lane et al., 2007b), Bordetella pertussis (Deora et 
al., 2001), Vibrio cholera (Gardel & Mekalanos, 1996), Salmonella (Clegg & Hughes, 
2002) and Proteus mirabilis (Li et al., 2001). 
However, this study showed that there does not appear to be a strong link between 
motility and type 1 fimbriae production, in contrast to what was previously 
described by Barnich et al., (2003). Using flhC::Km; which is non-motile, does not 
express flagellin and is positive for type 1 fimbriae expression; it was shown that 
flagella are required to allow LF82 to swim towards the epithelial monolayer. 
Flagella may also play a role in the physical attachment process, as when the 
adhesion assay was repeated with a centrifugation step in order to approximate 
bacteria and epithelial cells, the number of flhC::Km cells attaching was still 50% 
lower than that of the wild-type. Indeed, this has been documented for EPEC, STEC 
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and NMEC (Giron et al., 2002; Parthasarathy et al., 2007; Rogers et al., 2006). 
Moreover, LF82 mutants in flhD or fliA (expressing the fim operon to overcome the 
type 1 fimbriae defect) still exhibited an attachment defect, even when the 
attachment assay was carried out with a centrifugation step (Claret et al., 2007). In 
summary, flagella-mediated motility plays a role in the ability of LF82 to adhere to 
the epithelium via active motility and the flagellar filaments may also play a role in 
mediating the binding of LF82 to the epithelium.  
An interesting finding in this study was the non-motile phenotype of LF82 bdm::Km. 
Considering that Bdm has not been previously implicated in motility (despite a 
number of comprehensive genetic screens in E. coli) the nature of this phenotype 
warranted further investigation. Southern blotting confirmed the presence of a 
single copy of the transposon in the genome of LF82 bdm::Km, ruling out any 
possibility of a secondary insertion which could be affecting motility. A subcloning 
experiment (where the transposon and flanking DNA were cloned into the vector 
pBR322 and transformed into LF82) revealed that the motility phenotype 
associated with the bdm::Km mutation was dominant. This suggested that the 
transposon could be inducing the expression of a molecule, which is repressing 
motility. Indeed, Northern analysis revealed the presence of a possible sRNA that 
was expressed from both the bdm-subclone plasmid and the chromosomal 
bdm::Km mutation in LF82. The role of this sRNA (if any) in motility has still to be 
determined. However, it has recently been shown that motility in E. coli strain 
MG1655 is regulated at the post-transcriptional level by small non-coding RNA’s (De 
Lay & Gottesman, 2012). The group identified four sRNA’s (ArcZ, OmrA, OmrB and 
OxyS) which negatively regulated motility and flhDC expression and one sRNA 
(McaS) which positively regulated motility and flhDC expression. They also 
identified another sRNA (MicA) which positively regulated motility independently of 
flhDC. Interestingly, when the bdm-subclone was transformed into the E. coli K-12 
strain, MG1655, it did not affect motility; suggesting that the regulatory networks 
may be different in these strains. Moreover, Clustal W alignment of the IG regions 
between bdm and osmC showed that this region is identical in LF82 and S88, which 
is also of the B2 phylogroup, but differed considerably from the corresponding 
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region in the K-12 strain MG1655. Indeed, phylogenetic analysis showed that the 
sequence of this IG region is common among members of the B2 phylogroup. This 
suggests that this region may have evolved to enhance the fitness of B2 strains of E. 
coli. 
Expression of this putative sRNA in LF82 bdm::Km is presumably activated by the 
transposon, and hence, may not be physiologically relevant. However, it does not 
rule out the possibility that the sRNA may play a role in regulating motility in LF82 
under certain environmental conditions. Western blotting showed that expression 
of this putative sRNA does not appear to be affecting FliC production, therefore, it 
is not exerting its regulatory effects at the level of the flagellar master regulator, 
FlhDC. Rather, it would seem that the cells are just unable to use the flagella. 
Mutational analysis has revealed that mutants in fliG, fliM, fliN, motA or motB are 
non-motile, however they still assemble flagella (Macnab, 1992) and therefore still 
express flagellin. The flagellar motor is composed of two major components, the 
stator and the rotor. The stator is composed of the proteins MotA and MotB; while 
the rotor is composed of FliG. Together, the stator and the rotor are responsible for 
torque generation. The switch is composed of FliG, FliM and FliN, which functions in 
changing the direction of the motor between a CW and a CCW direction, which is 
essential for the movement of an organism (Macnab, 2003). Therefore, it could be 
possible that the putative sRNA in LF82 bdm::Km is inhibiting the normal 
expression/production of one of these proteins. 
The putative sRNA could also be affecting c-di-GMP signalling. c-di-GMP is a 
bacterial secondary messenger which controls lifestyle changes in bacteria. In 
particular, elevated levels of c-di-GMP are associated with a change from a motile 
lifestyle to a surface-attached lifestyle (Hengge, 2009; Romling & Simm, 2009). c-di-
GMP mainly exerts its regulatory affects at the level of flagellar gene expression, 
however, a recent paper describes how c-di-GMP can post-translationally regulate 
flagellar motility in E. coli, thus mediating this change from a motile to a non-motile 
state (Fang & Gomelsky, 2012). Specifically, the group show that elevated levels of 
c-di-GMP causes the c-di-GMP receptor protein YcgR to bind to FliG, a component 
of the flagellar switch complex. This binding biases flagellum rotation to a CCW 
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direction, meaning that the bacterial cells can only spin in one direction and 
therefore cannot move through semi-solid agar (Fang & Gomelsky, 2012). 
Additionally, it has been shown here that a mutation in LF82 of the c-di-GMP 
phosphodiesterase, yhjH, results in a non-motile phenotype. The motility defect of 
a yhjH mutant has previously been attributed to the fact that this mutant can only 
move in the CCW direction (Girgis et al., 2007). The function of YhjH is to promote 
motility by degrading c-di-GMP, which subsequently suppresses the activity of the 
motility effector protein, YcgR (Hengge, 2009). Therefore, targeting of YhjH by a 
sRNA may lead to a constitutive non-motile phenotype. 
Hfq is a sRNA-binding protein which functions as a global posttranscriptional 
regulator of gene expression by binding to sRNA molecules and facilitating their 
interaction with their target mRNA. Interestingly, it has previously been shown that 
LF82 virulence is dependent on Hfq (Simonsen et al., 2011). Specifically, Hfq was 
required for motility, stress tolerance, epithelial cell invasion, intramacrophagic 
replication and virulence in Caenorhabditis elegans (Simonsen et al., 2011). This, in 
addition to the findings presented here, may suggest that sRNA molecules may play 
an important role in the regulation of AIEC pathogenesis. However, further work is 
required to deduce the nature and precise mechanisms of action of this putative 
sRNA and the potential role it may play in the regulation of motility in LF82 and 
indeed in other strains in the B2 phylogroup. 
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Chapter 7: General Discussion 
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Overall, the results presented in this thesis highlight the important and 
fundamental role played by bacterial metabolism in supporting the intracellular 
lifestyle and virulence of HM605. Specifically, we have shown that the ability to 
metabolise hexose sugars is required to sustain HM605 during infection of 
macrophages. We have also established a link between HM605 and the 
inflammasome, a major driver of inflammation in mammals. In this way, we have 
shown that AIEC strains are more pro-inflammatory than non-AIEC strains. 
Moreover, and perhaps most importantly, we have shown that successful 
inflammasome activation by HM605 is dependent on an active bacterial 
metabolism, thereby potentially establishing the ability of HM605 to metabolise 
within the host as a key factor in the virulence of this organism.  
Several molecular studies have been carried out on the prototypical AIEC strain, 
LF82, and indeed a number of genes have been identified which are required for 
the ability of this strain to replicate in the phagosome of macrophages, such as 
dsbA and htrA (Bringer et al., 2005; Bringer et al., 2007). However, these genes are 
also present in the genomes of non-AIEC strains (which are unable to replicate 
within macrophages), and therefore do not represent virulence factors per se. 
Indeed, recent genomic studies have failed to identify any specific virulence genes 
associated with this group of bacteria (Clarke et al., 2011; Krause et al., 2010; 
Miquel et al., 2010; Nash et al., 2010). Therefore, it is emerging that AIEC are not 
pathogens in the traditional sense, but can be considered as pathobionts i.e. 
commensals in the healthy gut but opportunistic pathogens in a compromised gut, 
such as that of a CD patient. The findings of this study also support this hypothesis. 
In the absence of special pathogenicity genes, AIEC may solely rely on the most 
fundamental aspect of pathogenicity, that is, the ability to metabolise nutrients and 
hence grow within the host. Nutrition is fundamental to life and all organisms, 
including intracellular pathogens must metabolise available nutrients in order to 
generate the energy and metabolic intermediates required for growth and 
proliferation. Indeed, it is emerging that without adequate nutritional resources, 
pathogens do not cause disease. For example, it has been shown that S. 
Typhimurium requires glucose and glycolysis for replication within macrophages, 
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and indeed, mutants in this strain which are unable to transport and/or metabolise 
glucose are avirulent in a mouse model of infection (Bowden et al., 2009). This 
attenuated virulence may be related to a down-regulation in virulence factor 
expression, as presumably, pathogens need to be alive and metabolically active in 
order to express virulence genes. In this way, for traditional pathogens, intracellular 
metabolism and hence, growth, is a prerequisite to virulence. 
However, we have shown in this study that bacterial metabolism itself can 
constitute an intracellular signal which licences inflammasome activation by 
HM605, thereby providing a mechanism by which HM605 can induce an 
inflammatory response, and thus inflammation in the host. The idea that molecules 
associated with bacterial growth can activate an innate immune response has been 
alluded to in the literature. For example, it has been shown that the cyclic 
nucleotides c-di-AMP and c-di-GMP can be sensed within the cytosol of immune 
cells, resulting in the induction of an IFN-β response (McWhirter et al., 2009; 
Woodward et al., 2010). The ability of AIEC to activate the inflammasome to higher 
levels than non-AIEC strains is likely to have a significant impact on CD pathology 
and on the progression of the disease. As already discussed in Chapter 1 (Section 
1.9), the proposed model for the role of AIEC in the pathogenesis of CD is that they 
act as secondary invaders. The inflammatory conditions in the CD intestinal 
environment favour the expansion and invasion of AIEC, which are then taken up by 
macrophages in the lamina propria or in the underlying the Peyer’s patches. AIEC 
intramacrophagic replication and subsequent cytokine production then aggravates 
the inflammatory process, resulting in a positive feedback loop of invasion and 
inflammation. The findings presented in this thesis enhance our understanding of 
this process, as we have established the molecular mechanisms by which AIEC can 
induce an inflammatory response. Further work is required to establish the specific 
NLR protein engaged by HM605 and indeed the nature of the metabolic signal 
generated by HM605. However, future therapeutic strategies designed to disrupt 
the intracellular metabolism of AIEC or to target components of the inflammasome 
pathway, may be viable options for the treatment of CD. 
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In addition to any potential benefits in CD therapeutics, this work also has 
important implications in our fundamental understanding of the interactions 
between bacteria and the host innate immune system. The innate immune system 
generates a response to a bacterial infection by the recognition of MAMP’s by PRR’s 
(Ishii et al., 2008). However, MAMP’s are common to both pathogens and 
commensals. Therefore, a critical question in immunology is how the innate 
immune system can discriminate between a pathogenic organism and a non-
pathogenic organism and mount an appropriate response. It has been described 
that the innate immune response may be regulated in proportion to the level of 
threat it perceives, and this has been the subject of some recent excellent reviews 
(Blander & Sander, 2012; Vance et al., 2009). Some developments have been made 
in this area recently, where it has been shown that the NLRP3 inflammasome can 
distinguish between viable and dead bacteria by the detection of vita-PAMP’s 
(Sander et al., 2011). A vita-PAMP is a signature of microbial viability, which is 
absent from dead bacteria. Bacterial mRNA has been identified as such a vita-PAMP 
(which is not present in dead bacteria due to the inherent instability of this 
molecule) (Sander et al., 2011). Therefore, the sensing of bacterial mRNA allows the 
innate immune system to mount an appropriate response, which would not be 
warranted for dead bacteria. A common feature of pathogens is their ability to 
survive and multiply within host cells, and therefore it would be beneficial if the 
innate immune system could distinguish between a viable bacteria which grows (or 
even survives) intracellularly and a viable bacteria which does not survive 
intracellularly (Vance et al., 2009). Indeed, our findings suggest that the innate 
immune system may be capable of doing just that, by the sensing of metabolic 
signals. Therefore, bacterial metabolism may be used by the innate immune system 
as a means to identify bacteria that can survive (and therefore metabolise) in the 
macrophage.  
Many pathogens employ specific virulence mechanisms which target host cellular 
pathways in order to enhance nutrient availability to support their intracellular 
proliferation, a process which has been termed “nutritional virulence” (Abu Kwaik & 
Bumann, 2013). For example, it has been shown that Legionella pneumophila 
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injects a type IV secretion system (T4SS) effector protein, AnkB, into the host cell 
cytosol, which is then anchored to the lipid bilayer of the pathogen-containing 
vacuole (PCV), where this organism resides. AnkB serves as a platform for the 
assembly of polyubiquinated proteins, which are then targeted for degradation by 
the proteasome. This protein degradation generates elevated levels of cellular 
amino acids, which are transported into the PCV and thus serve as a source of 
carbon and energy for L. pneumophila (Price et al., 2011). It is quite possible that 
this concept of nutritional virulence could also be applied to AIEC. We have shown 
that like Salmonella, HM605 requires sugar metabolism in order to proliferate 
intracellularly. However, when glucose enters the mammalian cytosol, it is rapidly 
phosphorylated and degraded by host cell glycolysis, therefore the level of free 
glucose present in the cell at any given time is believed to be only in the 
submicromolar range (Fuchs et al., 2012; Gotz et al., 2010). Interestingly, enzymes 
involved in mammalian glycolysis has been identified as substrates of caspase-1 
(Shao et al., 2007). Specifically, biochemical studies showed that fructose 
bisphosphate aldolase, glyceraldehyde-3-phosphate dehydrogenase, enolase and 
pyruvate kinase can be cleaved by recombinant caspase-1. Cleavage resulted in the 
inactivation of enzymatic activity, suggesting that caspase-1 activation in vivo may 
downregulate eukaryotic glycolysis. Consistent with this, glycolysis enzymes were 
cleaved in wild-type macrophages infected with Salmonella, but not in caspase-1 
deficient cells (Shao et al., 2007). Therefore, it is possible that in HM605-infected 
macrophages, caspase-1 activation results in inhibition of eukaryotic glycolysis; 
which may in turn increase the intracellular levels of free glucose, which HM605 
may scavenge in order to replicate. Therefore, it is possible that for AIEC, and 
indeed for Salmonella, activation of caspase-1 may serve a dual purpose – the 
induction of inflammation and an increase in the intracellular pool of glucose, which 
may facilitate pathogen proliferation. 
Sugars (possibly glucose) appear to be important carbon sources for the 
intramacrophagic replication of HM605. Therefore, commensal E. coli, which 
contain all the genes necessary for sugar metabolism (Blattner et al., 1997), should 
in theory also be capable of using this sugar source to replicate intracellularly. 
264 
 
However, this is not the case. This may be simply due to an increased sensitivity of 
commensal E. coli strains to hostile conditions within the phagolysosome, 
therefore, they may be degraded before they have a chance to proliferate. 
Alternatively, this could be a consequence of the above-mentioned “nutritional 
virulence” i.e. we have shown that the laboratory E. coli strain MG1655 does not 
activate caspase-1 to the same extent as AIEC, therefore intracellular glucose may 
not be available to non-AIEC strains. It has been demonstrated that many 
pathogens have metabolic genes which are absent or non-functional in their non-
pathogenic counterparts, which may enhance their survival within new niches by 
allowing them to exploit available nutrient sources (Abu Kwaik & Bumann, 2013; 
Fuchs et al., 2012). For example, UPEC has the genes necessary to detoxify and 
catabolise D-serine, which are disrupted in MG1655 and EHEC, thereby providing a 
mechanism by which UPEC can survive and grow in urine (which is rich in D-serine) 
(Brzuszkiewicz et al., 2006; Roesch et al., 2003). Similarly, genes encoding 
deoxyribose utilisation are only found in pathogenic  E. coli strains, and are absent 
in MG1655, which may facilitate colonisation of the intestine by pathogenic E. coli 
(Bernier-Febreau et al., 2004). Interestingly, in this study we identified a mutant in 
HM605 in a gene encoding a putative PTS system enzyme IID and further inspection 
of this genomic region revealed that it is absent in MG1655. Although the 
consequences of this mutation on the ability of HM605 to replicate intracellulary 
were not analysed, it may indicate that AIEC have acquired metabolic  genes which 
facilitate their proliferation within host cells. Interestingly, EIEC utilise glucose to 
replicate in the host cell cytosol (Gotz et al., 2010), however, when a UPEC strain 
was directly microinjected into the host cell cytosol, it failed to replicate (Goetz et 
al., 2001). This provides further evidence that differences in the metabolic potential 
or indeed, perhaps differences in the affinity of metabolic enzymes/transporters 
may facilitate the adaptation of pathogens to their intracellular niche. Therefore, 
future studies should focus on genome comparisons between AIEC strains and 
commensal strains in order to identify genetic regions which may allow AIEC strains, 
but not commensal strains to proliferate within host cells. This may facilitate the 
design of therapeutics which specifically target the metabolism of AIEC but do not 
affect commensal strains. 
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In conclusion, the findings presented in this thesis support the hypothesis that AIEC 
are pathobionts. In the absence of specialised pathogenicity genes, AIEC may rely 
on their ability to metabolise and thus grow within host cells, to cause disease in 
the CD-intestine. Therefore, therapeutics which selectively target the metabolism 
of these pathobionts, or indeed target components of the inflammasome, may 
prove invaluable in the treatment of CD. 
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